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2 Letters 
It’s high time to fix 
the malpractice mess 
Your article "Showdown" in the 
Summer issue of Yale Medicine 
brings out the sorry state of 
affairs in the medicolegal cli¬ 
mate. When I began the practice 
of ob/gyn after World War II, 
my malpractice insurance was 
$25 a year. 
Albert W. Diddle, m.d. '56 
Knoxville, Tenn. 
The lucid comments about the 
malpractice situation and its 
aggravations were apt and 
helpful in understanding the 
dilemma. However they failed 
to mention one of the major 
causes of premium increases, 
which is the failure of state 
medical examiners boards to take 
steps to reduce the number of 
compensable medical errors. 
For some years the Public 
Citizen Health Research Group 
(pchrg) has closely followed 
malpractice suits decided in 
favor of the plaintiff. During the 
period 1990-2000, 5 percent 
of the doctors were responsible 
for the payouts in 54 percent 
of the suits. In other words, over 
half the cases of successful 
litigation were the fault of only 
5 percent of the practitioners. 
Overall, of the 35,000 doctors 
who had two or more payouts 
during that period, only 8 per¬ 
cent of them were disciplined 
by their state medical examiners 
board.The pchrg publishes 
these figures periodically, and 
they emphasize that doctors 
who are repeatedly found to be 
at fault are responsible for the 
Increasing costs of insurance for 
the rest of the profession. The 
conclusion is obvious; state 
boards should recognize that it 
is their duty to discipline the 
repeat offenders and with more 
than a tap on the wrist. 
Frederick W. Coodrich Jr, 
M.D., H5 49 
Medford, Ore. 
In reporting on the current medi¬ 
cal malpractice crisis, author 
Eli Kintisch characterizes it as a 
battle between doctors and 
lawyers. The cliche is catchy, but 
it is also misleading.Thousands 
of attorneys in this country, 
myself included, devote their pro¬ 
fessional careers to defending 
health care providers and hospi¬ 
tals in medical malpractice cases 
and advocating for tort reform 
measures that limit physician lia¬ 
bility. This is not a case of doctor 
versus lawyer; it is both broader 
and more refined than that. At 
best, the generalization oversim¬ 
plifies the nuances of the debate. 
At worst, it serves to perpetu¬ 
ate the misguided animosity that, 
sadly, polarizes the professions 
and leaves patients stranded 
somewhere in the middle. 
Ken Baum, M.D. ’01, J.D. 'oi 
New Haven 
More letters on this topic appear on 
our website, info.med.yale.edu/ymm. 
Knowing when not 
to retire 
As a “mature physician”of 65,1 
found that I disagree with a 
significant proportion of Herbert 
Kaufmann's essay [“Knowing 
When It’s Time to Quit,” Summer 
2003]. I am at the stage of my 
medical career where I am work¬ 
ing because of my joy in the 
practice of medicine and the feel¬ 
ing that I have something addi¬ 
tional to offer to my patients. 
This is true of many physicians in 
their prime, who have continued 
to expand their base of medical 
knowledge and perhaps are now 
more willing to listen. It would be 
a shame for the medical com¬ 
munity and for patients to lose 
such a valuable resource. 
When I lose the desire to 
continue to learn, lose the joy 
of going to my office and talk¬ 
ing with my patients, then I 
will move to another phase of 
my life, retirement. 
Mark W. Lischner, m.d. ’65 
Roseville, Calif 
To my former fellow, Herbert 
Kaufmann: I read your recent 
essay and was delighted at your 
eloquence if pained at your 
conclusion that doctors should 
retire. I am grateful as I approach 
80 that you left unspecified 
the age for desuetude. You 
condoned your own retirement 
by saying that aging doctors 
grow out of touch with junior 
colleagues who prefer their 
own peer group anyway, that 
older practitioners no longer 
understand the science in medi¬ 
cal journals and that—in your 
words—they grow irrelevant 
as far as their colleagues are 
concerned. 
I failed you as a teacher if 
you imagine that most of the 
people who come to see me 
require that I trace the twists 
and turns of amino acids. It may 
be fun to read the latest science, 
but little of that is required to 
care for patients in the office or 
clinic.There are nowhere near 
enough physicians, and we who 
are spared can make a contribu¬ 
tion by working part time in 
an office or clinic to let someone 
else bear the heavier burdens 
of the hospital. We need elderly 
doctors In our intensive care 
units, not taking care of patients 
and not, one hopes, lying in 
a bed, but as knowledgeable 
patient advocates wandering 
around the unit asking ques¬ 
tions about what is being done 
and why, and to what purpose. 
The intensive care unit might 
even be a place for elderly doc¬ 
tors to talk to the families of 
the patients being taken care 
of by younger experts. 
There is much good also to 
be said for the viewpoint of the 
old, who have had experience 
and now have the leisure for 
contemplation. It takes staying 
power, iron pants and stamina— 
and a willingness, no an eager¬ 
ness, to accept a changed role. 
People may think that you are 
irrelevant, but as long as you are 
convinced that you are not, you 
have something to say to them. 
Howard M. Spiro, M.D. 
Professor emeritus of medicine 
New Haven 
The letter above is excerpted from a 
longer essay by Howard Spiro that 
appears in full on the letters page of 
our website, info.med.yale.edu/ymm. 
Dear Herbert: I am responding 
to your essay and Howard 
Spiro’s response. You eloquently 
describe how, as we get older, 
our relationship with our 
medical community changes— 
a discomfort and reality all 
physicians must experience. At 
some point in time, I agree, it 
would be wise to retire. At what 
point in time this happens will 
depend on the individual. 
Change in life is inevitable 
and we all respond differently. 
Your response, seemingly, was to 
retire; Howard’s was to adapt to 
it by accepting a "changed role”; 
and mine was to create a new 
career. I also retired three years 
ago, and although I loved the 
medical community that I left 
behind, I decided to enter a 
new field and way of life. I have 
been auditing courses at the 
Yale School of Forestry and Envi¬ 
ronmental Studies and am 
volunteering as a stewardship 
coordinator for a land trust. 
Like Howard, I have a new niche, 
friends and colleagues, and I am 
enjoying my new life immensely. 
I would like to believe retire¬ 
ment is a beautiful phase of 
life when a physician becomes 
free from the restrictions of a 
lifelong medical career.The time 
that decision is made and the 
life that is subsequently chosen 
will depend on one’s attitude, 
desires, ambition and health, not 
age. The three of us have made 
our choices. 
Vincent A. DeLuca Jr, m.d. 
Clinical professor of medicine 
(retired) 
Branford, Conn. 
Herbert Kaufmann’s article was 
Interesting and useful. I retired 
at 70 to run a vineyard and win- 
From the Editor 
ery. My experience is described 
in a chapter in a book called 
Doctors Afield, published by Yale 
University Press in 1999. 
In my time at the School of 
Medicine, there were a number 
of optional courses. Are those 
still offered? If so, I would sug¬ 
gest an elective on retirement. 
Young people entering medicine 
often have a narrow view of 
the world. Retirement is cer¬ 
tainly not what they are think¬ 
ing about. When I retired from 
psychiatry and psychoanalysis, 
I was struck by how many of 
my colleagues hung on way past 
the time when they should have 
quit. They had nothing else to 
do. Some planning earlier in life 
would have served them well. 
George W. Naumburg Jr., M.D. ’45 
North Salem, N.Y. 
Thanks for the news 
from Cedar Street 
Again I am awed by this spec¬ 
tacular publication you have 
crafted with its singular breadth 
and depth, sensitivity and his¬ 
torical continuity. Yale Medicine 
is one of many publications 
I receive but the only one 
I devour from cover to cover. 
Congratulations and thanks for 
an outstanding contribution to 
generations of Yale physicians. 
Glenn L. Kelly, M.D. ’62, HS '66 
Englewood, Colo. 
The things that matter 
As one can see from these pages, our mailbag has been 
bursting lately. Some of the letters affirm an idea expressed 
in Yale Medicine, while others offer a wholly different per¬ 
spective. I hope this means we’re covering topics of impor¬ 
tance to readers and presenting a diversity of views on 
questions that are too complex to have simple answers. Just 
as the university thrives on the exchange of ideas, so does 
this magazine. 
The topics in the Summer issue that drew the greatest 
response were physician retirement and the malpractice 
insurance debate. Alumnus Herbert Kaufmanris article on 
why he decided to retire while still in his prime (“Know¬ 
ing When It’s Time to Quit”) was unsolicited but perfect for 
the Essay section. For our feature on the malpractice debate 
(“Showdown”), we did ask readers for their opinions and 
received a great number in reply. The letters are still coming. 
Next we’re turning our focus to bioethics, a growth 
area in science and medicine if ever there was one—and an 
area of increasing strength at Yale. For our Spring issue, 
we’d like to hear from you about the ethical dilemmas you 
have faced in your professional life. We will then pose the 
thorniest of these problems to a panel of bioethics experts 
from the Yale faculty. Please send your story to: Ethics, 
Yale Medicine, P.O. Box 7612, New Haven, CT 06519-0612 
or by e-mail to ymm@yale.edu. We’ll publish a selection of 
dilemmas, along with responses from our resident experts, 
in Yale Medicine and on our website, info.med.yale.edu/ymm. 
And since it is next to impossible to find universal agree¬ 
ment on the things that really matter, expect to see more 
letters to the editor. 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters to the editor and news 
items to Yale Medicine, P.O. Box 
7612, New Haven, CT 06519- 
0612, or via electronic mail 
to ymm@yale.edu, and include 
a daytime telephone number. 
Submissions may be edited for 
length, style and content. 
VISIT US ON THE WEB 
info.med.yale.edu/ymm 
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4 chronicle news from cedar street 
In the dean’s office, 
it takes a brain surgeon 
Running the med school is a complex 
task, which may be why Yale tapped 
Dennis Spencer as interim dean. 
On a Monday afternoon in late June, 
close to a hundred senior faculty 
members filled the Historical Library 
to witness a changing of the guard. 
Then-Dean David A. Kessler, m.d., was 
about to announce his departure for 
the University of California, San Fran¬ 
cisco, where he had been named vice 
chancellor for medical affairs and dean 
of the school of medicine. Standing 
next to Yale President Richard C. 
Levin was a tall, bespectacled man 
in a dark suit and white beard who 
has a passion for cultivating water 
lilies and has been sighted more 
than once on Cedar Street astride a 
Harley-Davidson. 
“You may be asking yourself, as 
I did, ‘Why Spencer.^’” the new 
interim dean, neurosurgeon Dennis 
D. Spencer, m.d., hs ’77, said a few 
minutes later, evoking a laugh from 
the crowd. Looking at Levin, he went 
on: “He chose a surgeon, and so 1 
thought maybe he wants quick deci¬ 
sions. So I’ve made two already. 
First I will decree that the first floor 
of the Air Rights Garage will be 
reserved for the exclusive use of motor¬ 
cycles. Second, I have just decided 
that the third-year medical students 
will now be required to do a three- 
month rotation in neurosurgery.” 
The room erupted in laughter and 
thus Spencer took the helm—at least 
for a time—of the medical school 
where he began his career in 1972 as 
the allocation of laboratory and office 
space that becomes available as more 
than 700 investigators move into the 
Anlyan Center for Medical Research 
and Education. He said that Kessler’s 
“outstanding recruitments over the last 
few years” of senior faculty members 
have equipped the school with “an 
excellent complement in faculty leader¬ 
ship right now. ... At this stage we’re 
focusing on mid-level positions—some 
senior, some junior, too, but primarily 
mid-level positions that have been 
created in the process of bringing in 
new department chairs.” 
Spencer also noted President Levin’s 
announcement on June 23 of a S50 
million matching endowment fund for 
the medical school. “This promise is 
very real, and it’s going to be the top 
thing on our agenda,” Spencer said. 
A graduate of Grinnell College and 
Washington University School of 
Among the priorities demanding the atten¬ 
tion of the new interim dean, Dennis Spencer, 
are faculty recruitment, fund-raising and the 
allocation of space. 
I 
i 
a resident. The moment summed up 
much about the person who has led 
neurosurgery since 1987, building the 
section into a free-standing depart¬ 
ment in 1997 and serving as its chair: 
people notice him. they listen and they 
seem to enjoy the experience. “He’s 
the quintessential neurosurgeon and a 
wonderful exemplar of the physician- 
scientist," said Carolyn W. Slayman, 
PH.D.. deputy dean for academic and 
scientific affairs and Sterling Professor 
of Genetics. 
Spencer himself sees the post as 
an opportunity to keep the school on a 
steady course during a time of transi¬ 
tion, and to move it ahead in certain 
critical areas pending the appointment 
of a permanent successor to Kessler, 
who came to Yale as dean in 1997. 
In July, Spencer said that his initial 
areas of focus would be faculty recruit¬ 
ment, fund-raising and shepherding 
BEAUMONT ROOM 
BiirCB 
5 
Medicine in St. Louis, Spencer came to 
Yale in 1972 as a resident in the Sec¬ 
tion of Neurosurgery. He served as 
chief resident, then joined the faculty 
as an assistant professor in 1977. 
Over the next 25 years, working with 
colleagues including his wife, Susan S. 
Spencer, m.d., fw ’78, a Yale neurolo¬ 
gist and past president of the Ameri¬ 
can Epilepsy Society, he developed new 
approaches to the surgical treatment 
of epilepsy and new models for under¬ 
standing the biochemical and physio¬ 
logical mechanisms of the disease. 
In a September e-mail message to 
faculty. Levin announced the forma¬ 
tion of a 15-member advisory commit- 
! tee to assist him in the selection of 
the next dean. “The committee’s first 
task will be to assist me in evaluating 
the 41 candidates who have been 
■ identified by nominations and in my 
■ conversations with the department 
chairs and other leaders of the School,” 
he wrote. “If a wider search is under¬ 
taken, I will seek the committee’s 
advice on how to proceed.” 
In the interview, Spencer said he 
had not decided “whether to think 
about [the deanship] as a full-time 
position” and is focusing his attention 
on the tasks before him. He has 
appointed Joseph M. Piepmeier, m.d., 
HS ’82, as the interim chair of the 
Department of Neurosurgery and cut 
back his time in the operating room 
and clinic. 
“My role is to keep things moving 
forward, and if Rick Levin thought 
that was important and that I was the 
right person to try to do that. I’m 
happy to do it, however long it takes,” 
Spencer said. 
Levin praised Kessler for “six years 
of accomplishment and real advances 
for the school,” notably the completion 
of the Anlyan Center and the recruit¬ 
ment of more than a dozen department 
chairs and program leaders. “This is a 
moment of sadness but also excitement 
as he takes on what is a tremendous 
new challenge,” Levin said. 
—Michael Fitzsousa 
A security review drags on, 
devastating a scientist and 
derailing cutting-edge work 
As a scientist, Heng Zhu, ph.d., is 
used to dead ends, setbacks and road¬ 
blocks. But nothing prepared him 
for the obstacles he would encounter 
this past year when he tried to renew 
his expired visa and continue work¬ 
ing as a postdoctoral fellow in the 
Department of Molecular, Cellular, 
and Developmental Biology. 
“It screwed up my life totally,” said 
Zhu. “I wasn’t able to work for a 
year, and I lost my fellowship.” With¬ 
out an income, Zhu also lost his apart¬ 
ment and car, and his credit rating 
was ruined. Because he was stranded 
in China for months, he and his 
fiancee broke up. 
Zhu’s troubles began in March 
2002, when he realized he had let his 
work visa expire. Returning to his 
native China to renew it, he wound up 
languishing in Beijing for a year 
while the State Department did a secu¬ 
rity review. He was finally allowed to 
re-enter the United States in mid-April 
of this year. 
Zhu, 35, became mired in the quick¬ 
sand of heightened security meas¬ 
ures implemented after the September 
II terrorist attacks. His case drew 
national attention, in part because his 
delay was longer than most, but also 
because his work is groundbreaking 
and well-known. 
“He invented a whole new tech¬ 
nology that has enormous value 
for understanding basic biological 
processes,” said Michael Snyder, 
PH.D., chair of Zhu’s department. 
Snyder said Zhu developed a method 
to study the function of all 6,300 
proteins encoded in the yeast 
genome. Zhu’s work, likely to aid 
drug discovery efforts, yielded a 
$1.5 million grant from the National 
Institutes of Health. 
When Zhu got stranded in China, 
Snyder and others circulated a peti¬ 
tion, wrote to congressional represen¬ 
“Basically, I lost everything here,” scientist 
Heng Zhu said of his year in diplomatic limbo. 
tatives and called the State Department, 
all to no avail. The State Department 
doesn’t respond to questions about par¬ 
ticular cases, said Bureau of Consular 
Affairs spokesperson Stuart Patt. 
At Yale Zhu is not alone. Accord¬ 
ing to Ann Kuhlman, director of the 
Office of International Students and 
Scholars, about 20 foreign under¬ 
graduates, graduate students, postdocs 
and faculty members experienced 
visa delays during the 2002-03 aca¬ 
demic year. 
Zhu finally renewed his visa and 
returned to New Haven—but not for 
long. Late in the summer, as his post¬ 
doctoral position at Yale came to an 
end, he accepted a faculty position at 
Johns Hopkins. 
Although he’s back in the United 
States and his career is back on track, 
Zhu will never recover the time he lost 
at Yale. “I can’t turn back the clock— 
that’s the bottom line—which is a loss 
to Yale and the United States as well as 
to me.” 
—Jennifer Kaylin 
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chronicle 
Neuropeptide’s presence 
in high levels suggests soldiers 
are born, not made 
Contrary to the image of hardened 
drill sergeants molding untrained 
youths into skilled fighting machines, 
a Yale psychiatrist suspects that 
some soldiers may be born that way. 
Charles A. Morgan III, m.d., 
associate professor of psychiatry, stud¬ 
ied troops taking a rigorous survival 
course at Ft. Bragg, N.C., home to the 
XVIII Airborne Corps, to see whether 
some handled stress better than others. 
Working with researchers from the 
base, he found that the Army Special 
Forces, also known as Green Berets, 
consistently outperformed the other 
soldiers. When he looked at the levels 
of neuropeptide Y, a brain chemical 
that is linked to stress, he noticed that 
the Berets released higher levels dur¬ 
ing periods of stress and then returned 
to baseline more quickly once the 
stress was removed. 
“As a group, the Special Forces 
were releasing so much more, we could 
identify who was in that unit just by 
looking at the numbers,” Morgan said. 
“The more neuropeptide Y they were 
releasing during stress, the fewer 
symptoms of confusion or mental dis¬ 
connection during stress were reported.” 
During their training, soldiers are 
deprived of food and sleep, pursued 
through rough terrain by other soldiers 
Special Forces troops, such as these searching a 
home in Afghanistan, release higher levels of 
neuropeptide Y, which helps them deal with stress. 
acting as the etremy and, if “captured,” 
subjected to interrogation. 
Morgan has published his research 
in several journals, most recently 
last year in Biological Psychiatry. But as 
soldiers prepared to go to war in Iraq 
in the spring, Morgan’s studies drew 
attention from the national press. 
He says the question raised by his 
findings is whether the Special Forces 
soldiers have always released higher 
levels of the chemical or whether their 
training somehow enhanced their 
ability to do so. “I don’t think that’s 
likely. I think those guys are just differ¬ 
ent,” Morgan said, “but we’re still test¬ 
ing that hypothesis.” 
Morgan’s findings could help the 
Army select the most likely candidates 
for dangerous duty, but there are also 
civilian applications. “Because we found 
that neuropeptide Y is low in people 
with anxiety disorders and depression, 
this raises the possibility of new ways 
of treating them. One might expect 
that pharmacologic agents that act as 
agonists at the npy-i receptor might 
diminish anxiety,” he said. 
Morgan is now looking at ways to 
help soldiers bounce back from stress¬ 
ful situations more quickly and man¬ 
age stress more effectively so they don’t 
make costly—or deadly—mistakes. 
—Jennifer Kaylin 
WARSHAW RETURNS FOR SYMPOSIUM 
For the second year, Joseph B. Warshaw, m.d., former deputy 
dean and chair of pediatrics, visited Yale from his post as dean of 
the University of Vermont College of Medicine. Eight scientists 
from around the country came to Yale in March to discuss the car¬ 
diovascular system at the Joseph B. Warshaw Symposium on 
Developmental Biology. Clifford W. Bogue, m.d., hs ’90, fw ’93, 
chief of the pediatric intensive care unit, welcomed Warshaw, 
describing him as a “leader in pediatrics throughout his career,” 
with a strong interest in nurturing pediatric scientists. 
Keep religion out of stem cel! 
research, Reeve urges medical 
school audience 
Social and religious conservatives have 
robbed American scientists of their 
chance to play a leading role in the prom¬ 
ising field of stem ceU research, actor 
and writer Christopher Reeve said dur¬ 
ing a visit to the medical school in April. 
“We’re giving away our pre-eminence in 
science and medicine,” he said. “We’re 
going to lose incredibly valuable time. 
“When matters of public policy are 
being decided, no religion should 
have a seat at the table—that is what is 
provided for in the Constitution,” 
Reeve said. Yet religious conservatives, 
including the Pope, he said, “have 
an undue influence in the debate.” 
Because of their plasticity—their 
ability to differentiate into any cell in 
the human body—stem cells “have 
! unlimited potential to cure disease,” 
j Reeve told the crowd that filled the audi- 
In a talk sponsored by the Yale Stem Cell 
ii Interest Group, actor Christopher Reeve said 
' science, not religion, should drive the debate 
over stem cell research. 
I 
torium of the Anylan Center for Medi¬ 
cal Research and Education. Reeve also 
hopes that stem cell research will lead 
to a cure for paralysis such as his, the 
result of a 1995 riding accident. 
In a talk sponsored by the Yale 
Stem Cell Interest Group, Reeve criti- 
I dzed President Bush’s order of August 
! 9, 2001, restricting federal funding 
for embryonic stem cell research to 
only 64 extant cell lines. (Last May, 
National Institutes of Health Director 
Elias A. Zerhouni, m.d., acknowledged 
that only ii of those lines were eligi¬ 
ble for federal research funds.) Reeve 
suggested that the decision made no 
ethical sense in light of Bush’s objec¬ 
tion to using embryos for research. 
“Those lines were derived from left¬ 
over embryos from infertility clinics. 
Did he suddenly develop a new moral¬ 
ity effective August loth?” 
Reeve noted that, although typically 
about a third of embryos are discarded 
as medical waste, even vocal oppo¬ 
nents of using embryos for research 
have never suggested banning in vitro 
fertilization. “They know very well that 
you can’t go to a couple and say, ‘You 
can’t have a child this way.’” 
President Bush has followed his 
ruling on stem cells with a call for a 
ban on all forms of human cloning, 
whether therapeutic or reproductive. 
Reeve made a distinction between 
reproductive cloning of human beings 
(which “sounds like Frankenstein’s 
work,” and which he opposes) and 
cloning stem cells from embryos and 
adult tissues for research. Reeve 
rejected the implication “that science 
has no ethics and that it will run ram¬ 
pant if religion and conservative ideol¬ 
ogies aren’t brought into the picture.” 
He called stem cell research “the 
future of science.” “There’s going to be 
a seismic shift,” Reeve told an audi¬ 
ence composed largely of medical and 
doctoral students, “and you will ride 
the wave into an era when stem cells 
will be able to aid millions of people.” 
He urged the audience to “make it 
happen here,” but advised young scien¬ 
tists to leave the United States and 
pursue the research elsewhere, if nec¬ 
essary. “It’s a big world. ... If you really 
want to heal people, you go where the 
work is being done. 
“Even though I sit here in a wheel¬ 
chair, frustrated by today’s public poli¬ 
cy, I’m very hopeful about tomorrow 
and what will be achieved,” Reeve said. 
“And so, go do it.” 
—Cathy Shufro 
UNIVERSITY, UNIONS SETTLE CONTRACT 
The university and two unions representing 
4,000 workers reached an agreement in 
September to end a three-and-a-half-week 
strike, the ninth on the campus in 35 years 
including a week-long job action in March. 
The agreement resulted in unprece¬ 
dented eight-year contracts with Locals 34 
and 35 of the Hotel Employees and Restaurant 
Employees International Union. President 
Richard C. Levin and the union’s national 
president, 1967 Yale College alumnus John W. 
Wilhelm, reached the accord on September 
18 in a bargaining session mediated by New 
Haven Mayor John DeStefano Jr. 
Members of Local 34, which represents 
clerical and technical workers, and Local 35, 
representing service and maintenance 
employees, had walked off their jobs on 
August 27 over pay and pension issues. 
The new contract, which is retroactive to 
January 2002, increases pension benefits 
and will boost the pay of workers in 
Local 34 by 43 percent by 2009. For Local 35 
employees, the total increase will be 32 
percent. All workers will receive a signing 
bonus equal to two-thirds of the wage 
increase since January 2002. 
—Jennifer Kaylin 
SPELLBOUND BY SPELLING 
Don’t count on keeping up with the competi¬ 
tors in Spellbound, the Oscar-nominated docu¬ 
mentary about the 1999 National Spelling Bee. 
But if you see the movie, you may spot three 
members of the medical school community. 
They include Suzanne P. Lagarde, m.d., hs 
’77, FW ’80, assistant clinical professor of medi¬ 
cine, and David Stagg, ph.d., research scientist 
in pharmacology, parents of Emily Stagg, one 
of eight children profiled in the film. Emily’s 
participation introduced Lagarde and Stagg 
to the spelling bee subculture, in which the 
Paideia, a collection of spelling bee words, is 
considered the Bible. Emily’s strategy was to 
learn roots from four languages. 
Eighth-grader Emily was one of 250 final¬ 
ists from a field of 9 million competitors. So 
how did she do? See the film, with its cameo 
of the 1971 champion, Jonathan P.S. Knisely, 
M.D., associate professor of therapeutic radi¬ 
ology. His winning word: “shalloon.” 
—Cathy Shufro 
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8 Rounds MEDICINE AND HEALTH AT YALE 
Lisa Suter, a resident in the Clinical Scholars 
Program, raises a question during a classroom 
session on medical statistics. 
Thinking nationally, 
acting locally 
A reconfigured Clinical Scholars 
Program looks to strengthen 
partnerships with the community. 
In 1973 Yale was one of the founding 
sites for the Robert Wood Johnson 
Foundation’s (rwjf) Clinical Scholars 
Program, a two-year fellowship with 
rigorous methodological training, a 
strong mentoring component and 
work in disciplines such as clinical epi¬ 
demiology and health policy. The pro¬ 
gram teaches research skills, health 
policy, leadership, media/communica- 
tion skills and community health. 
Founded under the direction of the late 
Alvan R. Feinstein, m.d., hs ’54, the 
program has seen more than 100 
physicians complete research projects. 
In 1995, when Yale’s participation 
in the national program received a 10- 
year renewal, there was change in the 
air at the rwjf. Four sites remained in 
the program and three new sites were 
added. “We knew for some time that 
there would be a new competition 
at the end of that funding cycle,” said 
Harlan M. Krumholz, m.d., director 
of the program at Yale. 
Early in 2002, the rwjf announced 
how the program would change— 
although about the same number of 
scholars would receive training, the num¬ 
ber of participahng institutions would 
drop from seven to four in 2005. Other 
programs offered similar training, and 
the foundation decided to emphasize 
community-based research by scholars. 
Yale applied for a renewed grant in 
the new program. 
The application process came at a 
difficult time for Yale. Feinstein, who 
had served as director or co-director 
until 1997 when he became director 
emeritus, had recently died. And 
shortly after the application process, 
the program’s co-director and chair 
of internal medicine, Ralph I. Horwitz, 
M.D., FW ’77, a former clinical scholar 
himself, announced he would leave 
Yale to become dean of the medical 
school at Case Western Reserve Uni¬ 
versity in Ohio. “'The program owes a 
great debt to Alvan and Ralph,” Krum¬ 
holz said. “Fortunately it had already 
undergone a transition in leadership at 
the time of the application. Alvan and 
Ralph were instrumental in setting up 
the program for the future and ensur¬ 
ing its future success. The dean also 
played a critical role in demonstrating 
Yale’s commitment to the program.” 
RESIDENTS HOLD THEIR OWN RESEARCH DAY 
For a couple of hours on May 29, the FItkin Amphitheater resem¬ 
bled the Hope Building on Student Research Day—with physicians 
clustered around posters as younger doctors explained their 
research. The event was the first Research in Residency Day, which 
the Department of internal Medicine intends to make an annual 
event. Four students presented posters and two others made 
oral presentations. Topics included cholesterol transport mecha¬ 
nisms, myocardial infarctions among the elderly and risk factors 
for heart disease in postmenopausal women. 
—John Curtis 
New center opens with goal 
of streamlining treatment for 
women with breast cancer 
9 
In April the rwjf announced that 
Yale would be one of the four sites— 
along with medical schools at ucla, the 
University of Michigan and the Univer¬ 
sity of Pennsylvania—in the program’s 
new configuration. Annie Lea Shuster, 
the rwjf’s national program director, 
said that the foundation was looking for 
institutions that had a curriculum 
designed specifically for clinical scholars 
and the ability to do research based 
in the local community. Yale had both. 
“This emphasis on participatory 
community-based research distinguishes 
our program,” said Shuster. “There has to 
be a lot of planning and work in establish¬ 
ing relationships with the community.” 
Much of that effort was already 
under way at Yale. Then-Dean David A. 
Kessler, m.d., established the Office of 
Community-Based Research to provide 
clinical scholars with opportunities to 
participate in projects with community 
organizations and Yale faculty. Krumholz 
hopes that the new office will help unify 
“a great fragmentation of effort” by coor¬ 
dinating the school’s myriad projects 
in New Haven. 
The RWJF is also requiring participat¬ 
ing programs to provide a self-contained 
curriculum specifically designed for 
the clinical scholars, rather than send 
scholars elsewhere within the univer¬ 
sity for course work. Both Krumholz and 
Shuster noted that Feinstein had been 
adamant about doing just that. “He 
always thought that the Clinical Scholars 
Program should be a real center of grav¬ 
ity, not just an administration office. So 
from the outset, we have taken on the 
commitment to develop a program that 
is most likely to foster the professional 
growth of each scholar,” said Krumholz. 
—Colleen Shaddox 
Breast cancer is one of those frighten¬ 
ing diseases that inspires races, rib¬ 
bons and celebrity support for those 
fighting it. Now, a consortium of New 
Haven health care providers is doing 
its part by offering a user-friendly place 
where women needing breast care can 
come for confidential medical and 
emotional treatment. 
The Yale-New Haven Breast Center, 
composed of staff from Yale-New 
Haven Hospital, the Yale Cancer Cen¬ 
ter and the Yale Medical Group, 
promises convenient appointments, 
rapid diagnoses and same-day pro¬ 
cedures all under one roof. The center, 
at 800 Howard Avenue, opened 
this fall. 
“We want to make it an easy and 
good experience," said Donald R. 
Lannin, m.d., the center’s executive 
director. “It can sometimes take 
weeks to get answers; our goal is to 
coordinate specialties so we can 
expedite the diagnosis and start pro¬ 
viding care quickly.” 
Lannin said the center was a 
response to women’s frustration with 
being shunted from one building and 
one specialist to the next in pursuit of 
answers and treatment. He said the 
new center represents the rejuvenation 
of a program that has long been recog¬ 
nized as a leader in breast cancer 
research and treatment but which had 
outgrown its space and equipment. 
The new center will consolidate 
breast care specialties with surgery and 
diagnostic imaging on the lower level 
and oncology on the second floor. The 
center will also provide counseling for 
patients and educational programs 
for physicians, patients and the public. 
“A woman who is diagnosed with 
breast cancer has all sorts of worries,” 
he said. “There are a lot of emotional 
overtones, and we have to be sensitive 
to that as well.” 
—Jennifer Kaylin 
FENDING OFF DELIRIUM 
Taking daily walks and talking about current 
events can lower the risk of delirium in the 
elderly, according to a study published April 
25 in Archives of Internal Medicine. What’s 
more, sticking to a regimen of such activities 
appears to be as important as taking one’s 
pills on time. 
“It has been well-established that com¬ 
pliance with drug treatments is very impor¬ 
tant for their effectiveness, but the effect 
of compliance with non-drug treatments has 
not been studied before this report,” said 
Sharon K. Inouye, m.d., m.p.h. ’89, professor 
of medicine and geriatrics. “It really does 
lend credence to the fact that the amount of 
nonpharmacologic therapy patients receive 
is just as important as drug therapy, where 
a dose-response relationship is expected.” 
Patients ages 70 or older who complied 
with the intervention, which also included 
word games, fluids for rehydration and 
improvements in sleep, vision and hearing, 
showed an 89 percent reduction in delir¬ 
ium risk. 
—John Curtis 
CARBS? IT’S CALORIES THAT COUNT 
Researchers at Yale and Stanford have con¬ 
cluded that cutting out potatoes, pasta 
and bread doesn’t necessarily translate into 
greater weight loss than high-carbohydrate 
diets. At least there’s little published 
evidence to support the theory behind the 
Atkins and other low-carb diets, they 
reported this spring. “We found that calorie 
content and how long you’re on the diet 
are the factors that predict weight loss, and 
not carbohydrate content,” said Dawn M. 
Bravata, m.d., assistant professor of medi¬ 
cine and a co-author of the study. (The 
lead author was Bravata’s twin sister, Dena 
Bravata, m.d., who’s at Stanford.) 
The study, published in JAMA: The Journal 
of the American Medical Association in April, 
examined past research to gauge the effect 
of cutting back on starch. “The medical 
literature is lacking studies about the long¬ 
term safety and efficacy of low-carbohydrate 
diets,” Dawn Bravata said. “We need these 
kinds of studies in order to counsel patients 
who want to lose weight.” 
—John Curtis 
Chimeric “icon” 
finds another target 
A molecule effective against 
tumors may also be relevant to 
macular degeneration. 
A versatile molecule developed at Yale, 
already shown to destroy blood ves¬ 
sels in tumors, now shows promise 
for arresting macular degeneration, 
a leading cause of vision loss in the 
United States. 
Known as an icon—short for 
immunoconjugate—the chimeric mole¬ 
cule is made, using recombinant dna 
technology, from part of an antibody 
and a molecule that targets abnormal 
blood vessels. “We describe it as a syn¬ 
thetic antibody, because it really func¬ 
tions as an antibody, but its targeting 
mechanism is different,” said Alan 
Garen, ph.d., professor of molecular 
biophysics and biochemistry. Garen 
used as a model an anhbody found in 
camels, because it is more suitable for 
manipulation by recombinant technol¬ 
ogy than human antibodies. The target¬ 
ing portion, fVlI, draws the molecule 
tightly and specifically to the abnormal 
vessel; then the anhbody portion acti¬ 
vates an immune attack, destroying the 
vessel. An important feature of the icon 
is its flexible design that can generate 
an all-human molecule for clinical use. 
The icon’s targeting mechanism 
ignores normal blood vessels and 
zeroes in on tissue factor (TF), a pro¬ 
tein produced on the inner wall of 
abnormal but not of normal vessels. 
'The same search-and-destroy strat¬ 
egy works against tumors by destroying 
the blood vessels that nourish them, 
while leaving normal tissue unharmed. 
“The pleasing result is that the same 
mechanism can apply to two very dif¬ 
ferent medical problems: cancer and 
macular degeneration. What links them 
are the unique properties of the blood 
vessels that are involved in both dis¬ 
eases,” said Garen, who collaborated on 
the work with Research Scientist Zhi- 
wei Hu, PH.D., M.D. Ophthalmologist 
Henry J. Kaplan, m.d., and associates at 
the University of Louisville performed 
the macular-degeneration studies, 
which were published in the March 4 
issue of the Proceedings of the National 
Academy of Sciences. 
Macular degeneration is the deterio¬ 
ration of the macula—a tiny spot at the 
center of the retina—resulting in blurs 
and blank spots in the held of vision. 
Abnormal blood vessels are the culprit 
in the wet form of the disease; they 
leak fluid onto the macula, damaging 
the cells. The Yale molecule destroys 
those leaky vessels without harming 
normal ones. 
So far, the icon has been tested in 
mouse models of both diseases, and 
studies are under way at Louisville on a 
model of macular degeneration in 
pigs, whose eyes are similar to those of 
humans. The researchers plan to apply 
to the U.S. Food and Drug Administra¬ 
tion for permission to begin clinical 
trials of the icon for patients with can¬ 
cer and macular degeneration. 
An icon could be administered in 
either of two ways, said Garen. “One 
way would be to produce it externally 
and administer it by injection,” either 
into the bloodstream or directly into the 
affected area. A second method, which 
the researchers are proposing to use in 
the cancer trial, involves the insertion of 
a gene for the molecule into an adenovi¬ 
ral vector that has been rendered harm¬ 
less. “Then you inject the vector directly 
into the tumor,” said Garen. “It infects 
the tumor cells, and this sets up what 
you might call in vivo factories for pro¬ 
ducing the molecule in the body. With 
this method, you get continual synthe¬ 
sis, and it seems to be more effective.” 
—Nancy Ross-Flanigan 
When errant proteins stray, 
a cellular cowboy rides in 
to save the day 
In the drama of life at the cellular 
level, proteins can be heroes or villains. 
When they’re wearing their white 
hats, proteins provide and maintain 
structure, act as enzymes and hor¬ 
mones and perform vital functions 
such as transporting oxygen in the 
blood. But they can also run amok, 
contributing to cancer, heart disease 
and inflammatory conditions such 
as rheumatoid arthritis. 
The cellular scenario of this Wild 
West tale stars Protac, a molecule devel¬ 
oped by researchers at Yale and Howard 
Hughes Medical Institute investigators 
at the California Institute of Technology. 
Playing the role of tire sheriff galloping 
in to save the day, Protac rounds up 
rogue proteins inside cells and orches¬ 
trates the proteins’ demise. One end of 
the dumbbell-shaped molecule is cus¬ 
tomized to bind to the protein of inter¬ 
est: the other end homes in on the 
cell’s natural protein-degrading appara¬ 
tus. “By bringing the protein into close 
proximity to the degradation machinery, 
you can target it for destruction,” said 
Craig M. Crews, ph.d., an associate pro¬ 
fessor in the Department of Molecular, 
Cellular, and Developmental Biology 
with joint appointments in chemistry 
and pharmacology. 
In a presentation at the Experimen¬ 
tal Biology 2003 meeting in San Diego 
in April, Crews and co-workers showed 
that Protac—for protein-targeting 
chimera—degrades targeted proteins 
in intact cells. In a proof-of-concept 
experiment, they engineered Protac to 
bind to green fluorescent protein 
(GFP), a naturally occurring protein 
that gives off a bright, green glow 
under ultraviolet light. When Protac 
was added to cultured cells containing 
GFP, it gathered up the glowing pro¬ 
tein and promoted its destruction. 
Within an hour, the cells that con¬ 
tained GFP had lost their fluorescence. 
While Protac has potential for treat¬ 
ing disease, its more immediate use 
probably will be in screening large num¬ 
bers of proteins for better understand¬ 
ing of their functions, much as genetic 
screens currently are used, said Crews. 
“When a genetic screen is used to 
study some aspect of cell biology, the 
process involves generating a lot of dif¬ 
ferent mutants that are each defective 
in some gene that encodes some pro¬ 
tein, and then looking for individuals 
that have a defect in the particular 
process that you’re interested in. The 
geneticist then determines which gene, 
and which corresponding protein func¬ 
tion, has been altered,” said Crews. 
“But there are several areas of cell bi¬ 
ology that are difficult to study using 
traditional genetics. So what we’d like 
to do is induce the loss of protein func¬ 
tion, not by altering the underlying 
encoding mechanism—the dna—but 
by physically inducing the degradation 
of particular proteins. One can imag¬ 
ine doing large-scale screens, knocking 
out every protein individually and look¬ 
ing for loss of particular functions. In 
this way, we hope to discover new, criti¬ 
cal proteins that are required for intra¬ 
cellular processes. So in addition to 
targeting known proteins, we hope this 
molecule will aid in the discovery of 
things we don’t even know about.” 
—Nancy Ross-Flanigan 
et cetera... 
NEW AXONS IN MICE 
A Yale scientist has encouraged axonal sprout¬ 
ing in mice by removing a protein, Nogo, 
that blocks the regrowth of nerve fibers in the 
brain and spinal cord. The research builds on 
previous findings by Stephen M. Strittmatter, 
M.D., PH.D., the Vincent Coates Professor 
of Neurology. 
“In the mice with a mutation that pre¬ 
vents Nogo A/B expression, the central nerv¬ 
ous system is largely normal but responds to 
injury in a unique fashion with robust axonal 
sprouting and long-distance growth,” said 
Strittmatter, lead author of a study published 
in the April issue of the journal Neuron. 
The researchers bred mice without the 
Nogo A and Nogo B proteins. In these mice 
new axons sprouted after a spinal cord 
injury, and the mice showed better recovery 
of locomotor function than control mice. 
“Once we can demonstrate that the Nogo 
protein constitutes an important pathway 
limiting axon growth, then we can phar¬ 
macologically improve functional recovery 
first in animals and then in humans,” 
Strittmatter said. 
—John Curtis 
A DOUBLING OF THE HUMAN GENOME? 
A new analysis of the well-studied chromo¬ 
some 22 suggests that there may be far more 
than the estimated 30,000 genes in the 
human genome. “Our study reveals twice as 
many transcribed bases than have been 
reported previously,” said first author John L. 
Rinn, a fourth-year graduate student, 
“potentially indicating there are twice as 
many genes in the human genome.” 
Rinn and colleagues in molecular, cellular 
and developmental biology used advanced 
microarray technology to map the 34 million 
bases of gene-dense chromosome 22. Earlier 
this year in the journal Cenes & Development, 
the team reported finding previously undis¬ 
covered sequences which were also found in 
the mouse genome. “This study was a proof 
of the principle that we can find, en masse, 
all the regions of a chromosome that are bio¬ 
logically relevant,” Rinn said. “In the future 
we will scale this process to tackle the entire 
human genome.” 
—John Curtis 
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12 Books 
Manual of Dermatologic 
Therapeutics, 6th ed. 
by Kenneth A. Arndt, m.d. ’61, 
HS '62, clinical professor of 
dermatology, and Kathryn E. 
Bowers, m.d. 
Lippincott Williams e[ Wilkins 
(Philadelphia, Pa.) 2002; 416 pages 
This pocket manual is a practi¬ 
cal, accessible guide to the 
diagnosis and treatment of skin 
disorders. The book outlines 
the pathophysiology, symptoms, 
clinical findings, assessment 
and therapy for each disease 
and offers detailed guidelines 
for choosing among thera¬ 
peutic options. 
Principles of Geriatric Medicine 
and Gerontology, 5th ed. 
by Mary E. Tinetti, m.d., profes¬ 
sor of medicine (geriatrics) 
and epidemiology, William R. 
Hazzard, M.D., [ohn P. Blass, 
M.D., Jeffrey B. Halter, m.d., 
and Joseph G. Ouslander, m.d. 
McGraw-Hill Professional 
(New York) 20oy, J,jj6 pages 
This book continues its tradition 
of presenting the latest in 
diagnosis and management of 
disorders affecting the elderly 
as it addresses the prevailing 
principles of gerontology. This 
orientation, which features 
experts from the fields of geri¬ 
atric medicine and gerontology, 
provides for a uniquely holistic 
approach to elder care. It fea¬ 
tures expanded coverage of 
managing the nursing home 
patient, diagnosis and treatment 
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of Alzheimer’s disease, move¬ 
ment disorders, managing the 
multidrug patient, menopause, 
health care issues in women, 
health care systems, coronary 
heart disease and more. 
The Visionary Life: Selected 
Writings of Lee Sannella 
by Lee S. Sannella, m.d. '40 
Infinity Publishing 
(Haverford, Pa.) 200J; lyy pages 
Sannella has spent 40 years 
trying to understand the various 
states of consciousness in his 
own body-mind. This book is his 
attempt to portray the experi¬ 
ences, insights, experiments, con¬ 
versations and loving exchanges 
that formed the shape and 
substance of that inquiry. These 
are stories about some of the 
cosmic explorers he has met. He 
hopes that these tales will 
enrich humanity by expanding 
the collective vision of our own 
human potential. 
Listening to Children: 
Talking With Children About 
Difficult Issues 
by Nancy L. Close, ph.d., 
assistant professor in the Child 
Study Center 
Allyn Bacon 
(Boston) 2002; 128 pages 
The object of this book is to 
inform and educate teachers, 
parents and other caregivers 
about how to interact with chil¬ 
dren ages 2 to 5 and how to 
respond appropriately to issues 
of personal concern.The book 
includes discussions of common 
challenges for children, such as 
dealing with anger, aggression, 
siblings, birth and death, and 
addresses their concerns about 
the adult world and growing up. 
First Three Years & Beyond: 
Brain Development and 
Social Policy 
by Edward F. Zigler, ph.d.. 
Sterling Professor of Psychology 
and a member of the Child Study 
Center, Matia Finn-Stevenson, 
PH.D., associate research scien¬ 
tist in the Child Study Center, 
and Nancy W. Hall, doctoral can¬ 
didate at Yale University 
Yale University Press 
(New Haven) 2002; 272 pages 
The authors affirm that sound 
social policy providing for safe 
and appropriate early care, edu¬ 
cation, health care and parental 
support is critical not only for 
the optimal development of 
children but also for strengthen¬ 
ing families, communities and 
the nation as a whole.This book 
draws on the latest research 
from the social sciences and 
studies of the brain to make rec¬ 
ommendations for infant and 
toddler care and development. 
Controversies & Conversations 
in Cutaneous Laser Surgery 
edited by Kenneth A. Arndt, m.d. 
’61, HS ’62, clinical professor 
of dermatology, and Jeffrey S. 
Dover, m.d., f.icc.p.c., associate 
clinical professor of dermatology 
AMA Press 
(Chicago) 2002; 354 pages 
This timely reference will bene¬ 
fit both the beginner and 
experienced laser and aesthetic 
surgeon. It examines new laser 
techniques, and provides expert 
guidance on using lasers suc¬ 
cessfully in a wide range of clini¬ 
cal situations. 
The Yale Guide to Women’s 
Reproductive Health: From 
Menarche to Menopause 
by Mary Jane Minkin, m.d. ’75, 
HS ’79, clinical professor of 
obstetrics and gynecology, and 
Carol V. Wright, ph.d. 
Yale University Press 
(New Haven) 200j; 448 pages 
This comprehensive book 
addresses nearly every aspect of 
reproductive health in readable, 
straightforward language.The 
authors provide the scientific 
background women need to 
make vital personal decisions 
about sexual activity, contracep¬ 
tion,family planning and main¬ 
taining reproductive health. 
Research Design in Clinical 
Psychology, 4th ed. 
by Alan E. Kazdin, ph.d., 
director of the Child Study Center 
and professor of psychology 
Allyn el Bacon 
(Boston) 2002; 6jy pages 
This textbook describes and 
explains the methodology and 
design of research in clinical 
psychology. It covers experimen¬ 
tal design, assessment, sources 
of artifact and bias, data evalua¬ 
tion and interpretation, and 
ethical and professional issues. 
The book identifies and dis¬ 
cusses the principles, obstacles, 
artifacts, biases, strategies and 
guidelines relevant to each 
stage of research. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu 
on campus 
From workbench to bedside: 
an inventor’s tale 
Dean Kamen’s portfolio of medi¬ 
cal inventions ranges from infu¬ 
sion pumps to home dialysis 
machines to the iBOT, a mobility 
device for disabled people that 
is soon to be marketed by John¬ 
son &i Johnson. While he may 
slog through years of trial and 
error before solving a problem, 
creating technology is the easy 
part, Kamen recently told the 
Associates of the Cushing/Whit¬ 
ney Medical Library. Getting 
technology to patients is the 
challenge. 
It often means waiting 
decades for fda approval, mar¬ 
shaling support from the scien¬ 
tific community and persuading 
insurance companies to cover 
new devices. While not propos¬ 
ing specific reforms, Kamen 
called for a faster, more stream¬ 
lined process for taking medical 
devices to market."Just because 
it took longer, is it any better?” 
asked Kamen, president and CEO 
of DEKA Corporation. "Did it 
make it any safer? And what is 
the lost opportunity cost of not 
using it in between?” 
Technology, Kamen added, is 
often misunderstood. He 
amazed the Harkness audience 
with a video of the iBOT in 
action.The machine allows the 
user to climb stairs, navigate 
rough terrain, reach high shelves 
and look a standing person in 
the eye. Kamen’s fear about the 
iBOT? That it will be perceived as 
just a souped-up wheelchair. 
"Technology is moving 
faster,” he said, "but our adjust¬ 
ment to it is not. It took people 
15 years to stop calling the 
Model T a horseless carriage.” 
—Colleen Shaddox 
The human genome—more 
than a list 
Among the estimated 30,000 
human genes are more than 250 
genes that are implicated in 
oncogenesis.That, according to 
Michael R. Stratton, ph.d., the 
Distinguished Lecturer for 2003 
at the Cancer Center grand 
rounds in May, is extraordinary: 
close to 1 percent of known 
genes are risk factors for cancer. 
Stratton, head of the Cancer 
Genome Project at The Well¬ 
come Trust Sanger Institute in 
England, is tracing the history of 
such mutations and looking for 
patterns of behavior to try to 
develop methods of analysis. His 
team has found, for example, 
that kinases are heavily repre¬ 
sented in cancer genes, while 
phosphatases are not. "There 
has to be something biologically 
configured about phosphatases 
that does not allow them to 
become cancer genes. It is this 
sort of analysis—that is not 
hypothesis-based, that is purely 
based on statistical constructs 
from analysis of the genome 
sequence—^that will give us new 
biological insights.” 
That could change the way 
cancers are classified, or lead to 
new treatments, Stratton said, 
before cautioning, "We just 
don’t know whether it is going 
to end up that way. But I think it 
is a reasonable aspiration that 
through these global descrip¬ 
tions of the cancer genome we 
will begin to move closer to an 
understanding of the core 
processes through which cancer 
develops.” 
—John Curtis 
From Seattle to Botswana, 
partnering to fight aids 
For nearly three years Merck & 
Co., the Bill &i Melinda Gates 
Foundation and the government 
of Botswana have worked 
together to help prevent the 
spread of Hiv and mitigate 
the impact of the aids epidemic. 
The Merck Company Foundation 
and the Gates Foundation are 
each contributing $50 million; 
Merck is also donating its two 
HIV medicines. 
Why Botswana? "Botswana 
has the highest hiv prevalence 
in the world,” said Jeffrey L. 
Sturchio, PH.D., vice president 
for external affairs, Europe, Mid¬ 
dle East & Africa at Merck. 
But because it also is one of the 
wealthiest nations in Africa, 
basic health care infrastructure 
was already in place and 
Botswana’s leaders were com¬ 
mitted to the fight against 
Hiv/AiDS.The African Compre¬ 
hensive hiv/aids Partnerships 
has helped build health resource 
centers at district hospitals 
and trained nurses and doctors 
in hiv/aids prevention and 
treatment, Sturchio told an 
audience at the Center for Inter¬ 
disciplinary Research on aids 
in April. 
"Implementing a compre¬ 
hensive hiv/aids program 
like this is a complex, dynamic 
and time-intensive process,” 
Sturchio said. “It has to be done 
in the context of broader 
development policies. Mobiliz¬ 
ing local capacity and local 
resources is absolutely critical. 
Working together it is possible 
to make a world of difference 
in the lives of people living with 
hiv/aids.” 
—John Curtis 
Using genomics to craft a 
safer pharmacopeia 
Every year some prescriptions 
go awry, causing the deaths of 
about 100,000 patients from 
toxic responses to medications. 
"We can’t predict who will 
respond to a drug,” said Janet 
Woodcock, M.D., director of the 
Center for Drug Evaluation and 
Research at the U.S. Food and 
Drug Administration (fda).That 
could change with the applica¬ 
tion of genetic knowledge to 
predict individual responses to 
medications. It is “more than 
promise now,”Woodcock said. 
"It’s starting to happen.” 
Woodcock, the keynote 
speaker at the annual Pharma¬ 
cogenetics and Medicine Lec¬ 
tures sponsored by Genaissance 
Pharmaceuticals in April, over¬ 
sees federal regulation of 
emerging knowledge about the 
role genetic variability plays 
in reactions to medications. 
Labels for a small number of 
drugs, she noted, already include 
information about genetic dif¬ 
ferences that could affect a 
patient’s response.The fda has 
begun to study electronic for¬ 
mats for providing more of such 
information to physicians. 
According to Woodcock, the 
FDA has requested that compa¬ 
nies provide genetic information 
when available, but has no 
plans to require pharmaceutical 
companies to submit genetic 
response data about their medi¬ 
cations. "We need to understand 
the science,” she concluded, 
“so that we can develop an 
appropriate policy” which will 
allow the public to benefit from 
this knowledge. 
—Marc Wortman 
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In the footsteps of 
Watson and Crick 
At the double helix’s half-century, four Yale professors 
share memories of molecular biology’s early days. 
By John Curtis 
15 
When hundreds of scientists gathered 
in England in April to celebrate the 
50th anniversary of the structure of 
DNA, among them were four Yale fac¬ 
ulty members who trained as post¬ 
docs in the late 1960s at the Medical 
Research Council’s (mrc) Laboratory 
of Molecular Biology. The lab was orig¬ 
inally a division of the Cavendish Labo¬ 
ratory in Cambridge, where Francis 
H.C. Crick, ph.d., and James D. Wat¬ 
son, PH.D., discerned the double helix. 
While the four were at the mrc 
lab—about a decade and a half after 
Watson, Crick and their collaborators 
had outlined their model of dna in the 
pages of Nature—molecular biology 
was viewed as anything but a growth 
industry. Everyone in the field knew 
everyone else, few labs were training 
molecular biologists and only three 
journals were interested in articles on 
the topic. Joan A. Steitz, ph.d.. Sterling 
Professor of Molecular Biophysics 
and Biochemistry, recalls thinking that 
her interest in the molecular basis of 
genetic phenomena had relegated her 
to an “esoteric intellectual baclcwater.” 
At the time she couldn’t imagine 
all that would transpire over the half- 
century since Crick and Watson solved 
the structure. “It has had an impact 
on every aspect of biomedicine,” said 
Steitz. “Look at what it has done for 
the pharmaceutical companies and 
the whole biotechnology industry that 
never existed. The impact on forensics 
is astounding.” 
The biological importance of dna’s 
structure, says her husband, Thomas 
A. Steitz, PH.D., Sterling Professor of 
Molecular Biophysics and Biochemistry, 
lies less in its double helix than in its 
base pairings. ‘“That immediately said 
how DNA could be copied and how dna 
could be copied into rna. It laid the 
foundation for the understanding of the 
genetic code,” he said. New tools and 
techniques such as sequencing, cloning 
and recombinant dna have been derived 
from the bases spiraling along the 
double helix. “It’s the first important 
structure in structural biology.” 
The Steitzes started their three-year 
fellowships in Cambridge in 1967. Peter 
B. Moore, ph.d.. Sterling Professor of 
Chemistry and professor of molecular 
biophysics and biochemistry, had arrived 
earlier that year for an 18-month fellow¬ 
ship. In their last year in Cambridge, the 
Steitzes overlapped with Sidney Altman, 
PH.D., Sterling Professor of Molecular, 
Cellular, and Developmental Biology and 
professor of chemistry. (In 1989 Altman 
shared the Nobel Prize in Chemistry 
with Thomas R. Cech, ph.d., for their 
work on the catalytic properties of rna.) 
“Of course, the lab itself was such an 
amazing place to work,” Altman said 
at the celebration. “The ideas generated 
whizzed around the lab, many not use¬ 
ful, but when one was, it was recog¬ 
nized as such and shone brilliantly. ... 
You were expected to work more or less 
alone with no immediate help from 
senior people. 'The assumption was that 
everybody could do experiments well. 
The senior people taught by example: 
everybody was in the lab working.” 
'The invigorating atmosphere, said 
Thomas Steitz, extended to the canteen, 
where seating was limited and post¬ 
docs shared tables with Crick or Max F. 
Perutz, PH.D., a 1962 Nobel laureate, 
Frederick Sanger, ph.d., who won two 
Nobel Prizes, or Sydney Brenner, ph.d., 
a 2002 Nobel laureate. 'The conversa¬ 
tion, Steitz said, was “always science. 
You wouldn’t talk about what you saw 
at the theater.” 
“At the time we were there Sanger 
was just able to sequence small rna 
molecules, which was a significant 
advance,” Moore said. The scientists, 
fellows and postdocs there, he said, were 
encouraged to continue that tradition 
of discovery and tackle the most chal¬ 
lenging problems. “What the mrc was 
always masterfully good at was maldng 
sure that most of its people were work¬ 
ing most of the time on things that 
really counted,” he said. “It was the best 
18 months of my scientific career. It 
was a wonderful place to do science.” 
John Curtis is the associate editor of 
Yale Medicine. 
ABOVE Among the luminaries at the Medical 
Research Council’s Laboratory of Molecular 
Biology (lmb) were Fred Sanger, Sydney Bren¬ 
ner and Max Perutz, shown here at a party at 
the laboratory’s canteen in 1980 celebrating 
Sanger’s second Nobel Prize. Brenner received 
an honorary doctorate from Yale in May. 
OPPOSITE CLOCKWISE FROM BOTTOM 
At Cambridge, intellectual stimulation was 
cultural as well as scientific for Yale faculty 
members who trained at the lmb. Tom and 
Joan Steitz attended a garden party before 
the annual May Ball held at each college. Joan 
Steitz is fourth from left in this photograph. 
Punting on the River Cam was another attrac¬ 
tion of Cambridge. Tom Steitz, with pole on 
right, and Joan Steitz, seated on right. Joined 
Richard Henderson and his wife. Penny, on 
the river in 1969. Richard Henderson, now the 
director of the lmb, was a postdoc at Yale 
from 1970 to 1973. 
Tom Steitz, left, and the late Yale faculty mem¬ 
ber Paul Sigler attended a scientific meeting 
in Herschlag, Austria, in 1968. 

Building a better drug 
While new technologies and industrial-scale 
approaches to drug discovery are changing the field, 
academic pharmacology remains a mixture of 
art and science. 
By Marc Wortman “Serendipity” is a word pharmacologists use to describe the 
Illustration by Gary Clement way they discovered many effective medications. Even with 
modern molecular tools, scientists still stumble upon 
drugs in unexpected ways. “Serendipity” is what happened 
one afternoon in 1983 in the Yale Co-op bookstore. Leafing 
through an old chemistry textbook, Krishnamurthy Shyam, 
PH.D., came across a chemical reaction that he thought 
might be adaptable to the design of a new series of antitumor 
agents. He brought his idea back to the laboratory of Alan 
C. Sartorelli, ph.d., the Alfred Gilman Professor of Pharma¬ 
cology, where Shyam was a postdoctoral associate and is 
today an associate research scientist. 
Sartorelli urged Shyam to follow his hunch. “If we 
knew what was going to happen ahead of time,” says 
Sartorelli, “it would be trivial. I want people to have a chance 
to invent.” Shyam synthesized a compound that targeted 
DNA and tried it on five mice transplanted with a leukemia. 
Two were cured, but three suffered rapid toxic—and fatal— 
side effects. Shyam continued synthesizing compounds in 
this family. Three years later Philip G. Penketh, ph.d., 
now an associate research scientist, joined Sartorelli’s labora- 
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Building a better drug 
It is becoming more and more difficult to develop drugs 
in an academic setting. The technology requires such a 
huge investment that academic labs can't compete with 
the Pfizers and Mercks. 
—Joseph Schlessinger 
tory as a postdoc and began to study how these compounds 
worked. Based on Penketh’s findings, Shyam synthe¬ 
sized versions of the compound called “prodrugs,” which 
reduced host toxicity. One of these drugs was selected 
for clinical trials. 
Today the compound, VNP40101M, is being tested in 
humans by Vion Pharmaceuticals, a New Haven-based 
biotechnology company that Sartorelli and outside investors 
founded in 1993. The data from the Phase I clinical trials 
appear promising. “If this agent works in refractory [drug- 
resistant] tumors,” says Shyam, “that would be a great break¬ 
through.” Two decades after Shyam’s hunch, it will still take 
a great deal of luck for the drug to gain approval from the 
Food and Drug Administration (fda). Animal studies and 
even early human studies often raise hopes that later, larger 
trials dash. According to Sartorelli, “The chances of a 
compound succeeding are very, very slim.” Still, Shyam is 
pleased. “Many scientists,” he says, “spend a lifetime with¬ 
out getting a drug into the clinic.” 
A mix of old and new 
Yale pharmacologists have, over the years, achieved remark¬ 
able successes by following their hunches. In the 1940s the 
department produced the first anticancer drug, nitrogen 
mustard, to treat lymphoma. In the 1950s the hrst antiviral 
agent was developed at Yale. The work of Paul Greengard, 
PH.D., on molecules that regulate metabolism led to his 
Nobel Prize in 2000. 
Now the trend in pharmacological research is to 
move away from serendipity and happenstance. Science and 
industry are looking to evidence and statistics, rather than 
hunches, to lead them to successful drug discovery. Auto¬ 
mated, industrial-scale analysis of compounds—so-called 
high-throughput screening—is the norm. 
“It is becoming more and more difficult to develop 
drugs in an academic setting,” says the pharmacology 
department’s new chair, Joseph Schlessinger, ph.d., also the 
William H. Prusoff Professor of Pharmacology. “The tech¬ 
nology requires such a huge investment that academic labs 
can’t compete with the Pfizers and Mercks.” 
Moreover, there are fewer and fewer of what Schles¬ 
singer calls “classical pharmacologists” such as Prusoff who 
discovered the first anriviral medicahon, idoxuridine, and 
codiscovered the aids drug Zerit. Rare is the individual today 
who possesses advanced chemistry skills, knowledge of 
molecular biology and a “nose” for sleuthing out the recipe for 
a compound that can hit a disease target without harming 
the pahent. 
Recognizing this new landscape, Yale has taken sev¬ 
eral steps that embrace new approaches while coexisting 
with the old. This fall Yale is celebrating the completion of a 
four-story extension to Sterling Hall of Medicine’s B Wing, 
as well as two floors of renovated laboratories in the original 
B Wing. Most of that space is for Department of Pharmacol¬ 
ogy faculty. (A gift from Bristol-Myers Squibb included $2 
million to help defray part of the construction costs.) In 
2001, the department recmited Schlessinger from New York 
University, along with his wife, Irit Lax, ph.d., an assistant 
research scientist in pharmacology. Schlessinger, an expert 
in cell signaling and founder of two biotech companies, was 
charged with reshaping the department by hiring seven new 
full-time faculty members to complement the department’s 
14 full-time members and 16 others with secondary appoint¬ 
ments. Discussions have also been under way for establish¬ 
ing a quasi-independent unit, to be known as the Center for 
Drug Discovery, which would seek to increase Yale’s chances 
of finding industrial markets for its benchside discoveries. 
In addition, Yale is seeking partnerships with industry 
over and above the traditional licensing of patents and 
formation of biotech firms. The international drug company 
Pfizer is building a $35 million center for clinical trials 
near the medical school. Although the unit will focus on 
testing Pfizer compounds in humans and will draw heavily 
on Yale’s strengths in magnetic resonance and other imag¬ 
ing techniques, including pet scanning, in research, Yale 
faculty also will have opportunities to study Pfizer’s library 
of compounds. 
Within the Yale campus, pharmacologists can also 
turn to colleagues in the Department of Chemistry on 
Science Hill for assistance. The former chair of that depart¬ 
ment, Andrew D. Hamilton, ph.d., now Yale’s deputy 
provost for science and technology, served on the committee 
that recruited Schlessinger to Yale. He notes that several 
laboratories, including his own, collaborate with pharmacolo¬ 
gists at the medical school. “Chemistry teaches us about 
biology,” he says, “and biology in turn teaches us about chem¬ 
istry. We can use this increased knowledge to find novel 
strategies for disrupting biological targets.” 
Adopting “guerrilla tactics” 
; Schlessinger, once a captain in the Israeli army, says that the 
pharmacology department “should adopt creative guerrilla 
tactics” as it seeks a role for drug discovery efforts -within the 
K academic setting. Rather than having laboratories focus on 
j: the costly search for promising compounds, he favors “target 
b discovery,” studies of the intracellular pathways, genes and 
i; proteins that influence disease states and lend themselves to 
p modulation by drugs. Those high-value findings can then be 
i) licensed to outside entities, when possible, for their use in 
ij: high-throughput screening of compounds, 
ij Drug discovery at that point becomes what Schles- 
1 singer terms “a scientifically trivial step” more appropriately 
\ undertaken in an industrial setting. The medical school 
1, should instead, he contends, “explore the mysteries of nature, 
j digging and exploring where you know nothing, where 
you’re in complete darkness.” Unlike pharmaceutical compa- 
I j nies, which must be concerned vflth the size of the market, 
.; says Sartorelli, “We don’t care what the size of the market is 
1, for our discoveries.” 
: Industry already values Yale’s strengths in pharma- 
I' cology and other drug-discovery-related fields. “The depart- 
I, ment’s knowledge base—especially strong in the areas of 
I  neuropharmacology and chemotherapy—and Yale’s reputa¬ 
tion as a world leader in imaging technologies played a 
i major part in Pfizer’s decision to locate the clinical research 
' unit in New Haven,” says Diane K. Jorkasky, m.d., vice 
)i president of clinical sciences at Pfizer. 
J Partnerships between Yale and pharmaceutical com- 
I panics could help diminish the huge risks of taking on 
new discoveries for development. Bringing new treatments 
I to patients has proven increasingly difficult in recent years, 
j despite the wealth of recent discoveries about genetics and 
gene targets. Industry figures show that only one in 5,000 
compounds registered with the fda for testing is ever 
! approved. The costs—of manufacturing the drug, establish¬ 
ing study centers, recruiting patients and collecting data— 
! for compounds that fail are astronomical. At its earliest 
stages, a clinical trial with fewer than 50 patients can cost 
between $2 million and $4 million. Later-stage trials 
with large numbers of patients can cost many times that. 
When the price of those failures is figured into the cost 
of a single success, by some estimates the average drug now 
costs more than $900 million to reach patients. 
Department of 
Pharmacology 
decade by decade 
1940s 
• Department of Pharmacology 
founded with William Salter as the 
first chair. 
• Discovery of first anticancer agent, 
nitrogen mustard, for treatment 
of lymphoma; demonstration of its 
effectiveness and the development 
of drug resistance by Alfred Gilman, 
Louis Goodman and Gustaf Lindskog. 
1950s 
■ Discovery of first antiviral agent, 
lUdR, for the treatment of ocular 
herpes, a major cause of blindness, 
by William Prusoff. 
•Arnold Welch becomes chair and 
develops first biochemically oriented 
pharmacology department in the 
country, steering the field away from 
a physiological approach, 
1960s 
• Work by Joseph Bertino on mecha¬ 
nism of action of antifolate 
chemotherapeutic agents which con¬ 
tributed to use of methotrexate, 
an anticancer agent still in wide use. 
• Floyd Bloom and George Aghajanian 
pioneer electron-microscopic studies 
of the monoamine neurons in the 
central nervous system which under¬ 
lie anxiety, depression and other psy¬ 
chiatric disorders. 
• Nicholas Giarman and Daniel 
Freedman show that LSD alters the 
function of serotonin neurons, pro¬ 
viding a connection between this 
neurotransmitter and psychosis, 
• Robert Roth and Giarman discover 
that the central nervous system 
depressant gamma hydroxybutyrate 
is a naturally occurring endogenous 
brain metabolite that influences 
the function of dopamine neurons. 
• Murdoch Ritchie recruited as chair, 
bringing with him two full profes¬ 
sors, Paul Greengard and William 
Douglas. 
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20 Building a better drug 
Joseph Schlessinger, once a cap¬ 
tain in the Israeli army, says that 
the pharmacology department 
“should adopt creative guerrilla 
tactics” as it seeks a role for drug 
discovery efforts within the aca¬ 
demic setting. 
I 
21 
Despite the averages, Yale enjoys an enviable record 
of success. Several breakthrough compounds have been 
discovered at Yale, and Yale and its pharmaceutical partners 
have one compound on the market and lo in clinical trials. 
Few of the largest pharmaceutical companies can boast a 
comparable “pipeline” of drugs in development. For instance, 
Bristol-Meyers Squibb, the firm that markets Zerit and 
one of the world’s largest pharmaceutical corporations, lists 
1 lo compounds in clinical development. 
I While making money may not be the goal of Yale sci- 
i entists, few areas of investigation in the medical school 
have as much value for outside business entities or as much 
potential to bring additional revenue to the school. Returns 
from drug sale royalties have proven a great help to Yale. 
For several years, Yale received around $40 million annually 
I in royalties from sales of Zerit. That money helped fund 
'i research and facility expansion. Outright sale of all rights to 
! the drug in 1999 to a trust created by Royalty Pharma AG 
! helped to finance construction of the new Anlyan Center for 
Medical Research and Education at 300 Cedar Street. 
Finding targets 
In his efforts to reshape the Department of Pharmacology, 
j Schlessinger has begun hiring faculty who will focus less on 
classical pharmacology and more on molecular biology, he 
il says, “defining targets and analyzing processes which occur 
' in cells.” 
Ya Fia, ph.d., an assistant professor who joined the 
faculty in 2002, typifies the new generation of academic 
I pharmacologists. A crystallographer, he spends much of his 
i time modeling three-dimensional molecular structures. He 
'! seeks targets for chemical intervention in the processes that 
'1 form the plaque in the brains of Alzheimer’s patients that 
: gums up and eventually kills their neurons, causing memo¬ 
ry loss and dementia. To model those structures he crystal¬ 
lizes key proteins linked to plaque formation in the brain 
tissue of Alzheimer’s patients. He then brings these protein 
crystals to a synchrotron in Brookhaven, N.Y., where he 
shoots them with intense X-rays. The scattered X-rays are 
recorded, and computer workstations combine the data 
into a three-dimensional molecular model of the protein he 
is studying. He posts the images to the scientific commu¬ 
nity as part of the Protein Data Bank (www.rcsb.org/pdb), an 
international repository for protein-structure data. 
1970s 
•Alan Sartorelli elucidates the concept 
of bioreductive activation of pro¬ 
drugs by oxygen-deficient (hypoxic) 
tumor cells. 
• Sartorelli and Sara Rockwell demon¬ 
strate preferential kill of hypoxic 
tumor cells by mitomycin C, leading 
to clinical use of drug with ionizing 
irradiation in treatment of cancers of 
the head and neck. 
• Ritchie provides seminal contribu¬ 
tions to the understanding of 
the mechanism of action of local 
anesthetics. 
•Creengard describes the function of 
the cyclic nucleotides, molecules regu¬ 
lating metabolism, which ultimately 
leads to his being awarded a Nobel 
Prize in Physiology or Medicine, 
• Discovery and characterization of 
dopamine autoreceptors by 
Aghajanian, Benjamin Bunney and 
Roth lead to the development of 
dopamine autoreceptor-selective 
drugs for the treatment of psychi¬ 
atric disorders. 
• Douglas conducts pioneering work 
on the essential role of calcium 
in "stimulus-secretion coupling” in 
the release of hormones and 
neuromodulators. 
1980s 
• Discovery of Zerit (d4T) for the 
treatment of aids by Prusoff and 
Tai-Shun Lin. 
•Aghajanian, Herbert Kleber and 
Eugene Redmond show clonidine, an 
antihypertensive drug, is useful in 
treating opiate withdrawal. 
• Discovery of cyclophilin, the receptor 
for the important immunosuppres¬ 
sive agent cyclosporine, by Robert 
Handschumacher. 
• Studies by Redmond and Roth on 
MPTP in monkeys lead to a primate 
model of Parkinson’s disease and 
the development of neural grafts, 
gene therapy and stem cells for 
treatment of this disease. 
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Building a better drug 
Our faculty members need to be catalysts whose 
work pushes the frontiers of science and helps translate 
science into treatments. 
—Carolyn Slayman 
Ha uses the data to identify molecular sites to which 
small compounds could bind tightly. From there, he will 
try to design a compound that will inhibit the processes that 
lead to Alzheimer’s disease. “The three-dimensional molecu¬ 
lar model will help design a molecule that could serve as a 
possible drug,” he says. “That doesn't mean it is a good drug. 
That has to be tested in a classical pharmacological context.” 
He turns to colleagues for that help in testing the compound 
on cells and then in animals. “The integrated approach,” he 
says, “is the strength of this department.” 
One of the people Ha turns to is Yung-Chi Cheng, 
PH.D, the Henry Bronson Professor of Pharmacology, who 
collaborates with a broad range of colleagues and has had 
a hand in a wide range of discoveries. Before coming to Yale 
from the University of North Carolina in 1989 he identified 
two compounds now in clinical use, one used for treating 
cytomegalovirus and another for treating hepatitis B virus. 
His laboratory has six other compounds in clinical trials, and 
clinical testing should begin on two others this year. 
Despite his e.xtraordinary success rate, Cheng has 
adapted to the changing nature of pharmacology studies. He 
now uses data derived from structural biology, proteomics 
and genomics to help him tease apart biological processes 
and find the optimal chemical to alter them therapeutically. 
“For many years we were hypothesis-driven,” he says. “Now 
we are also taking an information-driven approach. You ask 
your computer to help you out. That’s critical for the future 
of drug discovery.” 
Cheng has long drawn on input from other scientists 
and clinicians in the Developmental Therapeutics Program, 
which he co-directs. Operated by the Yale Cancer Center, this 
consortium of 30 faculty members in multiple disciplines 
focuses on the discovery of new compounds for treating can¬ 
cer and viruses that have strong associations with the devel¬ 
opment of cancer. While Cheng’s own research leads to the 
discovery of compounds, turning them into drugs requires 
testing in patients. “The Developmental Therapeutics Pro¬ 
gram is really translational between the clinical sciences and 
basic sciences. It works both ways,” he says, providing him 
with insights from the clinical use of drugs into ways to dis¬ 
cover better compounds. Program co-director Edward Chu, 
M.D., professor of medicine (oncology) and pharmacology, 
directs the Cancer Center at the "VA Connecticut Healthcare 
System in West Haven. “We can develop biomarkers to see if 
a molecule is hitting the target you intended,” he says. “The 
only way to do that is by scientists working hand-in-hand 
with clinicians.” 
Although Yale can provide evidence of a drug’s poten¬ 
tial effectiveness, internal efforts at Yale by themselves will 
never bring a drug into widespread clinical use. “You need a 
partner,” says Chu. He and others in the Developmental 
Therapeutics Program work closely with private industry to 
test Yale-discovered and other compounds which have been 
licensed to pharmaceutical companies. 
Even industrial entities must attempt to reduce the 
risks they face in developing compounds, often choosing not 
to study compounds that appear to have little promise 
for success in humans. That is one of the major reasons few 
compounds ever advance to that stage of development. 
Discussions have been under way at Yale for several years to 
help improve the likelihood that university-discovered 
compounds will reach patients and that molecular targets 
for drug discovery will prove of value to industry. After arriv¬ 
ing at Yale in 1997 from the fda, where he had been the 
commissioner, former Dean David A. Kessler, m.d., encour¬ 
aged the formation of a committee to consider the crea¬ 
tion of a Center for Drug Discovery. The center would, 
according to Carolyn W. Slayman, ph.d., Sterling Professor 
of Genetics and deputy dean for academic and scientific 
affairs, “sit at the boundary between the academic and com¬ 
mercial worlds.” Such a center would take Yale discoveries 
and develop them further to create increased value for 
partners. “If you want to do more than convince industry 
to make a major investment,” she says, “the more informa¬ 
tion you have that a drug will work, the more likely faculty 
research will progress right through to the clinic.” 
Besides increasing the likelihood of discoveries reach¬ 
ing patients, it could provide Yale with a means of taclding 
discovery projects that the pharmaceutical industry might 
avoid for business reasons. For instance, drugs for diseases 
that industry deems unlikely to generate enough revenues or 
that might compete with their existing drugs could be de¬ 
veloped. Cheng says, “There is a big difference between Yale 
and the pharmaceutical industry. We are not driven by 
product but for the common good without profit in mind.” 
Faculty and administrators continue to discuss the creation 
of the Center for Drug Discovery while Schlessinger and 
colleagues reshape the department. “We need instrumenta- 
23 
tion and a facility staffed by chemists and biologists who 
will carry Yale discoveries to the next step,” says Slayman. 
“Pharmacology is not an inward-bounded world. Our faculty 
members need to be catalysts whose work pushes the fron¬ 
tiers of science and helps translate science into treatments.” 
Yale’s move away from pure serendipity in the pursuit 
of therapies should increase the chances of success and 
help improve patients’ lives. It should also push science in 
ways that industry cannot or will not. “Studies may not 
help pharmaceutical companies to market their products 
and may even damage their products’ profit,” says Cheng. 
“It would be a mistake to leave industry solely responsible 
for pharmaceutical science.” Pharmacology department 
Chair Schlessinger agrees: “We have the capacity to take on 
more risky projects at the forefront of science, to define 
molecular paradigms and involve technologies that need to 
be developed. If we find drugs,” concludes Schlessinger 
with a shrug, “that would be fine.” ym 
Marc Wortman is a contributing editor of Yale Medicine. 
1990s 
Sartorelli's laboratory discovers two 
anticancer compounds,Triapine and 
VNP4O101M, currently in clinical trials. 
Yung-Chi Cheng discovers one 
anticancer and five antiviral agents, 
currently in clinical trials. 
Robert Innis develops transmitter- 
specific SPEC! and pet imaging probes 
to study integrity of brain dopamine 
systems in the central nervous systems 
of humans and monkeys. 
Leonard Kaczmarek's pioneering work 
on potassium channels reveals how 
a certain type of potassium channel 
underlies the fidelity of firing of audi¬ 
tory neurons. 
Bunney shows that dopamine cell 
depolarization blockade is a useful 
model for predicting the therapeutic 
efficacy of antipsychotic drugs. 
Eric Nestler conducts studies of 
molecular mechanism of drug addic¬ 
tion and dependence, identifying 
delta FosB as a molecular switch for 
addiction. 
Ronald Duman’s studies on synaptic 
plasticity and mood disorders 
provide insight for development of 
novel therapeutics. 
Roth develops primate model of 
cortical dopamine deficiency and 
enduring cognitive dysfunction 
useful in study of drugs for cognitive 
disorders. 
James Howe describes fundamen¬ 
tal properties of single glutamate¬ 
gated ion channels (which underlie 
most excitatory transmission in 
the brain). 
2000s 
Joseph Schlessinger becomes depart¬ 
ment chair and oversees significant 
expansion. 
Tamas Horvath, Redmond and Roth 
demonstrate that coenzyme 0 is 
neuroprotective in the monkey mptp 
model of Parkinson's disease. 
Marina Picciotto’s work using geneti¬ 
cally altered mice helps in understand¬ 
ing the basis of nicotine addiction. 
Sources: Robert Roth, Alan Sartorelli 
and William Sessa 
When a global outbreak 
becomes local 
For the shoe-leather work of public health, 
Connecticut officials seek help from Yale’s 
disease detectives. 
By Jennifer Kaylin 
Illustration by Tomaso Walenta 
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26 When a global outbreak becomes local ■ James L Hadler, M.D., m.p.h. ’82, like public health officials 
around the country, spent last winter reading with only mild 
concern about an atypical pneumonia outbreak in south 
China. But then something happened to catapult the illness 
from “something that bears watching” to an urgent priority. 
A student from the University of Connecticut had flown to 
Germany in March on an airplane with a doctor from Singa¬ 
pore who had been diagnosed with the potentially lethal 
new illness called Severe Acute Respiratory Syndrome (sars). 
Even more alarming, the student was running a fever but 
continued to attend classes. 
“We were facing the possibility of a sars outbreak 
on the largest campus in Connecticut,” says Hadler, chief epi¬ 
demiologist for the state Department of Public Health and 
associate clinical professor of epidemiology at Yale. “And we 
had two prominent basketball teams playing in national 
tournaments. If those players had been exposed, they could 
have spread the disease across the country.” 
Working with UConn officials, Hadler and his staff 
immediately went to work identifying everyone who attended 
classes or had contact with the potentially infected student. 
Classmates and professors were notified and examined if they 
developed symptoms of fever or cough. Blood samples from 
the student went to the Centers for Disease Control and 
Prevention (cdc) for testing. Miraculously, nobody developed 
a SARS-like illness. The blood test results for the student on 
the plane returned negative for the SARS-related coronavirus. 
While the outcome could not have been brighter for 
Connecticut, the incident raised questions in the minds 
of researchers at the cdc who were working frantically to 
unravel the sars mystery. If the student had direct exposure 
to someone with the illness, why didn’t he get infected.^ 
And if SARS isn’t transmitted through face-to-face contact, 
then how is it spread? The cdc researchers decided to 
look more closely at how the infection might or might not 
spread on an airplane, and because Connecticut was the 
first state to deal with a large-exposure scare and had several 
persons who had shared a flight with someone with sars, 
they decided that was one place to start. 
The monumental task of getting airplane manifests and 
contacting every Connecticut resident who had been on a 
flight with a confirmed sars sufferer was too much for a state 
health department already overburdened with other public 
health emergencies, most notably bioterrorism preparedness, 
administering smallpox vaccines and dealing with suspected 
SARS cases—not to mention the more prosaic task of track¬ 
ing less novel diseases that cause significant mortality and 
morbidity. So Hadler turned to the Connecticut Emerging 
Infections Program (eip) at Yale for help. 
The federally funded program is housed in a suite of 
offices in downtown New Haven and staffed by the Depart¬ 
ment of Epidemiology and Public Health. A joint program of 
the state health department and the cdc, it was created in 
1995 in response to an Institute of Medicine report that found 
that the nation was not equipped to deal with infectious dis¬ 
ease outbreaks, partly because the infrastructure that had once 
been in place had been decimated by budget cuts and eroded 
by complacency. 
“There was a degree of hubris involved,” says 
James I. Meek, m.p.h., associate director of the eip at 
Yale. “The attitude was ‘We have antibiotics now, so 
everything is under control.’ Then, of course, aids burst 
our bubble.” Add to that a resurgence of tuberculosis, 
antibiotic-resistant bacterial infections, changing habitats, 
a global food supply and worldwide travel, and Meek 
says it’s safe to say that “infectious diseases are going to 
be a continuing threat to us.” 
Connecticut’s eip is one of 10 such programs around 
the country. They are run by state health departments, but 
some, like Connecticut’s, have links to academic institutions. 
The Yale staff works with the state health department to con¬ 
duct population-based surveillance and research. “We’re basi¬ 
cally disease detectives doing shoe-leather epidemiology,” 
Meek says. 
When the Yale researchers were contacted by the state 
to help with the sars outbreak, they began working with 
the CDC. The cdc had by then secured the cooperation of the 
airlines and reviewed its lab results to identify which flights 
had confirmed sars cases. It took two months before they 
actually started contacting passengers, so Meek says nobody 
was too alarmed when a health worker phoned to discuss their 
potential exposure to sars. “Once we explained to them that 
if they were going to get sick they’d already be sick, everyone 
was very cooperative and happy to help.” 
EIP epidemiologists contacted 15 Connecticut residents 
who were on a flight with a confirmed sars case and inter¬ 
viewed them about their seat location and movements on the 
plane as well as their post-travel health. They also obtained 
blood samples to see whether the passengers had developed 
antibodies to the sars corona virus, which would indicate that 
they’d been exposed and transmission had occurred. Meek 
says the goal is to learn more about the transmission dynam¬ 
ics of the virus and to gain a better understanding of how 
much asymptomatic illness may be present. 
A global prescription for 
a global outbreak 
If the SARS outbreak has taught 
us anything, it is how intercon¬ 
nected the world is and how vital 
is the need for global cooperation 
on public health issues. 
So says Ilona S. Kickbusch, ph.d., 
head of the division of global 
health at the School of Public 
Health. “This isn’t just an issue for 
developing countries,” she says. 
A case in point is how, in a matter 
of weeks, travelers spread the 
disease from China’s Guangdong 
province throughout Asia, Europe 
and North America. “When the 
SARS outbreak spread to Canada 
we saw just how close to home it 
really was.” 
Although it falls largely to the 
World Health Organization (who) 
to provide international public 
health oversight, prior to the 
emergence of sars, Kickbusch 
says, the agency’s hands were tied 
economically and statutorily. The 
WHO budget has been stagnant at 
$800 million a year (less than it 
takes to run the average hospital 
in the United States) for the past 
15 years. (It has another “voluntary 
budget” of about $800 million, 
but that money must be spent on 
projects identified by the con¬ 
tributing countries.) 
What’s worse, if an outbreak 
occurred, the who had to get 
permission from the host country 
to investigate. “For political and 
economic reasons, some countries 
weren’t as compliant as one might 
wish,” she says. Also, countries 
only had to report named illnesses, 
not atypical syndromes, so a 
new illness like sars could go 
unreported. 
As a result of sars, though, the 
World Health Assembly, who’s 
governing body, voted to give the 
WHO more latitude in responding 
to global health threats. A resolu¬ 
tion adopted by the assembly in 
May requests that who consider 
information about epidemics from 
nongovernmental sources and 
conduct on-the-spot studies with¬ 
in affected countries to ensure 
that control measures are ade¬ 
quate to prevent international 
spread of the syndrome. Kickbusch 
says that’s a good start, but more 
must be done, including intensi¬ 
fied global surveillance and labo¬ 
ratory work, funded in part by 
public/private initiatives. 
Kickbusch would also like to 
see more well-trained public 
health professionals working at 
the ground level, and she says 
there need to be clearly stated 
consequences, such as economic 
sanctions, for those countries 
that withhold important public 
health information or fail to 
act as responsible global citizens. 
“It’s a matter of global security 
in the widest sense,” she says. 
—Jennifer Kaylin 
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28 When a global outbreak becomes local 
James Meek, left, and Robert 
Heimer led a team of epidemiolo¬ 
gists that tracked down Conn¬ 
ecticut residents who had been on 
a flight with a confirmed SARS 
case. Their goal is to have a better 
understanding of the SARS virus 
and how it is transmitted. 
I 
One obstacle to getting meaningful results is the accu¬ 
racy of people’s memory. “Recall is always a problem with 
epidemiological research, and after two months it’s going to 
be very limited,” says Meek. “Still, it was a 14-hour flight, 
so we found their recall was pretty good.” 
Robert Heimer, m.s. ’80, ph.d. ’88, associate professor 
of epidemiology and pharmacology, is in charge of the pro¬ 
gram. “It’s not glamorous work, but it’s necessary work,” he 
says of the eip, which has an annual budget of roughly $1.5 
million and a staff of 12 to 14 full-time epidemiologists and lab 
technicians. Three physicians also work part time as clinical 
consultants and principal investigators for some studies. 
The researchers all have ongoing projects, such as studies 
of food- or tick-borne illnesses, but they can be temporarily 
reassigned if there’s an emergency. 
In the case of sars, for example, the airplane study 
was just one part of their mission. Researchers also 
had to turn their attention to the Yale campus to attend to 
another important facet of their jobs: education. With 
its population of international students and faculty, many of 
whom travel frequently to Asia, the Yale community was 
understandably jittery. “There was a good deal of anxiety and 
misunderstanding in the beginning,” says Michael H. 
Merson, m.d., dean of public health. 
Working with university officials, Merson joined with 
other Yale physicians to hold three briefings around campus 
and post advisories on a website. “We did our best to keep 
people informed and to set sound policies,” such as recom¬ 
mending that graduation go forward and that guests from 
China be allowed to attend, he says. 
As the program’s director, Heimer understands the 
fear and misunderstandings a new infection can generate. 
Occasionally a disease comes along with great destructive 
force, as happened after World War I when an influenza 
pandemic killed 25 million people worldwide. Heimer said 
that with SARS the initial fear was that it could be that 
kind of easily transmittable, upper-respiratory infection. 
But once that turned out not to be the case, he thinks 
the focus should have shifted from sars, which has infected 
8,500 people and cost an estimated $30 billion so far, 
to other public health threats, such as hiv, which infects 
15,000 people a day. 
“Once we knew what it was, that it wasn’t an influenza 
thing, and we knew how not to get infected, we should have 
stopped worrying, and the media and the public should have 
focused on more pressing issues,” Heimer says. 
Meek and his colleagues agree. “All anyone at the soccer 
field wants to talk to me about is what’s going on with sars,” 
says researcher Ruthanne E. Marcus, m.p.h., a lecturer in epi¬ 
demiology. But the EiP also tracks many other illnesses that 
pose a far more immediate threat to most Connecticut resi¬ 
dents. “Everyone thinks of the biggies, like aids, sars and West 
Nile, but there are a lot of mn-ofthe-mill infectious diseases 
out there,” Marcus says. For example, she focuses on food- 
borne pathogens, such as E. coli and Salmonella, which are a 
growing concern because of the number of meals eaten in 
restaurants and America’s growing appetite for imported foods. 
Chronic liver disease, tick-borne ailments and unex¬ 
plained illnesses and death are other health issues eip 
researchers monitor. They predict that as the population ages 
and as Connecticut residents choose to live in wooded environ¬ 
ments that bring them into closer contact with ticks, rodents 
and other potential disease carriers, emerging infections 
will become an increasingly important health care specialty. 
If SARS has served as a distraction, the even larger 
recent diversion of resources has been to bioterrorism. Far 
from seeing this as undermining their work to cope with 
less headline-grabbing health threats, though, epidemiologists 
see the focus on bioterrorism as a potential boon for the 
whole field of emerging infections. The recent anthrax scare 
and the ongoing fear of bioterrorism have contributed to a 
heightened awareness about infectious diseases in general, 
they say, and an understanding within the public health com¬ 
munity of the importance of a well-supported public health 
infrastructure to deal with them. It will be another hurdle to 
get the public to focus on public health and not be sidetracked 
by the next new thing in emerging infections. 
Still, for researchers in the eip, tracking down the 
causes and transmission dynamics of elusive illnesses, 
whether new and emerging or old and resurgent, comes 
down to creative, grass-roots detective work and a mind 
open to the unexpected. As Meek says, “When most people 
hear the pounding of hooves, they look for horses. As 
epidemiologists, now we also have to look for zebras.” ym 
SARS remains 
a moving target 
The disease that emerged in Asia 
late last year, sars, is a moving 
target, according to Vincent J. 
Ouagliarello, M.D., HS ’8i. “Every 
day,” he told an audience at this 
year’s medical school reunion, 
“there is something new reported 
in The New York Times from some¬ 
where around the world.” 
What is known about sars, said 
Ouagliarello, professor of medicine 
and clinical director of the Section 
of Infectious Diseases, is this: it is a 
previously unrecognized member 
of the well-known coronavirus 
family which causes about a third 
of the cases of the common cold. 
It was first reported last November 
in China and, in very short order, 
swept across three continents. 
Infections travel through close 
person-to-person contact, mostly 
among family members or health 
care workers. Symptoms include 
fever, headache, myalgias, a dry 
cough and shortness of breath. 
Although only about 8,500 people 
worldwide have been infected. 
SARS has a mortality rate of 9 per¬ 
cent and it has provoked fears 
around the world. The resulting 
economic impacts have been 
devastating for Asia and Toronto. 
China and South Korea have lost 
about $2 billion in tourism, retail 
sales and productivity. Hong Kong, 
Taiwan and Singapore estimate 
losses at $1 billion each. 
Major league baseball players 
were advised to avoid crowds 
in Toronto, where thousands of 
people were quarantined. All 
over Asia people donned protec¬ 
tive face masks. In Singapore, 
Ouagliarello said, the Catholic 
Church suspended confessions and 
granted a general forgiveness. 
SARS, he continued, is a sign of 
globalization. “Within weeks 
SARS has spread over three conti¬ 
nents to cause a devastating 
impact on our societies,” he said, 
adding that there is a bright 
side. “At the same time, however, 
investigators from over 10 coun¬ 
tries have collaborated to identify 
the virus, screen for potential 
antiviral therapies and initiate 
vaccine development.” 
—John Curtis 
Jennifer Kaylin is a freelance writer in New Haven. 

and shattering stereotypes have 
's career path. 
It seems fitting that in order to reach the Cedar Street labo¬ 
ratory of Linda M. Bartoshuk, ph.d., a visitor passes 
through a motley and aromatic gantlet of outdoor food carts 
offering some of Earth’s most piquant cuisines—Thai, 
Mexican, Szechwan. These vendors owe their livelihood to the 
never-ending fascination and pleasure humans derive from 
the sense of taste and, in her own way, so does Bartoshuk. 
Bartoshuk is one of the world’s foremost authorities 
on the sense of taste, best known for her discovery in the 
early 1990s that one in four people is a “supertaster.” These 
individuals “live in a neon taste world,” she says, where 
sweet is far more cloying, and bitter more astringent, than 
for most of us. But this finding is just a capstone of 40 
years’ work devoted to unraveling the most enigmatic of the 
human senses, a body of research honored in April by 
Bartoshuk’s election to the National Academy of Sciences. 
Along the way, Bartoshuk has relished the demolition 
of scientific dogma—she proved that the sweet/bitter/salty 
“tongue map” found in textbooks is pure hokum, for exam¬ 
ple—but her career trajectory has been most decisively 
shaped by a dogged refusal to accept discrimination at the 
hands of science’s male establishment. 
As a young girl in the tiny prairie town of Aberdeen, 
S.D., Bartoshuk devoured science fiction novels and dreamed 
of becoming an astronomer; she spent long wintry nights 
in vacant lots learning the constellations, armed only with 
star maps and a flashlight. In high school, she was the only 
girl in her physics, chemistry and trigonometry classes. 
“To say I was a nerd ... would be an understatement,” 
she says unabashedly, still looking the part with closely 
cropped hair, utilitarian eyeglasses and monochromatic 
clothes that seem pointedly unchic. Her guidance counselor 
cautioned her that a small-town upbringing might make 
the shift to college life difficult, but Bartoshuk, whose forth¬ 
right speech retains the Midwestern cadence of her youth, 
insists that no one in Aberdeen ever discouraged her from 
pursuing science because she was a girl. 
Bartoshuk was well into her astronomy course work 
at Minnesota’s Carleton College when professors told 
her that her chosen field was hostile to women, and that it 
would be nearly impossible for her to obtain a position at 
an observatory. Shock soon gave way to anger, and when she 
learned that the psychology department would accept her 
math and science credits, she immediately changed majors. 
I 
I 
PREVIOUS PACES Cedar Street 
at lunch hour is a sensory delight, 
with cuisine from Mexico, China, 
Thailand, India and the Middle East 
available to all palates. During 40 
years of research, Linda Bartoshuk 
has shattered myths and become 
one of the world’s leading authori¬ 
ties on taste. 
She had abruptly abandoned a lifelong ambition, but 
before long Bartoshuk found an unexpected bridge between 
astronomy and her newly adopted field. 
Beginning in ancient Greece, astronomers have used 
g magnitude scales to compare the perceived brightness of 
^ stars; in modern times such scales were used to determine 
the size of the universe. Bartoshuk was thrilled to discover 
n that magnitude scales also formed the core of psychophysics, 
' the rich and rigorous branch of psychology that deciphers 
I the relationships between the physical properties of sensory 
stimuli and the subjective sensations they evoke. Psycho¬ 
physical methods have been the foundation of her research 
I ever since. 
^ Her undergraduate advisor had trained with the distin¬ 
guished taste researcher Carl Pfaffmann, ph.d., at Brown 
. University, and he helped Bartoshuk secure a place as a gradu- 
' ate student in Pfaffmanris lab. On her arrival, Pfaffmann 
told her outright that he didn’t want women there, and she is 
I convinced that the first experiment he assigned her was 
■ expressly designed to fail. In any case, her male lab mates 
eventually convinced Pfaffmann that he was being unfair, 
and she went on to become a creative and productive student. 
Bartoshuk eventually moved to Yale, and spent 20 
: prolific but trying years at the Yale-affiliated John B. Pierce 
Laboratory, an interdisciplinary research institute. In an 
i autobiography published in a collection of reflections of emi- 
I nent women, she wrote that “sexism started at the top and 
trickled down" at Pierce in those days. In an incident she 
( calls typical, the lab’s then-director stopped a newly pregnant 
Bartoshuk in the hall to tell her that he would be sorry to see 
' her go. Puzzled, she said that she planned to continue her 
research unabated. His reply: “Women like you are going to 
destroy Western civilization.” 
In 1990, Bartoshuk found a safe haven as a professor 
in the Department of Surgery’s section of otolaryngology, 
where her lab, pleasantly cluttered with stacks of scientific 
articles and bedecked with kitschy plastic tongues and chili 
peppers, remains today. 
At just about the time of her move to the School 
of Medicine, a peculiar circumstance threw Bartoshuk and 
her mentor Pfaffmann together once more. Pfaffmann 
was suffering from Ramsey Hunt syndrome, which had 
damaged the sense of taste on the left side of his tongue. 
' Pfaffmann had told his graduate students that he would 
gladly serve as a research subject if an illness ever compro¬ 
mised his sensory function. Now he had his chance, and he 
called Bartoshuk. 
Experiments with Pfaffmann produced valuable new 
data, but Bartoshuk says that the most enduring outcome 
of the work is personal: the intimacy of the lab gave her the 
courage to ask Pfaffmann about his biased behavior dur¬ 
ing her graduate school years. In reply, he told her that he 
never thought of her as anything but a gifted student, and 
she was content to leave it at that. Bartoshuk and Pfaffmann 
planned to publish a full account of their findings, but 
he suffered a stroke shortly thereafter and died in 1994. 
“I haven’t had the heart to write it up,” she says. 
Despite the uphill battles she has fought, Bartoshuk 
does not seem to harbor resentment about the course of her 
career. Instead, at 64, she displays the unbridled enthusiasm 
of a freshly minted graduate student. As Jeremy M. Wolfe, 
PH.D., a longtime friend who studies the visual system at 
Harvard Medical School, puts it, “The great thing about talk¬ 
ing to Linda is that the most exciting thing in the world is 
whatever she’s working on right nowl” 
When asked whether she ever wonders what her life 
would have been like if she had worked in some other 
field, Bartoshuk says that she’s had little time to consider it. 
“Studying taste has been like following a trail of peanuts. 
As soon as I’ve picked one up, there’s another one waiting.” 
But the curiosity that propelled her out of Aberdeen soon 
surfaces. “My life looks to me like a series of accidents, 
which worries me,” she says. “What about all the accidents 
I didn’t have.^” ym 
Peter Farley is a freelance science writer based in Boston. 
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34 Faculty 
New hand on the 
Cancer Center tiller 
Richard Edelson sees growth ahead 
for one of the country’s oldest and 
proudest cancer research facilities. 
When Richard L. Edelson, m.d. ’70, 
came to Yale in 1986 as professor and 
chair of the Department of Derma¬ 
tology, the Yale Cancer Center (ycc) 
was just a dozen years old and had 
fewer than 185 faculty members in its 
ranks. Edelson, a physician-scientist 
who had developed a treatment for 
a rare form of lymphoma, was one of 
them. By July i of this year, when 
Edelson took office as its fifth director, 
the Cancer Center had grown enor¬ 
mously. It now has 342 members from 
more than a dozen medical school 
departments and oversees 18 core facil¬ 
ities funded by a $2.1 million annual 
grant from the National Cancer 
Institute (nci). It helps draw $118 mil¬ 
lion in cancer-related research funding 
to Yale investigators yearly, making 
it one of the more vigorous cancer 
research engines in the country. 
Edelson, 58, credits that progress to 
two of his predecessors in the direc¬ 
tor’s office, pharmacology pioneer Alan 
C. Sartorelli, ph.d., and former nci 
Director Vincent T. DeVita Jr., m.d., hs 
’66, as well as current ycc Deputy 
Director Jose Costa, m.d. “They did the 
heavy lifting,” Edelson said during an 
interview in mid-July. “Alan built the 
reputation the center enjoys today as a 
powerhouse in basic science and can¬ 
cer pharmacology. And Vince, who is 
credited with having cured Hodgkin’s 
disease and is essentially the father of 
combination chemotherapy, has really 
Richard Edelson is heading the Yale Cancer 
Center as the university and Yale-New Haven 
Hospital enter a new era of collaboration 
and growth. 
laid out the framework for developing 
the center into a clinical powerhouse.” 
Therein lies Edelson’s main chal¬ 
lenge. Despite a worldwide reputa¬ 
tion and key contributions to cancer 
research, Yale historically has not been 
able to draw the desired volume of 
cancer patients, especially for all- 
important clinical trials of new thera¬ 
pies. It was among the first centers 
designated a Comprehensive Cancer 
Center by the nci, but until recently 
has not had the resources to meet all 
of its clinical goals. As a result, rumors 
abounded last year that the center 
might even lose its nci comprehensive 
designation when the most recent five- 
year grant expired on June 30. 
Instead, the nci agreed to extend 
funding for a year. The university has 
agreed to fund the core facilities for 
two additional years, if necessary, while 
the center builds up steam and over¬ 
comes some of its growing pains. 
Edelson said that is already happen¬ 
ing. Both the university and Yale- 
New Haven Hospital have pledged 
resources, and the director predicted a 
new era of collaboration, cooperation 
and growth. 
“I’m convinced we have the oppor¬ 
tunity to develop field-shaping pro¬ 
grams in every important area of can¬ 
cer care,” said Edelson, who will 
remain chair of dermatology but is 
stepping down as deputy dean for 
clinical affairs, a position he has held 
for the past three years. “We have 
the people, we have the setting and we 
have the science.” 
To solve a nagging space crunch in 
its patient areas, Edelson negotiated 
the immediate renovation of 25,000 
square feet of clinical space in the Yale 
Physicians Building and elsewhere on 
campus, close to doubling the existing 
clinical facility. The long-term solution 
to the space problem, he said, will 
take the shape of a new Cancer Center 
building of approximately 170,000 
square feet, to be open by 2007. 
Several possible locations around the 
medical center are under discussion. 
One key to growth, Edelson 
believes, is rebuilding the Section of 
Medical Oncology, which is down in 
ranks but now has a new structure for 
appointments and promotions and a 
commitment to hiring new faculty. As 
part of his recruitment, Edelson gained 
approval to hire 18 to 24 new faculty 
members in cancer-related fields, about 
half of whom will be medical oncolo¬ 
gists. “This will be the clinical engine 
that drives cancer care, and it is one of 
the best routes for new patients into 
trials,” he said. Edelson is also explor¬ 
ing arrangements with cancer facilities 
outside Connecticut that would bring 
Yale discoveries to a vhder public while 
increasing the number of patients 
available for Yale trials. 
“I don’t have the slightest doubt 
that we’re going to quickly succeed 
here. If I did, I wouldn’t have taken 
this job,” Edelson said. 
—Michael Fitzsousa 
New appointments 
in provost’s office place 
science in the spotlight 
New appointments in the office of Yale 
Provost Susan Hockfield, ph.d., leave 
science and the medical side of campus 
well-represented in the upper echelons 
of the university. 
Andrew D. Hamilton, ph.d., the 
Irenee duPont Professor of Chemistry 
and professor of molecular biophysics 
and biochemistry, has been named the 
deputy provost for science and technol¬ 
ogy. Bruce F. Carmichael, m.s.n, sc.d., 
former associate dean for resources and 
management at the School of Nursing 
and former executive director for major 
projects and facilities at the School of 
Medicine, is the new interim assistant 
provost for science and technology. 
Barbara A. Shailor, ph.d., director of 
the Beinecke Rare Book and Manuscript 
Library, has been named deputy provost 
for the arts. 
Hamilton’s area of focus includes 
the Faculty of Arts and Sciences depart¬ 
ments in the natural sciences. 
Carmichael will oversee the natu¬ 
ral science and engineering depart¬ 
ments. At the School of Medicine his 
major task was to oversee the initial 
stages of construction at the new 
Anlyan Center for Medical Research 
and Education. 
Shailor will help to shape and 
implement policies for the Schools of 
Art, Architecture, Drama, Music and 
Divinity; the Institute of Sacred Music; 
the Departments of History of Art, 
Classics and Music; the Yale Univer¬ 
sity Art Gallery; and the Center for 
British Art. 
—John Curtis 
A legend in the annals of 
Yale medicine returns, 
in person and on canvas 
when new interns in the Department 
of Internal Medicine arrived in July 
1964, little did they know that they 
would be the last group to be trained 
at Yale by Paul B. Beeson, m.d., then 
chair of the Department of Internal 
Medicine. A year and three months 
into their training, Beeson left for 
Oxford University. In May, nine of that 
last cadre of house staff gathered with 
Beeson, his family and members of the 
Department of Internal Medicine in 
the Historical Library for the unveiling 
of a portrait of the legendary physician. 
Beeson, who served as department 
chair from 1952 to 1965, specialized in 
infectious disease and discovered a 
class of proteins known as cytokines. 
In 1996 the medical service at Yale 
was named “The Beeson Medical 
Service” in his honor. 
“No contemporary figure has had 
more infiuence on the way Western- 
trained doctors practice medicine than 
Paul Beeson,” said John N. Forrest Jr., 
M.D., Hs ’67, who heads the Office of 
Student Research. “Paul Beeson was 
revered in medicine because he pro¬ 
moted those around him rather than 
himself, valued patients and the voca¬ 
tion of medicine rather than reputation 
and never forgot that treating sick peo¬ 
ple and training young physicians was 
a precious gift and responsibility.” 
“In his presence we all felt great¬ 
ness,” said Lewis Landsberg, m.d. ’64, 
HS ’70, now dean of the medical 
school at Northwestern University. 
“His humbleness stood as a sharp 
rebuke to the hubris of lesser men.” 
The portrait was accepted for the 
Department of Medicine by David 
Coleman, m.d., the interim chair of 
the Department of Internal Medicine. 
“The Beeson tradition and values 
continue to play a major role in the 
training of students and house staff,” 
Coleman said. “This portrait will be 
a constant reminder of that influence.” 
The portrait, painted by Vermont artist 
Richard Whitney, will hang in Fitkin 
Amphitheater. 
—John Curtis 
Nine physicians who began their residencies 
at Yale under the tutelage of Paul Beeson 
returned to the medical school in May to honor 
their mentor. 
I 
v
a
le
 
M
e
d
ic
in
e
 
a
u
tu
m
n
 
20
03
 
36 Faculty NOTES 
Roland Baron Alan Dardik 
Elizabeth Bradley Jorge Calan 
Sonia Caprio Thomas Steitz 
I 
( 
Researchers at the School of 
Medicine have received 13 grants 
from The National Alliance for 
Research on Schizophrenia and 
Depression (narsad) totaling 
almost $780,000. NARSAD is a 
leading donor-supported organi¬ 
zation funding worldwide 
research on brain disorders.The 
following researchers will 
each receive a two-year Young 
Investigator Award of approxi¬ 
mately $60,000; Patrick B. Allen, 
PH.D., assistant professor of 
psychiatry; Vladimir Coric, M.D., 
assistant clinical professor of 
psychiatry; Carrol M. D’Sa, PH.D., 
associate research scientist in 
psychiatry; Naomi R. Driesen, 
PH.D., associate research scien¬ 
tist in diagnostic radiology; 
Wen-Jun Cao, M.D., PH.D., associ¬ 
ate research scientist in neurobi¬ 
ology; Xingguang Luo, M.D., 
postdoctoral associate in psychi¬ 
atry; Snezana M. Milanovic, 
M.D., hospital resident; Maria 
Mouratidis, PSY.D., postdoctoral 
fellow in psychiatry; Edward B. 
Perry, M.D., assistant professor 
of psychiatry; Samuel N. 
Sathyanesan, PH.D., associate 
research scientist in psychiatry; 
Cities D.Tamagnan, PH.D., assist¬ 
ant professor of psychiatry 
adjunct; Christopher P.Turner, 
PH.D., associate research scien¬ 
tist in pediatrics (endocrinol¬ 
ogy); and Pieter Joost van 
Wattum, M.D., PH.D., assistant 
clinical professor in the Child 
Study Center. 
Roland E. Baron, D.D.S., PH.D., 
professor of orthopaedics 
and cell biology, received the 
Louis V. Avioli Founders Award 
from the American Society 
for Bone and Mineral Research 
at its 24th annual meeting in 
San Antonio in September 2002. 
This award is given for "funda¬ 
mental contributions to bone 
and mineral basic research.” 
Baron also received a Docteur 
Honoris Causa from the 
Universite Rene Descartes in 
Paris in December 2002. 
Elizabeth H. Bradley, M.B.A., 
PH.D. ’97, associate professor 
in public health, is the first Yale 
researcher to be awarded the 
John D.Thompson Prize for 
Young Investigators by the Asso¬ 
ciation of University Programs in 
Health Administration (aupha). 
The award, presented in June 
at the AUPHA national meeting, 
recognizes investigators for their 
contributions to research litera¬ 
ture in the health services field. 
Bradley’s work focuses on the 
quality of care provided to the 
elderly population. 
A researcher who studies meta¬ 
bolic changes associated with 
obesity and type 2 diabetes has 
received the first fellowship at 
Yale from the newly established 
Bayer Endowment for Scholars 
in Medicine and Management. 
Sonia Caprio, M.D., associate 
professor of pediatric endo¬ 
crinology and a graduate of 
the Universita di Medicina e 
Chirurgia in Naples, is inter¬ 
ested in the prevention and 
treatment of type 2 diabetes 
among young people. "There is a 
growing and serious epidemic 
of childhood diabetes, especially 
among African-Americans and 
Hispanics,” she said. 
The $2 million endowment 
from Bayer will fund a fellow¬ 
ship to be awarded each year 
to a faculty member making 
significant contributions to 
advances in medicine or health 
care management. In addition 
to supporting the work of the 
Bayer Fellow, the Bayer Endow¬ 
ment will foster interaction 
between Yale scientists and 
Bayer employees through 
lectures and conferences on 
topics of shared interest. 
David C. Cone, M.D., associate 
professor of surgery (emergency 
medicine) and public health, 
was installed in January as sec¬ 
retary/treasurer of the National 
Association of Emergency 
Medical Service Physicians 
(naemsp). Cone has served on 
the NAEMSP board of directors 
since 1996 and is deputy editor 
of Prehospital Emergency Care, 
the organization’s Journal. The 
NAEMSP provides medical over¬ 
sight and research leadership 
for out-of-hospital emergency 
care systems. 
Alan Dardik, M.D., PH.D., assist¬ 
ant professor of surgery (vascu¬ 
lar) at Yale and assistant pro¬ 
gram director of the department 
of surgery at St. Mary’s Hospital, 
was awarded the Wylie Scholar 
Award in Academic Vascular 
Surgery by the Pacific Vascular 
Research Foundation in San 
Francisco in 2002.The $150,000 
multiyear award is presented 
to productive scientists with 
independent research programs 
in North America. Dardik stud¬ 
ies the effects of the force 
of flowing blood on cells in the 
blood vessels. 
Jorge E. Calan, PH.D., D.V.M., chair 
and Lucille P. Markey Professor 
of Microbial Pathogenesis and 
professor of cell biology, and 
Thomas A. Steitz, PH.D., Sterling 
Professor of Molecular Bio¬ 
physics and Biochemistry, were 
elected in April as fellows by 
the American Academy of 
Microbiology. Calan was hon¬ 
ored for his innovative use of 
microbial molecular genetics 
and molecular cell biology to 
further the understanding of 
how microbial pathogens com¬ 
municate and interact with 
their animal hosts, and for his 
molecular genetic characteriza¬ 
tion of the Salmonella patho¬ 
gen. Steitz’s specialty is the 
study of the structures of pro¬ 
teins and nucleic acids to deter¬ 
mine their biological function. 
His lab recently determined the 
atomic structure of a subunit 
of the ribosome. 
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Mark J. Gorman, M.D., assistant 
professor of neurology, was 
appointed director of the Acute 
Brain Injury/Stroke Program at 
Yale-New Haven Hospital in 
April. Gorman heads a coordi¬ 
nated multidisciplinary stroke 
team, which is aimed at diag¬ 
nosing and treating stroke 
patients as rapidly as possible. 
Jeannette R. Ickovics, PH.D., 
associate professor of epidemi¬ 
ology (chronic disease) and psy¬ 
chology, was elected as a fellow 
by the American Psychological 
Association (apa) for 2003. apa 
fellows are selected for excep¬ 
tional and outstanding contribu¬ 
tions to the research, teaching 
or practice of psychology. The 
APA is the largest scientific and 
professional organization repre¬ 
senting psychology in the United 
States and is the world's largest 
association for psychologists. 
Akiko Iwasaki, PH.D., assistant 
professor of epidemiology and 
immunobiology, received the 
2003 Wyeth-Lederle Vaccines 
Young Investigator Award in 
Vaccine Development in October 
from the Infectious Diseases 
Society of America at its annual 
meeting in San Diego. She also 
received the Ethel F. Donaghue 
Women’s Health Investigator 
Program Award in July. 
Ilona S. Kickbusch, PH.D., profes¬ 
sor of public health (global 
health) and political science, was 
invited to be a member of the 
Hungarian Ministry of Health 
International Advisory Board in 
January by the Republic of 
Hungary’s Ministry of Health, 
Social and Family Affairs. This 
board was established to help 
promote health, consolidate 
and modernize the health care 
system and reform health 
care financing, as part of the 
government’s “Decade of 
Health” initiative. 
Luke M. Kitahata, M.D., PH.D., 
professor emeritus and former 
chair of anesthesiology, was 
honored in November 2002 at 
the 50th anniversary celebration 
of the establishment of the 
Department of Anesthesiology 
at Tokyo University, his alma 
mater. He was the keynote 
speaker and received honorary 
membership in the Japanese 
Society of Anesthesiologists. The 
celebration was organized by 
one of his former Yale trainees, 
Kazuo Hanaoka, M.D., FW ’77, 
who is professor and chair of the 
Department of Anesthesiology 
at Tokyo University. 
Michael H. Merson, M.D., the 
Anna M.R. Lauder Professor of 
Public Health, dean of public 
health and chair of the Depart¬ 
ment of Epidemiology and 
Public Health, was named chair 
of the Global Health Commit¬ 
tee, part of the Association of 
Schools of Public Health execu¬ 
tive committee, effective last 
January. 
John A. Persing, M.D., professor 
and chief of plastic surgery, is 
president-elect of the Associa¬ 
tion of Academic Chairmen of 
Plastic Surgery and vice chair of 
the American Board of Plastic 
Surgery. Both elections were 
held in Baltimore in May. Persing 
was also named president of 
the American Society of Maxillo¬ 
facial Surgeons in November 
2002 at its annual meeting in 
Orlando, Fla. 
Among those receiving Seton 
Elm-Ivy Awards in April for their 
contributions to relations 
between the city and the univer¬ 
sity was Mary E. Schwab-Stone, 
M.D., the Harris Associate 
Professor of Child Psychiatry in 
the Child Study Center and asso¬ 
ciate professor of psychology. 
Schwab-Stone helped to develop 
a clinical consultation service for 
New Haven’s Special Education 
Department, which evaluates 
between 35 and 40 children and 
youths each year, offers the 
department advice on program 
and policy issues and trains new 
generations of child psychia¬ 
trists on how to work in and 
with schools. Since 1992 she has 
developed and led the Social 
and Health Assessment Pro¬ 
gram, which oversees the 
assessment of mental health 
symptoms, competencies. 
Problem behaviors and risk fac¬ 
tors in the middle and high 
school population. 
Hongyu Zhao, PH.D., the Ira V. 
Hiscock Associate Professor of 
Public Health (Biostatistics) and 
Genetics, has received a three- 
year, $1.2 million grant from the 
National Science Foundation 
for a system biology study. Zhao 
and colleagues in statistics, 
genomics and proteomics, bioin¬ 
formatics and computer science 
will develop an integrated 
approach to reconstructing bio¬ 
logical pathways. Zhao was 
also awarded a pilot grant by 
the Yale Center for Genomics 
and Proteomics, where he and 
colleagues will research tissue- 
and cell-specific expression 
profiling of the rice genome. 
Mark Gorman 
Jeannette Ickovics 
Akiko Iwasaki 
Ilona Kickbusch 
Luke Kitahata 
SEND FACULTY NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
Michael Merson 
John Persing 
Mary Schwab- 
Stone 
Hongyu Zhao 
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38 students 
ABOVE This year’s Commencement was the 
soggiest in recent memory. It rained through¬ 
out the ceremony, leading graduates to process 
under the shelter of umbrellas. Jennie Bailey 
was among the first in the procession. 
OPPOSITE Expressions on the faces of gradu¬ 
ates and faculty captured the prevailing mood. 
39 
Medicine from the heart, 
as weil as the head 
Graduates hear a prayer for wisdom 
and humility, and a reminder to heed 
not only science, but also the spirit. 
Sheltered under a tent to ward off a 
driving rain, 97 students received their 
medical degrees on Memorial Day 
and heard admonitions to retain their 
humanity, to find meaning in their 
lives and careers and to take comfort 
from lives of service. 
Making their way through a shel¬ 
tering gantlet of umbrellas, the Class 
of 2003 processed to the tent on 
Harkness Lawn where their families 
and friends waited. In his opening 
remarks, then-Dean David A. Kessler, 
M.D., told students to take pride in 
their accomplishment. “As you go 
beyond these walls,” he said, “you will 
increasingly recognize the degree to 
which you have been shaped by this 
place. Today you go forward to shape 
the future of American medicine. 
You are proof that this great experi¬ 
ment called the Yale System works 
and that you have been shaped by an 
incredible faculty.” 
Joahd Toure, one of the graduates, 
offered an invocation of thanks 
and a call for humility. “Let us pray 
that success follows us from this 
place,” Toure said. “Let us pray for 
continued support from mentors, 
family and friends. Let us pray our 
education serves us well. Let us pray 
for knowledge to understand illness. 
And let us pray we remember that 
knowledge is not all that is needed 
to address the concerns of our 
future patients. Let us also pray for 
Photographs by Terry Dagradi 
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40 students 
compassion, wisdom, patience, 
humility and grace.” 
In her Commencement address, 
Rachel N. Remen, m.d., clinical profes¬ 
sor of family and community medicine 
at the University of California, San 
Francisco, School of Medicine, con¬ 
tinued with a similar theme. Medicine’s 
emphasis on intellect and science often 
disregards the instincts of the heart, 
she said. “It may cause us to believe 
that the perception of the heart is soft, 
unprofessional, even dangerous, that 
the heart will somehow mar our judg¬ 
ment and make us incompetent as 
medical people,” said Remen, author of 
Kitchen Table Wisdom: Stories That Heal 
and My Grandfather’s Blessings: Stories of 
Strength, Refuge, and Belonging. “It has 
taken me years to realize that being a 
human being is not unprofessional. ... 
The heart is the strongest place from 
which to live a life, especially a physi¬ 
cian’s life.” 
This year’s Bohmfalk Prizes went to 
Sheldon M. Campbell, m.d., ph.d., 
FW ’92, assistant professor of labora¬ 
tory medicine, and Cyrus R. Kapadia, 
M.D., professor of medicine. Auguste 
H. Fortin VI, m.d., assistant clinical 
professor of medicine, received the 
Arnold P. Gold Foundation Fluman- 
ism in Medicine Award. The Leah M. 
Lowenstein Award went to Susan M. 
Richman, m.d., assistant professor 
of obstetrics and gynecology. John S. 
Hughes, M.D., HS ’76, associate profes¬ 
sor of medicine, received the Francis 
Gilman Blake Award, and the Betsy 
Winters House Staff Award went to 
Stephen M. Kavic, m.d. 
—John Curtis 
TOP TO BOTTOM 
Nikki Pinkerton received her diploma from 
then-Dean David Kessler in the company 
of her two daughters. 
Karen Kim’s family Joined her for a celebra¬ 
tory photo. 
John Cowden was among several students 
who accepted their diplomas with children 
in tow. 
41 
TOP TO BOTTOM 
Vivek Murthy gets a congratulatory hug. 
Nimi Tuamokumo shared the high spirits 
of the day with her uncle Jide Labinjo, mother, 
Yomi Wilcox, and uncle Edward Labinjo. 
Essmaeel Abdel-Dayam’s mother, Ayda 
El-Shirbiny, also a physician, came to New 
Haven for the ceremony. 
ABOVE 
Commencement speaker Rachel Remen 
urged graduates not to ignore the instincts 
of the heart. 
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42 students 
It takes **a posse” to protect 
the world’s health, former 
CDC director asserts 
Jeffrey P. Koplan, m.d., m.p.h., says 
cowboys get a bad rap. In his youth 
he lived the cowboy life himself 
on a “quarter-acre spread in suburban 
Boston ... A scene that stirred me 
repeatedly was the formation of a 
posse, setting off to apprehend the bad 
guy,” Koplan told the crowd gathered in 
Battell Chapel for the School of Public 
Health Commencement on May 26. 
The world needs something like a 
posse to band together to solve pub¬ 
lic health crises, said Koplan, former 
director of the Centers for Disease 
Control and Prevention (cdc). In some 
circumstances, he acknowledged, “con¬ 
sensus is not possible. ... But there are 
many more when restraint, dialogue. 
sensitivity and listening to others are 
called for. Not just for diplomatic show 
but to serve our national interests. 
“There is a prevailing mind-set that 
we can reject a global warming treaty, 
be a nonsignatory to a land mine 
ban and seek to dilute a U.N. treaty [on 
tobacco control] ... with no obvious 
penalties,” said Koplan, who is now vice 
president for academic health affairs at 
Emory University’s Woodruff Health 
Sciences Center and was elected in June 
to the Yale Corporation. The advent of 
severe acute respiratory syndrome, or 
SARS, makes clear “the value of having 
trushng and close working relahonships 
with a wide variety of nations.” 
Students graduating into the public 
health community form part of a posse 
“with a sacred mission to improve the 
health of people everywhere,” Koplan 
told the 121 men and women receiving 
NiAiD director receives 
honorary degree 
At Commencement ceremonies on Old Campus, 
Anthony Fauci, director of the National Institute 
of Allergy and Infectious Diseases and chief 
of the Laboratory of Immunoregulation at the 
National Institutes of Health, was awarded 
an honorary doctor of medical sciences degree. 
Fauci has been at the forefront of efforts to 
understand and treat hiv infection. 
master’s and doctoral degrees in 
public health. 
Sahar Rooholamini and Andee 
Krasner gave the student address 
together. Krasner told their classmates 
“to seek justice as the prerequisite of 
health. It is our view that the greatest 
advantage of a Yale education is the 
platform it provides graduates to be 
able to amplify the voices of those who 
would otherwise not be heard.” 
The students honored Kaveh Khosh- 
nood, M.P.H. ’89, PH.D. ’95, assistant 
professor of epidemiology, with the 
Award for Excellence in Teaching. The 
Dean’s Prize for an outstanding thesis 
was awarded to Jennifer Collins and 
Amelia Shaw. The Henry J. (Sam) 
Chauncey Jr. Inspirahon Award went to 
Sarah George, and Gina Engler won The 
Gortlandt Van Rensselaer Greed Award. 
—Cathy Shujro 
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CLOCKWISE FROM TOP LEFT 
The School of Public Health held its Commence¬ 
ment ceremony in Battell Chapel. 
Victor Edgerton indulged in a long-standing 
tradition by decorating his mortarboard with 
action figures. 
Keynote speaker Jeffrey Koplan, former head 
of the Centers for Disease Control and 
Prevention, said public health requires the 
equivalent of an international “posse” to 
work together to solve crises. 
Alice Yeung shared a moment with classmates 
at the ceremony in Battell Chapel. 
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44 students 
Leo Kim discussed his work during the poster 
session at Student Research Day in May. 
For young physician-scientists, 
a mentor is no longer a 
single sage but a network 
Unlike past generations, physicians 
now entering the world of academic 
medicine no longer seek a single men¬ 
tor, said Edward }. Benz Jr., m.d., fw 
’80, a former Yale faculty member who 
is president of the Dana-Farber Cancer 
Institute. Mentorship for young scien¬ 
tists, said Benz, a prominent hematolo¬ 
gist, has undergone a paradigm shift. 
Rather than learning from a succes¬ 
sion of experienced scientists, as he 
did, young scientists now benefit from 
“spontaneously forming networks” 
of investigators in diverse disciplines, 
Benz told the audience at Student 
Research Day in early May. 
Posters lining the corridors of the 
Jane Ellen Hope Building described 
the research of 63 students completing 
M.D., M.D./PH.D. and M.p.H. degrees. 
Projects included a comparison of 
expected and actual waiting times in 
emergency departments, a study of a 
South African program to prevent 
vertical transmission of hiv, research 
on the impact of controlled ovarian 
hyper stimulation on the success rate of 
in vitro fertilization and a study of 
how the molecular genetics of kriti 
affect the pathogenesis of cavernous 
malformations. 
Reflecting on Benz’s description 
of changes in the system of mentoring, 
yth-year m.d./ph.d. student Stephanie 
Eisenbarth said she'd had several 
key mentors, in particular H. Kim 
Bottomly, ph.d., professor of immuno¬ 
biology. Graduate school, Eisenbarth 
said, is structured to provide students 
with a committee of three to six faculty 
members. “They, too, have a signifi¬ 
cant impact on your development as a 
scientist, and I think this is a positive 
influence on the process,” she said. 
Her study of the role of endotoxin in 
asthma pathogenesis was published in 
The Journal of Experimental Medicine 
last December. 
After hearing presentations by five 
students with award-winning theses, 
Dennis D. Spencer, m.d., hs ’77, the 
Harvey and Kate Cushing Professor of 
Neurosurgery, gestured toward the 
presenters and commented: “We see 
not students, but future colleagues.” 
Some of the student theses can be 
read online at http://ymtdl.med.yale.edu. 
—Cathy Shufro 
The war between ideology 
and science is costing lives, 
speaker tells aids gathering 
People are dying because public health 
policy has fallen victim to “the war of 
ideology over science,” keynote speaker 
Geeta Rao Gupta, ph.d., said at the 
annual aids Science Day at the School 
of Public Health in April. A health 
policy based on ideology rather than 
research “is not just wrong,” she said, 
“it is fatal.” 
Gupta, president of the International 
Center for Research on Women, said 
social change arising from globaliza¬ 
tion has pushed societies “backwards 
to fundamental ideals and primary cul¬ 
tures, to hold on to what is seemingly 
sacred.” The reversion to fundamental¬ 
ism typically limits women’s mobility 
and sexual and reproductive autonomy, 
she said. 
The “most stunning examples” of 
ideology-based policy have come from 
the United States, she said, which has, 
at United Nations conferences, pro¬ 
moted abstinence as the only sure way 
to prevent sexual transmission of Hiv 
and called for the deletion of “condom 
use” from a list of strategies to prevent 
infection. Such “ideological posturing,” 
said Gupta, “costs lives, tens of mil¬ 
lions of lives.” 
Policy based on research should 
include cultural analysis, said Gupta. 
For instance, women’s ability to protect 
themselves from hiv is limited by 
societal rules governing how women 
(and men) should behave. If an aids 
vaccine is developed, some societies 
will regard getting vaccinated as an 
admission of promiscuity. 
“We just presume that once you 
have the solution, it’s a good solution,” 
said Gupta, adding: “Biomedical inter¬ 
ventions are not gender-neutral.” 
During the day of panels and poster 
sessions, scientists, anthropologists, 
social workers, faculty and students 
discussed an array of issues related to 
hiv/aids, including prevention and 
care in international settings, interven¬ 
tions to stop the spread of the disease 
and the implications of race, gender 
and poverty. 
—Cathy Shufro 
Geeta Rao Gupta, right, the keynote speaker 
at AIDS Science Day, said science, not ideology, 
should guide health policy. 
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46 Alumni REUNION 2003 
Reunion 2003 
Amid the catching up, serious 
consideration of how war, terrorism 
and disease affect society and 
public health. 
Harold Bornstein, Andrew McGowan and 
Robert Donohue, from left, were honored with 
the Distinguished Alumni Service Award at 
this year’s reunion. 
Although the theme of panels at both 
the medical school and the public 
health school reunions was the impact 
of disease and disaster on society, 
Donald O. Lyman, m.d. ’68, turned 
that topic on its head. 
“It is not so much that infectious 
disease affects society,” he said, speak¬ 
ing at the medical school symposium. 
Infectious Disease and How It Impacts 
Society, Public Health and Safety. “It is 
that societal patterns influence the dis¬ 
eases we suffer.” 
Past epidemics of infectious disease 
stemmed from unusual social patterns 
such as urban crowding. Long before 
antibiotics these diseases were success¬ 
fully addressed by easing congestion 
and providing basic sanitation. That 
lesson—addressing societal problems 
to eliminate disease—is now being 
applied to lifestyle patterns such as 
smoking and nutrition. 
Most deaths, illnesses and disabili¬ 
ties today stem from two sources, 
cardiovascular disease and cancer, 
Lyman said. And they, in turn, are 
largely the result of three things— 
smoking, poor nutrition and lack of 
exercise. In California, where he is 
chief of preventive medicine for the 
state’s Department of Health Services, 
Lyman has begun to address those 
matters. An anti-smoking campaign 
has reduced adult smoking by a third 
47 
and consumption of tobacco products 
by two-thirds. Over the past decade the 
incidence of cancer in California has 
fallen by lo percent, he said. The state 
has seen a similar reduction in cardio¬ 
vascular disease. “Our next step will be 
nutrition and physical activity,” he said. 
Also on the panel was Frank J. 
Bia, M.D., M.P.H., Fw ’79, professor of 
medicine and laboratory medicine, 
who outlined the early history of anti¬ 
microbial agents, including the first 
use of penicillin at Yale during World 
War II. Vincent}. Quagliarello, m.d., 
HS ’81, professor of medicine and clini¬ 
cal director of the section of infectious 
diseases, offered an update of the sars 
epidemic around the world (See “sars 
Remains a Moving Target,” p. 29). 
What is known about the emerging syn¬ 
drome, he said, keeps changing as 
more is learned about it. Margaret K. 
Hostetter, m.d., chair and professor 
of pediatrics and professor of microbial 
pathogenesis, discussed diseases 
common to children adopted from 
other countries. 
After the symposium, then-Dean 
David A. Kessler, m.d., spoke on 
the effects of hiv/aids on children. 
Calling the disease the “worst epi¬ 
demic in world history,” Kessler said 
that by the end of the decade, 45 
million people will be infected. Despite 
that dire figure, Kessler noted that 
the world is responding to the crisis 
with offers of aid. The Bill & Melinda 
Gates Foundation, he said, has pledged 
$15 million for projects to prevent 
mother-to-child transmission of hiv. 
An ongoing program at Yale sends 
first- and second-year medical students 
to South Africa to work on local hiv 
prevention projects. 
“I think increasingly we are becom¬ 
ing a global medical school at a global 
university,” Kessler said. 
At the annual meeting of the Asso¬ 
ciation of Yale Alumni in Medicine 
(ayam), three graduates received the 
Distinguished Alumni Service Award: 
Flarold D. Bornstein Jr., m.d. ’53, 
HS ’56; Robert J. Donohue Jr., m.d. ’58, 
HS ’59: and Andrew J. McGowan Jr., 
M.D. ’58. 
The ayam’s executive committee 
elected new officers at the reunion. 
Donald E. Moore, m.d. ’81, m.p.h. ’81, 
is the new president. Francis M. 
Lobo, M.D. ’92, was elected vice presi¬ 
dent. Ghristine A. Walsh, m.d. ’73, is 
the secretary. 
TOP Barry Levy, left, and Victor Sidel discussed 
the effects of war and terrorism at the reunion 
of the School of Public Health at the New Haven 
Lawn Club. 
ABOVE Andrew McBride was one of two public 
health alumni inducted into the Alumni Public 
Service Honor Roll. 
War and public health 
In Vietnam the unintended conse¬ 
quences of war persisted after hostili¬ 
ties ended. Bomb craters filled with 
water and became breeding grounds 
for mosquitoes. The effects of Agent 
Orange continue to emerge genera- 
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Joseph Zaccagnino 
tions later. In early June, despite the 
declaration of an official end to the 
second Persian Gulf War, unexploded 
ordnance continued to kill and maim 
Iraqis. And the disruption of the Iraqi 
infrastructure spread disease, as evi¬ 
denced by cholera outbreaks. 
At the public health reunion on 
June 6 at the New Haven Lawn Club, 
keynote speakers Barry S. Levy, m.d., 
M.P.H., and Victor W. Sidel, m.d., 
co-editors of War and Public Health 
and Terrorism and Public Health, cited 
these and other examples as they 
described the effects of war and terror¬ 
ism on public health. 
In the United States, the anthrax 
outbreaks that followed the September 
II attacks highlighted the importance 
of public health and led to increased 
funding to handle bioterrorism. But 
according to Sidel, the overall picture 
is less than rosy. 
“What we have seen over the past 
year or so,” Sidel said, “is the diminu¬ 
tion of public health resources. Very 
few bioterrorism funds can be put 
to dual use. They do not make up for 
huge losses that health departments 
have suffered because of economic 
downturns and sharp reductions in 
state and local government budgets." 
In the afternoon, the discussion 
focused on the consequences of war 
for public health. Gregory Hess, 
M.p.H. ’95, who designed and man¬ 
aged the Peace Through Health 
program for the World Health Organi¬ 
zation, described how relief efforts 
offer a chance for peace-building. War, 
said Unni Karunakara, m.p.h. ’95, 
health advisor for Doctors Without 
Borders, disrupts many aspects of 
human security, including politics, the 
environment, the economy and food 
supplies. “All of those impact health,” 
he said. 
Other speakers included Bruce R. 
Grogan, m.p.h. ’76, principal in The 
Grogan Group, which advises both 
the private and public sectors on sus¬ 
tainable development and institutional 
capacity building, and Richard C. 
Poole, M.P.H. ’78, a Naval Reserve 
Medical Service Corps commander, 
who is organizing a conference on 
bioterrorism and emerging infectious 
disease in Latin America. 
Karunakara and Andrew D. 
McBride, m.p.h. ’77, were inducted 
into the Alumni Public Service Honor 
Roll. Karunakara was honored for his 
international work and McBride, direc¬ 
tor of public health for Milford, Conn., 
was honored for his years of service, 
including a stint as commissioner of 
health for North Carolina. For his 
service to the School of Public Health, 
Eric Mood, m.p.h. ’43, became the 
first recipient of a new award, the eph 
Alumni Bulldog Award. 
Joseph A. Zaccagnino, m.p.h. ’70, 
president and CEO of Yale-New Haven 
Hospital, received the 2003 Distin¬ 
guished Alumni Award. 
“Health care is an industry in tran¬ 
sition,” Zaccagnino said after receiving 
the award. “It is an industry that leads 
and lags the rest of the world. We have 
access to the most advanced medical 
technology anywhere, but our popula¬ 
tion is not as healthy as those in many 
other industrialized nations, and we 
have 40 million citizens who are not 
protected by medical insurance.” 
—John Curtis 
Lycurgus Davey 
Lycurgus “Bill” Davey receives the 
Peter Parker Medal 
In a ceremony in the Beaumont Room on May 
27, Lycurgus M. Davey, m.d. ’43, hs ’52, was hon¬ 
ored with the Peter Parker Medal for his service 
to medicine, the university and the medical 
school. “Dr. Davey’s dedication to the Yale 
School of Medicine and his profession continues 
to this day,” said then-Dean David A. Kessler, 
M.D. During his career Davey has won honors 
from medical organizations, published articles 
on neurosurgery and the history of medicine 
and served as a medical officer in the U.S. Navy 
during World War II. While president of the 
Association of Yale Alumni in Medicine, Davey, 
85, reached out to graduates beyond the East 
Coast to bring them into the fold. Davey 
thanked those assembled by paraphrasing the 
poet Robert Burns. “It is a gift to see ourselves 
as others see us,” Davey said, adding that “a 
person is truly a composite of all the influences 
of a lifetime.” 
i 
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1938 
65th reunion 
I Ben and Blanche Lyons moved 
this year to a new and very 
I active retirement community in 
West Redding, Conn., just 10 
miles from Westport and Nor- 
I walk, where he had his oph- 
‘ thalmology practice. We had 
I to forgo attending the 65th 
reunion activities because 
' Blanche fell and injured her 
pelvis just before the scheduled 
meeting. She is recovering at 
home after spending some time 
in the hospital. Lester Wallman, 
married to Elizabeth, has spent 
more than 50 years on the faculty 
of the University of Vermont 
Medical School as a professor 
of neurological surgery and 
remains active as an emeritus 
professor. The Wallmans found 
it difficult to attend the Yale 
reunion because of his close 
relationships at Vermont and 
was attending some of the fes¬ 
tivities of the reunion there. 
He has three children, a son, 
also a physician, and two daugh¬ 
ters. John McCillicuddy is in an 
I assisted-living facility in Fram- 
j ingham. Mass., and for the past 
I lo years has had extensive neu- 
i rological problems, including 
I severe loss of sensation in both 
I legs. Ed Roberge of Stratford, 
Conn., also suffers from exten¬ 
sive neurological problems. Jim 
Radcliff, who is almost blind, 
lives in Fairhaven, Mass., with 
his wife, Betty. With all of us in 
I our 90s, it is difficult to attend. 
I Ben Lyons 
1943 March 
60th reunion 
; Eight members of the Class of 
1943M attended the reunion in 
I June. Our class numbered 48 at 
; graduation.This was a remark¬ 
able attendance when one con- 
I siders classmates who are ill 
and those who have died, 
f “Bill” Davey received the 
H Peter Parker Medal this year for 
W exceptional service to the Yale 
■ medical school. (See opposite 
■ page.) He is preparing two 
H manuscripts for publication— 
A History of the Yale Medical 
Library and A History of 
Neurosurgery. Rocko Fasanella, 
now fully retired, contributed his 
unique charm, warmth and 
good humor during the gather¬ 
ing. He was accompanied by 
his daughter. Gerard Fountain 
retired from psychiatric consul¬ 
tation and supervision of psychi¬ 
atric residents at the Dartmouth 
Medical School. He devotes 
many hours each day to paint¬ 
ing. He comments: 
“Some paintings I keep; 
others I throw away.” 
Stuart Joslin, having complet¬ 
ed several decades of pediatric 
practice in Stratford, Conn., 
was increasingly concerned as 
to why so many children are 
unhappy. In 1970 he entered a 
psychiatric residency and a 
fellowship program at the Yale 
Child Study Center. Following 
this training he practiced child 
psychiatry in Stratford, retiring 
in 1998. He hopes to write a 
book about his experiences. 
Henry Markley practiced 
internal medicine in Greenwich, 
Conn., from 1950 to 1979. He 
continues to direct the Green¬ 
wich Hospital Home Care serv¬ 
ice, which he founded in 1956. 
This program added hospice 
care in 1980. It serves as a model 
for new home care programs 
throughout the country. 
Sophie Trent-Stevens, after an 
extraordinary career in tropical 
medicine in various parts of the 
world and 20 years of primary 
practice in Meriden, Conn., 
enrolled as a graduate student 
in the art department at Central 
Connecticut State University, 
and received her M.A. degree in 
art and art education in 1982. 
Her "new career” in the art field 
has led her to serve as a docent 
at the New Britain Museum of 
American Art. She spends much 
of her time writing poetry and 
painting. She has published four 
books of poetry. Many of her 
paintings have received awards. 
Morris Wessel continues as 
pediatric consultant two days a 
week at the Clifford W. Beers 
Child Guidance Clinic. He was 
one of the founders of the 
Connecticut Hospice 25 years 
ago and has an interest in the 
role primary pediatricians can 
play in serving children who 
experience significant losses. 
He has published several articles 
on this subject. Robert Wyatt 
retired lo years ago from a 
gynecological practice in Green¬ 
wich, Conn., and moved to Del 
Ray Beach, Fla. His son accompa¬ 
nied him to the reunion. 
Morris Wessel 
1943 December 
60th reunion 
On one of the rare perfect days 
of June this year we began our 
60th reunion celebration. Only 
Hunter Comly and Tom Bucky 
came. Tom, with wife Doris, and 
Hunter, with Rita lannace, 
attended the wonderful clam¬ 
bake together and sat with 
members of the Class of’43 
March and enjoyed their humor 
as they spouted poetry. We 
enjoyed ourselves, but regretted 
not seeing again our old class¬ 
mates; there are now only about 
20, and it was a lost opportunity. 
They would have appreciated, 
as we had, that the old coopera¬ 
tive spirit of Yale Med toward 
teaching and learning has not 
changed, despite the enormous 
growth. The new buildings on 
the medical campus were bewil¬ 
dering (after 60-plus years) but 
beautiful and inspiring.The 
modern medical student is for¬ 
tunate. We hope you’ll all attend 
the next reunion. 
Tom Bucky and Hunter Comly 
1948 
55th reunion 
Spring seems to have escaped 
us this year. But we did catch a 
day of sunshine on Friday, June 
6, which made the clambake all 
the more enjoyable. Although 
turnout for our class was disap¬ 
pointing, our financial secretary, 
Ben Rush, provided information 
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50 Alumni REUNION REPORTS 
about some of our absentees. 
Ben’s wife, Nora, passed away 
this year after a long illness. Ben 
continues in his retirement role 
as professor emeritus of surgery 
at the New Jersey Medical 
School, teaching medical stu¬ 
dents and imparting his medical 
and surgical experiences to resi¬ 
dents as well. He was able to 
take the Yale alumni trip to 
Australia. He reports that out of 
a class of 55,40 of us are still on 
this side of the green although 
the health status of most is 
unknown. He did report that Jim 
Needham and Art Terrill felt that 
travel was not an option and 
that others felt the same way. 
Our other secretary, Paul 
Koehler, was present with his 
wife. Marge. Paul has two new 
hips and a knee and has 
remained sequestered at his 
home in Newbury, N.H. Our for¬ 
mer secretary, Paul Goldstein, 
with spouse Betty, did not have 
to travel far from Branford, 
Conn., to be part of the celebra¬ 
tion. Paul spends his retirement 
keeping his hand in the delivery 
of health care. He is a supervis¬ 
ing attending in the pediatric 
primary care clinics at Yale-New 
Haven and the Hospital of St. 
Raphael. The young, sharp and 
bright residents help to keep his 
cerebral circuits stimulated. He 
finds they can still stand a bit of 
gray-haired wisdom. Howard 
Simon with wife Chris came to 
the clambake but couldn’t 
make the dinner on Saturday. 
Bob Lempke and wife Mary were 
present at our dinner at the 
Graduate Club, where we were 
guests of the medical school 
along with the Class of 1953. Bob 
has found his niche in retire¬ 
ment with painting in oils, 
acrylics and watercolors. He has 
been rewarded with shows both 
locally in West Lafayette, Ind., 
where he and Mary live, and 
statewide as well. Mary also cele¬ 
brated her reunion here with 
the Yale School of Nursing. Our 
stalwarts Allyn Bridge and wife 
Charlie came in from Moreno 
Valley, Calif. Charlie is the class 
agent for the School of Nursing 
’48 and celebrates her 55th as 
well. She is busy as a volunteer 
for AARP, helping seniors in tax 
counseling. Al is active in a 
Learning in Retirement program 
at the University of California, 
Riverside.They love California. 
News from some of our 
absentees; Bud Rowland and 
wife Ester were scheduled to 
be with us, but last-minute per¬ 
sonal matters cancelled their 
plans. Bud recently retired as 
chair of neurology and director 
of the Neurological Institute at 
Columbia. In his retirement he 
published a book celebrating the 
50th anniversary of the National 
Institute of Neurological 
Disorders and Stroke. Arden and 
Helen Miller just sold their 
home and moved into a villa 
nearby, where many of the 
chores of home ownership are 
delegated to others. Paul 
Goldstein found David Holman 
celebrating his 50th at the 
Graduate Club; David reported 
that brother Hal Holman, M.D. 
’49, is still full time at Stanford 
Medical School. Hal continues 
his research in autoimmune dis¬ 
orders and recently was cited by 
the American Rheumatoid 
Arthritis Society for his work. He 
spends most of his time promot¬ 
ing and developing a unique pri¬ 
mary care delivery system to the 
great Palo Alto community. 
We had a remarkable class 
and produced many stars in the 
medical science and health care 
fields.There are many great 
memories of years in New 
Haven, particularly the first class 
show we produced with the 
Class of’49 and the basketball 
and squash games in facilities 
now gone. You would be amazed 
at the renovation and expansion 
that has taken place.The Boyer 
Center, the Hope restoration and 
the new six-story building at 
300 Cedar St., the site of the old 
nursing dorm, are reasons alone 
to come back for our 60th. 
A stronger effort to attend 
would make for an even more 
pleasant event. Stay well! 
Paul Goldstein 
1953 
50th reunion 
Wow!! Our 50th reunion broke 
all alumni attendance records, 
with 27 of our 46 survivors, 
almost 60 percent, attending. As 
far as we can tell, this is the 
largest number and the highest 
percentage in medical school 
history. All enjoyed a busy and 
convivial weekend filled with 
camaraderie and love. 
Fred Young requests reverse 
alphabetical order so let’s say he 
and Mary Lou are among our 
most consistent returnees. Bill 
and Martha Wilson ferried in 
from Block Island. BUI and 
Connie Shepard were first-timers 
from California. From the coast 
of Maine came our devoted 
Barbara and Irv Rosenberg—he's 
in charge of our reunion fund 
giving. Flying in from Puerto 
Rico were Jose and Leila 
RamIrez-RIvera. Paul and Betty 
Oule arrived from Minneapolis. 
Rhoda and Ed Powsner arrived 
from Ann Arbor. Wick Potter was 
accompanied by his New Haven 
native, Joanne. Harvey Peck, still 
working full time, brought Betty 
Thompson, recently retired. 
Janiece and Bob Nolan returned 
for their second 50th, having 
been here last year. Faithful Hyla 
and Bob Melnick tooled up from 
Larchmont. Equally faithful in 
their attendance are Carol and 
Fred Lane. Dick Knowles, from 
Newport, accompanied by his 
delightful son and daughter, 
arrived for Saturday’s events. 
From across the country came 
Dave and Barbara Holman. Our 
other gracious first-time couple 
was Bernice and Bud Hauser. 
Vince Gott, who chaired the 
committee responsible for the 
class survey, brought both 
Iveagh and his PilotPoint. Peggy 
and Irv Goldberg returned, but 
had to leave before the Sunday 
brunch. Betty and Tom Centsch, 
now in Seattle, are reunion regu¬ 
lars. Lou Del Guercio, just elected 
to the Executive Committee of 
the alumni association, was 
accompanied by his wife, Paula. 
Rex Conn joined us once again. 
Tooling down from Auburn, N.Y., 
51 
were Emily and Bill Chaffee. 
Jeanne and Remi Cadoret made 
their every-five-year trip from 
Iowa. Hal Bornstein proudly 
received his Distinguished 
Alumni Service Award from then- 
Dean Kessler at the annual meet¬ 
ing of the alumni association. 
Claude Bloch joined us for much 
of the weekend. We enjoyed 
Andrea and Seth Abramson’s com¬ 
pany for both Saturday dinner 
and Sunday brunch. 
Our classmates and spouses 
were especially pleased and 
proud to welcome back four of 
[ our class widows: Anne-Marie 
Doppman, Doe Dunn, Helen 
i Etzwiler and Nina Whalen. While 
It was not always easy for them, 
we’re sure they enjoyed them- 
I selves, since they indicated 
they’d be back in five years!! 
As the 50th we were guests 
of the medical school for both 
the Friday night clambake and 
j Saturday night dinner. We had a 
I class meeting on Saturday after- 
I noon in the sparkling new edu- 
I cation and research building at 
I the corner of Cedar and 
I Congress, previously the site of 
I the nurses’ dormitory.The week- 
[ end closed on a talkative and 
I delicious note as Maureen and I 
accommodated 44 guests at our 
home for Sunday brunch. 
; The good Lord willing, all the 
classmates who returned plan 
j' to come back in five years. We 
I hope some of the non returnees 
I will also plan to join us. 
I Harold D. Bornstein Jr. 
I 1958 
I 45th reunion 
The 45th reunion of the Class 
of 1958 was an outstanding suc¬ 
cess with 20 members of the 
class entering into the festivi¬ 
ties. The high point of the week¬ 
end came when Andy McGowan 
and Bob Donohue each received 
the Distinguished Alumni 
Service Award. The awards were 
given during the alumni associa¬ 
tion business meeting, which 
was held in the new Aniyan 
Center for Medical Research and 
Education, a major addition to 
the campus on the site of the 
1963 
40th reunion 
Neither the noisy union demon¬ 
strators on Friday nor the rainy 
weather on Saturday could 
dampen our enthusiasm as we 
gathered in New Haven on June 
6th and 7th to celebrate our 
40th anniversary as Yale m.d.s. 
The sumptuous clambake on 
Friday provided an ideal venue 
for aggiornamento, with ample 
food, drink and conversation. 
Our class dinner Saturday night 
at Zinc on Chapel Street pro¬ 
vided a more intimate ambiance 
to continue our reminiscences 
and share our current lives. 
Apparent throughout the week¬ 
end were the youth and beauty 
of the wives and significant 
others in attendance. The salu¬ 
tary effects on their partners 
were quite obvious. 
Of the i6 classmates in 
attendance, three have retired 
completely: Dave (Carol) Fulmer 
from internal medicine. Bob 
(Mamie) Mueller from pul¬ 
monary medicine and Chuck 
Wilson from radiology. The pro¬ 
fessors In our midst, actively 
involved in advancing our pro¬ 
fession, included John (Michelle) 
Conte In infectious diseases. Bill 
(Jackie) Friedewald in biostatis¬ 
tics, Craig (Gail) Llewellyn in mili¬ 
tary medicine and Sheldon 
(Doren) Pinnell in dermatology. 
Also still actively in practice are 
Art Ackerman in anesthesia, 
Dudley (Hedva) Danoff in urol¬ 
ogy, Alex (Christine) Gaudio in 
retinal surgery, Bob Grummon in 
primary care, Ben (Janice) Harris 
in rheumatology, George Holsten 
in pathology, John (Judy) 
Mahoney and Jay Pomeranz In 
psychiatry. Hal (Barbara) Kaplan 
continues an active mix of gas¬ 
troenterology and hospital 
administration. 
After dinner we shared memo¬ 
ry lane excursions and philo¬ 
sophical insights and enjoyed a 
drop-in visit from then-Dean 
David Kessler. We distributed 
and shared the written responses 
from many classmates who sent 
their regrets along with some 
old nurses’ dormitory at 300 
Cedar Street. 
Friday afternoon, early 
arrivals gathered to talk about 
what they were doing and going 
to do. Pauline Wood, who had 
retired from the University of 
Rhode Island’s Health Services, 
was honored by having a build¬ 
ing named the Dr. Pauline B. 
Wood Health Services. Her medi¬ 
cal school compatriot, Marcia 
Kraft Goin, has not retired and 
has been elected president of 
the American Psychiatric 
Association. 
Otherwise the rest of the 
weekend was spent feasting. 
Friday evening the group 
attended the medical school 
clambake. Saturday there was a 
buffet at Harkness after the 
awards. A small group opted for 
clam pizza at Pepe’s. Saturday 
night we dined at the Union 
League Cafe through the good 
works of Michael Kashgarian. 
The dinner was attended by 
George K. Aghajanian, John P. 
Arnot, Gerard N. Burrow, David 
A. Carlson, John A. Creatura, 
Robert J. Donohue Jr., Lawrence 
Dubin, Donald D. Duncan, Marcia 
Kraft Goin, Stanley Harris, 
Michael Kashgarian, Theodore W. 
Lieberman, Andrew J. McGowan 
Jr., Albert Muggia, Carol F. 
Phillips, William B. Radcliffe, Paul 
A. Rudnick, Raymond W. Turner, 
John Patrick Wood and Pauline B. 
Wood. 
Jay Kislak and Jim Greenwald 
were scheduled to attend but 
never appeared. Ted Miller sent 
his regrets. Suffused with good 
fellowship and warm feelings 
for the Class of ’58, the group 
disbursed, vowing to return in 
five years. 
Jerry Burrow 
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insights. Barbara Rosenthal 
Almond continues an active 
practice in psychoanalysis; Dave 
Cross and Dave Holden have 
both retired from primary care. 
Professor Peter Gregory has 
gone emeritus, but still does 
some liver clinic time. Tom 
Tillack is still a full-time profes¬ 
sor of pathology, but going part 
time in July. Lee Talner is already 
on the part-time track in aca¬ 
demic radiology. Jerry Winer 
remains active full time as pro¬ 
fessor of psychiatry. 
We remembered with fond¬ 
ness and sadness our deceased 
classmates: Miguel Alonzo, 
Millard Amdur, David Langtree, 
Peter Livingston, Tom Peters, 
Marvin Skolnick, Robert Shapiro 
and Cary Van Calder. 
Finally, planning has already 
begun for our 45th reunion. 
Everyone in the class has been 
deputized to get on the phones 
and help ensure a massive 
turnout in 2008. We felt badly 
for all the classmates who 
missed out on sharing a great 
weekend. We missed them. 
Alex Caudio and Hal Kaplan 
1968 
35th reunion 
We shared our 35th reunion 
dinner in New Haven at the 
Quinnipiack Club. Then-Dean 
Kessler joined us for cocktails 
and spoke optimistically 
about new activities and build¬ 
ings on campus. 
The sad news for us was the 
loss of C. Bruce Wenger in 
November of 2002. We shared a 
note from his wife and remem¬ 
bered all our classmates who 
have died since graduation. 
Rutledge Currie enjoys the 
good life as a radiologist in 
North Adams, Mass. Alan 
Finesilver goes west from his 
Wisconsin rheumatology prac¬ 
tice to fly-fish in Montana as 
often as he can. William Flynn, 
surgeon in Boston, is as eager 
and energetic as ever, and ... con¬ 
tinues as a baseball "nut.” Grace 
Jordison-Boxer enjoys a practice 
in community medicine in 
Jackson, Mich., while husband 
Larry teaches and practices at 
the University of Michigan. 
Frank Lucente leaves New York 
City for long weekends at his 
country house near West Point, 
N.Y., where he enjoys the rural 
life and cooks wonderful things. 
Don Lyman continues as a public 
health official for the state of 
California and will serve as presi¬ 
dent of the American Cancer 
Society (California Division) in 
2003-04. Rod and Joan Martinez 
invite us all to visit them in San 
Pedro Sula, Honduras, where— 
they say—the town has gone 
modern with strip malls and 
traffic lights. Chuck Post seems 
to spend more time at sea and 
less in the air with his gadget¬ 
laden sailing craft. Elizabeth 
Short is moving from Washing¬ 
ton, D.C., to Pasadena, Calif., 
where her husband will be CEO 
of City of Hope hospital. 
Donald O. Lyman 
1973 
30th reunion 
Thirty years later, eight mem¬ 
bers of the Class of ’73 met for 
dinner and reminiscing at the 
Polo Grille in New Haven.There 
were the customary reunion 
activities reported elsewhere, 
but the eight of us that made it 
found that three decades make 
you closer, if grayer—all grayer 
except for Chris Kull Walsh, who 
everyone agreed hasn’t aged, 
and Tom Sweeney, whose red 
hair has matured well. 
Chris, a professor of clinical 
pediatrics and pediatric cardi¬ 
ologist at Albert Einstein, has 
completed two terms on the 
executive board of the ayam 
and was elected its new secre¬ 
tary. Her election keeps her 
on the board and the class rep¬ 
resentation at two, including 
yours truly, giving our class the 
singularly best representation. 
Chris brought her husband, Sean. 
Reunion gave me and my 
wife. Sue, the excuse and the 
motivation to come in from 
our new home in Santa Rosa, j 
Calif, where I now work for 
Kaiser as a full-time plastic sur¬ 
geon. Coincidentally, Jim 
Robertson is also in Santa Rosa, 
practicing nephrology. He 
couldn’t make it but sent his 
regards. I also had e-mails 
expressing similar wishes from 
John McDowell, Tom Romano, 
George Lister and my former 
Houston next-door neighbor. 
Bob Galloway. 
Next furthest, Marvin Miller, 
a pediatrician,flew in from 
Dayton, Ohio. 
David Coulter drove down 
from Boston. David is a pediatric 
neurologist at Children’s 
Hospital Boston and Harvard. 
Incidentally, David was recently 
elected vice president of the 
American Association on Mental 
Retardation, making him, in June 
2004, the first M.D. to serve as 
AAMR president in 20 years. 
The others were the faithful -i 
local denizens. Harry Romanowitz ’i 
and his wife, Sheila, remain in ' 
Stamford, where he now serves I 
as pediatrician-in-chief for 1 j 
Stamford Hospital. Jim Sullivan | 
lives in Waterford with his wife, F 
Rita, and practices adult and j 
pediatric neurology with a multi- { 
specialty group in Mystic. Tom | 
and Anne Sweeney and Rick 
and Dotty Young remain in New f 
Haven. Tom is in a private vascu- 1 
lar surgery practice, the heir • 
to Stern and Toole. Rick is chief 
of pediatrics at St. Raphael’s. 
The class population, accord¬ 
ing to most recent records, 
remains at 87. We noted and 
respected the passing of four: 
Omieri Mitoko, John Frederick 
Neil, Robert Joseph Polakwich 
and Charles F. Stroebel. 
The conversation over dinner, 
as you might expect, brought us 
up to date with current careers, 
children and interests.Then- 
Dean Kessler stopped by to visit. 
Reminiscing suffered somewhat 
from failing memories. Some 
paths have crossed in the last 30 
years, and Chris seems to have 
maintained correspondence 
1 
with most of the women. We 
had a room in the restaurant 
all to ourselves to chat the 
hours away, until we all realized 
it was getting past our bed¬ 
times— that never happened 
in medical school. 
Harold R. Mancusi-Ungaro Jr. 
1978 
25th reunion 
Twenty-five members of the 
Class of 1978 gathered in New 
Haven in early June for their 
25th reunion and enjoyed a 
warm, relaxing evening at the 
Graduate Club Saturday night 
for dinner.This report is offered 
with apologies for omissions, 
misspellings and misidentifica- 
tions, but with hope that eve/y- 
one will return for the next 
reunion to set the record 
straight. I’m especially sorry for 
crimes against spouse names. 
With Bacchus as my witness, 
and with your forgiveness, here’s 
who was there; Stan Tillinghast 
(cardiology practice in 
California) and wife Margaret, 
Sally Rudicel (alive and well in 
Boston), Kathy Ales (internal 
medicine and hospice care in 
Pennsylvania), Emily Fine 
(ob/gyn in New Haven), Suzie 
Hodgson (pediatrics) and hus¬ 
band John, Duke Cameron (car¬ 
diac surgery at Johns Hopkins), 
Jonathan Weinberg (psychiatry 
in Boston), Robert Kraft (plastic 
surgery on Long Island) and wife 
Ruth, Harry Staszewski (heme- 
onc in Long Island) and wife 
Sherrie, Stu and Amy Forman 
(psychiatry in Hartford), David 
Cawthon (neurology in Seattle), 
Ken Lee (hand surgery in 
California), Cindy Kretschmar 
(oncology in Boston) and hus¬ 
band John, Joanne Bodurtha 
(genetics in Virginia) and Tom 
Smith (oncology in Virginia), Eric 
Einstein (internal medicine in 
Norwalk) and wife Claudia, Art 
Cershkoff (internal medicine in 
Philadelphia) and wife Grace, 
Olag Ogland (psychiatry in 
Connecticut), Bob Celfand 
(endocrinology and drug devel¬ 
opment near New Haven) and 
wife Susan Boulware, Rich Baron 
(internal medicine in Philadel¬ 
phia), Tom Amatruda (oncology 
in Minnesota) and wife Lynn, 
Mac Hansing (directs a new 
internal medical school in the 
United Kingdom), Seth Powsner 
(psychiatry at Yale) and wife 
Elizabeth Yen, Kay Johnson-Keys 
(ob/gyn in South Windsor, 
Conn.) and her family. John 
Wagner was in for the reunion, 
but had to leave before the din¬ 
ner. Linda Hall and Marcia Wade 
both sent regrets. Pictures 
of each class member will be 
printed on decks of cards at 
the next reunion and distributed 
to make identification easier. 
See you in 2008! 
Duke Cameron and 
Seth Powsner 
1983 
20th reunion 
To describe the many contribu¬ 
tions of our classmates to the 
fields of clinical practice, aca¬ 
demic medicine, teaching of 
medical students and resi¬ 
dents, basic research, clinical 
research, government service, 
public health, international 
health, genomic and pharma¬ 
ceutical enterprises, state soci¬ 
eties and national association 
leaderships would take far more 
space than we are allotted. In 
fact, asking any classmate "what 
are you doing?" results in an 
answer that would more than 
fill our column in Yale Medicine. 
Included here are thus Just snip¬ 
pets of news about classmates. 
Once again we show that our 
class really is, as we sang in our 
second-year show theme song, 
"one singular sensation, Yale 
Med Class of’83 ...” 
Our 20th reunion included 
opportunities to learn what is 
new at Yale both academically 
and architecturally in the medi¬ 
cal area. A highlight of the 
reunion was the visit by then- 
Dean David Kessler at our class 
reunion dinner at Sage’s Grill 
(best known to us by its former 
name. Chart House, home of 
"mud pies” and ocean views). 
Attendees at our reunion 
included: Brent Neuschwander- 
Tetri, gastroenterology/hepatol¬ 
ogy, St. Louis University; Elena 
Citkowitz, cardiac rehabilitation, 
St. Raphael’s, New Haven, and 
teaching internal medicine, 
Yale; Lois Morton, psychiatry, 
Connecticut; Alan Reznick, 
orthopaedics, Connecticut, with 
Liz; Dwight Stapleton, cardiology, 
Guthrie Clinic, Pennsylvania, 
with Susan and their two kids; 
Michael Tom, otolaryngology. 
New York, with Linda; David 
Norton, pediatrics, Mary Lane 
Hospital, Ware, Mass., and 
teaching and international 
health work; Leslie Creengard, 
mathematics and computer sci¬ 
ence, NYU, and founder, software 
company, Connecticut; Steve 
Socket, immunobiology/allergy. 
New York. 
Other classmates heard from 
or about recently include: Peter 
Blier, pediatrics, Riverbend 
Medical, Massachusetts; Alan 
Bloom, ophthalmology, 
Rochester, N.Y.; Linda Grais, 
founder, structural biology com¬ 
pany, California; Jim Crober, 
rheumatology. Northwestern, 
Illinois; Tammy Harris, family 
practice, Southboro, Mass.; David 
Helfgott, internal medicine/ 
infectious disease, nyc; Don 
Johns, neurology, Beth Israel 
Deaconess Medical Center, 
Massachusetts; Judy Melin, 
internal medicine and adminis¬ 
tration, Lahey Clinic, Massa¬ 
chusetts; Dan Oren, psychiatry, 
Bristol-Myers Squibb, and teach¬ 
ing psychiatry, Yale; Susan 
Seward, internal medicine, 
Massachusetts General Hospital; 
Dan Sosin, CDC, Atlanta; Valerie 
Stone, internal medicine, 
Massachusetts General Hospital; 
Eric Winer, medical oncology, 
Dana-Farber Cancer Institute, 
Massachusetts; Tina Young 
Poussaint, radiology. Children’s 
Hospital, Massachusetts. 
We owe special thanks to 
David Helfgott for doing the 
initial coordination work to get 
us ready for our reunion. Many 
thanks to David Schwartz for 
leading the philanthropy efforts 
for our class. Particular thanks 
to David Norton, Elena Citkowitz, 
Leslie Creengard and the 
alumni association staff who 
provided information about 
our reunion events. We are, as 
always, indebted to Patty 
DiNatale, Sharon McManus and 
Diane Morrissey of the Yale 
Medical School Alumni Affairs 
Office for their terrific coordi¬ 
nation and planning efforts, 
and to Claire Bessinger of Yale 
Medicine for assuring our 
events are recorded. Let’s all get 
together in 2008 to hear about 
each other’s accomplishments. 
See you (all) at the 25th! 
Judy Melin 
1988 
15th reunion 
We had an intimate number of 
returnees for our 15th reunion. 
Ironically, the Yale medical school 
campus seems more different 
than any of our classmatesi 
Things are looking clearer to 
Joi Barrett, who recently had 
LASIK surgery. She can now find 
her children in the swimming 
pool.This is important in Sacra¬ 
mento, Calif, where Joi is an 
internist. Joi takes the farthest- 
traveled award, hands down. 
Closest was Mike DiCiovanna, 
who walked over after oncology 
rounds to get one of the last 
lobsters Friday. Mike devotes 
most of his time to breast can¬ 
cer research. 
Martha Brochin brought hus¬ 
band Joe Camilleri and two chil¬ 
dren. As a pediatrician, she 
seems to know everyone in the 
greater New Haven area and 
had a lot of news from various 
encounters at Stop and ShopI 
Rhonda Karol and Steve 
Bowers joined us for Saturday 
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dinner. Rhonda recently took 
over her father’s Queens derma¬ 
tology practice. She and hubby 
Gordon Berger have two chil¬ 
dren. Steve spent five years in 
the Indian Health Service before 
returning to New Haven. 
Apparently an ER job and family 
aren’t challenging enough, so he 
is beginning the master’s in 
public health program. 
A weekend highlight was a 
tour of the new anatomy lab 
with Bill Stewart. Shiny stainless- 
steel boxes with downdrafts 
hold cadavers, and computer 
monitors hang from the ceiling. 
The entire course is available 
online.The beautiful new 
Aniyan Center (half classroom, 
half lab space) towers over 
our old parking lot, and the site 
of Acky’s coffee shop is now 
the bookstore. 
Several classmates sent news 
via e-mail. Ken Andreoni is doing 
transplant surgery in Chapel 
Hill, N.C., and has two daugh¬ 
ters. He reports that Joe Dizon 
lives in Westchester and is com¬ 
muting into NYC. Walt Stadler 
does oncology in Chicago, and 
Cerri Mogavero reads X-rays in 
Indianapolis. 
Lisa Conrad Larkin writes 
from Cincinnati, where she prac¬ 
tices internal medicine and has 
two children. She hears from 
Kelle Harbert Moley, who does 
reproductive medicine research 
in St. Louis. Depending on the 
season, Mike Mockavack tells me 
he is either snow or water ski¬ 
ing, when he isn’t doing oph¬ 
thalmology. 
Nicole Davis and Alex Vukasin 
couldn’t come, due to their 
children’s soccer and ice hockey 
schedules. (Who’s running 
our lives, anyway?) They have 
surgical practices (gynecology 
and urology, respectively) in 
Princeton, N.J. 
In Alamo, Calif, Sue Valley 
rides horses with her daughter. 
Julia won a world championship 
in 2000 in Louisville! At work. 
Sue is the chief of anesthesi¬ 
ology at the VA Northern 
California Health Care System. 
I recently saw Leslie 
Weinstein and met her 2-year- 
old son. Leslie has a solo ent 
practice in San Francisco. I am 
practicing dermatology in 
Rhode Island. In the winter, we 
enjoy skiing. In other seasons, 
I live on soccer fields with my 
three children. 
I hope all of you will put June 
2008 on your calendars and 
come for the 20th!! 
Kathleen Carney-Godley 
1993 
10th reunion 
Most of us agreed that we 
looked the same and that no 
one had aged. Most of us had 
moved beyond or were on the 
verge of moving beyond the 
fellowship-training era. Conver¬ 
sation focused on practice asso¬ 
ciations, billing, mortgages and 
children. In keeping with Yale 
tradition, the class continues to 
demonstrate leadership in areas 
in and out of medicine. We were 
all delighted to find the Yale 
System still intact!! The reunion 
was attended by i8 alumni and 
several family members. 
Juan Bartolomei is practicing 
neurosurgery at Yale. He and 
his wife, Nicole, were both pres¬ 
ent. A few alums retired to 
Juan’s place in Madison, Conn., 
after the clambake to remi¬ 
nisce about good times. Adina 
Chelouche and husband 
George Tellides, m.d., a cardio¬ 
vascular surgeon at Yale, came 
with children Theodore, Julia 
and Alexander. Adina is practic¬ 
ing obstetrics and gynecology 
at Yale. 
Eileen Deignan arrived with 
husband Victor Hsu, m.d. 
(rheumatology, Brigham and 
Women’s Hospital), and son 
Evan. Eileen is in a private der¬ 
matology practice in the Boston 
area. Dee Dockery, who made 
the trip from Dallas, Texas, is 
practicing radiology at Baylor 
University Medical Center. Ann 
Dolinsky lives in New York City, 
where she is an attending psy¬ 
chiatrist at Columbia University. 
Stephanie Falcone, who brought 
her daughter, Hana, practices 
general surgery and specializes 
in breast surgery in New York. 
Christopher Fey is practicing 
radiology in Greenwich, Conn., 
and continues to make even the 
grumpiest among us laugh. He 
was all smiles, as was everyone 
else around him. Joe Fodero 
made the trip from Livingston, 
N.J., where he practices plastic 
surgery. Myles Greenberg, who 
traveled from North Carolina, 
has joined a venture capital 
investment firm interested in 
promoting biotechnology. He 
continues to serve as part-time 
faculty in emergency medicine 
at the University of North 
Carolina. Gregory Heinen 
brought the entire clan all the 
way from Riverside, Calif His 
wife, Judith, and children, 
Geoffrey, Jonathan and Katrina, 
were all a pleasure. Greg is prac¬ 
ticing orthopaedic surgery and 
specializing in arthroscopic 
reconstruction. John Houston 
practices pediatric urology in 
Chicago at the Children’s 
Memorial Hospital, Northwest¬ 
ern Medical School. Robert 
lannone practices pediatric 
hematology-oncology in 
Philadelphia at the University of 
Pennsylvania. Michael Kaiser is 
an attending neurosurgeon at 
Columbia Presbyterian in New 
York. His wife, Michelle, is an 
attending at Columbia in inter¬ 
nal medicine. Children Nicole, 
Cindy and Christopher were 
present. William King made the 
trip from Philadelphia. He is 
currently practicing general 
pediatrics at Temple University 
Children’s Medical Center. 
Stephen Marshalko, wife Lisa 
and son Stephen were present. 
Stephen completes his fellow¬ 
ship in interventional cardiology 
at Yale this June. York P. Moy 
practices urology in Waterbury, 
Conn. He and wife Veronica and 
son Nicholas were present. 
Stephen Solomon made the trip 
from Baltimore. He is an attend¬ 
ing radiologist at The Johns 
Hopkins Hospital & Health 
System.Thanks go to Dave 
Tendler who rallied many of you 
to attend. Dave made the trip 
from Durham, N.C., where he is 
an attending gastroenterolo- 
gist/hepatologist at Duke 
University Medical Center. 
The reunion was certainly a 
joyous celebration and ended 
after dinner with hugs, hand¬ 
shakes and good wishes. We 
hope all 1993 grads will plan to 
be in New Haven in 2008 to cel¬ 
ebrate our 15th reunion. 
John T.B. Houston 
1998 
5th reunion 
A record-breaking 26 members 
of the VMS Class of 1998 
returned to New Haven for our 
5th Reunion. 
Childsy (Robinson) Art is a pri¬ 
vate practice pediatrician in 
Williamstown, Mass., where she 
lives with her husband, Jamie, 
and daughter, Maddie. Although 
she misses California, she does 
appreciate her proximity to the 
Woodchuck Cider brewery. 
Not content with a mere 
M.D., Senai Asefaw has been 
moonlighting as a hospitalist at 
YNHH while pursuing an m.b.a. 
at the Yale School of 
Management. 
Tamar Braverman and hus¬ 
band Michael live in Westville 
with their daughters, Yael 
and Talia.Tamar is a community 
internist, and reports annual 
attendance at the second-year 
show, although we’re not 
sure why. 
Christ! Cavaliere drove from 
Michigan to the reunion with 
her grandmother, and reported 
making a U-turn across the medi¬ 
an of I-80 to avoid a jackknifed, 
burning tractor-trailer. Christ! is 
finishing the two-year research 
component of her plastic surgery 
residency at the University of 
Michigan and starts back on the 
wards this summer. 
Also a resident in plastic sur¬ 
gery at Michigan, Catherine 
Curtin has embraced the oppor¬ 
tunity to be a Robert Wood 
Johnson Fellow by taking art les¬ 
sons, joining a women’s soccer 
team and studying epidemiology. 
She and Terry Spauling also 
enjoy the occasional golf round. 
Dan Coghlin has just joined 
wife Barb in a community pedi¬ 
atrics practice in Rhode Island. 
Their infant daughter, Molly, 
states that all of her immuniza¬ 
tions are up-to-date. 
A second-year dermatology 
resident at Northwestern, 
Naomi Donneliey enjoys living in 
Chicago, where she and her 
golden retriever take regular 
walks in Lincoln Park. Naomi’s 
dog is named after the Mark 
Twain character. Huckleberry 
Finn. He is not, as we had origi¬ 
nally thought, named after the 
Hanna-Barbara character. 
Huckleberry Hound. 
Caroline Dumont and hus¬ 
band Brian Tobin continue to call 
New Haven “home” and to call 
their new daughter “Cecille.” 
Caroline is finishing up her psy¬ 
chiatry residency on a part-time 
basis; though she has two more 
years of 20-hour weeks, she 
appreciates the time she gets to 
spend with Cecille and Brian. 
Lori Etter is joining a derma¬ 
tology practice in Durham, N.C. 
She and her boyfriend, Jeff 
Welty, have recently purchased a 
home to share with their dog, 
Miliie, and their dog-to-be, Otis. 
Naomi Botkin has one year 
ieft in her cardiology fellowship 
at UMass. She lives in Worcester, 
and purports to be able to pro¬ 
nounce it. 
Karin Finberg, after spending 
47 consecutive years in New 
Haven, is heading to Boston 
for a pathoiogy residency at 
Mass General. 
Scott Floyd has finished an 
internship at St. Raphael’s. He, 
wife Stephanie and son Jack 
have bought a house in Boston, 
where Scott will complete a 
residency in radiation oncology. 
Actually, we doubt Jack really 
contributed much toward the 
down payment. 
Peter Hunt stayed on at UCSF 
for a fellowship in infectious 
disease. He has been awarded 
a five-year grant to study Hiv. 
He reports playing trumpet 
fortnightly in a band that fea¬ 
tures Finnish folk tunes as 
well as jazz standards. 
Now a dermatology faculty 
member at the University of 
Maryland, Lynda Kauls is settling 
into Baltimore with her husband, 
Geoff Emerson, an ophthalmol¬ 
ogy resident at Johns Hopkins. 
Despite looking like he hadn’t 
slept in about two years. Matt 
Levine reports being thrilled to 
be a general surgery resident at 
Mass General. Matt and wife 
Leslie enjoy living in Charlestown 
with their dog. Jack. 
After finishing a combined 
residency in medicine and 
pediatrics. Rich Lyn-Cook is stay¬ 
ing at Mt. Sinai for a med-peds- 
epidemiology fellowship. His 
wife, Monica Lopez, is a surgery 
resident at Einstein. 
Ursula McVeigh has finished 
her chief resident year in inter¬ 
nal medicine at the University of 
Vermont and will stay on as a 
hospitalist in Burlington after a 
one-month solo hike along the 
Appalachian Trail. 
Matt Mealiffe made a heroic 
effort to make it to the reunion, 
coming up for Friday night 
despite having to present a 
poster at the gene therapy 
meeting in Washington, D.C., 
on Saturday afternoon. Matt 
continues his fellowship in 
medical genetics at the 
University of Washington, and 
will be moving down the block 
to a new lab at the Fred 
Hutchinson Cancer Research 
Center this summer. 
Heather Nye has completed 
her combined med-peds resi¬ 
dency at Harvard and is heading 
out to San Francisco to be a hos¬ 
pitalist at UCSF. She is particu¬ 
larly looking forward to being 
near family after i6 years of East 
Coast living. 
Leo Otake is completing his 
internship at ynhh in general 
surgery on his way to becoming 
a plastic surgeon. 
Greg Raskin’s daughter 
Daphne won several awards at 
the reunion, including Least 
Likely To Smear Herself With 
Food. Greg, who works at a 
biotech investment fund in nyc, 
thinks that Daphne got most of 
her charm from her mother, 
Jackie Weiss. 
AJ. Rubineau (nee Babineau) 
is a family practice resident at 
Brown. She and partner Brian 
Rubineau (ne Rubin) have two 
children, Eli and Daisy. 
Lisa Gaie Suter is completing 
a rheumatology fellowship at 
Yale before starting a two-year 
Robert Wood Johnson fellow¬ 
ship. She and husband Lindsay 
have an i8-month-old son, Fenn, 
and a lo-foot waterfall, com¬ 
plete with sluice gate. 
Having finished her pedi¬ 
atrics residency at the University 
of Washington, Meena Thayu 
has been a hospitalist at the 
University of Pennsylvania for 
the past year. She eagerly antici¬ 
pates starting a pediatric Gl fel¬ 
lowship at CHOP. 
Steven Williams is a plastic 
surgery resident at ynhh. 
We would like to apologize for 
having teased him so much 
during medical school for his cell 
phone—if only because we 
pretty much all have one now. 
Just another reminder that 
it’s a fine line between punch 
line and prophet. 
Ashley Wivel is a chief resi¬ 
dent in emergency medicine at 
the University of Indiana. She 
and husband Ryan Kime, also an 
ER resident, have become huge 
NASCAR fans. 
Greg Raskin 
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A new MASH for a new millennium 
Hymns, novels and phone calls home sustain a Yale alum 
on the ground in Baghdad. 
By Cathy Shufro 
Intensive training for handling wounds prepared Air Force 
Major John C. Lundell, M .□. ’94, for the casualties he 
might encounter as a battlefield anesthesiologist. But in 
the weeks after Lundell arrived at his post in a tent 
hospital at the Baghdad airport in early July, his caseload 
resembled family practice more than trauma medicine. 
At Camp Sather Lundell treated several patients who were 
dehydrated and some who had blood in their urine, 
sutured cuts inflicted by can tops and pocket knives and 
took care of an airman having a heart attack. 
All that changed with the bombing in August of 
the United Nations office in Baghdad. Since then, his wife 
Andrea L. Lundell, M.D. ’94, reports from their home in 
Texas, he has treated both soldiers and civilians, Americans 
and Iraqis, some with severed limbs or serious burns result¬ 
ing from the ongoing violence in Iraq. And it turns out 
that at Brooke Army Medical Center in San Antonio, where 
she is chief of cardiothoracic imaging, she has treated 
patients her husband stabilized in Baghdad. “A lot of the 
bad cases end up coming here for further work,” she said. 
In e-mail messages to Yale Medicine in July, Lundell 
reported that when he was not working shifts, he kept 
busy playing bridge with tent mates, washing his clothes 
and reading novels, the Book of Mormon and the hymns 
he’d loaded onto his Palm Pilot before leaving his home 
base in Texas. When he couldn’t sleep, his cycle disturbed 
by the rotating shifts, Lundell sometimes hung out at the 
hospital, chatting with those on duty or with other rest¬ 
less airmen who had drifted up to the hospital tent. Twice 
a week, Lundell could count on phoning his wife and 
children, 5-year-old Madeline and 3-year-old John W. 
Lundell said he felt safe where he worked, well inside 
the base for 1,500 Air Force personnel. He went to Iraq 
as part of what he calls “a lean, mean wound-fighting 
machine,” a five-person mobile field surgical team that 
also includes a general surgeon, an orthopaedic surgeon, 
an emergency medicine physician and a critical care nurse. 
With equipment they carry in 70-pound backpacks, the 
team can assemble a portable OR in less than two hours. 
Their supplies can see them through 10 life- or limb-saving 
operations.The team can also collect fresh blood from any 
service member whose blood type, printed on dog tags, 
matches the patient’s. 
A week before his departure Lundell explained 
that his team is trained to treat patients during “the gold¬ 
en hour of trauma,” when the team has the best chance 
of saving a life by controlling bleeding—which causes 
about half of combat deaths. “The old system of dragging 
them off the battlefield and shipping them off to an Army 
hospital took much more time. ...We can pack a spleen 
or amputate a leg,” he said. Now the team can stabilize 
patients before sending them on to a larger hospital. 
Team members do face limitations. For instance, they 
can’t use all their fluids on a single patient, even if a life 
depends on it. “In a level one trauma center, where we 
have basically unlimited resources, there’s a better chance 
of saving someone that is severely injured, but in the field 
there would be nothing left for the nine other patients 
we’re supposed to treat,” says Lundell. “Sometimes you 
have to make tough decisions and decide who is going to 
be treated expectantly, meaning comfort measures— 
mostly analgesia, morphine.” 
The possibility of letting a patient die “is something 
we’ve had to think about.... That would be rough, 
because we’re trained to not let people die. We’re trained 
to save lives.” 
Lundell’s role in the mobile field surgical team 
brought him what he jokingly calls “my 15 seconds of fame.” 
In May, he appeared in “Blood on the Battlefield,” a National 
Ceographic Explorer documentary on battlefield medicine. 
Lundell’s 15 seconds (actually more like 30) showed his team 
practicing setting up an OR and then operating on “victims” 
hemorrhaging fake blood. Lundell and his team members 
actually learned most of what they know of trauma care by 
treating real-life victims at Wilford Hall Medical Center on 
Lackland Air Force Base in San Antonio, where they were sta¬ 
tioned before going to Iraq. Lundell said taking care of peo¬ 
ple injured in drunken-driving accidents kept them “up to 
speed in dealing with people who are bleeding to death.” In 
Baghdad, the team is working as a “building block” for a 
hospital staff of about 25. They work in a 20- by 70-foot air- 
conditioned vinyl tent with a wooden floor. 
57 
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^ Lundell supported the U.S. invasion of Iraq, likening 
‘ it to surgery. “You really would rather not operate on peo- 
1 pie. An operation is a controlled injury, controlled trauma. 
But if you have to operate, you want a finely honed instru¬ 
ment. The military is the knife. You have to cause injuries, 
I but hopefully it's for the greater good.... Certainly I regret 
some of our troops having to pay the ultimate price to free 
i the Iraqi people, but I do support the president.” He says 
i that his wife agrees, then adds: “I don’t know how our sup- 
! port would change if something were to happen to me. 
It’s not something we have much control over. We do our 
j best to do what we signed up to do.” 
Doing what they signed up to do has made life for 
the couple unpredictable since September n. Both were in 
the Air Force and were periodically “at risk” for deployment, 
potentially at the same time—in which case the children 
would have stayed with relatives. The pressure eased in 
July 2002, when Andrea completed her three-year Air Force 
obligation and began a civilian job at Brooke Army Medical 
Center. Both husband and wife, who met as first-years at a 
volleyball game on Harkness lawn, took part in the Armed 
Forces Health Professions Scholarship Program. The govern¬ 
ment paid their medical school costs and provided a salary 
for John’s fellowship year in cardiothoracic anesthesia. In 
return, the Lundells spent a year in service for each year of 
support they received: she for three, he for five. 
Andrea Lundell says she is coping with her husband’s 
absence, expected to last four months, by keeping the big 
picture in mind: “I try to remember that there are many 
other men and women over there who are making sacri¬ 
fices, too, and there have been many others who have in 
the past.... I keep a positive attitude.” She feels supported 
by colleagues at Brooke Army Medical Center. "A lot of peo¬ 
ple over there know what it’s like to have somebody go.” 
When John Lundell completes his Air Force service in 
June, he expects to go into private practice to maximize time 
with his family. “I like doing and I like teaching. If I can find 
a place where I can teach some and do, then I’ll be happy.” 
Lundell is grounded by his faith as a Mormon, which 
is “part of the fiber of my being. It helps me feel prepared 
for whatever may come.” 
Cathy Shufro is a contributing editor of Yale Medicine. 
In July, John Lundell, a 1994 gradu¬ 
ate of the medical school and 
a major in the Air Force, arrived in 
Baghdad, where he is an anes¬ 
thesiologist in a mobile surgical 
team that can assemble a battle¬ 
field operating room in less 
than two hours. 
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TOP TO BOTTOM 
Ruth Potee, with her husband, 
Stephen Martin, also a physician, 
and their children, Ella and Ben. 
Alexander Zuckerbraun continues 
to see patients and raises grapes 
on his vineyard in California. 
Laurence Tanner heads New 
Britain General Hospital, where 
he keeps seeking ways to ease 
the financial crunch. 
Medicine and society 
have changed—but not 
conditions for residents 
When Ruth Potee’s father started 
his medical residency at Boston 
City Hospital in 1949, the system 
was pretty simple: young medi¬ 
cal school graduates received 
room, board and a lab coat in 
return for patient care and the 
training that went along with it. 
At the time, only residents at 
Bellevue Hospital in New York 
City received a stipend. 
That changed when Gale 
Potee and his colleagues formed 
the first house staff association 
in the country and won stipends 
from the city of Boston. "It started 
a movement where residents 
were recognized as not just stu¬ 
dents, but doctors who deserve 
some compensation,” says Ruth 
Potee, M.D. ’99. But change is 
slow. Half a century later, when 
Potee was deciding where to 
train, she could safely expect a 
paycheck, but she also wanted 
an Institution where the house 
staff had a say in how the hospi¬ 
tal runs. “I didn’t want to be at a 
place where I was a voiceless 
peon in the system,” she says. 
She joined Boston Medical 
Center, where in 1972 the house 
staff association became a 
union with bargaining rights, 
and became an active member 
of the organization her father 
had helped found. 
In 2002, In the final year of 
her residency in family medicine, 
Potee became national president 
of the union, the Committee of 
Interns and Residents (cir). 
(Union rules allow members to 
remain on the executive commit¬ 
tee for two years after complet¬ 
ing a residency.) Now the largest 
house staff union In the country, 
CIR still represents only about 12 
percent of the nation’s 100,000 
residents. "It’s hard to organize 
residents,” Potee says. "They have 
no time to organize themselves. 
They are so tired and broken and 
depressed, they can’t imagine 
things ever getting better.” 
But Potee firmly believes resi¬ 
dents need to be organized, 
especially since medicine and 
medical students have changed 
so much since the system was 
devised. For much of the 20th 
century, residents were usually 
young, male and single.Today’s 
resident is far more likely to be 
older, female, married and a par¬ 
ent. Potee was a member of the 
first majority female medical 
school class in Yale history, 
entering medical school at age 
26 after working in politics in 
Texas and New York. She mar¬ 
ried and had her first child while 
at Yale, and gave birth to her 
second child during residency. 
(Half of women in medicine give 
birth during medical school, resi¬ 
dency or fellowship, says Potee, 
who wrote her thesis on medi¬ 
cine and motherhood.) 
Through her position at cir, 
Potee works to make residency 
better for today’s graduates. 
Founded in New York City’s pub¬ 
lic hospitals in 1957, cir won a 
collective bargaining agreement 
and established a benefit plan 
for house staff early on, and in 
1975 negotiated a contract provi¬ 
sion limiting call to one night in 
three. In a landmark 1999 case 
brought by CIR, the National 
Labor Relations Board ruled that 
residents are employees, not 
students, cir helped shape New 
York state’s Bell Regulations on 
duty hour limits for house staff, 
a model for the new duty hours 
guidelines from the Accredita¬ 
tion Council for Graduate 
Medical Education, which went 
into effect in July. 
The union also fights for 
minimum staffing levels for 
ancillary hospital personnel, so 
hospitals can’t cut nurses or 
technicians and expect residents 
to fill in. Those kind of cuts are 
bad for residents and for 
patients, Potee says. "The hospi¬ 
tal can’t balance its budget on 
the backs of residents,” she says. 
But with budget deficits in most 
states, hospitals’finances aren’t 
likely to improve any time soon. 
"I worry that residents are the 
group that tends to fill in the 
cracks, and the cracks are ever 
widening.” 
—Karen Schmidt 
From Brooklyn to the 
vineyards: how a surgeon 
became a country doctor 
Alexander Zuckerbraun, PH.D., 
M.D. ’55, often finds fresh fruits 
and vegetables in the back of his 
pickup truck—in late May two 
sacks of oranges, a week later a 
flat of Bing cherries. These 
anonymous gifts come from this 
"country doctor’s” patients who 
are farm workers. Although at 
age 79 Zuckerbraun calls himself 
a country doctor, he is really 
a hybrid: a family practitioner 
who spent 20 years as a sur¬ 
geon, a California ranch owner 
with a Brooklyn accent. 
Zuckerbraun took a while 
getting to medical school. 
After studying chemistry at the 
University of Michigan, he was 
drafted in 1943 and spent three 
years working on the atomic 
bomb project at Columbia Uni¬ 
versity, Oak Ridge,Tenn., and Los 
Alamos, N.M. When he applied 
to study medicine 14 schools 
rejected him. He’s not sure why 
he was turned down; perhaps 
it was because his stellar chem¬ 
istry grades contrasted with 
some dismal grades in other 
subjects. (He recalls a D in his¬ 
tory.) Nonetheless, he says, "I 
was going to do medicine what¬ 
ever it took.” Figuring a ph.d. in 
chemistry would be good prepa¬ 
ration for medicine, he earned 
his doctorate at the University 
of Minnesota and applied again. 
He got into Yale. 
Zuckerbraun and his new 
wife, medical technician Ruth 
Hitchcock, moved into veterans’ 
housing—a two-family Quonset 
hut near the Peabody Museum. 
Zuckerbraun laughs when he 
recalls inviting an admired pro¬ 
fessor, pathologist Averill A. 
Liebow, m.d., and his wife over 
for drinks. "They acted like they 
were very much at home.This 
was almost like a shack.” 
More daunting than living in 
a near-shack, however, was the 
transition from chemistry to 
medicine. He didn’t like anato¬ 
my at first, and he suspects he 
would have failed the first few 
quizzes at some other medical 
school."I wouldn’t have made 
it without the Yale System. Any 
other medical school would 
have thrown me out.” After 
graduation and surgery resi¬ 
dency, Zuckerbraun and his wife 
settled in Santa Maria, a small 
town near the central coast of 
California where they raised 
seven children. 
In the late 1970s Zuckerbraun 
made another radical lifestyle 
change."! decided to be a coun¬ 
try doctor, to work out of my 
office. No appointments. You 
just come in when you’re sick. I 
won’t see you in two weeks; I’ll 
see you when you’re sick." 
He still thinks like a surgeon, 
always considering both a surgi¬ 
cal and a medical remedy for a 
problem. From his patients, most 
of them field workers, he has 
learned to speak fluent Spanish. 
Along with his prescriptions 
comes preaching."! don’t 
preach religion. That’s personal. 
I preach education." He asks a 
young man, "Would you like to 
keep doing what you’re doing 
for the next 30 years? Bent over 
picking strawberries?” 
Not that Zuckerbraun is 
averse to picking fruit himself. 
He and his wife own a 317-acre 
ranch east of town, where 
nearly an acre of wine grapes 
should be ripe for winemaking 
in a year or two. Zuckerbraun 
has no plans to retire. "I wanted 
to be a medical doctor since 
I was five years old. What am 
I supposed to do, quit now?” 
He hopes to be practicing 
medicine in 2005, he says, and 
to join his classmates in cel¬ 
ebrating their 50th reunion. 
—Cathy Shufro 
On the front lines 
of the battle to provide 
affordable care 
New Britain General Hospital 
was the eighth-largest employer 
in town two decades ago. Now 
it’s number one. That may sound 
like good news, but it’s not, says 
hospital President and CEO 
Laurence A. Tanner, M.P.H. ’72. 
His hospital now ranks as top 
employer because the city’s 
seven largest manufacturers all 
left town, went under or 
reduced their work force. Tanner 
has long experience with how 
that kind of economic pressure 
affects health care: since study¬ 
ing hospital administration 
under John Thompson at Yale in 
the early 1970s, he has served 
three decades as a hospital 
administrator, working for 15 
years at two other Connecticut 
hospitals before joining New 
Britain General as its president 
in 1987. Now Tanner foresees 
"chaos” as local economic pres¬ 
sures combine with cuts in gov¬ 
ernment funding and the end of 
the "Robin Hood theory of 
health care.” 
The struggle to survive finan¬ 
cially overshadows all other con¬ 
cerns for Tanner as he runs the 
Central Connecticut Health 
Alliance, which employs 3,000 
people and comprises three hos¬ 
pitals, two nursing homes, two 
assisted-living facilities and a 
mental health center with sev¬ 
eral locations. Two-thirds of New 
Britain General’s income comes 
from "inadequate and drastically 
shrinking” state and federal 
funds. Last spring, Connecticut 
was paying only 50 cents per 
dollar of costs for Medicaid, 
while the federal government 
paid 90 to 94 cents per dollar 
for Medicare. Insurance compa¬ 
nies no longer bridge those gaps 
through higher fees paid by 
insured patients."Industry has 
said they can’t afford it,” says 
Tanner.The problem is com¬ 
pounded by the expectation of 
patients that they will have 
access to the latest diagnostic 
technologies and therapies, 
regardless of cost. 
New Britain Generai has 
controlled costs by restricting 
prescription formularies, post¬ 
poning building repairs and join¬ 
ing with other hospitals to buy 
supplies.The hospital has also 
diverted funds from education 
and prevention into the operat¬ 
ing budget. "We think we’re 
doing a disservice from a public 
health perspective, but we have 
a financial imperative,” says 
Tanner."! have the day-to-day 
dilemma of how to provide care 
for the person in the hospital 
today.”Tanner worries that 
recent medical advances and 
those on the horizon will be 
denied to patients who can’t 
pay. For instance, a cardiac defib¬ 
rillator like Vice President Dick 
Cheney’s costs $30,000 to buy 
and implant. Medicare reim¬ 
burses less than $20,000. So 
who gets to have one? 
Tanner’s strategy for improv¬ 
ing financing long term is to 
talk to policy-makers. He occa¬ 
sionally visits the Connecticut 
Legislature and has twice 
addressed the federal House 
Ways and Means Committee. 
His goal is to help lawmakers 
understand the impact of 
cuts in funding, of new regula¬ 
tions and of the nursing short¬ 
age—"informing the decision 
makers on the consequences of 
acting or failing to act.” 
In fact, the nation’s decision¬ 
maker-in-chief visited New 
Britain General on June 12. 
President George W. Bush chose 
Tanner’s hospital as the venue 
for a speech on Medicare reform 
and prescription benefits. The 
president addressed 250 people 
in the hospital cafeteria en 
route to Maine to celebrate his 
father’s birthday. Although 
Tanner did not get to button¬ 
hole Bush to convey his own 
policy proposals, he found the 
visit satisfying. "It tied public 
policy to a real hospital.” 
The region’s bad economy 
has touched Tanner personally: 
his wife, Janice Ann Piazza, 
recently lost her job as a manu¬ 
facturer’s website developer. 
"She was outsourced and down¬ 
sized,” he says wryly. 
When he feels overwhelmed. 
Tanner visits the neonatal icu. 
There he likes to watch the pre¬ 
mature babies "and see them 
thrive.” Visiting the newborns 
provides an antidote to the 
"daunting process” of running a 
hospital with shrinking resources. 
"It’s a frustrating process and in 
some cases a depressing process,” 
says Tanner. "In some ways it’s 
also an invigorating process. 
When you have a small victory, 
it’s a victory. You know that 
what you’re doing is benefiting 
people. There’s somebody 
out there who’s getting a serv¬ 
ice that they wouldn’t other¬ 
wise get.” 
—Cathy Shufro 
Familiar Faces 
Do you have a colleague who 
is making a difference in 
medicine or public health or 
has followed an unusual 
path since leaving Yale? We’d 
like to hear about alumni 
of the School of Medicine, 
School of Public Health, 
Physician Associate Program 
and the medical school’s 
doctoral, fellowship and resi¬ 
dency programs. Drop us a 
line at ymm@yale.edu or write 
to Faces, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612. 
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60 Alumni NOTES 
Franklin Epstein Kenneth Arndt Robert Maudsley Michael Apuzzo Paul Wang 
1940s 
Franklin H. Epstein, M.D. ’47, HS 
’49, professor of internal medi¬ 
cine (nephrology) at Harvard 
Medical School and Beth Israel 
Deaconess Medical Center, 
received the David M. Hume 
Memorial Award from the 
National Kidney Foundation in 
April at the annual meeting in 
Dallas.The honor is presented 
to a distinguished scientist- 
clinician who exemplifies the 
high ideals of scholarship 
and humanism. 
William E. Kenney, M.D. ’41, HS 
’45, an orthopaedic surgeon, 
writes to say that he retired n 
years ago after a severe coronary 
attack. Kenney began his career 
as a coroner’s physician in St. 
Louis, and later served as presi¬ 
dent of the medical staff at 
Truesdale Hospital in Fall River, 
Mass. He established a treat¬ 
ment program for children at 
The Cerebral Palsy Rehabili¬ 
tation Center and Services in 
Fall River, where he was also 
medical director. 
1950s 
As a result of a bequest, 
arranged by his children, from 
the estate of Kent Ellis, M.D. ’50, 
the Historical Library at the 
School of Medicine has named 
the reference room in his honor. 
At a dedication ceremony 
held in January a plaque was 
installed on the door, and 
bookplates will soon adorn the 
books which were purchased 
with the bequest. 
1960s 
Robert A. Achtel, M.D., HS ’69, 
FW '71, clinical professor of pedi¬ 
atrics (cardiology) at Stanford 
University School of Medicine, 
has joined the Northwest 
Pediatric Cardiology outreach 
program for Stanford University 
Medical Center, based in 
Sacramento, Calif 
Kenneth A. Arndt, M.D. ’61, HS 
’62, clinical professor of derma¬ 
tology at Yale and in private 
practice at SkinCare Physicians 
of Chestnut Hill, Mass., received 
the Leon Goldman Memorial 
Lectureship Award from the 
American Society for Laser 
Medicine and Surgery in April at 
its annual meeting in Anaheim, 
Calif The award honors a physi¬ 
cian who has demonstrated 
excellence in clinical laser 
research and services to 
patients. Arndt was a founding 
member and former president 
of the society. 
Robert N. Frank, M.D. '66, profes¬ 
sor of ophthalmology, anatomy 
and cell biology at Wayne State 
University School of Medicine in 
Detroit, was elected editor-in¬ 
ch ief of t h e jo u rn a I //i vesf/gaf/ve 
Ophthalmology & Visual Science 
(lovs). His five-year term started 
January 1. lOVS is the major pub¬ 
lication of the 10,500-member 
Association for Research in 
Vision and Ophthalmology. 
Frank also writes to say that his 
youngest child, Ariel Frank, is 
beginning her first year at the 
School of Medicine this fall. 
Robert L. Marier, M.D. ’69, for¬ 
mer dean of the Louisiana State 
University (lsu) School of 
Medicine, was named acting 
dean of the new School of Public 
Health at lsu Health Sciences 
Center. Marier stepped down as 
dean of the medical school last 
October to oversee planning of 
the new school of public health. 
After 27 months, Robert F. 
Maudsley, M.D., HS ’69, has 
stepped down as dean of Health 
Sciences at Aga Khan Univer¬ 
sity in Karachi, Pakistan, and 
returned to Nova Scotia, Canada. 
He writes that he is now retired 
for the third time and plans to 
volunteer at a local hospital and 
Dalhousie Medical School. 
1970s 
Michael L.J. Apuzzo, M.D., FW ’67, 
HS ’73, the Edwin M.Todd/ 
Trent H. Wells Jr. Professor of 
Neurological Surgery, Radiation 
Oncology, Biology and Physics 
at the Keck School of Medicine 
at the University of Southern 
California, Los Angeles, received 
the Gagna A. and Charles Van 
Heck Prize from the National 
Funds for Scientific Research in 
Belgium for his contributions to 
the management of previously 
untreatable diseases, such as 
neurodegenerative diseases and 
brain tumors. King Albert II of 
Belgium presented the award in 
September at ceremonies at 
the Royal Academy of Medicine 
in Brussels. 
Kelsey Wirth and Samuel Myers ( 
Joseph A. Zaccagnino, M.P.H. ’70, 
president and CEO of Yale- ■ 
New Haven Hospital and the 
Yale New Haven Health System, 1 
was awarded an honorary doc- ! 
torate of humane letters from 
Quinnipiac University for his 
civic and humanitarian contribu¬ 
tions and his superior leadership * 
skills. In addition, he gave the 
commencement address to 
graduate students in nursing, 
physical therapy, health sciences 
business, communications and 
education. Zaccagnino was also 
sworn in as chair of the National 1 
Committee for Quality Health 1 
Care at its 25th anniversary I 
meeting in March in Washing- i| 
ton. He will lead the board of 2 
trustees of the nonprofit organi- I 
zation, which is dedicated to 1 
enhancing the quality of health 1 
care in the United States. 1 
1980s - 
After a 27-year career, Mark L. 
Dembert, M.D., M.P.H. ’83, retired 
from the Navy Medical Corps 
with the rank of captain in 
November 2002. Dembert writes 
to say that he has combined 
preventive/occupational medi¬ 
cine, disaster medicine and 
psychiatry to work for the 
Virginia Department of Health. 
He is the Eastern Region Medi¬ 
cal Consultant for Emergency 
Preparedness and Response 
(chemical-biological terrorism), 
which is based in Norfolk and 
covers a population of 1.5 million 
and an area of several thousand 
square miles. 
6i 
Heather J. Folsom, MED ’8i, M.D., 
a psychiatrist who began her 
medical studies at Yale with the 
Class of 1981, has written a book 
titied Philosophie Thinly Clothed, 
and Other Stories, which draws 
on her experience and fascina¬ 
tion with the hidden world of 
unconscious meanings and 
motives. Her book, published 
this year by Cadmus Editions, is 
a collection of 42 short stories, 
ailegories and moral tales. 
Paul P. Wang, M.D. ’86, associate 
director of clinical development 
at Pfizer Global Research and 
Development in New London, 
Conn., will complete a four-year 
term in December as a founding 
member of the subboard of 
Developmental and Behavioral 
Pediatrics for the American Board 
of Pediatrics. This subspecialty, 
established in 1999, focuses on 
problems such as mental retar¬ 
dation, autism, cerebral palsy, 
ADHD,enuresis,school refusal 
and behavior management. 
1990s 
Stephen Allegretto, M.P.H. ’97, 
lecturer in public health at Yale 
and administrative director of 
finance at Yale-New Haven 
Hospital, has been promoted to 
vice president of financial plan¬ 
ning at the Yale New Haven 
Health System. His responsibili¬ 
ties will include financial plan¬ 
ning and analysis and decision 
support for the three-hospital 
system, which includes Yale- 
New Haven, Bridgeport and 
Greenwich hospitals. 
Jennifer S. Meltzer, M.P.H. ’97, 
pediatrics department adminis¬ 
trator at the Beth Israel Medical 
Center in New York, was married 
in October 2002 to Vineet 
Goswami, an account executive 
for office equipment at Konica 
Office Products in New York. 
Samuel S. Myers, M.D. ’92, an 
internist in a private medical 
research and guidance practice 
and a clinical instructor at 
the School of Medicine at the 
University of California, San 
Francisco, was married in 
October 2002 to Kelsey D. Wirth, 
founder, board member and 
former president of Align Tech¬ 
nology in Santa Clara, Calif. 
Scot Phelps, J.D., M.P.H. ’95, was 
appointed assistant commis¬ 
sioner of emergency manage¬ 
ment at the New York City 
Department of Health and 
Mental Hygiene in 2002 and has 
been teaching a course on dis¬ 
aster management at the New 
York Medical College. He writes 
that as head of the new emer¬ 
gency management bureau he is 
getting the opportunity to com¬ 
bine his experiences as a para¬ 
medic, emergency manager and 
administrator to better prepare 
New York City against terrorism. 
Dan Stolar, MED ’93, who began 
medical studies at Yale with the 
Class of 1993, writes to say that 
after completing four and a half 
months of third-year clerkships, 
he took a leave of absence from 
the School of Medicine to pur¬ 
sue creative writing and even¬ 
tually withdrew as a student 
in good standing. This spring his 
first book. The Middle of the 
Night, was published by Picador 
USA, a division of St. Martin’s 
Press. "Though I did not gradu¬ 
ate from Yale School of 
Medicine, I am very grateful to 
the many medical school faculty 
and students who offered their 
support while I struggled with 
this difficult decision. It is no 
exaggeration to say that this 
book might never have been 
written without their help.” 
2000s 
Angeli Achrekar, M.P.H. ’01, 
received the 2003 Carl W. Tyler Jr. 
Award for Excellence in Public 
Health Practice at the annual 
CDC Partnering Meeting in 
Atlanta on February 12,2003. 
Achrekar is an Association of 
Schools of Public Health fellow 
with the CDC’s National Center 
for Chronic Disease Prevention 
and Health Promotion, Division 
of Adolescent and School Health. 
Nicole S. Cundiff, M.P.H. ’00, 
product manager in marketing 
for Sanofi-Synthelabo in New 
York, and Scott C. Durbin, M.P.H. 
’99, executive director of finance 
and corporate development for 
Alteon, a small public biotech 
company in Ramsey, N.J., were 
married in July in New York. 
SEND ALUMNI NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
info.med.yale.edu/ymm 
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62 in Memoriam 
Brandon Brei, of Orange, Conn., 
a predoctoral student in the 
School of Epidemiology and 
Public Health, drowned on 
March 22 off the coast of San 
Juan, Puerto Rico, while trying 
to save a fellow student caught 
in an undertow. He was 26. Brei 
studied the ecology of vector- 
borne spirochetes. His research 
provided valuable information 
about strategies for controls. 
Edward S. Brown, M.D. ’45, of 
Sagamore Hills Township, Ohio, 
died on April 30 at the age 
of 85. Brown was the director of 
emergency services at St. Luke’s 
Hospital in Cleveland for more 
than 20 years and director of 
the hospital’s health services. 
He was a captain in the Army 
Medical Corps during World War 
II, receiving a decoration from 
the Philippine government. 
Felix M. Brown, M.D. ’93, a 
pathologist and associate direc¬ 
tor of surgical pathology at 
Brigham and Women’s Hospital, 
died of cancer on May 27 at 
his home in Dedham, Mass., at 
the age of 36. In his honor, the 
Department of Pathology at 
Harvard has created an annual 
award to be presented to 
pathologists-in-training whose 
qualities of humanity, generos¬ 
ity and dedication complement 
their talent as physicians. 
Nicholas J. Daukas, M.D., former 
assistant professor of ophthal¬ 
mology at Yale, died on February 
25 at the age of 80. Daukas, of 
Middletown, Conn., and Watch 
Hill, R.I., was an All-American 
football player in college and an 
All-Pro tackle for the minor- 
league Brooklyn Dodgers football 
team while in medical school. 
Robert M. Donaldson Jr., M.D., 
the David Paige Smith Professor 
Emeritus of Medicine and former 
deputy dean and acting dean 
of the School of Medicine, died 
on July 9 at the age of 75 at 
his Cape Cod home. Donaldson 
joined the Yale faculty in 1973 
and later served as vice chair 
and acting chair of the Depart¬ 
ment of Internal Medicine. 
From 1991 to 1992 he served as 
acting dean. A specialist in 
gastroenterology and a prolific 
contributor to the medical liter¬ 
ature, Donaldson edited the 
journals Gastroenterology and 
Current Opinion in Gastro¬ 
enterology and served on the 
editorial board of The New 
England Journal of Medicine. 
Donnell D. Etzwiler, M.D. ’53, 
HS ’54, died of cancer on April 6 
at the age of 76. Etzwiler founded 
the International Diabetes 
Center in St. Louis Park, Minn., in 
1967. He established 60 dia¬ 
betes care programs around the 
world, including 30 in Russia, 
for which he won the Russian 
Peace Prize in 1994. For 25 years 
he served as medical director 
of Camp Needlepoint, a summer 
camp for children with diabetes 
in Hudson, Wis. 
Evelyn T. (Stotz) Farnsworth, M.N. 
’38, M.P.H. ’55, of Wellesley, 
Mass., died on February 12 at 
the age of loo. Farnsworth 
served as an ensign in the U.S. 
Navy Nurse Corps in World 
War II. During her career she 
was an assistant administrator 
at the Boston Dispensary 
and Rehabilitation Institute. 
James E.D. Cardam, M.D. ’45, for¬ 
mer vice president of medical 
services and governmental 
health programs at Prudential 
Insurance Co. of America, died 
on May 30 in Millville N.J., at the 
age of 81. While at Prudential, 
Cardam received a citation from 
the Secretary of Health and 
Human Services for his efforts 
to accelerate the federal reim¬ 
bursement for new medical 
tests, services and procedures. 
After his retirement he founded 
the Argyle Medical Associates, 
consultants to health insurers. 
Patricia Coldman-Rakic, PH.D., 
professor of neurobiology, 
neurology, psychiatry and psy¬ 
chology, died on July 31 at the 
age of 66 from injuries after 
being struck by a car. Coldman- 
Rakic, who joined the faculty in 
1979, pioneered the study of 
memory function. She was the 
first researcher to explore the 
frontal lobe, formerly considered 
inaccessible to scientific analy¬ 
sis, and to discover and describe 
its order and structure, which is 
responsible for the highest level 
of cognitive functions. She also 
studied amphetamine abuse 
in adolescents and young adults 
and how it diminishes the 
mind’s performance. 
S. Jerome Greenfield, M.D. ’39, 
died on May 6 in the Boca Raton 
(Fla.) Community Hospital at the 
age of 88. Creenfield, a retired 
ophthalmologist from Millburn, 
N.J., served as a physician in 
the Army Air Corps in England 
and Iceland during World War II, 
attaining the rank of major. 
William A. Cryboski, M.D. ’56, 
HS ’62, of Tequesta, Fla., died of 
lung cancer on January i8 at his 
vacation home in Creensboro, 
Ca., at the age of 73. Cryboski, 
formerly of New Britain, Conn., 
served as a chief surgical officer 
in the Navy aboard the aircraft 
carrier u.s.s. Essex and as chief 
of surgery at the U.S. Naval 
Submarine Base in New London, 
Conn. During his 26 years as a 
senior attending surgeon at 
New Britain Ceneral Hospital he 
introduced several new proce¬ 
dures, including the insertion of 
cardiac pacemakers. 
Jerold A. Haber, M.D. ’71, of 
Atlanta, died on April 30 at the 
age of 57. Haber, an orthopaedic 
surgeon, pioneered outpatient 
IDET (intradiscal electrothermal 
annuloplasty) and apld (auto¬ 
mated percutaneous lumbar dis¬ 
cectomy) "Band-Aid” back surgery. 
Haber, an accomplished photog¬ 
rapher and potter, has permanent 
photographic exhibits at North- 
side Hospital and the radiation 
oncology department at St. 
Joseph’s Hospital Cancer Center, 
both in Atlanta. 
Frederic L. Holmes, PH.D., the 
Avalon Professor of the History 
of Medicine at Yale, died on 
March 27 at the age of 71 after 
a long illness. As chair of the 
Section of the History of Medi¬ 
cine from 1977 to 2002, Holmes 
was a leading force in building 
Yale’s program in the history of 
science and medicine, both as a 
scholarly field and as a link 
between the humanities, natu¬ 
ral sciences and medicine. 
Peter B. Hukill, M.D. '53, died 
on May i8 at his home in Win¬ 
chester, Conn., at the age of 
76. He was the former director 
of laboratories at Charlotte 
Hungerford Hospital and direc¬ 
tor of the Connecticut Dermato- 
pathology Laboratory. Hukill 
was also on the faculty at Yale 
as an associate clinical professor 
of pathology from 1979 until 
his death. 
Margaret F. Knapp, M.P.H. ’49, a 
retired commissioned officer of 
the U.S. Public Health Service, 
died on March 20 at the age of 
95.While working at the National 
Cancer Institute in Bethesda, 
Md., Knapp wrote the first nurs¬ 
ing manual on cancer treat¬ 
ment, which was distributed to 
state health departments. She 
was also chief of the Division of 
Nursing Services at the Indian 
Health Service in Washington. 
Ira R. Levine, M.D., an associate 
clinical professor of psychiatry at 
Yale and an attending psychia¬ 
trist on the Dual Diagnosis Unit 
of Yale-New Haven Psychiatric 
Hospital, died after a brief illness 
I on January 31. He was 65. At the 
ii VA Connecticut Healthcare Sys- 
'j tern in West Haven, Levine was 
' I director of ambulatory services 
Ij and chief of the day hospital and 
: mental hygiene clinic. 
Robert A. Mino, M.D. ’42, of 
Evansville, Ind., died at home on 
February 8 at the age of 86. 
Mino was on the surgery staff at 
St. Mary’s Medical Center and 
Deaconess and Welborn Baptist 
hospitals in Evansville. He was 
a member of the American 
Medical Writers Association and 
the Mississippi Valley Medical 
Writers Society, and he published 
numerous scientific articles in 
medical and surgical journals. 
Russell R. Monroe, M.D. ’44, of 
San Francisco, died on April 4 
of pneumonia at the age of 82. 
Monroe, a former chair of psy¬ 
chiatry at the University of 
Maryland School of Medicine, 
explored the relationship 
between madness and genius, 
as well as the electrical storms 
deep in the brain that trig¬ 
ger violence. Monroe studied 
offenders at the Patuxent 
Institution in Maryland and 
wrote several books on episodic 
behavioral and brain disorders. 
Elpenor R. Ohie, M.D., HS ’44, 
died on May 25 in Green Bank, 
W. Va., at the age of 88. OhIe 
started a medical practice in 
Celo, N.C., after a tour of duty 
with the U.S. Public Health 
Service in 1944. He was an old- 
fashioned family physician for 
nearly 40 years, until he retired 
to pursue gardening and 
landscaping. In 1997 Ohie was 
honored by the National 
Weather Service for 50 years 
of continuous recording of 
weather in the South Toe Valley 
in North Carolina. 
Harold C. Patterson, M.D., HS ’48, 
of North Wilkesboro, N.C., died 
on February 12 at the Villages of 
Wilkes Skilled Care at the age 
of 91. Patterson was a clinical 
instructor in ophthalmology at 
Yale and had a private practice 
in Danbury, Conn. 
Claire E. (Burton) Reinhardt, 
PH.D. ’42, of West Hartford, 
Conn., died on January 30 at the 
age of 87. Reinhardt spent her 
career as a public health profes¬ 
sional with the Connecticut 
departments of Public Health 
and Education until her retire¬ 
ment in 1981. 
Arnold Schoolman, PH.D. ’54, 
M.D. ’57, of Prairie Village, Kan., 
died on April 14 at the age of 
75. Schoolman was professor 
of surgery (neurology) at the 
University of Kansas School 
of Medicine and had a private 
neurological surgery practice 
until his retirement in 1998. 
David B. Skinner, M.D. ’59, for¬ 
mer president and CEO of the 
New York Weill Cornell Medical 
Center, died of a cerebral hem¬ 
orrhage on January 24 at the 
age of 67. Skinner presided 
over the merger of New York 
and Presbyterian hospitals and 
directed the building of the New 
York-Presbyterian Healthcare 
System. He oversaw the con¬ 
struction of the Maurice R. and 
Corinne P. Greenberg Pavilion, an 
850,000-square-foot structure 
that extends over Franklin D. 
Roosevelt Drive. Skinner con¬ 
tinued performing esophageal 
surgery throughout his adminis¬ 
trative career. 
Kenneth J.W. Taylor, PH.D., M.D., 
professor of diagnostic radiology 
and obstetrics and gynecology at 
Yale, died on February 15 at the 
age of 63. Taylor explored the use 
of diagnostic “grayscale” ultra¬ 
sound in cancer patients at the 
Royal Marsden Hospital in 
Australia and received grant sup¬ 
port from the American Cancer 
Society and the National Insti¬ 
tutes of Health for his work on 
detection of tumor vascularity by 
Doppler ultrasound. He authored 
and edited numerous books on 
diagnostic ultrasound including 
the Atlas of Ultrasonography and 
Clinical Applications of Doppler 
Ultrasound. 
Jack L. Westcott, M.D., clinical 
professor of diagnostic radiology 
at Yale, died on January 31 at the 
age of 71. Westcott, former chair 
of radiology at the Hospital of 
St. Raphael, past president of 
the Society of Thoracic Radiology 
and a radiologist at Hartford 
Hospital, was the creator of the 
Westcott biopsy needle, which 
is used in hospitals today. 
SEND OBITUARY NOTICES TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
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64 FOlloW-Up Archives 
Providing care in a changed world 
Exotic travel is nothing new for David Hilmers, M.s., m.d., m.p.h. 
Hilmers has already landed in dozens of countries as a Marine 
pilot and orbited the Earth 400 times on the space shuttles 
Atlantis and Discovery. But for Hilmers, an assistant professor of 
pediatrics and medicine at Baylor College of Medicine, the 
chance to go to Bolivia as a Yale/Johnson & Johnson Physician 
Scholar in International Health is appealing.The former astro¬ 
naut looks forward to learning about tropical diseases like leish¬ 
maniasis during two months working in a Bolivian hospital. 
Sponsoring established physicians like Hilmers is new 
for Yale’s International Health Program, which has been send¬ 
ing residents overseas since 1981 [“A World of Difference,” 
Autumn 2001]. With continuing support from Johnson & 
Johnson, the program is expanding. This year a $500,000 
grant will fund trips for 14 career doctors, 53 Yale residents and 
15 residents from other medical centers. Participants will 
spend six to eight weeks in 17 foreign countries and at two 
Indian Health Service clinics in the United States. Despite ter¬ 
rorism, the war in Iraq and sars, co-director Michele Barry, 
M.D., HS ’77, said interest in working abroad remains strong. 
"We got hundreds of applications for these 82 spots.” 
Increasing hostility to Americans has raised safety con¬ 
cerns. "The aura which kept an American off-limits to some 
threats has diminished,” said co-director Frank J. Bia, aa.d., fw 
'79. But anti-Americanism may, paradoxically, motivate some 
physicians to go overseas, Barry said."When there’s so much 
anti-Americanism, physicians applying to our program seem 
to be committed to working in underserved areas overseas in 
an effort to mitigate this sentiment—to prove that Americans 
do care past their own self-interests and borders.” 
That global perspective became clear to Hilmers from 
300 miles above Earth. It motivated him to begin medical 
school at age 42, after 12 years with NASA. "During the dark 
times of your orbiting ... you see the backdrop of the stars, and 
you see the earth as this tiny little rock,” recalled Hilmers, now 
53. “You get a different perspective—that we have to take care 
of each other, and to survive, everyone has to survive together.” 
—Cathy Shufro 
WINTER 1969 
“The Departments of Medicine 
and Pediatrics have combined 
forces to organize a Division of 
Genetics embracing all ages from 
the fetus to old age. This section ... 
includes pediatricians and 
internists whose interests com¬ 
prise the detection of abnormal 
chromosomal patterns, screening 
for inherited defects, and the bio¬ 
chemical and physiological investi¬ 
gation of the nature of these 
defects. 
“A number of important 
research projects are now under 
way, including evaluation of the 
chromosome pattern of all babies 
born in the Yale-New Haven 
Hospital during the past year; 
investigation of the nature of the 
transport defects in renal glyco¬ 
suria and in the amino acid ureas; 
a study in the isolated cells of tis¬ 
sue culture from patients of the 
nature of the biochemical defect 
in diseases involving the interme¬ 
diary metabolism of amino acids 
and purines. 
“Both in its spread of interest 
and in the range of age of the 
patients it serves, this group is vir¬ 
tually unique in American aca¬ 
demic medical institutions.” 
SPRING 1983 
“Two recent School of Medicine 
building projects have received 
awards. The New Haven 
Preservation Trust presented a 
Merit Award to the School for its 
sensitive rehabilitation and crea¬ 
tive reuse of the historic Jane 
Ellen Hope Building. The oldest 
building on the school’s campus, 
the red brick and rough stone 
building was built in 1902 as a 
clinic building.... 
"First prize for excellence in 
consulting engineering in the cat¬ 
egory of mechanical and electrical 
design was awarded the school by 
the New York Association of 
Consulting Engineers for fostering 
excellence in engineering of its 
new chilled water thermal storage 
system.... 
“The facility was built to 
increase the capacity of the 
Sterling Power Plant in order to 
provide air conditioning for the 
Yale-New Haven Medical Center.” 
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Closing the gender gap Once an exclusively male bastion, surgery is 
beginning to resemble the rest of academic 
medicine as more women join its faculty ranks. 
ON THE COVER 
Barbara Kinder was one of the 
first two women to 
Yale’s general surgery 
the late 1970s. The 
rooms have changed 
since then, with a steadily 
ing number of women entering 
the field. At Yale, 17 percent of the 
surgery department’s m.d. faculty 
is female, compared to a national 
average of 11 percent. 
BACKGROUND 
Endocrine surgeon Julie Ann Sosa 
scrubs in before starting a case. 
BACK COVER 
Ronnie Rosenthal, who specializes 
in geriatrics, is chief of surgery 
at the VA Connecticut Healthcare 
System’s West Haven campus. 
For profiles of Rosenthal and other 
women surgeons at Yale, see 
pages 26 to 32 and our website, 
info.med.yale.edu/ymm. 
Photographs by Terry Dagradi 
Yale Medicine 
Pl^lWea.yiK.edu/ymm ’ - "' : ^ 
On our website, readers can submit class notes or a change of address, 
check the alumni events calendar, arrange for a lifelong Yale e-mail alias 
through the virtual Yale Station and search our electronic archive. 
An insider’s view * 
A program to encourage diversity in the health professions 
gives college students a closer look at the art, science 
and culture of medicine. ' 
By Jennifer^ Kaylin 
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48 Follow-Up 
48 Archives Fighting the good food fight 
Yale's Kelly Brownell has turned concern about obesity 
and the American diet into a debate about our “toxic food 
environment.” Not everyone is pleased. 
By Peter Farley ’ , 
Closing the gender gap 
Once an exclusively male bastion, surgery is beginning = 
to resemble the rest of academic medicine as more women 
join its faculty ranks# 
By Cathy Shufro * 
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2 Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters to the editor and news 
items to Yale Medicine. P.O. Box 
7612, New Haven, CT 06519- 
0612, or via electronic mail 
to ymm(a)yale.edii, and include 
a daytime telephone number. 
Submissions may be edited for 
length, style and content. 
VISIT US ON THE WEB 
info.med.yale.edu/ymm 
From the witness 
stand, more evidence 
on malpractice 
Your article on the malpractice 
crisis ["Showdown,” Summer 
2003] prompted me to think 
about the huge challenges our 
profession confronts in the face 
of rising insurance premiums 
and jury awards against physi¬ 
cians. During 22 years as an 
expert witness in otolaryngol¬ 
ogy malpractice cases, I have 
learned that lawsuits can arise 
from almost any doctor-patient 
interaction and that a jury’s 
determination of guilt or inno¬ 
cence is not always rational. 
My first experience on the 
stand was in 1981 in a lawsuit 
filed against a physician who 
had treated a 20-year-old man 
for earache. Four days later, he 
came to a large, inner-city ER 
with stupor and seizures and 
died while under care. A post¬ 
mortem revealed high levels of 
heroin in his blood and a tem¬ 
poral lobe abscess, probably 
related to talc deposits in his 
heroin mixture. But the abscess 
was near the site of his recent 
ear infection, and the ent was 
sued for alleged failure to diag¬ 
nose a life-threatening situation. 
After testifying on behalf of 
the physician, I was amazed to 
learn the case had been settled 
for an astounding $450,000.1 
was even more aghast to hear 
that all the jurors had thought 
the physician at fault and would 
have awarded $1.5 million to the 
plaintiff.The jury foreman told 
the judge that I had done a fine 
job but did not sway them. 
Over the next 18 years I acted 
as an expert for the defense 
in more than 200 cases. During 
the past four years 1 have also 
done a small amount of plaintiff 
expert review, both to make 
me a more acceptable witness 
before the courts and in recogni¬ 
tion that there are incidents of 
gross negligence in otolaryngol¬ 
ogy. It is true that hmos and 
poor reimbursement have frus¬ 
trated doctors, and it seems 
that these frustrations have con¬ 
tributed to worsened communi¬ 
cation between referrers and 
specialists and between physi¬ 
cians and patients. The easiest 
way physicians can avoid law¬ 
suits is to listen to patients and 
to be honest with them about 
expectations. The level of dis¬ 
trust patients have in their medi¬ 
cal care is at an all-time high, 
and this is something physicians 
must address. 
I chose to leave my practice 
of 25 years to two well-trained 
otolaryngologists who are lo 
years and 21 years younger than 
I am. I have no clear solution 
that will help them cope with 
the dilemmas of our malpractice 
crisis. National health care has 
been a failure in Canada (patients 
who can afford the best care 
come to our country quickly). The 
huge multispecialty groups that 
are gobbling up solo practices 
would appear to insulate them 
from litigation, but consolidation 
has not decreased the number 
of lawsuits. 
We must police ourselves and 
not allow attorneys to do it for 
us.The small number of physi¬ 
cians who are providing substan¬ 
dard care should be identified 
by their colleagues and not be 
allowed simply to relocate to 
another state to inflict harm on 
a new community. 
I wish the next generation 
of physicians good luck. It seems 
that fewer of our graduates, 
products of the Yale System, are 
going into clinical practice these 
days. Our grandchildren will 
depend on this group for their 
medical care. Who will remain 
to upgrade this talent gap? 
Donald Kent, m.d. ’72, hs ’76 
Palm Harbor, Fla. 
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From the Editor 3 
Changing medicine’s cultural landscape 
when I was a child in Washington in the early 1960s, I was 
present for, if not exactly cognizant of, the reaching of sev¬ 
eral milestones on the road to equal opportunity. One was 
Martin Luther King’s “I Have a Dream” speech, which I 
witnessed from the Mall near the Lincoln Memorial with my 
parents at the age of 3. Another fell under the general 
heading of school desegregation; my first classroom expe¬ 
rience was at a nursery school and kindergarten called 
Friendship House, which brought together children from 
varied racial, social and economic backgrounds. Friend¬ 
ship House was a success, and I still have a yellowed 
Washington Post photograph from the day Lady Bird Johnson 
came to our classroom for a visit. 
Despite this atmosphere of equality, neither of my 
parents can recall an African-American physician among 
their acquaintances or on the staff at Children’s Hospital, 
where my grandmother worked as a receptionist in one of 
the clinics. In fact, by 1970 only 2 percent of American 
medical students were members of underrepresented minor¬ 
ity groups, compared to 13 percent today. While a signih- 
cant step forward, that increase is not enough to balance the 
skewed demographics of American medicine, a situation 
that has inspired medical schools to try to diversify the 
physician workforce. 
The article that begins on page 16, “An Insider’s 
View,” by Jennifer Kaylin, describes one of several efforts at 
Yale to promote diversity in the medical profession. The 
Summer Medical Education Program, funded by The Robert 
Wood Johnson Foundation, has graduated more than 765 
participants in the past eight years at Yale and increased the 
number of students of color bound for careers in medicine. 
The six-week program is organized around the central idea 
that by exposing applicants to the culture of academic 
medicine and offering help in the classroom, it can greatly 
increase their chances of admission to medical school. 
The undergraduate students who come to New Haven each 
summer go on rounds, observe in the OR and ER and 
strengthen their communication and interviewing skills. The 
program works, says its co-director, at least in part “by fun¬ 
damentally [altering] their view of the world.” 
Our cover story, “Closing the Gender Gap,” tells of 
another demographic change, this one affecting the tradi¬ 
tionally male-dominated discipline of surgery. Since the mid- 
1970s, Yale has trained an increasing number of female sur¬ 
geons and now has one of the highest percentages of 
women on the surgical faculty. Contributing Editor Cathy 
Shufro explores the factors behind this change and profiles 
eight women on the Yale faculty, starting on page 26 and 
continuing on our website, info.med.yale.edu/ymm. 
Finally, a parting note that takes us back to Washington, 
this time to the National Press Club. Tliere, in early November, 
Associate Editor John Curtis received a top award from the 
Association of American Medical Colleges (aamc) for his 
2002 article, “Everyone Loves the Yale System. So Why Can’t 
They All Agree?” It was the second year running that John 
received an Award of Distinction from the aamc for his 
feature writing, and I doubt it will be the last time he distin¬ 
guishes this magazine or the School of Medicine. If you 
missed these articles, they, too, may be read on our website 
by visiting the address above and selecting “Awards.” 
Michael Eitzsousa 
michael.fitzsousa@yale.edu 
SECOND OPINION BY SIDNEY HARRIS 
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4 chronicle news from cedar street 
Preparing schools for 
the worst-case scenario 
A Yale pediatrician trains educators 
in New York and around the world 
to help children cope with crisis. 
In a hotel conference room last April 
in New York, Yale pediatrician David J. 
Schonfeld, m.d., guided 100 school 
counselors, teachers and administra¬ 
tors through a hypothetical school cri¬ 
sis; the star of a high school play has 
died of cancer, and classmates hold a 
fund-raiser in her memory to benefit 
medical research. When a television 
news team covers the event, they learn 
that a second student had died of the 
same form of cancer. They also report 
that toxic substances have been found 
in the soil around the school. 
The next day half the student body 
is absent, and the school is surrounded 
by reporters; finally, the principal 
says that she has been diagnosed with 
another form of cancer. 
Working in teams, Schonfeld’s 
audience had to respond to each stage 
of the crisis. They discussed how 
to determine whether there were any 
health risks to students and staff; 
what to tell staff, students, parents and 
the press; and how to support the 
students, the principal and other staff. 
The teams had 10 minutes to spring 
into action, the same deadline many 
New York City educators faced on 
September ii, 2001. 
In fact, the attacks on the World 
Trade Center were a major reason for 
the exercise. New York City school 
officials had asked Schonfeld, an asso¬ 
ciate professor of pediatrics with an 
appointment in the Child Study Center 
who has been helping schools deal 
with crises for more than a decade, to 
train response teams that include edu¬ 
cators, administrators, mental health 
professionals, nurses and safety person¬ 
nel from the city’s approximately 1,200 
schools. Along with Scott R. Newgass, 
M.S.W., and David Szydlo, m.d., ph.d., 
Schonfeld provided more than 50 
full-day workshops for teams from 
throughout the school system. With 
colleagues at the National Center for 
Children Exposed to Violence (nccev), 
he also developed guides for talking 
about 9/11, the anthrax scares, the war 
in Iraq and death. 
Though the participants in the 
cancer-scare scenario groaned with 
each mounting crisis, they found the 
discussion instructive. Most had lived 
through 9/11, when administrators 
had to decide whether to send children 
home amid the chaos. Parents flocked 
to schools seeking not only their chil¬ 
dren but also information. News spread 
by word of mouth, more distorted with 
each telling. Teachers waited for hours 
with students who had no way to get 
home. And educators had to explain to 
children why this was happening while 
grappling with their own distress. 
“It was hours and hours of dealing 
with things you never could have antici¬ 
pated,” said Janet Hughes, a Bronx 
high school principal. “There were a lot 
of things on the school level that people 
were just not prepared to deal with.” 
And not only in New York. Educators 
around the world are thinking more 
about how to help children cope with 
disasters, including plane crashes and 
earthquakes, as well as political vio¬ 
lence. Schonfeld has also provided 
training in England, Sweden and Israel; 
in March 2003, he provided a series 
of workshops in Osaka and Tokyo as 
part of the establishment of Japan’s 
National Mental Support Center for 
School Crisis. 
Ten years ago Schonfeld was run¬ 
ning the School Crisis Prevention and 
Response Initiative in New Haven, with 
an eye to designing a national model. 
5 
Today that model is in place as part of 
the NCCEV at the Yale Child Study 
Center, nccev grew out of the Child 
Development-Community Policing 
Program established by Steven Marans, 
PH.D., the NCCEv’s director, and the 
late Donald J. Cohen, m.d. ’66, who led 
. the Child Study Center from 1983 until 
his death in 2002. 
Schonfeld’s model is broad enough 
to help guide children through a range 
; of events. It helps educators plan for 
the needs of children and school staff 
I at a time of crisis. It also aids schools 
)i in identifying and addressing symp- 
I toms of emotional distress and devising 
I memorial events that are meaningful 
and healing. And the model empha- 
|i sizes the importance of letting students 
vent. “When comments or questions 
come up naturally, if the teacher is 
ready for them, there can be useful dis¬ 
cussion,” Schonfeld said. 
Schonfeld wants to bring mental 
health needs into the mainstream of 
pediatric medicine. As the physical 
health of children has improved, atten¬ 
tion in pediatrics has shifted to develop¬ 
mental and behavioral concerns, a 
relatively new area of specialization. 
Yale’s Department of Pediatrics recently 
created a subsection for developmental- 
behavioral pediatrics, and it is the 
site of one of nine fellowship programs 
funded in July 2003 by the Maternal 
and Child Health Bureau, an agency 
of the Department of Health and 
Human Services, for training in the 
emerging discipline. 
In November 2002, the American 
Board of Pediatrics offered the first 
exam for certification in the field, but 
Schonfeld wasn’t immediately eligible 
to take it, despite his obvious familiar¬ 
ity with the topic. He, along with other 
members of the subspedalty board, 
had to take a different test—one that 
they hadn’t written themselves. 
—Anne Thompson 
In gleaming anatomy lab, 
more room to work and a new 
way of teaching 
when the 100 students of the Class of 
2007 donned their scrubs and rubber 
gloves on September 5, they became 
the first group to study anatomy in the 
new labs at the Anlyan Center for 
Medical Research and Education. As 
first-timers they had no point of com¬ 
parison for the brand-new, shining, 
stainless steel facilities. But to anyone 
who has ever set foot in the old dissec¬ 
tion rooms, one change was obvious. 
“I’m working without a mask,” said 
Lawrence J. Rizzolo, ph.d., associate 
professor of surgery and course direc¬ 
tor. He was, of course, referring to 
the strong odor of formaldehyde—or 
lack of it—in the new lab. Each sta¬ 
tion has a vent that draws odors out, 
and that drew a word of caution from 
William B. Stewart, ph.d., associate 
professor of surgery and chief of 
the anatomy section. “The last thing 
you ask yourself is, ‘Did I turn the 
vent off.^’ Because if the vent is on 
24 hours a day, your cadaver will be 
sucked dry,” he said. 
Rizzolo delighted in another 
difference—more space. “I can walk 
between tables,” he said. 
The extra space and absence of 
strong odors are more than mere crea¬ 
ture comforts. They’ve led to a change 
in the study of anatomy. “Students 
often come back to work extra hours,” 
Rizzolo said. “In the old lab your eyes 
would get itchy and your throat would 
get scratchy. The odor made you sick to 
your stomach if you stayed a long time.” 
The tables are bigger and there are 
more of them—40 as opposed to 32. 
That means each dissecting station has 
four instead of five students. (Although 
only 25 tables are needed for medical 
students, others are used by the Physi¬ 
cian Associate Program, residency pro¬ 
grams and other institutions, such as 
Quinnipiac University, which don’t have 
their own anatomy facilities.) Computer 
terminals, which were being installed 
at each station during the fall, will allow 
students to refer to online resources 
while they are dissecting. “If a question 
comes up at the dissection table, the 
instructor can just say, ‘Let’s look at the 
computer resource,’ and make a point 
you can’t make if the computers are 
10 steps away,” Rizzolo said. 
Perhaps the biggest change for the 
first-year anatomy course has been the 
creation of what the faculty call “learn¬ 
ing societies” within the class. Each is 
made up of 20 students and a mentor. 
“The idea is for these groups to develop 
a sense of community and share each 
other’s work,” Rizzolo said. “In the old 
labs, where everyone was standing on 
top of one another and it was hard to 
move around the lab, students would 
look at their own dissection and not 
look at who was next to them. ... The 
geography of the lab has allowed us to 
organize this massive number of stu¬ 
dents into manageable groups that then 
become a community.” 
—John Curtis 
William Stewart, chief of the anatomy section, 
works with first-year students, from left, 
Krishan Soni, Michael Martinez, Aida Kuri and 
Danielle Guez, as they make their first 
incision into a cadaver. 
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Eviil Tia tio n 
Clinical-skills course prepares 
students for the wards and a 
new Step 2 
Medicine became very personal for 
Jessica Kattan, a second-year student, 
shortly after she took a patient’s his¬ 
tory. “I figured he probably had the 
flu,” Kattan said. But tests revealed 
Burkitt’s lymphoma, a rare and aggres¬ 
sive form of cancer. 
“The next time I saw him, he was 
very ill from his chemo,” Kattan remem¬ 
bered. “Before that, this disease had just 
been some words in a book to me.” 
Kattahs experience was part of the 
“Doctor-Patient Encounter.” Now 
called the “Preclinical Clerkship,” it is 
a two-year course aimed at teaching 
skills that students will need to care for 
patients when they begin their clini¬ 
cal rotations. Margaret J. Bia, m.d., 
who has directed the course since 1999, 
sums up its content as the heart of 
“doctoring”—sensitive interactions 
with patients, thoughtful diagnoses and 
" effective treatment plans. 
3 For the past five years, Yale students 
2 have had their history and physical exam 
skills assessed at the nearby University 
of Connecticut assessment center at the 
end of their second year. This year, stu¬ 
dents are returning to the center at the 
end of their third year for an assessment 
of history and physical exam skills. 
Students will also have to demon¬ 
strate their mastery of these skills on a 
new national exam that all medical stu¬ 
dents must pass in order to obtain a 
medical license. The exam, a new, sec¬ 
ond component of Step 2 of the United 
States Medical Licensing Exam (usmle), 
will be required of all medical students 
graduating in 2005. 
This emphasis on skills assessment 
is part of a national movement recog¬ 
nizing the importance of clinical skills 
in medical training and clinical care. 
According to a Harris Poll, two-thirds 
of Americans support the new national 
exam, a one-day test that strives to 
replicate a typical doctor’s work day. 
Students will examine 10 standardized 
patients—actors feigning symptoms 
and ailments—and formulate diag¬ 
noses and treatment plans. 
The board that oversees the usmle 
sees this as a matter of public safety, 
since good clinical and communication 
skills correlate with a lower incidence 
of malpractice suits, better treatment 
compliance and greater patient satisfac¬ 
tion. Slightly more than half of the 
medical schools in the United States 
now require a clinical-skills exam 
before graduation, yet a survey by the 
USMLE found that 4 percent of medi¬ 
cal students had never taken a history 
or conducted a physical under the 
tutelage of a faculty member. 
The exam is meeting resistance 
from the American Medical Student 
Association, because it will increase 
students’ debt burdens by $975, the 
cost of the exam, plus expenses to 
travel to testing sites—Philadelphia, 
Atlanta, Chicago, Los Angeles 
and Houston. 
The new exam reflects a change 
from times past, when students picked 
up their clinical skills in large part by 
observing physicians. “Now we have 20- 
minute clinic visits, which markedly 
reduces the available time for students to 
practice and receive feedback,” Bia said. 
The “Preclinical Clerkship,” taken 
in the first two years of medical school, 
fills that gap with weeldy sessions that 
emphasize history taking and physi¬ 
cal examinations. Students work with 
faculty to develop specific skills and 
meet weekly with clinical tutors who 
observe them taking histories and per¬ 
forming physical exams. Students 
learn communication skills—history 
taking, social history taking, breaking 
difficult news—in workshops where 
they practice on standardized patients 
before seeing real patients. 
“Hopefully these developments in 
clinical-skills acquisition and assess¬ 
ment will lead to students graduating 
with a greater mastery of the skills they 
need to be compassionate, competent 
physicians,” Bia said. 
—Colleen Shaddox 
7 
HONORING AN NMR PIONEER 
A June symposium, “From Molecules to Mind: Celebrating the 
Contributions of Robert G. Shulman to Biological nmr,” honored 
Robert G. Shulman, ph.d.. Sterling Professor Emeritus of Molecular 
Biophysics and Biochemistry, for his use of nuclear magnetic reso¬ 
nance (nmr) to study metabolic pathways In live subjects. Shulman, 
a pioneer in magnetic resonance research, has used high-field 
NMR spectroscopy to follow chemical reactions and brain activity 
and to develop methods for localizing brain function. The sym¬ 
posium drew researchers and colleagues from around the world. 
—John Curtis 
For interns, a place to eat 
pizza and unload the stress 
of a frenetic first year 
“Do I know enough to care for this 
patient?” “I feel so out of touch with 
the rest of the world.” 
These thoughts are likely to pass 
through the mind of the typical 
intern during the first year of resi¬ 
dency, a whirlwind time that has a 
component of self-doubt accompany¬ 
ing rapid learning and maturation. 
In the past, interns kept such worries 
to themselves. But at the Waterbury 
Hospital Health Center, 20 miles 
north of New Haven, first-year resi¬ 
dents gather at noon each Friday to 
compare notes on the challenges and 
rigors of training. 
The lunchtime talkfest is led by 
Seth R. Segall, ph.d., director of psy¬ 
chology at Waterbury Hospital, and 
Auguste H. Fortin VI, m.d., m.p.h., 
director of the psychosocial curriculum 
at Yale’s Primary Care Residency 
Program. Fortin, who said he was 
“concerned that the house staff didn’t 
have a forum to share the feelings 
and the stresses of being an intern,” 
began holding the weekly meetings 
with Segall three years ago. 
What is said in the room stays in the 
room. Over pizza and Pepsi, the interns 
talk about the issues that affect them 
on the ward—the death of a patient, the 
fear of an accidental needle stick, the 
grueling schedule that can lead to mari¬ 
tal stress. “This is not a regular life,” 
said intern Juanita Smith, m.d., “so if 
you have other people around you who 
say, ‘Yes I feel that too,’ it makes you 
realize that your feelings are normal for 
the context that you are in.” 
Segall starts each session with a few 
moments of meditation. “We’re train¬ 
ing physicians to listen to themselves,” 
he said, “and I think that will help 
them to be more compassionate doc¬ 
tors.” Fortin would like to expand the 
program to Yale’s other primary care 
residency training hospitals, St. Mary’s 
in Waterbury and Yale-New Haven. 
—Lisa Quirindongo 
LATE NEUROSCIENTIST HONORED 
In recognition of her pioneering work on the 
brain’s frontal lobe and her studies of the 
cerebral cortex and its links to schizophrenia, 
the National Alliance for Research on 
Schizophrenia and Depression (narsad) has 
created a prize to honor Patricia S. Goldman- 
Rakic, PH.D., who died in July after being 
struck by a car. And in November, Pfizer 
announced that it will fund a graduate fellow¬ 
ship in neuroscience in honor of Goldman- 
Rakic, the Eugene Higgins Professor of 
Neurobiology. Each year, an outstanding 
graduate student in the Combined Program 
in Biological and Biomedical Sciences will 
receive full support for a year’s study. 
NARSAD announced The Dr. Patricia S. 
Goldman-Rakic Memorial Prize for Cogni¬ 
tive Achievement in Neuroscience in 
October. The annua! $40,000 prize will 
reward “excellence in neurobiological 
research at the cellular, physiological, or 
behavioral levels that may lead to a greater 
understanding of major psychiatric disease.” 
The first recipient of the award is 
Solomon H. Snyder, m.d., chair of neurosci¬ 
ence at Johns Hopkins and a longtime friend 
and collaborator of Goldman-Rakic. Snyder 
discovered the role nitric oxides play as a 
class of neurotransmitter in the brain and 
created techniques for understanding 
and manipulating brain receptors. 
—John Curtis 
CHAGAS DRUG LICENSED TO NONPROFIT 
The nation’s first nonprofit pharmaceutical 
company has licensed a new class of com¬ 
pounds from Yale and the University of 
Washington that could lead to treatments 
for the parasitic Chagas disease, which 
affects between i6 and i8 million people, 
mostly in Latin America. 
The compounds, called azoles, were 
developed by teams led by Andrew D. Hamil¬ 
ton, PH.D., deputy provost for science and 
technology at Yale, in collaboration with fac¬ 
ulty at the University of Washington. Azoles 
inhibit production of a chemical that is nec¬ 
essary for the survival of the parasite Trypa¬ 
nosoma cruzi without harming human cells. 
The Institute for OneWorld Health in 
San Francisco will have exclusive license to 
develop azole compounds. 
—John Curtis 
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Rounds MEDICINE AND HEALTH AT YALE 
The surgical approach 
to morbid obesity 
Rising demand for gastric bypass 
procedure keeps Yale surgeon busy 
and looking for reinforcements. 
Americans spend $33 billion annually 
on products and services they believe 
will help them lose weight. The invest¬ 
ment is usually a bad one, as sustained 
weight loss remains an elusive goal 
in an increasingly supersized nation. 
According to the U.S. Surgeon General, 
61 percent of American adults are 
overweight or obese (as are 13 percent 
or more of children aged 6 to 19) and 
face a higher risk for diabetes, heart 
disease and other illnesses. 
This may be why Robert L. Bell, 
M.D., HS ’01, is one of the busiest 
surgeons on the Yale faculty. Recruited 
in 2002 after a fellowship at the 
University of Maryland, Bell brought 
with him a minimally invasive proce¬ 
dure known as laparascopic gastric 
bypass, in which the surgeon uses spe¬ 
cial instruments to create a small gas¬ 
tric pouch, then attaches a y-shaped 
limb of small bowel to form the outlet 
to the intestines. After surgery the 
patient’s appetite is sated by very small 
amounts of food; a 50 to 80 percent 
loss of excess body weight is typical. 
The procedure is appropriate for patients 
who are morbidly obese—generally 100 
to 400 pounds overweight—and for 
whom other methods of weight loss 
have failed. 
Similar procedures were performed 
occasionally at Yale, as open surgery, 
about 15 years ago. Doing the bypass 
laparoscopically, while reducing com¬ 
plications and discomfort for patients, 
is relatively rare because of the elite 
skill level the procedure demands, said 
Robert Udelsman, m.d., m.b.a., chair 
of the Department of Surgery, who 
recruited Bell to Yale. Seeing someone 
perform the delicate operation guided 
only by video images amazes students 
and veteran surgeons alike. Bell, said 
Udelsman, “is of the Star Wars gen¬ 
eration.” Speaking at grand rounds in 
September, Udelsman said Bell has a 
six-month waiting list and may soon be 
joined by a second surgeon. “It may 
be we’ll need seven bariatric surgeons,” 
Udelsman said. “I don’t know.” Patient 
interest in the procedure has soared 
nationally since nbc weatherman Al 
Roker lost more than 100 pounds 
following the surgery in 2002. 
Pre- and postoperative care are as 
crucial as the surgery itself, said Bell, 
and are the factors that distinguish 
well-run programs. Each patient must 
be evaluated by a psychiatrist or psy¬ 
chologist and a dietician before being 
accepted as a candidate for surgery. All 
of Bell’s patients are what he terms 
“professional dieters” who have gone 
the traditional diet and exercise route 
many times without being able to shed 
weight permanently. 
But for Bell’s patients, losing weight 
is a matter of health more than appear¬ 
ance. “You’re not going to be a size 
2,” Bell tells them. His goal is to bring 
their weight down enough to reduce 
the health risks associated with obesity. 
Postoperative support is equally impor¬ 
tant. With less room to accommodate 
9 
li food, patients need to be sure that they 
are using the smaller gastric pouch to 
fj get adequate nutrition; otherwise pro- 
fi tein deficiency and other complications 
j; can result. 
': Hunger is not a problem. “The brain 
: is fooled into thinking that the body is 
, in a full state,” said Bell. Levels of the 
. appetite-stimulating hormone ghrelin, 
I/, which spikes prior to a meal and dips 
11 after a meal, stay consistently low in 
gastric-bypass patients. This may hold 
: some clue as to why these patients 
■'! generally avoid the “yo-yo” dieting syn¬ 
drome that plagues many who try to 
; lose weight by nonsurgical means. 
Acceptance of surgical treatment 
O' for obesity is growing, but societal pre¬ 
conceptions about obesity linger. “It 
, truly is the last accepted form of big- 
k otry,” Bell said. The simplistic assump¬ 
tion is that obese people are overweight 
■r because they are lazy and/or they 
eat too much, but science increasingly 
belies that idea. One of Bell’s col¬ 
li leagues is fond of giving the bariatric 
surgeon some advice on dealing with 
patients: why don’t you just tell them 
to eat less.^ 
“Of course, he’s kidding,” said 
Bell. “Mostly.” 
—Colleen Shaddox 
i 
i 
When it comes to defining 
outcomes, caregivers and 
patients don’t always agree 
Physicians often turn to a patient’s 
friends or family members to make a 
decision on medical treatment. But 
a Yale study has found that seriously 
ill elder patients and caregivers dis¬ 
agreed approximately 40 percent of 
the time over the acceptability of out¬ 
comes such as memory loss, physical 
impairment and chronic pain. 
According to Terri R. Fried, m.d., 
lead author of a paper published in 
the Archives of Internal Medicine in 
September, this is “the first study that 
asked how acceptable different states 
of health would be as a result of treat¬ 
ment.” Fried, an associate professor 
of internal medicine (geriatrics) at the 
School of Medicine, said caregivers may 
not be representing patients’ desires. 
Although approximately 60 percent 
of patient-caregiver pairs agreed on the 
acceptability of severe memory loss as 
an outcome, about 40 percent could 
not agree. An outcome of chronic 
pain generated 35 percent disagree¬ 
ment, and being bed-bound evoked 43 
percent disagreement. Without treat¬ 
ment, patients faced further decline 
and death. The 193 patients in the 
study were over age 60 and seriously 
ill with cancer, congestive heart fail¬ 
ure or chronic lung disease. 
According to Fried, patients and 
their caregivers are often in denial 
about the illness and try to spare each 
other’s feelings. The failure to discuss 
difficult possibilities leaves caregivers 
ill-prepared to make treatment deci¬ 
sions for seriously ill patients. 
Physicians must educate the patient 
about the course of the illness and 
the decisions that need to be made, 
Fried said. “Most patients do have 
strong views about the quality of life,” 
she said. “We need to translate that 
into choices that are useful in medical 
decision making, and that’s what we 
tried to do in the study.” 
—Mary Anne Chute Lynch 
CLOZAPINE AND DIABETES RISK 
Patients taking the antipsychotic drug cloza¬ 
pine have a higher-than-average chance of 
developing diabetes, but recent research 
suggests that clinicians may not be finding 
at-risk patients. 
In a study by Michael J. Sernyak Jr., aa.d., 
HS ’91, professor of psychiatry, a screening 
of 121 patients taking clozapine—none pre¬ 
viously diagnosed with diabetes—found 
that 23 percent showed elevated glucose 
levels, a frequent precursor to diabetes. The 
results suggested that a patient taking 
clozapine should be followed closely, said 
Sernyak, chief of psychiatry at the VA Conn¬ 
ecticut Healthcare System in West Haven. 
Sernyak said that early intervention would 
reduce morbidity and the high costs of the 
complications of diabetes. The study was 
funded by the Department of Veterans 
Affairs and reported in May in The Journal 
of Clinical Psychiatry. 
—Cathy Shufro 
DRUGS AND THE ADOLESCENT BRAIN 
The adolescent mind that impels teenagers 
to dye their hair purple and go airborne 
on skateboards also makes them more vul¬ 
nerable to drug addiction. According to an 
analysis by Yale researchers of more than 
140 studies in the basic and clinical neuro¬ 
sciences, their stage of brain development is 
to blame. "Several lines of evidence suggest 
that sociocultural aspects particular to 
adolescent life alone do not fully account 
for greater drug intake,” said R. Andrew 
Chambers, m.d., assistant professor of psychia¬ 
try and lead author of the study published in 
June in The American Journal of Psychiatry. 
“And while we strongly suspect that genetic 
factors in individuals can lower the threshold 
of drug exposure required for ‘tripping the 
switch’from experimental to addictive drug 
use,” Chambers said, “here we have a phe¬ 
nomenon where a neurodevelopmental stage 
common to virtually everyone, regardless of 
genetic make-up, confers enhanced neurobio- 
logical vulnerability to addiction.” 
—Cathy Shufro 
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Findings from the bench 
On tumor’s surface, 
a telltale molecule 
Yale scientists discern an abnormal 
sugar that gives cancer cells 
mobility but also gives them away. 
The little white grains that sweeten 
our cereal at breakfast are usually all 
we have in mind when we speak 
of “sugar.” Inside the human body, 
though, sugar exists in many forms, 
most of them readily convertible to 
energy. Each of these contributes to 
everyday functioning and the mainte¬ 
nance of general good health. But 
when John M. Pawelek, ph.d., senior 
research scientist in dermatology, 
observed strangely branched oligosac¬ 
charide molecules crowded together 
on the surface of one particular type 
of cell, he knew those sugars had 
nothing to do with good health: the 
cells had all come from human 
metastatic tumors. 
“There have been 20 years of work, 
in vitro and in animal models, showing 
that cancer cells tend to exhibit sugars 
on their outer surface that aren’t pres¬ 
ent on their normal-cell counterparts, 
but no one had sat down and said, 
‘Let’s look for these sugars in human 
cancer cells,’” said Pawelek. "When he 
and Tamara Handerson, m.d., of Tufts 
University did just that, using a Yale- 
designed tumor microarray, they were 
surprised at the near-universal results. 
“We’ve now looked at slides from 
perhaps 500 different human metas- 
tases and found just a handful that 
don’t have these sugars,” said Pawelek. 
Handerson and Pawelek published 
their findings in the September i issue 
of the journal Cancer Research. 
Normally, such oligosaccharides 
appear only on the surface of the 
immune system’s white blood cells, or 
leukocytes, where their function is to 
allow the leukocytes to move on their 
own—as they must do in order to patrol 
the body and attack foreign cells effec¬ 
tively. In cancer cells, the same power of 
movement is conferred by the abnormal 
oligosaccharides on their surface and 
may play a key role in metastasis, the 
spread of malignant disease from one 
organ or part of the body to another. 
But the oligosaccharide coating on 
the cell surface that makes the tumor 
cells mobile may also make them easier 
to find and more vulnerable to cancer¬ 
suppressing therapy, says Pawelek. 
Since the branched oligosaccharides 
appear almost exclusively on cancer¬ 
ous cells and are readily detected by 
a method of staining known as lectin 
histochemistry, the sugar coating pro¬ 
vides a strong tool for diagnosis as well 
as for locating precisely the populations 
of cells that require treatment. Pawelek | 
and Handerson, in collaboration with 
Robert L. Camp, m.d., ph.d., associate 
research scientist in pathology, and 
David L. Rimm, m.d., ph.d., associate 
professor of pathology, also carried out 
studies focusing specifically on breast | 
cancer, in which they found that the 
quantity of abnormal sugar present in ; 
cells from a patient’s biopsy is a reliable ] 
inverse index of the patient’s odds for ; 
survival; the more oligosaccharides, the ' 
greater the likelihood that the cancer | 
will be fatal. The index seems to work j 
independently of the well-known risk 1 
factors: stage and type of cancer, age of 
patient and even the extent of metasta¬ 
sis. As Pawelek sees it, “This is a com¬ 
pletely new predictor.” 
At the same time, the pervasiveness 
of the sugar coating among cancerous 
cells means that any treatment that 
destroys tumors by attacking the oligo- j 
saccharide molecules could probably be 1 
applied to a broad range of carcinomas, 
from cancer of the breast, lung or colon 
to prostate cancer or Hodgkin’s lym¬ 
phoma. “What we have now is a univer- j 
sal target,” said Pawelek, adding, “If j 
you have something that is characteris¬ 
tic of all metastases, it’s really worth | 
your while to go after it.” 
While continuing to apply the tumor 
microarray technique to as many 
types of cancer as possible, the scien¬ 
tists are also seeking to learn more 
about the workings of the branched 
oligosaccharide structures on the sur- j 
face of tumor cells. Most important, } 
said Pawelek, “We’re going to put all I 
our efforts into exploiting these sugars f 
for therapy, because in the end, we’d j 
rather get rid of them than have them 
here to study.” 
—Sandra Ackerman 
Stains on a mkroarray of human carcinomas 
show the presence of sugars, which are par¬ 
ticularly prominent in metastases. 
B 
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A new class of rna molecule 
may help cells decide 
I how and when to grow 
i Two members of a class of tiny rna 
molecules discovered only a decade 
ago have been shown to play a role 
I in the timing of cell differentiation, 
according to a Yale researcher. 
Biologist Frank J. Slack, ph.d., 
who four years ago discovered the 
microRNA let-y, the second micro- 
RNA known to scientists, says that 
understanding the function of these 
regulatory rnas in the millimeter- 
long nematode C. elegans may 
provide insight into human biology 
as well. 
“Because C. elegans shares half 
its genes with humans, we hope to 
extend to humans what we’ve learned 
about how microRNAs function in 
C. elegans," said Slack, an assistant 
professor of molecular, cellular and 
developmental biology, whose find¬ 
ings were published in Developmental 
Cell last May. 
Slack showed that these noncod¬ 
ing RNAS provide temporal cues that 
control the larval worm’s maturation. 
The microRNAs determine when key 
DNA-binding proteins are active. Micro¬ 
RNAs turn off the genes that block 
neuronal development and cell differ¬ 
entiation, thus ensuring that differen¬ 
tiation occurs at the right time. 
Although the first microRNA, Hn-4, 
was not detected until 1993, micro¬ 
RNAs are now known to occur in the 
cells of many organisms, from weeds 
to humans. MicroRNAs are identified 
by their shape, initially a hairpin, and 
by their small size. (The ones Slack 
studied are 21 nucleotides long, while 
messenger rnas generally exceed 
1,000 nucleotides.) “They’re pretty 
widespread, and yet we didn’t know 
about them for so long. That’s why 
everybody is so excited,” said Slack. 
“The field has exploded.” 
Slack was a postdoctoral fellow at 
Harvard in 2000 when he identified 
let-y, seven years after the discovery 
of iin-4 by Victor R. Ambros, ph.d., 
at Dartmouth. Slack’s discovery sug¬ 
gested that the microRNA that Ambros 
had identified was not an anomaly. 
Since then, researchers have identi¬ 
fied about 400 microRNAs, the prod¬ 
ucts of genes encoded in the genomes 
of a wide range of organisms. So 
far, however, scientists understand 
how only a handful of those micro¬ 
RNAs function. 
Researchers hope that humans may 
be able to harness the ability of micro¬ 
RNAs to turn off harmful processes, 
such as the development of cancer cells 
or the replication of disease-causing 
vimses. Slack speculated that such appli¬ 
cations are a decade away. 
—Cathy Shufiv 
TOUCHED BY AN ILLUSION 
Why would multiple real stimuli register as 
a single stimulus in the brain? A paper pub¬ 
lished September 18 in the online edition 
of Science explains this quirk of perception, 
known as the tactile tunneling illusion. 
Yale neurobiologist Anna W. Roe, ph.d., 
and her colleagues studied the illusion in a 
portion of the primary somatosensory cortex 
(SI) of squirrel monkeys. They found that 
whenever they administered a mild electrical 
stimulus simultaneously to two nonadjacent 
fingers of the animal’s hand, the SI showed 
two separate activation spots that corre¬ 
sponded to the two sites of stimulation. By 
contrast, when they delivered simultaneous 
stimuli to two adjacent fingers, the SI 
showed a single activation spot located mid¬ 
way between the two sites. The study indi¬ 
cates that, contrary to previous thought, a 
finger’s “receptive field’’ for sensory stimuli 
can sometimes extend beyond the finger 
itself—a notion that could someday find 
clinical application, for example in rehabilita¬ 
tion after injury or stroke. 
—Sandra Ackerman 
RO’S ROLE IN LUPUS 
An estimated 1.5 million Americans suffer from 
lupus erythematosus, an autoimmune disorder 
that causes aching joints, fever, fatigue, 
numerous skin lesions and hypersensitivity to 
light. Many lupus patients carry in their blood 
an antibody against the autoantigen Ro 60- 
kDa.This RNA-binding protein passes unno¬ 
ticed in the normal immune system but is the 
target of an abnormal immune response in 
these patients. Nevertheless, the role of Ro in 
lupus erythematosus has been unclear. 
When Sandra L. Wolin, m.d./ph.d. ’85, 
associate professor of cell biology and 
molecular biophysics and biochemistry and a 
Howard Hughes Medical Institute associate 
investigator, and colleagues developed a 
knockout mouse without the gene for mak¬ 
ing the Ro protein, the mouse developed an 
autoimmune syndrome similar to lupus. The 
authors suggest that Ro may serve a quality 
control function by recognizing misfolded, 
defective rna molecules. When Ro is absent, 
abnormal RNA-protein complexes may accu¬ 
mulate and be viewed as foreign by the 
immune system. 
—Sandra Ackerman 
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12 Books 
Atlas of Cosmetic Surgery 
edited by Michael S. Kaminer, 
M.D., assistant clinical professor 
of dermatology, |effrey S. Dover, 
M.D., associate clinical professor 
of dermatology, and Kenneth A. 
Arndt, m.d. ’61, hs ’62, clinical 
professor of dermatology 
W.B. Saunders Co. 
(New York) 2002: ^y6 pages 
Experts present hands-on guid¬ 
ance for performing a broad 
range of cosmetic surgical pro¬ 
cedures, including face lifts, laser 
resurfacing, blepharoplasty for 
the eyelids, hair transplanta¬ 
tion, hair removal, chemical 
peeling, laser treatment of 
brown and red lesions and lipo¬ 
suction. Clinical photographs, 
combined with two-color illus¬ 
trations, demonstrate how to 
proceed and what outcomes 
to expect. 
Eliminating Stress, 
Finding Inner Peace 
by Brian L. Weiss, m.d. '70 
Hay House 
(Carlsbad, Calif.) 2ooj: 100 pages 
Stress kills, there’s no doubt. 
Stress eats away at our happi¬ 
ness and joy, as well as our stom¬ 
ach lining. It raises blood 
pressure and directly harms our 
cardiovascular system. Stress 
depresses our immune system 
and allows chronic illnesses to 
overwhelm us, causing pain, 
disability and even death. This 
book, which includes a stress- 
reduction CD, will enable readers 
to release the acute and chronic 
stress we constantly carry in 
our bodies and our minds. It can 
help us remove the blocks and 
obstacles to inner peace and 
joy, and prevent and heal stress- 
related illness and disease. 
Medicine’s Brave New World: 
Bioengineering and the New 
Genetics 
by Margaret O. Hyde and John F. 
Setaro, m.d., hs ’86, associate 
professor of medicine 
21st Century Books 
(Brookfield. Conn.) 2001: 144 pages 
The authors present a host of 
medical breakthroughs and pon¬ 
der the future of many versions 
of genetic manipulation to 
support medical science.Topics 
include fertility advances, xeno¬ 
transplantation, stem cell 
research, cloning, the Human 
Genome Project and genetic test¬ 
ing. There are also some notes of 
caution as the authors consider 
some of the many ethical objec¬ 
tions to genetic research. 
Help Me to Heal: A Practical 
Guidebook for Patients, Visitors, 
and Caregivers (Essential Tools, 
Strategies, and Resources for 
Healthy Hospitalizations and 
Home Convalescence) 
by Bernie S. Siegel, m.d., hs ’61, 
and Yosaif August 
Hay House 
(Carlsbad, Calif.) 200J; 200 pages 
Every hospitalization, period of 
convalescence or visit to a 
patient can be an opportunity 
for healing.This book is a 
resource to help readers realize 
this healing potential. It provides 
the empowering tools, strategies 
and resources that will enable 
readers to turn their bedside 
environment and illness experi¬ 
ence into a sacred space and 
time where healing can occur. 
100 Questions & Answers About 
Ovarian Cancer 
by Don S. Dizon, m.d., hs '98, 
Nadeem R, Abu-Rustum, m.d., 
and Andrea G. Brown 
Jones and Bartlett Publishers 
(Sudbury, Mass.) 2004; 160 pages 
Written by a gynecologic oncolo¬ 
gist, a gynecologic surgeon and 
an ovarian cancer survivor, this 
book offers practical answers 
to questions about treatment 
options, posttreatment quality 
of life and sources of support for 
ovarian cancer patients, family 
and friends. 
Fishman’s Manual of Pulmonary 
Diseases and Disorders, 3rd ed. 
by Alfred P. Fishman, M.D., Jack 
A. EJias, M.D., professor of medi¬ 
cine, Jay A. Fishman, Michael A. 
Grippi, Larry R. Kaiser and 
Robert M. Senior, m.d. 
McGraw-Hill Professional 
(New York) 2002; 1,174 
This quick-reference pocket 
manual presents important 
clinical information contained 
in the two-volume Fishman’s 
Pulmonary Diseases and Disorders, 
3rd ed. For each condition, the 
manual covers clinical evalua¬ 
tion, work-up, differential diag¬ 
nosis and treatment. 
Take a Deep Breath: The Haiku 
Way to Inner Peace 
by Sylvia Forges-Ryan and 
Edward R. Ryan, ph.d., associate 
clinical professor of psychology 
in psychiatry 
Kodansha International 
(New York) 2003; i2q pages 
This volume provides guidance 
on combining the ancient forms 
of haiku and meditation to 
improve health. The authors see 
haiku as the perfect form for 
their exercises because a few 
phrases can set off a chain of 
thoughts, which when incorpo¬ 
rated into meditation lead to 
insights that can be used to 
enhance well-being. 
Compelled by Data: John D. 
Thompson, Nurse, Health 
Services Researcher and Health 
Administration Educator 
edited by William D. White, 
PH.D., former associate professor 
of public health 
Department of Epidemiology and 
Public Health, Yale University 
(New Haven) 2003; 199 pages 
This volume celebrates the life 
and accomplishments of John D. 
Thompson, a distinguished and 
inspiring leader in the fields 
of health services research and 
health administration educa¬ 
tion. Thompson’s career spanned 
more than 40 years, including 
over 30 years as a member of 
the faculty of the Department of 
Epidemiology and Public Health 
at Yale. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612. New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu 
on campus 
At grand rounds, sex columnist 
comes armed with advice 
In the 1960s, Masters and 
' Johnson moved the study of sex 
away from the anecdotal and 
into the scientific realm: they 
observed sexual encounters in a 
laboratory, monitoring brain 
waves, heart rates and signs of 
arousal. "Everything that could 
be measured was measured,” 
Ruth Westheimer, ed.d., said 
during Department of Psychiatry 
grand rounds in September. “You 
may be wondering how they 
were able to find subjects will¬ 
ing to perform on demand.... 
I Fortunately for all of us, there 
were medical students who 
needed money,” she said, to 
much laughter. 
"Dr. Ruth,” who has for 
decades dispensed her advice on 
the radio, in newspaper columns 
I, and in books, said that medical 
r schools should include sexuality 
I' in their curricula. “Many of you 
1 will be‘significant others’for 
I your patients when it comes to 
I' information about sexuality,” she 1! said, adding that students 
should also have the opportunity 
to consider their own feelings 
t about sex. For example,"Doctors 
f can get aroused examining their 
:j patients. If you do, go out and 
:■ get a glass of water—there’s no 
If time to take a shower!—or take 
il 
f. a deep breath.... Be aware of it 
but don’t get upset. If you’re 
I aware,you can go on and ask the 
[ next question.” 
‘' —Michael Fitzsousa 
;! 
Stressing the human touch in 
health care 
When Anna Quindlen told a 
friend with aids she was giving 
a talk at the Yale School of 
Nursing, the friend said, "Tell 
them to treat the patient, not 
the file.” 
Quindlen, a Pulitzer Prize¬ 
winning columnist and author, 
did just that when she delivered 
the 38th annual Sybil Palmer 
Bellos lecture recently. She 
stressed the need for doctors to 
apply a “human touch” and cred¬ 
ited women with pushing the 
health care pendulum in that 
direction. “We have the most 
astonishingly competent health 
care system in the world,” she 
said. “Now we want it to be as 
empathetic as it is competent.” 
Quindlen spoke from experi¬ 
ence. During her mother’s losing 
battle with ovarian cancer, she 
said,"there was no attempt on 
the part of her doctors to engage 
with her or us as people.” But 
times have changed as more 
women have entered the profes¬ 
sion, and women, the chief health 
care consumers, have demanded 
personalized attention. 
She sees parallels between 
journalism and health care. 
Newspapers diversified their 
content because consumers 
demanded it. Quindlen says her 
New York Times column focused 
on the “human experience" 
because that’s what she and 
readers found most satisfying. 
She’s optimistic that health care 
providers are finally realizing 
that’s what patients want, too. 
—Jennifer Kaylin 
Fighting assumptions about the 
disabled, as well as bias 
People assume that the nation’s 
estimated 50 million disabled 
people live lives of grim struggle, 
says Harriet McBryde Johnson. 
That’s untrue, says Johnson, a 
South Carolina lawyer who uses 
a wheelchair because of a con¬ 
genital neuromuscular disease. 
Such assumptions about disabled 
people constitute prejudice 
akin to racism, she said in a 
September talk on campus. “Our 
lives are interesting and rich,” 
said Johnson, who wants disabled 
people to “bear witness to our 
pleasures.” 
Johnson garnered national 
attention in February 2003 with 
an article in The New York Times 
Magazine describing her conver¬ 
sations with Princeton ethicist 
Peter Singer, who argues that it is 
ethical to kill severely disabled 
babies, an argument based, in 
part, on assumptions about qual¬ 
ity of life. Johnson acknowledges 
that disabled lives, like nondis¬ 
abled lives, include some suffer¬ 
ing. She, for example, is dealing 
with a swallowing problem that 
sometimes makes her a “basket 
case.... But I wouldn’t say I need 
to be euthanized; there is much 
more to my life than swallow¬ 
ing,” said Johnson. Nor does 
she want to be a special case, or 
“a little Harriet exception” to 
prejudice. “I believe that living 
our strange, peculiar lives is a 
contribution, and doing it openly 
and without shame is really a 
revolutionary act.” 
—Cathy Shufro 
On eating well, and bringing 
values to the table 
The family meal was once the 
central civilizing activity in a 
child’s life, says Alice Waters, 
owner of Chez Panisse, the 
trendsetting restaurant in 
Berkeley, Calif She acquired her 
own core beliefs “almost uncon¬ 
sciously, at the table of my fam¬ 
ily.” Nowadays, however, families 
no longer give priority to the 
“ritual of the table,” she said in 
September at a colloquium 
sponsored by the Program in 
Agrarian Studies. 
Waters believes public schools 
can help restore that daily ritual 
by encouraging children to grow, 
prepare and eat their own food 
and by making lunch a for-credit 
course. In The Edible Schoolyard, 
a program she helped found at a 
Berkeley public middle school, 
she says students not only find 
that work can be a pleasure, but 
also learn to think seriously 
about food and where it comes 
from, and to relate to each other 
in a respectful and social way. 
Waters wants schools nationwide 
to follow suit, creating “a curricu¬ 
lum that teaches the essential 
values of nourishment, commu¬ 
nity and stewardship of the 
land.” She said funding must be 
found, because unhealthy food, 
inactivity and the destruction 
wrought by factory farming carry 
hidden costs. 
Waters has already helped 
to transform cuisine on the Yale 
campus. She’s an advisor to 
the Berkeley College dining hall, 
which last fall began serving 
mostly seasonal, sustainably 
grown foods. The menu attracts 
more diners than the college 
can serve. 
—Cathy Shufro 
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H capsule 
By Colleen Shaddox 
Inside Sterling Hall of Medicine, brain 
specimens from Harvey Cushing’s 
collection share shelf space with 19th 
century physicians’ implements, his¬ 
toric photographs and aging tomes 
on the healing arts. But the medical 
school’s wealth of notable specimens 
is not confined to the great indoors. 
Outside its walls, an observant 
visitor can spot the sycamore tree the 
grounds crew calls the Hippocratic 
The 1920s were considered boom years for the 
School of Medicine and in 1925 the Sterling Hall 
of Medicine was dedicated. Planning for the 
building began in 1921, and its construction was 
the crowning achievement of Milton 
Winternitz’s tenure as dean. 
A nurturing vision 
The medical school’s external face owes a great debt to a pioneer of 
American landscape design. 
Growth, which grew from a seed that 
came from the birthplace of Hippocra¬ 
tes in Greece. Within its courtyards 
grows one of the only American elms 
to survive New Haven’s Dutch elm out¬ 
break in the 1930s. And the landscap¬ 
ing for the medical campus—for much 
of the university, in fact—is the design 
of Beatrix Jones Farrand, one of the 
first American landscape architects. 
Farrand studied landscapes and plants 
during an apprenticeship at Harvard’s 
Arnold Arboretum, and as a young 
woman made several grand tours of 
Europe—one with her aunt, novelist 
Edith Wharton—where landscape 
paintings and vistas of the Old World 
informed her sense of design. 
Before coming to Yale in 1922 to 
start almost a quarter-century of 
landscape consulting, she designed 
gardens at Princeton and Dumbar- 
“3 Sfvfly for T^ntrancc 
^ The Injtitute of Jfiiman Relation s and 
S the Sterling Jfall f Jltedicine 
j yalc Universt ty 
Beatrix Farrand’s designs could be seen in the 
planning for the Institute of Human Relations, 
which was dedicated in 1931. The institute, which 
occupied the left portion of the remodeled 
Sterling Hall of Medicine (above), expanded the 
building and added a central facade. 
ton Oaks in Washington. At Yale 
her first project was the Memorial 
Quadrangle, now Branford and 
Saybrook colleges. She went on to 
design grounds at the divinity school, 
the president’s house, the residen¬ 
tial colleges and the medical school. 
Although many of the gardens at 
the medical school remain out of 
view to the public, Channing C. Harris, 
senior associate with Towers/Golde, 
Landscape Architects and Site Planners, 
and a longtime landscape consultant 
to Yale, said that horticulture helps to 
shape life on Cedar Street. On the large 
lawn outside Harkness dormitory 
students receive their white jackets in 
the fall, their medical degrees in the 
spring, and in between bask in the sun¬ 
shine enjoying pad thai and other treats 
from street vendors. The narrow plant¬ 
ing beds along the street pour color 
into the neighborhood, along with the 
honeyed fragrance of Russian olive. 
Towers/Golde has done site and 
landscape design for new building and 
renovation projects, courtyards, rooftop 
gardens and streetscapes at Yale for 25 
years. This work often involves efforts to 
preserve older trees and mature plant¬ 
ings, or recreate Farrand’s original land¬ 
scapes. Where possible, Harris said that 
he tries to be true to Farrand’s philoso¬ 
phy, but practicality can dictate change. 
For example, Farrand loved climbing 
vines, many of which damage build¬ 
ings. So the wisteria has mostly gone. 
Farrand believed that the landscape 
was as important to university life as 
the classroom: “We all know that edu¬ 
cation is by no means a mere matter of 
books, and that the aesthetic environ¬ 
ment contributes as much to growth as 
facts assembled from a printed page,” 
she told the alumni weekly at Prince¬ 
ton in 1926. 
When the roof of the Yale Animal 
Resources Genter, then located in the 
B wing of the Sterling Hall of Medicine, 
developed leaks in 1986, the School 
of Medicine restored a rooftop garden 
in keeping with Farrand’s original 
vision. Using historic photographs, 
Norman Brody, the medical school’s 
associate director of buildings and site 
services, and his team of carpenters 
recreated original trelliswork, and roses 
and weeping cherries now complete 
the genteel scene. There is even some 
wisteria, a maintenance nightmare 
that Brody restrained himself from clip¬ 
ping back for two full years. 
Throughout Yale, many gardens have 
been lost to new buildings and renova¬ 
tions. At the medical school new con¬ 
struction constantly encroaches on the 
flora. But great care is taken to preserve 
important specimens and to expand 
plantings wherever possible. The more 
venerable and fragile trees in Farrand’s 
gardens give Brody “a white-lcnudde 
ride every winter,” he said. By and large 
they make it. 
A number of improvements that 
would bring more blooms and greenery 
to Gedar Street between York Street 
and Congress Avenue are under consid¬ 
eration. Farrand favored spring- and 
fall-blooming plants, reasoning that no 
one would be on campus during the 
summer. But the new plantings would 
extend floral displays into the summer 
months in recognition that life on 
Cedar Street is now a 12-month affair. 
Colleen Shaddox is a freelance writer in 
Hamden, Conn. 
Beatrix Farrand came to Yale in 1922 and stayed 
for almost 25 years. While at Yale she designed 
landscapes for the divinity school, residential 
colleges and the medical school. 
Still standing on Harkness Lawn is a sycamore 
that is sometimes referred to as the Hippocratic 
Growth. The tree grew from seeds imported 
from Ephesus, the birthplace of Hippocrates in 
ancient Greece. 
Yale's Summer Medical Education 
Program helps aspiring physic 
dans to understand what’s in store 
for them in medical school. 
Elvis Rodriguez (center) donned 
scrubs to observe a gastric 
bypass operation performed by 
Robert Bell (left). 
17 
An insider’s view 
A summer program to encourage diversity 
in the health professions shows college 
students a clearer path to becoming a doctor— 
by acquainting them with the art, science 
and culture of medicine. 
By Jennifer Kaylin 
Photographs by Terry Dagradi 
It’s nearly i a.m. on Sunday morning of the July 4 weekend, 
and the constellation of examination cubicles and work sta¬ 
tions in the Yale-New Haven Hospital emergency department 
is as peaceful as a library. Patients who have already been 
treated rest comfortably on stretchers while awaiting rooms 
upstairs. Meanwhile, doctors and nurses review files, check e- 
mail messages and talk quietly about fireworks displays and 
holiday traffic. Suddenly the triage nurse gets a radio dispatch. 
“How many?” she asks, and then immediately activates the 
trauma response. Spines straighten and conversation stops as 
everyone in the room is ordered to gown up in sterile clothing. 
Minutes later the doors fly open and a platoon of fire¬ 
fighters and EMTs wheel in a stretcher carrying a young man 
who is screaming in pain. The trauma team moves the patient 
to a hospital bed, cuts off his clothing and crowds around to 
assess his condition: “He’s nonverbal.” “He has blood in his 
mouth.” “130 over 90.” “Two broken teeth.” “Anesthesia to 
trauma room stat!” While this is going on, another victim 
from the same car accident is rushed in. She is even younger 
and is also howling in pain. “How many more?” somebody 
yells. “They’re saying three,” answers a nurse. 
Standing on the periphery of this scene, but watching 
with the owl-eyed intensity of judges, are three college stu¬ 
dents. They are here as part of an intensive six-week summer 
course designed to encourage diversity in the physician work¬ 
force, in part by helping underrepresented minority students 
improve their chances of getting into medical schools. 
“Seeing someone my own age in so much pain was 
kind of upsetting,” Leonie Prao, a Howard University junior, 
Students on the midnight shift in 
the Yale-New Haven Hospital emer¬ 
gency department watched as a 
car accident victim was treated. 
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An insider’s view 
represented in the medical profession. For example, white 
students from rural areas lacking in health care resources 
have participated, as have non-minorities from economically 
or educationally disadvantaged backgrounds. At one program 
site, organizers say, the presence of a disadvantaged white 
student changed the outlook of classmates who said they had 
assumed all white people were wealthy. 
This gradual broadening of the program’s focus was 
reinforced last June, when the U.S. Supreme Court ruled in 
two affirmative action cases involving the University of 
Michigan. The court upheld the Michigan law school’s “nar¬ 
rowly tailored use of race in admissions decisions” because it 
treated all the applicants as individuals. In contrast, the uni¬ 
versity’s undergraduate admissions policy, which also encour¬ 
aged diversity, was rejected by the court because it took an 
approach that was deemed mechanistic, automatically award¬ 
ing bonus points, for example, to applicants on the basis of 
their race or ethnicity. 
The foundation and the Association of American 
Medical Colleges (aamc), which administers smep, used the 
Supreme Court ruling as an occasion to reexamine the sum¬ 
mer program’s goals and operations. In December, they ' 
dropped “Minority” from the name and rechristened it the 
Summer Medical Education Program. The announcement on | 
the program website said that smep “will no longer identify 
itself solely as a program for applicants from historically 
underrepresented racial and ethnic groups.” While affirming 
the need for a pipeline to help these applicants enter careers 
in medicine, the sponsors said that “the benefits of diversity 
cannot be fully realized by a program that focuses narrowly j 
on certain groups by excluding others.” , 
A transforming experience 
Since 1988, more than 10,000 students have participated in 
the program, and of the 5,500 who have applied to medical , 
school, 63 percent were accepted, according to the aamc. A 
1998 study published in jama: The Journal of the American 
Medical Association found that among students with identical 
GPAs and MCAT scores, program graduates were more likely to 
get into medical school than others. The largest improvement 
was seen in the acceptance rate for African-American males. 
“It definitely gives applicants a certain edge. It helps 
them present themselves as a much better candidate to medi¬ 
cal schools,” says Richele Jordan-Davis, director of diversity . 
and minority affairs at Columbia University’s College of Physi¬ 
cians and Surgeons, which has accepted graduates from Yale’s 
program and became a program site itself three years ago. 
Kevin Harris, a senior staff associate with the aamc’s 
division of community and minority programs, says about ' 
one in every six underrepresented minority students enrolled , 
in U.S. medical schools is an smep graduate. “That’s a pretty I 
large piece of the pie, so we feel very strongly that smep is a 
good program that we hope will continue.” , 
says later that night. Upsetting, but also invaluable, as she 
and her fellow classmates gain exposure to real-life medical 
situations and decide whether they’re cut out to be doctors. 
“I just tried to tune out the screaming and focus on what the 
doctors were saying,” she says. 
“It kind of threw me,” admits Rochelle Chijioke, a 
Georgetown University junior. “But I’m pretty calm in stress¬ 
ful situations, so 1 don’t think it’s anything I couldn’t handle.” 
Students attend this intensive course, the Summer 
Medical Education Program (smep), tuition-free and receive a 
small stipend to offset the income they would have earned at 
a summer job. The program, now offered at ii sites around 
the country, was started in 1988 by The Robert Wood Johnson 
foundation with the specific aim of increasing the number 
of medical students from underrepresented minorities, espe¬ 
cially African-Americans, Hispanics and Native Americans. 
Originally called the Minority Medical Education Program 
(mmep), it has since expanded to include members of other 
groups not thought of as minorities but which may be under- 
TOP Elvis Rodriguez, Wesley 
Chambers and Happy Wyche 
were among the smep 
students at Yale last summer. 
ABOVE The program gives 
students a taste of the academic 
rigors of medical school. 
I SMEP combines clinical exposure—such as spending 
a shift in the emergency department or observing an opera- 
I tion or an autopsy—with course work in the biological and 
If physical sciences. A wide-ranging lecture series, a writing 
and communications course, career counseling and a medi- 
I cal school recruitment fair are other major components of 
h the program. The aim is not simply to give students the 
nuts-and-bolts information they’ll need to get into medical 
school, but to demystify a world that to many seems as rar¬ 
efied and unapproachable as Mount Olympus. 
“A lot of SMEP students are working two or three jobs 
to pay for college. They don’t come from a long family line of 
physicians, and they think there’s no one like them at Yale,” 
says Andre R. Matthews, a program graduate who is now in 
his third year at the School of Medicine. “But then they come 
here and see that it’s less homogeneous than they thought.” 
Forrester A. Lee, m.d. ’79, hs ’83, the medical school’s 
assistant dean for multicultural affairs and co-director of 
Yale’s program, sees a transformation occur in many of the 
students. “I guarantee by the end of those six weeks, you 
I have fundamentally altered their view of the world,” he says. 
"This is a group who never dreamed they could come to Yale, 
and now they’re here and succeeding, and they can honestly 
! see themselves as medical students here.” 
Last summer’s class of 124 students came from 76 col¬ 
leges across the country. African-Americans constituted 48 
I percent of the class, 38 percent were Latino, and 10 percent 
were either Native American, Native Hawaiian or Southeast 
Asian. A concerted effort was made to attract more Latino 
I students, resulting in a jump from 19 percent in 2002 to 38 
percent last year. 
While the program began with a focus on underrepre¬ 
sented minority students, others have benefited from it at 
; Yale, as at other sites. For example, seven white students were 
enrolled in 2002 and two participated last year. Lee says that 
in most cases what binds students isn’t race or ethnicity so 
1 much as coming from an educational system that failed to 
1 equip them with the necessary skills to get into medical school. 
I “It’s a socioeconomic problem that is particularly severe 
in ethnic minority communities,” he says. “The nurturing has 
largely been left to the schools because the community and 
I the family aren’t functioning well. But this is a job the schools 
aren’t prepared to do, and they’re overwhelmed. Not surpris¬ 
ingly, the result is Idds who are not learners.” 
But sometimes, despite the educational disadvantages 
and deprivations, a Idd manages to learn anyway. These are 
the ones the program wants to reach before they fall by the 
wayside—students like Elvis Rodriguez. 
“This I have a passion for” 
“Coming here to Yale is the first time I ever slept in a dorm,” 
says Rodriguez, a compact 28-year-old with soft brown eyes. 
He and his brother and sister were raised by their mother 
in the South Bronx. Public assistance was the family’s 
main source of income, but Rodriguez, being the eldest child, 
helped out by working at McDonald’s and as a porter at 
Tavern on the Green in Central Park. 
“After graduation from high school, I worked full time. 
Then one day I got a call from my high school counselor. 
He wanted to talk to me about my future,” Rodriguez recalls. 
“He told me I should go to college. 1 was grateful someone 
else cared, that someone was there to tell me, so I did.” 
At around the same time Rodriguez enrolled in the 
City College of New York, his twin sons were born, so he had 
to work the midnight shift as a security guard while taking 
courses and commuting to school in upper Manhattan. “I 
thought I wanted to be an architect, but I found it wasn’t as 
appealing as I’d imagined,” Rodriguez says. “Then I made 
friends with an emergency room doctor who suggested I 
volunteer at a local hospital. This exposed me to the medical 
field for the first time and 1 thought, ‘Wow! This 1 can do. 
This I have a passion for.’” 
Still, there was his family to support, so Rodriguez 
hedged his bet by getting a master’s degree in secondary sci¬ 
ence education from Lehman College. That was in 2001, 
and he’s been teaching high school biology since then. “But 
it’s not where my heart is,” he says. “In both careers you do 
good, but medicine is a different level of good.” 
Happy Wyche, another student in the program, says 
she’s determined not to become the cultural stereotype every¬ 
one expects: “A single mother with a bunch of kids and a 
low-paying job.” What Wyche wants to be is an obstetrician. 
“When we were in the maternity ward and I saw the mothers 
with their new babies, I was like, ‘Oh, my gosh. I can see 
myself doing this every day.’ Obstetrics inspires me.” 
Wyche, who at 24 has the sleek elegance of a model, 
lived in the Dominican Republic until she was eight. Then 
her mother moved the family to a low-income neighborhood 
in Miami. “The teachers in our school had no time to guide 
us. You had to teach yourself At first I didn’t speak a word of 
English,” Wyche recalls of her early education in the United 
States. Eventually she enrolled at Florida State University and 
volunteered at a local hospital and in nursing homes. She 
earned a degree in business finance, married and gave birth 
to a son, who is now a toddler. 
Her life was on the move, but still something was 
missing. “I got a job helping people invest their money, but 
I wasn’t as caring and compassionate as I wanted to be. It 
was too cutthroat,” Wyche says. So when her husband was 
sent to Afghanistan with the 82nd Airborne Division, she 
and her son moved home with her mother in Charlotte, N.C., 
and she began mapping her route to medical school. “People 
said just relax and raise your kid, but I have too much energy. 
I was ready to go back to school,” she says. 
In 1970, only 2 percent of American medical school 
students were members of an underrepresented minority 
An insider’s view 
group, predominantly African-Americans, although they consh- 
tuted 12 percent of the general population. That year, the 
AAMC set a goal of attaining popularion parity by significantly 
increasing minority representation in medical schools. By 
1975, that inihahve showed real results, with a fivefold increase 
in the number of African-American students—close to 1,000— 
enrolled in medical schools compared to 1968. But by 1974 the 
number leveled off at about 1,500 underrepresented minorities, 
or 9.4 percent, enrolling in American medical schools each 
year, out of a total enrollment of roughly 16,000 students. 
Lee, who co-directs smep with Stephen J. Huot, ph.d. 
’81, M.D. ’85, HS ’87, associate professor of medicine, says 
that when he began his own medical studies at Yale in 1975, 
minority enrollment here was at its peak, with the school rou¬ 
tinely admitting 10 to 12 minority students a year for every 
class of 100. “From my point of view, we had solved the prob¬ 
lem,” he says. “Things were looking good.” 
But the illusion of success faded as the demographics 
of the nation underwent seismic changes. “I don’t think peo¬ 
ple realized how dramatically society was changing,” Lee says. 
“The same goals weren’t relevant anymore.” 
So, in 1990, with 1,470 underrepresented minority 
students entering first-year classes, U.S. medical schools 
rededicated themselves to boosring that number through a 
AAMC initiative called “Project 3000 by 2000.” The goal was 
to reach 3,000 students by the year 2000. According to 
Lee, during the first few years, significant progress was made, 
peaking in 1994 with just over 2,000 minority students. 
Since then, the numbers have dropped to about 1,775, “leav- 
"! guarantee by the end of 
those six weeks, you have 
fundamentally altered their 
view of the world,” says pro¬ 
gram co-director Forrester Lee, 
ing us with a decade of zero progress,” Lee says. Among the 
507 medical students at Yale, 91 are members of minority 
and other groups underrepresented in medicine. 
Yale responded to the challenge of “Project 3000 by 
2000” by implementing the program along with three other 
programs aimed at helping improve the competitiveness of 
minority students applying to medical schools. 
The Biomedical Science Training and Enrichment 
Program (BiosTEP) is a summer research training program 
designed to interest undergraduates in careers in biomedical 
science. The Science, Technology and Research Scholars 
Program (stars) assists Yale undergraduates, including 
women and minority students, who are pursing majors in 
science or engineering. The third. Science Collaborative 
Hands On Learning and Research (scholar), is a partner¬ 
ship between the School of Medicine and New Haven’s 
Hill Regional Career High School that prepares students for 
advanced academic work in biology and chemistry. 
Thinking on their feet 
Consistently, the most popular component of smep, accord¬ 
ing to Lee, is the writing and communications course. Seven 
instructors teach students how to tackle the logic-challenging 
MCAT essays. Students also spend a lot of time working on 
their personal essays, which can often be the tiebreaker used 
by admissions committees in deciding whether or not to 
accept a student into medical school. The third element of 
the communications program is the mock interview, which is 
intended to prepare students for another make-or-break ele¬ 
ment of the admissions process. 
“Communication is not every doctor’s strong suit,” 
says writing instructor Susan Froetschel, m.p.a., who has a 
bachelor’s degree in journalism from Penn State and a mas¬ 
ter’s in public administration from Harvard. “But how effec¬ 
tive can you be as a doctor if you can’t communicate in a 
clear, concise, compassionate way with your patients? That’s 
why the personal essay and the interview are so important.” 
During one of her classes toward the end of the pro¬ 
gram, Froetschel began the dreaded mock interviews. 
Students took turns sitting in the front of the room, being 
grilled by the instructor and then having their performance 
critiqued by the rest of the class. Before she began, Froetschel 
reminded the edgy students, “Doctors interview patients at 
their most vulnerable. Patients have to expose the most 
embarrassing, painful parts of their lives to their physicians. 
This interview is nothing compared to what patients will go 
through in front of you if you are physicians.” 
She asked questions that ran the gamut from “How 
will you know if you are a successful physician 10 years from 
now?” to “Will affirmative action still be necessary in 25 
years?” One student who said she wanted to be an infertility 
specialist floundered when asked how that specialty helps 
society and not just the couple that wants a baby. Another 
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struggled to answer a question that required knowledge of 
disease prevention programs. Asked about street life in the 
neighborhood where he grew up, a third student impressed 
Froetschel and classmates with the parallel he drew between 
gang behavior and some fraternity practices on his campus. 
But the question that took everyone by surprise was 
when Froetschel asked one young man, “What’s your favorite 
ice cream.^” He came up with an answer, “vanilla,” but it was 
clear he’d temporarily lost his footing. Later, Froetschel 
explained the reason for asking something so seemingly irrel¬ 
evant: “I do that to fluster them. Interviewers will do that to 
see what happens when they encounter difficult patients. I 
had a student once who said an interviewer asked whether 
her mother had helped pick out the suit she was wearing. She 
got into the school, but she said she was totally jangled for 
the rest of the interview.” 
As nerve-wracking as the mock interview can be, many 
students say writing the personal essay is even worse. “Not 
good,” is how Wesley Chambers, a Morehouse College sopho¬ 
more, describes the instructor’s response to his personal 
statement. Chambers, who hopes to join his father’s gynecol¬ 
ogical practice one day, recalls, “It was hard for me. I felt like 
I was saying the same old stuff I realized I need to get some 
more experience so I have something to write about and can 
show that I’d be a good doctor.” 
Froetschel says that by the end of the six weeks, she 
j sees a real improvement in the quality of the essays. 
I “Revisions.^ A lot of students haven’t practiced repeated revi- 
: sions, but they really do pay attention to the strategies we 
discuss in class. They are open to criticism, and when they’re 
done, they really have thought out the issues.” 
But SMEP isn’t just six weeks of blunt lessons and 
I sharp critiques. The social bonds that form are equally impor- 
i tant. A water balloon fight between students and program 
staff on the lawn outside the student dining hall was “one of 
the best times I’ve had in a very long time,” Wyche says. I “There is so much love and support that is shown to us. 
That’s been the best part.” 
Rodriguez took advantage of a personal connection he 
made during the program to observe a gastric bypass opera- 
. tion, a surgical procedure for morbidly obese patients (typi- 
• cally loo to 400 pounds overweight) to limit their food intake 
by reducing the size of their stomachs. 
Dressed in scrubs and standing next to the patient, 
Rodriguez was able to watch on two video monitors as Robert 
L. Bell, M.D., HS ’01, carefully manipulated a retractor to 
move the patient’s liver so he could staple across the top of 
her stomach and reattach the small intestine. “Every time I’m 
exposed to something new, it adds fuel to my fire to pursue 
medicine,” Rodriguez said after the procedure, his eyes flash¬ 
ing with excitement. 
As a former student in what was then mmep and now 
a program instructor, Matthews knows well the passion. 
doubts, drive and insecurities students feel, “mmep helps dis¬ 
pel a lot of myths about medical school,” he says. 
The oldest of five children raised by a single mother 
on Chicago’s south side, Matthews says the program was just 
what he needed. “I doubted myself I didn’t know if I could 
handle medical school, but mmep serves to inspire people,” 
he says. “I’m not saying it’s easy, but it can be done.” 
Matthews says what students need most, and what 
SMEP tries to provide, is a chance to have their questions 
answered by a wide range of people in the medical profes¬ 
sion. “There are a lot of fears,” he says. “Everyone knows that 
person with the great mcat scores who didn’t get in.” He says 
instructors stress that medical schools don’t just look at num¬ 
bers; they look at the whole person, which is a welcome mes¬ 
sage for students who may have taken a circuitous route to 
medical school or who, on paper at least, may not seem like 
the most likely candidates. 
But helping students fulfill their dreams of becoming 
doctors is only half the equation, says Lee. There is also 
the benefit to society that comes from making the medical 
profession more ethnically and racially diverse. “At a 
human, emotional level, there are three kinds of people 
with whom we want ethnic identification: those who pro¬ 
vide safety, those who nourish our spiritual lives and 
those who take care of our health,” he says. “It’s not essen¬ 
tial, but it helps a lot. It’s valid to seek and receive care 
from our own community.” ym 
Jennifer Kaylin is a freelance writer in New Haven.Terry Dagradi is a 
photographer with the MedMedia Group at the School of Medicine. 
Writing instructor Susan Froetschel, 
center, conducts mock interviews 
with her students so they’ll be able 
to handle the real thing when they 
apply to medical school. 
By Peter Farley 
Illustration by Christian Northeast 
With the pealing bells of St. Mary’s Church as counterpoint, 
a celebratory air prevailed in the seminar room of Kirldand 
Hall on a crisp autumn day last year. The psychology depart¬ 
ment’s weekly noontime talks are usually given by scholars 
from out of town, but on this occasion the faculty was hosting 
one of its own, department chair Kelly D. Brownell, ph.d. 
Brownell, who also serves as director of Yale’s Center 
for Eating and Weight Disorders, is a national figure in the 
raging public debate over the worldwide rise in obesity. He 
and a former graduate student, Katherine Battle Horgen, 
PH.D., had just published Food Fight, a new book on the topic, 
and he was fielding four or five interview requests per day 
from radio, television and print journalists eager to stoke an 
already heated debate with the controversial policy proposals 
outlined in the book. 
When introducing Brownell to the hometown crowd, 
William R. Corbin, ph.d., assistant professor of psychology at 
Yale, proudly called attention to his colleague’s highly visible 
role as the media’s go-to guy for commentary on America’s 
expanding waistlines, half seriously likening him to a “rock star.” 
The characterization pleased Brownell, a man who fol¬ 
lows popular music with as much fervor as he devotes to food 
policy. But as he took the podium, he playfully punctured the 
euphoric mood by drawing on every successful author’s sure¬ 
fire reality-check device; the mailbag. Holding an unsigned 
postcard that had arrived that morning from Baltimore, he 
read, “Mind your own damn business. You’re motivated, like 
nearly all liberals, by book sales, caring less about a person’s 
diet. What a person eats is none of your business, or teachers’ 
or the government’s. A pox on your house!” 
The postcard’s over-the-top language drew laughter 
from the sympathetic audience in Kirkland, but it also served 
as a reminder that emotions run high on Brownell’s chosen 
battleground. Eating is among the most intimate of human 
activities, and it is invested with deep feeling. Eood is a sen¬ 
sitive, serious business. 
Oddly enough, the high emotional pitch of the obesity 
wars may derive from the fact that there is so much agreement 
on the basic facts. Some of the most alarming statistics—the 
250 percent increase in obesity among American children over 
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24 Fighting the good food fight 
the last two decades, for example—are so stark that no one 
(except for a few outliers like Paul Campos, j.d., a law professor 
at the University of Colorado, who denies the basic premise 
that there is an obesity epidemic) disputes them. 
Since there are only a few plausible interpretations 
of these facts, and since there are billions of dollars at 
stake in the debate’s outcome, opponents have tended to 
take battle stations based in broader ideologies and to 
man them unwaveringly. 
Brownell is perhaps the best-known proponent of the 
view that the recent upsurge in obesity is the result of a 
“toxic food environment” created and promoted by the food 
industry. According to Brownell, we are biologically hard¬ 
wired to crave fats, sugars and salts, and to eat far greater 
amounts of them than we need. During the past 20 years, 
he says, this propensity has combined with the emergence of 
new “eating opportunities” to cause an epidemic of obesity. 
“Twenty years ago, who would have even thought of 
having lunch at a gas station?” Brownell asked the crowd at 
Kirkland as he prodded his laptop to pump out slide after 
PowerPoint slide illustrating the gargantuan portions, four¬ 
digit calorie counts and slick, kid-centered marketing that 
are the coin of the fast-food realm. 
Since he was on friendly turf, Brownell mostly let the 
images and statistics speak for themselves. A photo of a new 
Dunkin’ Donuts outlet in a corner of his local supermarket 
was followed by a close-up of a shopping cart that had been 
painstakingly retrofitted with a Dunkin’ Donuts cup holder, 
and one could almost see his listeners register the intended 
message: now we eat while we shop for food. Brownell’s calm, 
patient marshaling of the evidence was punctuated by chuck¬ 
les and gasps of recognition, as if these features of contem¬ 
porary American life were so ever-present that they had 
become the visual equivalent of background noise, and were 
being seen by his audience with fresh eyes. 
In Food Fight, Brownell and Horgen call for taxes on 
certain foods, for government oversight of food advertising 
(especially that directed toward children) and for better nutri¬ 
tion education and consumer information to counteract 
what they see as an incessant, virtually irresistible drone of 
marketing buzz bankrolled by the food industry. When his 
arguments are laid out in full as they were during his talk at 
Yale, Brownell’s conclusions are themselves almost irre¬ 
sistible, but most Americans have only heard him speak in 
Nightline-sized sound bites. 
In tliat form, his views are easy to caricature. Brownell’s 
critics paint him as a “Big Brother” figure hellbent on gov¬ 
ernment intrusion into private life, a puritanical killjoy on a 
crusade to legislate pleasure out of existence, a soft-headed 
liberal out to shield gluttons from their own irresponsibility 
at society’s expense. 
The feverish emotion of the obesity debate sometimes 
leads to personal attacks as well, and Brownell has felt their 
sting. On a website hosted by a group calling itself the 
Center for Consumer Freedom (ccf), for example, one finds 
a Yale publicity photo juxtaposed with a recent shot of an 
obviously overweight Brownell. A caption reads, “Would you 
take advice on good diets and nutrition from this man.^” 
Noting that the “trimmer” Brownell is featured on Food 
Fight’s dust jacket, the site’s anonymous authors accuse him 
and his publishers of a “truth-in-advertising scam.” 
But as I sat with Brownell in the quiet sanctuary of his 
office after the lecture, it was hard to imagine that he could 
inspire such invective. It was the heavier version of Brownell 
who had addressed his department colleagues that day, and 
he freely admitted to me that his weight “goes up and down.” 
Without apparent irony, he attributed his condition to fre¬ 
quent snacking, stress and a lack of exercise during the writ¬ 
ing of Food Fight. His weight gain was “not a permanent 
state,” he said, dismissing the ccf website as an ad 
hominem distraction from the serious issues at hand. 
Like most academics, Brownell has set up his office to 
reflect his professional preoccupations, but the decor has an 
unmistakable touch of whimsy. A framed Warholesque print 
of the 7-Eleven “X-treme Gulp” soft-drink container adorns 
one wall, while bizarre artifacts of junk food culture, includ¬ 
ing a baby-bottle-sized Mountain Dew container fitted with a 
nipple, are displayed on a side table, the way an anthropolo¬ 
gist might showcase a tribal mask. 
In the seminar room, Brownell had steered clear of 
polemics in favor of a deliberate, thorough line of reasoning, 
and he was much the same in private. Still boyish and 
sandy-haired at 52, Brownell calmly made his case in soft, 
measured speech inflected with the vowels of his Indiana 
childhood. He was considerably more animated when the 
talk turned to his avocation, bluegrass music, and to his 
beloved collection of acoustic guitars. (Fittingly, one favorite 
is an antique Gibson model called the “Jumbo.”) The over¬ 
all impression Brownell left was of that rarest specimen in 
American public discourse: the open-minded true believer. 
“Kelly is reasonable and gentlemanly,” says Gene 
Grabowski, who had occasion to spar with Brownell frequently 
when he served as chief lobbyist for the Grocery Manufactur¬ 
ers of America, the world’s largest food-industry organization. 
“One gets the feeling when dealing with him that he does 
want to learn, and he wants you to learn as well.” In a recent 
editorial in The Washington Times, Michael Fumento, a senior 
fellow at the Hudson Institute, wrote; “While I once con¬ 
sidered Mr. Brownell a radical, the fatter we grow the less radi¬ 
cal he seems.” 
The vociferous condemnations of Brownell may be 
more a reaction to his perceived influence than to his stated 
views, which are far more nuanced and moderate than those 
held by many in the anti-obesity camp. He does support gov¬ 
ernment regulation of food advertising to children, the dis¬ 
closure of calorie counts on fast-food menus and the 
removal of soft-drink machines from public schools. How¬ 
ever, he opposes filing lawsuits against the food industry 
on behalf of obese plaintiffs, a strategy that is beginning to 
take hold nationwide. Although he has been ridiculed as the 
mastermind behind proposals for a punitive “Twinkie tax” 
on snack food, Brownell is against levying such taxes at lev¬ 
els that would discourage consumption. Instead he supports 
a small tax—say, a penny a can on soft drinks—that would 
be earmarked to fund government-sponsored nutrition edu¬ 
cation and advertising. 
According to Brownell, the CCF and similar organiza¬ 
tions are fronts for the food manufacturing and restaurant 
industries in the guise of grass-roots consumer movements, 
akin to the “research councils” created by the tobacco compa¬ 
nies when the tide of public opinion began to turn against 
them. (On their website the ccf states that their funding 
comes from “restaurants, food companies and more than 
1,000 concerned individuals.”) 
Brownell first went public with his views in a 1994 
op-ed piece in The New York Times, years before obesity was 
much on the public’s mind. That article prompted blistering 
attacks, but Brownell said that he has seen a sea change in 
public opinion since then, one that has picked up steam 
exponentially during the last five years. Though he acquired 
a thick skin from almost a decade of hostile interviews, 
Brownell said that he’s now growing used to a more tolerant 
and supportive reception, even in the bare-knuckle arena of 
talk radio. 
Having been in the food policy game for so many 
years, Brownell surveys today’s battles with a long view. He 
approvingly cited a recent decision by the city of Los Angeles 
to remove soft-drink machines from all the city’s public 
schools, a decision that he said was unimaginable in 1994. 
“The anti-tobacco movement took 40 years to mature. This 
movement has made similar progress in 40 months.” 
Brownell has lately been finishing his talks with an 
optimistic aphorism from Gandhi, which he delivered at Yale 
from his preferred vantage point at the calm center of the 
maelstrom: “First they ignore you. Then they laugh at you. 
Then they fight you. Then you win.” ym 
Peter Farley is a freelance science writer based in Boston. Christian 
Northeast is an illustrator in Cobourg, Ontario. 

Closing the gender gap 
Once an exclusively male bastion, surgery is 
beginning to resemble the rest of academic 
medicine as more women join its faculty ranks. 
Stories by Cathy Shufro 
Photographs by Terry Dagradi 
Vvlien Barbara K. Kinder, m.d. ’71, hs ’77, trained at Yale three 
decades ago, surgical residents were just that: resident sur¬ 
geons who virtually lived at the hospital. They worked grueling 
128-hour weeks, and overnight call alternated with “short” 
days that ended at 10 p.m. or later. This went on for five years. 
If the residents of that era ever felt worn down or resentful, 
or if they ever longed for a schedule change to attend a wed¬ 
ding or hit the ski slopes, they kept it to themselves. 
“In my day, nobody complained about anything. Nobody 
ever uttered a word,” says Kinder, an endocrine specialist v/ho 
is now the William H. Carmalt Professor of Surgery. “We 
basically did as we were told and kept our eye on the goal: get¬ 
ting excellent surgical training and finishing the residency.” 
In fact, the odds were good that a resident who began training 
at Yale would not finish here. After the second year, the Yale 
group was cut from 12 residents to four. In those days, it was 
Lynne Henderson Kelley 
Vascular surgeon Lynne Henderson Kelley, 
M.D., had just finished her training in Boston 
when she went to France to hone her skills 
in new, less-invasive techniques for treating 
“survival of the fittest, a Darwinian approach to surgical train¬ 
ing,” says Kinder, who in 1977 was one of the first two women 
to complete the general surgery training at Yale. 
Things have changed. For one thing, the hours of 
training are much shorter. In July 2003, new rules limited 
residents’ time on duty to 80 hours per week, and effectively 
changed the way surgeons learn their craft from an immer¬ 
sion experience to one that is more diffuse. The new limits 
are in part a response to lawsuits claiming medical errors 
from fatigue, but they also reflect changes in societal attitudes 
about family life. Across all medical disciplines, women, in 
particular, have pushed for greater flexibility, making it some¬ 
what easier for physicians to combine career and family. 
Early in her career. Kinder sensed that Yale was commit¬ 
ted to maldng room for the increasing number of women choos¬ 
ing to become doctors. (Her enthusiasm for the school was 
ply her with X-ray vision as she operates. 
“Every day there’s something to learn and 
see,’’ says Kelley. [More on our website, 
info.med. yale.edu/ymm] 
patients with clogged or weakened blood 
vessels. To perform these surgeries, Kelley 
wears a heavy lead protective suit and works 
beside interventional radiologists who sup- 
Closing the gender gap 
such that she turned down a chance for a job at another 
high-powered program.) Yale’s commitment led to the estab¬ 
lishment in 1975 of the Office for Women in Medicine. 
Through informal get-togethers and by matching students with 
mentors, the office fosters ties among female students, resi¬ 
dents and faculty members. “Over the years,” says Director 
Merle Waxman, m.a., associate dean for academic development, 
“there’s been a strong base built here, a strong support center.” 
The above-average number of women on the surgery 
faculty attracts more women in turn. Women applying for 
faculty positions interview with both male and female sur¬ 
geons, including high-ranking women like Kinder. Candidates 
for residency get a similar picture. First-year resident Lemi 
Luu, M.D., says she chose Yale from among other competihve 
programs in part because the departmenf s chair, Robert 
Udelsman, m.d., m.b.a., emphasized the strong presence of 
women on the faculty. 
“That gave me a certain impression about the program, 
that it was forward-thinking,” says Luu, who graduated from 
Emory School of Medicine. “I felt that having an opportunity 
to interact with other female surgery attendings and to 
use them as role models was very important in my training 
and development.” 
The numbers do suggest that Yale has made signifi¬ 
cant headway toward increasing the proportion of female 
surgeons on its faculty. According to an analysis of 2002 fac¬ 
ulty roster data by the Association of American Medical 
Colleges (aamc), Yale ranked 14th out of 126 medical schools 
in the percentage of women among its surgeons. (For com¬ 
plete information, see our website, info.med.yale.edu/ymm.) 
The analysis showed that 17 percent of full-time faculty mem¬ 
bers holding M.D. degrees in Yale’s Department of Surgery 
were female, compared with a national average of 11.2 per¬ 
cent, as of December 31, 2002. (Of 52 Yale faculty members 
with medical degrees who perform surgery, 9 were women.) 
The numbers are likely to climb as more women choose 
surgery; at Yale, about 30 percent of residents in general sur¬ 
gery have been women over the past decade, according to 
Barbara Kinder [cover] 
"The changes that have taken place 
mirror social changes.” 
Barbara K. Kinder, m.d. ’71, hs ’77, says that 
when she trained in surgery at Yale in the 
mid-1970s, the attending surgeons—all of 
them men—never questioned her aptitude. 
Chief surgeons William F. Collins Jr., m.d. ’47 
and later C. Elton Cahow, m.d., “were both 
men who thought women could do any¬ 
thing. It was a matter-of-fact thing for them, 
not any kind of a crusade. Their attitude 
was,‘Why couldn’t they do it?’ ’’ 
Nonetheless, the culture of surgery has 
changed, shifting from a military model to 
one that accommodates give-and-take. “The 
changes that have taken place mirror social 
changes,” says Kinder, an endocrine surgeon 
and senior faculty member. Women have 
brought “a very different management style, 
a consensus-building style. I think men have 
become more this way, too.... The throwing 
of instruments doesn’t happen any more.” 
Kinder and fellow resident Mary Alice 
Helikson, m.d., hs ’77, who is now a pediatric 
surgeon in Oregon, were the first two women 
to complete general surgery training at Yale. 
Kinder says she tolerated five years without 
playing tennis, spending time with friends 
or reading anything except medical journals 
because, “I rotated into surgery and fell in 
love with it. It was an epiphany.” 
As for the long hours, “I think by and 
large everyone functioned pretty well doing 
the 128-hour workweek. On the other hand, 
I don’t think it made for a rich life outside 
of medicine,” Kinder says, and she laughs. 
Today, women and men alike want to 
take part in family life. “I think that’s prob¬ 
ably healthy,” says Kinder, whose daughter, 
Caitlin, was born in 1985 when Kinder was 
40. Once she became a mother. Kinder says, 
career became less important. “Could I be 
doing some more things in surgery nation¬ 
ally? Yes, I probably could, but that’s been 
my choice. From the day she was born, my 
daughter has been my first priority.” 
Kinder has reservations about the reduc¬ 
tion in residents’ hours. “The 8o-hour 
workweek necessarily diffuses the sense of 
responsibility that a surgeon-in-training has 
for his or her patient,” she says. As an attend¬ 
ing surgeon. Kinder feels responsible for her 
patients even when she leaves the hospital. 
“If it’s a weekend or a night, I expect to hear 
about my patient,” says Kinder. If younger 
surgeons “don’t learn it by living it, I’m not 
sure they’ll have the same sense of that con¬ 
tract with the patient. Maybe we overdid it.” 
Kinder says surgeons of her generation 
are disenchanted and are retiring, on aver¬ 
age, at age 58. (She is 59.) “I’m incredibly 
frustrated with medicine. We need national 
health care. Interspersed between the 
physician and patient are layers and layers 
of bureaucracy and nonsense.” 
As a member of the School of Medicine 
admissions committee she looks for applicants 
“who have concerns about social Justice ques¬ 
tions. I think we ought to recruit these people. 
Hopefully they’ll be part of solving this health 
care crisis.” 
A 
Amy Friedman 
A 
Sanziana Roman 
Transplant surgeon Amy L Friedman, m.d., 
brings more than just professional knowl¬ 
edge to the bedside when she checks on a 
transplant patient: her own mother received 
a donated kidney that extended her life for 
17 years. “From my own family experience,” 
says Friedman, “I have learned the agony and 
the ecstasy associated with the amazing 
field I work in.” [More on our website, info. 
med.yale.edu/ymm] 
She may have left behind an opera career to 
pursue medicine, but endocrine surgeon 
Sanziana A. Roman, m.d., hs ’99, retains defi¬ 
nite ideas about music. For a long, compli¬ 
cated case, she puts on a CD of Mozart, Brahms 
or the Romanian composer Enescu. For some¬ 
thing quick like an appendectomy, disco 
works. And when everyone’s exhausted, it’s 
rap. “Studies have shown that surgeons 
operate better with music,” says Roman. 
While different musical themes suit differ¬ 
ent cases, one mood runs through all of sur¬ 
gery for Roman: the awe she feels toward the 
surgeon-patient relationship. [More on our 
website, info.med.yale.edu/ymm] 
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30 Closing the gender gap 
A 
Julie Ann Sosa 
An abundance of mentors, 
both men and women 
Julie Ann Sosa, m.a., m.d., knows the value 
of finding a mentor. In fact, though she’d 
planned to go to medical school, meeting a 
mentor when she was a senior at Princeton 
almost landed her in a career as an economist. 
It happened when she was editor-in-chief 
at the Daily Princetonian. Student reporters 
heard some earthshaking news: Princeton’s 
president, economist William G. Bowen, was 
about to resign. The student paper broke the 
story, beating The New York Times. Annoyed 
by the premature announcement, Bowen 
summoned Sosa to his office to scold her— 
and then surprised her by offering her a sum¬ 
mer job. Together, they wrote an award¬ 
winning book about the labor economics of 
academia. Sosa went on to study economics 
as part of a master’s program at Oxford. 
Despite having ultimately chosen medi¬ 
cine, she has carried with her the lesson that 
a mentor can enrich a person’s life. 
Mentorship is part of the reason Sosa, 
37, came to Yale—to follow the department’s 
John H. Seashore, m.d. ’65, hs ’70, the residency program 
director. Nationally, 25 percent of general surgery residents are 
women, according to the aamc. 
Udelsman saw the relatively high percentage of women 
in the department as a plus when he was recruited from Johns 
Hoplcins in June 2001. He expects that the number of women 
in surgery at Yale and nationally will increase. Nonetheless, he 
does recognize that the surgery “lifestyle” puts off some prospec¬ 
tive surgeons: women and men alike worry tliat tlrey won’t have 
time for family and leisure if they choose the field. But he says 
that medical students have found the prospects less intimidating 
since the national Accreditation Council for Graduate Medical 
Education capped the workweek for residents at 80 hours. 
“People who in dieir heart of hearts wanted to be surgeons, and 
were dissuaded from it, are now considering surgery.” 
As more women choose the field, Udelsman says, sur¬ 
gery programs will be forced to acknowledge “the fundamen¬ 
tal biological difference that you can’t ignore: the issues of 
childbearing and family. We accept the fact that residents and 
chair, Robert Udelsman, m.d., m.b.a., north 
from Johns Hopkins after completing her 
training there in 2002. And as an assistant 
professor of surgery, she serves as a poten¬ 
tial mentor to others, from Yale undergradu¬ 
ates she meets as a fellow of Jonathan 
Edwards College to surgical residents begin¬ 
ning their careers. 
When she finished eight years of resi¬ 
dency training at Hopkins, Sosa was only the 
seventh woman to complete the full general 
surgery residency program there. She never 
felt any discrimination and Jokes that “every¬ 
one was uniformly punished for wanting to 
be a surgeon” by the grueling call schedule. 
At Yale, three of the five surgeons in her 
section, oncologic and endocrine surgery, are 
women. And she says the collegiality of Yale 
physicians, male and female, helps her do 
research, since “you can’t do good research in 
isolation. You need collaborators.” As a core 
faculty member for the Robert Wood Johnson 
Clinical Scholars Program, Sosa is working 
with several colleagues to evaluate the qual¬ 
ity of the research reported in peer-reviewed 
medical and surgical journals. She’s also study¬ 
ing the use of video cameras to record what 
goes on in the operating room. “Most of the 
teaching in surgery happens in the operating 
room, but it’s the thing we know least about.” 
she says. Yale suits Sosa well. “I’m extremely 
happy,” she says. “I’m thrilled to be here.” 
But Sosa tells a story suggesting that 
people still picture surgeons as male. Soon 
after moving into her new house recently, 
Sosa received some letters addressed to her 
neighbor. When she brought the misdeliv¬ 
ered letters next door, the neighbor looked at 
Sosa oddly. “You live next door?” she asked. 
“We’d heard a surgeon bought the house.” 
Stereotypes linger, but the prospects for 
women in surgery seem to be gradually 
improving. At Hopkins, where no woman had 
ever headed a large clinical department, 
there’s a new director of surgery. Her name is 
Julie A. Freischlag. 
31 
A 
Heidi Lee Frankel 
The emergency department serves as a 
socioeconomic barometer for trauma 
surgeon Heidi Lee Frankei, m.d. When the 
economy slips and community morale 
declines, shootings and stabbings increase, 
says Frankel, director of the surgical inten¬ 
sive care unit at Yale. As a medical student, 
Frankel dreaded her surgery rotation, but 
by the end of the month she was hooked; 
although she describes her life outside 
the OR as “tame,” she loves the intensity 
of caring for critically ill and injured 
people. [More on our website, info.med. 
yale.edu/ymm] 
A place for women in surgery 
to network, compare notes 
Attending a meeting of the Asso¬ 
ciation of Women Surgeons (aws) 
was a revelation for Vivian Gahtan, 
M.D. As a chief resident at the 
University of South Florida in 1987, 
Gahtan was one of only two 
women among two dozen general 
surgery residents. At the meeting, 
she discovered a wider world. "I had 
never been around lOO surgical 
women before," says Gahtan, until 
recently an associate professor of 
surgery at Yale and now chief of 
surgery at the State University of 
New York-Syracuse. "For the first 
time, I didn’t feel quite so isolated.” 
Now president of the i,600- 
member organization, Gahtan says 
the AWS hopes to attract female 
medical students into surgery, to 
make the profession more attrac¬ 
tive for them and to provide a 
structure for networking. 
Gahtan believes that women 
constitute a largely untapped 
resource for the profession. Women 
account for about half of medical 
students but only 12 percent of the 
nation’s 32,600 general surgeons, 
according to statistics for 2000 
from the American Medical Asso¬ 
ciation. General surgery ranked 
third in popularity as a specialty for 
men, but 10th for women, 
"Women are becoming a higher 
percentage of the total physician 
pool, and if you aren’t attractive 
to women, it’s going to be a prob¬ 
lem,” says Gahtan. "We have to 
change with the times." 
One major change has been the 
institution of an 8o-hour work¬ 
week for surgical residents. Other 
options that need to be explored, 
she says, include consolidating 
the standard training time for indi¬ 
viduals in surgery subspecialties; 
incorporating a standard family 
leave policy for men and women; 
and considering part-time practice. 
Gahtan notes that obstetrics and 
gynecology has adapted to the 
demands of the new generation: 
many physicians in that field 
practice part time, but surgeons 
rarely do. 
AWS offers a free handbook, 
Pocket A/le/itor, that gives practical 
advice to residents.The group 
helps its members find mentors by 
gathering every fall before the 
annual meeting of the American 
College of Surgeons. Its website 
(www.womensurgeons.org) pro¬ 
vides a place to ask about issues 
ranging from how to resolve a dis¬ 
pute over a call schedule to how to 
take a baby to a scientific meeting. 
"It’s networking, online," says 
Gahtan. The changes advocated by 
the group should improve the lives 
of all surgeons, male and female, 
she adds. “The ultimate goal should 
be fellowship." 
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32 Closing the gender gap 
faculty members who become pregnant will have special needs 
that in the past have not been major issues in surgery programs, 
because there have not been many women.” For instance, if 
complications require a pregnant resident to take a few months 
off, how will she accrue enough cases to meet certification 
requirements.^ “I don’t have the answers,” says Udelsman. 
He adds that the Yale surgery program will resolve those 
dilemmas to ensure that talented and dedicated women con¬ 
tinue to choose surgery. In the final analysis, Udelsman is not 
interested in strong female candidates any more than strong 
male candidates: he just wants good surgeons. “I’m interested 
in having the best surgery department in the country, period.” 
That focus on skill, not gender, originated in the 1970s. 
“Tlrere’s such a strong tradition of female surgeons, starting with 
Barbara Kinder,” says vascular surgeon Lynne Henderson Kelley, 
M.D., who joined the faculty last February. “There’s no distinc¬ 
tion. We’re allowed to be surgeons, not women surgeons.” ym 
Cathy Shufro is a contributing editor of Yale Medicine. Terry Dagradi is a 
photographer with the MedMedia Croup at the School of Medicine. 
A 
Milissa McKee 
For pediatric surgeon, endless variety, 
less real estate to cover” 
Milissa A. McKee, M.D., m.p.h., is only half 
joking when she says she has attention deficit 
disorder. She likes variety, and she likes to 
finish a Job and move on. That’s why pediatric 
surgery suits her. Pediatric surgeries are 
shorter than adult surgeries because “there’s 
less real estate to cover.” 
“I like doing technically demanding 
surgery and I like to take care of kids,” says 
McKee, 31, herself the oldest of seven. 
“Pediatric surgery fits me particularly well.” 
Pediatric surgery also offers variety. 
McKee gets to tackle a broad spectrum of 
cases, everything except cardiac and neuro¬ 
logical problems. “That’s very unusual in 
surgery specialties nowadays. In other spe¬ 
cialties, you just do endocrine, or you just do 
cancer, or you just do gastroenterology.” 
Although it’s true that McKee can talk 
cogently about surgery while also plowing 
through a stack of paperwork and occasion¬ 
ally glancing at her computer screen, you 
have to take her claim of having attention 
deficit disorder with a grain of salt—given 
that she managed to finish college at age 
15. She got her driver’s license that year, 
moved one state west from her Minnesota 
home and earned her medical degree at the 
University of North Dakota at 19. Her nine 
years of postgraduate training included both 
research and clinical fellowships at Johns 
Hopkins and a master’s degree in public 
health, also at Hopkins. She came to New 
Haven two years ago. 
At Yale, McKee has expanded the use 
of minimally invasive surgery for young 
patients. For example, she uses a crib-side 
procedure to treat gastroschisis, an abdomi¬ 
nal wall defect that until fairly recently 
required major surgery shortly after birth. 
The intestines of a baby born with gas¬ 
troschisis protrude outside the abdomen. 
McKee sidesteps major surgery by protecting 
the intestines in a silicone sac and, over the 
course of a day or two, gradually introducing 
them into the baby’s abdomen. 
She has noticed that some female medi¬ 
cal students rule out surgery prima facie. They 
have told McKee that “they’re only doing 
the rotation because they have to, and that 
they’d never do surgery because the resi¬ 
dency is too hard, it has no lifestyle and they 
want to have a family.” 
This frustrates McKee. “If it fits your 
personality to be a surgeon, you should be 
a surgeon.” She says that choosing a career 
in surgery may mean you can’t have the 
highest-paying practice, head your depart¬ 
ment and lead the nation in research and 
still have time to raise children. But having 
set priorities, McKee asserts that you can 
“set up your schedule so you can meet all 
your goals. I strongly believe you can have 
a fulfilling career and you can have children, 
and I intend to.” 
Essay JENNY BLAIR 33 
From the beautiful 
to the obscure 
A doctor’s words can enlighten, 
I obfuscate or amuse, a fourth-year 
j student observes. 
1 As someone who probably should have 
; majored in English instead of geology, I 
: often feel my mind oscillate between 
‘ two modes of thought: the scientific and 
‘ the lettered. I hear myself say “Romberg 
; negative, no dysdiadochokinesis or 
. pronator drift,” and the lexicophile in 
• me stands back, marveling. They may 
be English, but those words are as 
opaque to the layman as the treasured 
two-inch clipping on my fridge is to 
me. It announces a physics lecture at 
Yale—“Time-Reversal Breaking and I the Theory of the Gap in Underdoped 
! Cuprates.” But when it comes to 
, delightful obscurity, cleverness or just 
beauty, medical language holds its own, 
i ' even against the physicists. 
' We have the scimitar sign, the clover- 
j leaf skull and my personal favorite, the 
., jumping Frenchmen of Maine syn- 
I drome. Granted, you don’t see that dis- 
r j ease every day, but its appearance in 
' the dictionary proves that some august 
■ authority has accepted the term. We 
find incidentalomas on CT scans that 
t were done to check for something else 
entirely. Look at a pathology textbook. 
It’s full of phrases that make you won¬ 
der whether the microscopists were hal¬ 
lucinating: cells can have a starry-slcy 
appearance, owl’s eyes or Orphan Annie 
nuclei. Sometimes we anthropomor¬ 
phize, ascribing grumpy emotions to 
the body. There’s irritable bowel syn¬ 
drome, of course, but our circulation 
may become embarrassed. When phago¬ 
cytosis goes wrong—when a cell can’t 
slimily surround and eat something— 
it is frustrated. On the other hand, we 
make some body parts sound coy: to 
elicit the anal wink during a physical 
exam is to know that all is well with the 
nerves to the nether regions. 1 can’t be 
the only one who appreciates that. 
Some of us medical students used 
to wonder worriedly if we should have 
studied classical languages, the rumor 
being that it would help us learn medi¬ 
cal terminology. A groundless fear, of 
course—Spanish is a hundred times 
more useful—but medicine does have 
some splendid Greco-Latinate mouth¬ 
fuls. Consider the mellifluous confluence 
of consonants in sphygmomanometer 
(a blood pressure cuff), syzygy (when 
organs fuse to each other during devel¬ 
opment) or borborygmi (the sounds of 
overly vigorous digestion). Less lyrical 
but just as vivid is the cauda equina— 
horse’s tail—the bundle of nerve roots 
at the end of the spinal cord. 
When it comes to naming new phe¬ 
nomena, I’m in favor of eponyms over 
descriptive terms. Not only are they a 
portable history of medicine, but peo¬ 
ple’s names can be wonderful, alone or 
in combination. Carr-Barr-Plunkett 
syndrome is admittedly less descriptive 
than 48 xxxx syndrome, but which is 
more fun to say.^ The number-one silli¬ 
est medical word must be pseudo¬ 
pseudohypoparathyroidism. It may be 
descriptive, but it’s also a missed oppor¬ 
tunity to name a disease after oneself, 
if there ever was one. (No single word 
that is not German should consist of 12 
syllables: there are shorter poems.) I’m 
glad that the discoverers of Dandy- 
Walker syndrome and Howell-Jolly 
bodies weren’t as self-effacing. 
A fondness for abbreviation can 
reduce doctors’ notes to a very exclusive 
code. 1 can write “nph 8 u bid c fs q 
12 and ss as backup,” and nobody bats 
an eyelash. (It’s a set of instructions for 
keeping a diabetic patient’s blood sugar 
under control.) There are disease syn¬ 
dromes abbreviated leopard, hellp 
and POEMS, and medical trials have 
made an art form of the clever acronym 
for unwieldy descriptors like “Efficacy 
and Safety of Subcutaneous Enoxaparin 
in Non-Q-Wave Coronary Events.” 
ESSENCE is easier. 
We need most of our jargon, as does 
any specialized field, but for some 
words there seems to be no justification 
other than to befuddle the layman. We 
don’t say that the patient sweated if we 
can say that he diaphoresed. We never 
say he has a black eye when what he 
really has is a periorbital ecchymosis. 
There’s only one main use for a stetho¬ 
scope, and we call it auscultation. I 
remember watching one operation and 
asking “Is that all bleeding from the 
broken bone?” “Yes,” the resident 
replied, “that’s hematoma from the frac¬ 
ture.” Still, some doctors know when 
to put obtuse jargon aside in favor of 
more colloquial terms. To my next ques¬ 
tion—“Is that part of the fracture as 
well?”—the senior surgeon replied, 
“Yup, it’s busticated.” 
Jenny Blair, a fourth-year medical student, 
writes an award-winning monthly column for 
The Hartford Courant. 
WE WELCOME SUBMISSIONS 
Do you have an opinion to share on a vital 
topic in medicine, health or science.^ Send 
yours to Essay, Yale Medicine, P.O. Box 7612, 
New Haven, CT 06519-0612, or via e-mail 
to ymm@yale.edu. 
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34 Faculty 
Elaine Grant Mary Warner 
Mark Cerstein 
Paul Lombroso 
John Krystal 
Dieter Soil 
Fred Volkmar Joseph 
Woolston 
Physician associate director 
takes on a new role with 
teaching, alumni as the focus 
After 25 years as director of the Physician 
Associate Program, Elaine E. Grant, 
PA-c ’74, M.p.H. ’92, has stepped aside 
to become the program’s first director 
of clinical development and special 
projects. Her new position, which took 
effect October 15, will encompass clini¬ 
cal education and alumni affairs. 
Grant, an assistant dean who was 
among the first to graduate from the 
Yale program in the early 1970s, 
announced her move in a letter to stu¬ 
dents, faculty and colleagues. She said 
that over the past year, while also over¬ 
seeing clinical curriculum, she came to 
realize that much can be done to enrich 
the clinical experiences of students. 
“I am going to be interacting on a 
much higher level with clinical rotation 
faculty and educating them on the dif¬ 
ference between medical student educa¬ 
tion and physician associate student 
education,” Grant said. She’s also trying 
to organize an alumni association and 
hopes to establish a new program of 
“miniresidencies” for physician associ¬ 
ates who wish to enter new specialties 
or who are returning to work after an 
absence from the profession. 
Mary L. Warner, m.m.sc., pa-c, the 
program’s assistant director for didac¬ 
tic curriculum, has been named 
interim director. After receiving her 
degree as a physician associate from 
Emory University in 1991, she prac¬ 
ticed in cardiac and orthopedic surgery 
for nine years. She came to Yale in 
2000 to oversee curriculum for the 
program’s first-year courses. She also 
works at Bridgeport Hospital in emer¬ 
gency medicine and serves as the 
physician assistant member of the 
Gonnecticut Medical Examining Board. 
A committee will be formed to 
conduct a national search for a perma¬ 
nent director. 
—John Curtis 
University names six at 
medical school to 
endowed professorships 
The university has announced the fol¬ 
lowing endowed professorships: 
Mark B. Cerstein, ph.d., associate 
professor of molecular biophysics and 
biochemistry, has been named the 
Albert L. Williams Associate Professor 
of Biomedical Informatics. Gerstein’s 
group does research in the emerging 
field of bioinformatics. 
John H. Krystal, m.d. ’84, professor 
of psychiatry, has been named the 
Robert L. McNeil Jr. Professor of Clini¬ 
cal Pharmacology. Krystal is the found¬ 
ing director of the Center for the 
Translational Neuroscience of Alcohol¬ 
ism and deputy director for clinical 
research at the Abraham Ribicoff 
Research Eadlities at the Connecticut 
Mental Health Center. 
PaulJ. Lombroso, m.d., professor 
in the Child Study Center, has been 
named the Elizabeth Mears & House 
Jameson Professor of Psychiatry. 
A molecular biologist and child psy¬ 
chiatrist, Lombroso explores the 
molecular basis of childhood psychi¬ 
atric disorders. 
Dieter G. Soil, ph.d., professor of 
molecular biophysics and biochemis¬ 
try, chemistry and biology, was named 
the Henry Eord II Professor of Molecu¬ 
lar Biophysics and Biochemistry. His 
research focuses on genetic, molecular, 
biological and biochemical studies of 
the function of transfer rnas. 
Fred R. Volkmar, m.d., professor 
of psychiatry, pediatrics and psy¬ 
chology, has been named the Irving 
B. Harris Professor in the Child 
Study Center. Volkmar is an expert 
in the field of autism, Asperger’s 
syndrome and other Pervasive Develop¬ 
mental Disorders. 
Joseph L. Woolston, m.d., profes¬ 
sor of pediatrics, has been named 
the Albert J. Solnit Professor of Child 
Psychiatry. Last year he was named 
chief of child psychiatry at the Child 
Study Center. 
NOTES 
Joseph E. Craft, M.D., HS ’77, pro¬ 
fessor of medicine and immuno¬ 
biology and chief of the section 
I of rheumatology, was named 
chair of the scientific advisory 
board of the Alliance for Lupus 
' Research (alr) in July. Craft will 
oversee the board, help establish 
and monitor its scientific goals 
and guide the planning of the 
ALR annual meeting and summit. 
: Marie E. Egan, M.D., associate 
professor of pediatrics and of 
cellular and molecular physiol¬ 
ogy, was elected membership 
secretary of the Society for 
i Pediatric Research in May for a 
I term of six years. The society 
I bridges basic science and clinical 
research for the advancement 
of the health and well-being of 
children worldwide. 
'll ianine Evans, M.D., associate pro- 
■■ fessor of medicine (rheumatol- 
, ogy), was named associate 
:! director for clinical affairs at the 
Yale Medical Croup in June. She 
' will be responsible for practice 
i,j standards, HIPAA oversight, 
T credentialing and the Office of 
'fj Patient Advocacy. Evans will also 
■I play a leadership role in the devel- 
:l opment of practices at satellite 
T| offices, including the Shoreline 
■Medical Center in Guilford. 
fti Patrick G. Gallagher, M.D., associ¬ 
ate professor of pediatrics 
•' (neonatology), and Scott A. 
I j Rivkees, aa.d., associate professor 
i' of pediatrics (endocrinology), 
t have been named members of 
if the American Society for Clinical 
t Investigation, a selective group 
that honors outstanding achieve¬ 
ment in biomedical research. 
, Margaret K. Hostetter, M.D., chair 
and professor of pediatrics and 
( professor of microbial pathogen¬ 
esis, and Richard P. Lifton, Wi.D., 
PH.D., chair and Sterling Profes¬ 
sor of Genetics and professor of 
medicine and molecular bio¬ 
physics and biochemistry, were 
invited to serve on a Blue Ribbon 
Panel on Clinical Research at the 
National Institutes of Health 
(NiH).The panel will examine 
research conducted within nih 
laboratories and clinics and sug¬ 
gest ways to collaborate with 
researchers outside the nih. 
Zeev N. Kain, M.D., HS ’92, FW ’93, 
anesthesiologist-in-chief at Yale- 
New Haven Hospital Children’s 
Hospital and professor of anes¬ 
thesiology and pediatrics and 
child psychiatry, has been 
appointed an associate editor of 
Anesthesiology, the journal of 
the American Society of Anes¬ 
thesiologists. His renewable 
four-year term began January 1, 
2003. He also began four-year 
terms in January on the editorial 
board of Ped/ofrics, the journal 
of the American Academy of 
Pediatrics, and as a member of 
the Risk Prevention and Health 
Behavior Study Section, Center 
for Scientific Review at the 
National Institutes of Health. 
Erin Lavik, sc.D., assistant profes¬ 
sor of biomedical engineering, 
was one of two Yale faculty 
members named to the 2003 list 
of world’s 100 Top Young Innova¬ 
tors by Technology Review, 
the Massachusetts Institute 
of Technology’s magazine of 
innovation. Lavik’s research 
focuses on new approaches to 
repairing spinal cord injury and 
retinal degeneration. 
Jerold R. Mande, M.P.H., lecturer 
in pediatrics, was named associ¬ 
ate director for policy at the Yale 
Cancer Center in September. His 
initial goal is to define Yale’s 
role in the Connecticut Cancer 
Control Plan in conjunction 
with the Connecticut Cancer 
Partnership. Before coming to 
Yale, Mande served on the 
White House staff as an advisor 
to President Clinton and was sen¬ 
ior advisor and executive assist¬ 
ant to the commissioner of the 
Food and Drug Administration. 
The National institutes of 
Health has awarded a $2.1 mil¬ 
lion grant to I. George Miller Jr., 
M.D. The Method to Extend 
Research in Time Award provides 
five years of support for Miller, 
the John F. Enders Professor 
of Pediatric Infectious Diseases, 
professor of epidemiology and of 
molecular biophysics and bio¬ 
chemistry. In research spanning 
nearly 30 years. Miller has used 
an interdisciplinary approach 
to define the major properties of 
the Epstein-Barr virus and is 
now studying its pathogenicity. 
His laboratory also studies the 
gamma herpes virus, associated 
with Kaposi’s sarcoma and body 
cavity lymphomas. 
Harvey A. Risch, M.D., PH.D., pro¬ 
fessor of epidemiology, was 
awarded a $3.65 million National 
Institutes of Health (nih) grant 
for a five-year study of the etiol¬ 
ogy of pancreas cancer cases in 
Connecticut. His co-investigator 
on the study, Herbert Yu, aa.d., 
PH.D., associate professorof epi¬ 
demiology, also received $3.2 mil¬ 
lion from the nih for a five-year 
study of mitogenic growth factors 
and endometrial cancer. Risch is 
co-investigator on Yu’s study. 
Philip E. Rubin, ph.d., director 
of the Division of Behavioral 
and Cognitive Sciences at the 
National Science Foundation, 
Bennett Shepard Stone 
Shaywitz 
received a Commendable Per¬ 
formance award in September 
from the Human Subjects 
Research Subcommittee on 
Science of the National Science 
and Technology Council for his 
superior leadership of all federal 
government departments and 
agencies involved in the protec¬ 
tion of human subjects. Rubin 
has been chief operations officer 
at Haskins Laboratories since 
October and is returning to Yale 
where he is professor adjunct of 
surgery (otolaryngology) and a 
research affiliate in psychology. 
Bennett A. Shaywitz, AA.D., profes¬ 
sor of pediatrics and neurology 
with an appointment in the Child 
Study Center, received a Distin¬ 
guished Alumni Award from the 
Washington University Alumni 
Association in St. Louis. The 
award, presented at the 150th 
anniversary celebration in 
September, honors outstanding 
professional achievement, public 
service and exceptional service 
to the university. Shaywitz is 
known for taking a neurological 
approach to the study of dyslexia. 
Shepard B. Stone, aa.p.s., pa ’76, 
HS ’81, associate clinical professor 
of anesthesiology and a physi¬ 
cian associate-anesthesiologist 
at Yale-New Haven Hospital, is 
also on the board of trustees of 
the Associates of the Cushing/ 
Whitney Medical Library. Stone, 
a member of the Connecticut 
Army National Guard, was 
appointed state aviation medi¬ 
cine officer in March. 
SEND FACULTY NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
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36 students 
Another school year, 
100 new white jackets 
On both sides of the podium, 
the start of the academic year 
marks a new beginning. 
For the 100 students in the first-year 
class, the annual White Jacket Ceremony 
is a symbolic introduchon to medicine 
and a welcome to Yale. This year it was 
also a chance for Interim Dean Dennis 
D. Spencer, m.d., hs ’77, to introduce 
himself to the Class of 2007. 
Spencer, who has led the medical 
school since July, described his own 
journey into medicine, which started 
with a boyhood spent on a farm in 
Iowa. Although he plowed the fields, he 
identified most with the local general 
practitioner, just back from the Korean 
On White Coat day members of the Class of 
2007 lined up in front of the Sterling Hall 
of Medicine for the traditional class portrait. 
War. “He wore a white coat, walked with 
a limp from a shrapnel injury, carried 
a big black bag and drove an oversized 
black Cadillac around the countryside, 
literally—and what appeared to be 
miraculously—saving lives, including 
mine, with a newly discovered antibi¬ 
otic, penicillin,” Spencer said. 
In high school Spencer tried, unsuc¬ 
cessfully, to make an eeg amplifier, 
and then resolved to become a physi¬ 
cian. At Grinnell College and in medical 
school at Washington University in St. 
Louis, Spencer followed his interest in 
the nervous system, which led him to 
neurosurgery. Spencer came to Yale in 
1972 to begin a five-year residency and 
has led neurosurgery here since 1987. 
After sketching his own life, Spencer 
described the students. The 100 mem¬ 
bers of the Class of 2007, he said, have 
attended 46 colleges, earned master’s 
degrees at eight universities and ph.d.s 
at three. 
He urged the students to embrace 
the Yale System’s emphasis on the 
physician as scientist. “You must quan¬ 
titatively understand the physical- and 
biological-science underpinnings of the 
evolved human by sharing the bench 
with our scientists and our clinics with 
clinical researchers,” he continued. “You 
must wear the white coat comfortably 
in both places, speak both the language 
of science and the language of caring.” 
Margaret K. Hostetter, m.d., profes¬ 
sor and chair of the Department of 
Pediatrics, told the story of a white coat 
she first wore as an intern in Boston 
and the reminders of individual patients 
stitched into its cloth. “Today you will 
wear the white coat, and you too will see 
life’s fabric torn, its texture raveled and 
its pattern rent. ... And once you’ve put 
it on, don’t ever take it off” 
—John Curtis 
Remarks from the ceremony by Dennis 
Spencer appear in their entirety on 
our website, info.med.yale.edu/ymm. 
Put authority to the test, 
Commencement speaker urges 
physician associates 
In his Commencement address to the 
Physician Associate Class of 2003, 
Charles A. Morgan III, m.d., associate 
professor of psychiatry, offered a cau¬ 
tionary tale about an experiment done 
at Yale in the early 1960s. Stanley 
Milgram, ph.d., a psychologist, wanted 
to test people’s acceptance of authority. 
Test subjects were asked to play the 
role of a “teacher” who would adminis¬ 
ter increasingly strong electric shocks 
each time a “learner” failed to answer 
a question correctly. Unbeknownst 
to the “teachers,” the learners were 
actors feigning a pained response to 
the shocks. 
“No one was prepared for the 
results of that study,” Morgan said. 
With prodding from the experi¬ 
menters, most subjects in the experi¬ 
ment were willing to administer up to 
450 volts, despite the screams of the 
actor portraying the learner. 
“Milgram believed subjects per¬ 
formed as they did because they had 
an extremely difficult time disobeying 
authority. Why am I telling you all 
this today?” Morgan asked. As they 
begin their careers, he continued, the 
35 new physician associates will 
become authorities themselves and 
will have to maintain their habit of criti¬ 
cal thinking, Morgan said. He encour¬ 
aged them to ask, “What has someone 
told me, and why do I believe it?” 
He also suggested that they must be 
willing to accept new or contradictory 
information, admit mistakes and 
change a diagnosis. “Pay attention to 
the evidence that doesn’t conform to 
NOTES 
your hypothesis,” he said. “You need to 
question authority. You need to think 
about what you do.” 
Class President Peggy Peelman 
Vollstad praised her classmates for 
their dedication and willingness to help 
others: September ii, 2001, which 
came on the 22nd day of their studies, 
reminded them of why they had chosen 
to become physician associates. Some 
students immediately volunteered with 
the Red Cross. Others donated blood. 
“It has been a long and arduous 
road ... to attain this privilege of being 
a health care provider,” she said. “I 
urge you to step off and reflect on why 
you became a physician associate.” 
—John Curtis 
This year’s graduates in the Physician Associate 
Program chose psychiatry professor Charies 
Morgan as their Commencement speaker. His 
address aiso included a magic trick—tearing up 
a newspaper and then making it whole again. 
Danielle L. Drayton has received 
the 2003-2004 Schering- 
Plough/Leadership Alliance 
National Dissertation award for 
her work on the role of lympho- 
toxin/aiphabeta in lymphoid 
organ development.This annual 
award recognizes ph.d. candi¬ 
dates in the biological sciences 
who have demonstrated superior 
scholarship and exceptional 
promise for success as academic 
scholars, scientists and teachers 
in biological and biomedical 
research. Drayton is a fourth- 
year immunobiology graduate 
student in the laboratory of 
Nancy H. Ruddle, ph.d. ’68, the 
John Rodman Paul Professor of 
Epidemiology and Public Health 
and professor of microbiology 
and immunobiology. 
Sean Lucan, a fourth-year medical 
student in the m.d./m.p.h. pro¬ 
gram, has received a scholarship 
from the Pisacano Leadership 
Foundation, awarded annually to 
outstanding students who com¬ 
mit to entering family practice. 
Applicants must show leadership 
skills, academic achievement, 
communications skills and a 
noteworthy level of community 
service.The scholarship provides 
educational programs, leadership 
training and up to $28,000 in 
funding for students identified as 
future leaders in family practice. 
The money can be used to repay 
student loans and to travel to 
meetings and conferences. 
Kyeen Mesesan, an M.D./ph.D. 
student studying microbial dis¬ 
eases in the Department of 
Epidemiology and Public Health, 
received a predissertation fellow¬ 
ship from the Yale Center for 
International and Area Studies 
that allowed her to spend five 
weeks in South Africa last sum¬ 
mer. While there, she was at the 
HIV/AIDS Vaccine Division in 
the Perinatal hiv Research Unit 
of the Chris Hani Baragwanath 
Hospital in Soweto, the site of 
the first HIV vaccine trials in 
South Africa. 
Mesesan evaluated the site 
for a dissertation project involv¬ 
ing mathematical modeling of a 
partially effective hiv vaccine 
and the resulting policy implica¬ 
tions for South Africa. She also 
developed a survey to assess 
sexual risk-taking behavior in 
vaccine trial participants, who 
will be monitored throughout 
the trials to ensure that such 
behavior does not increase. 
Alison Norris, an M.D./ph.d. stu¬ 
dent in the Department of 
Epidemiology and Public Health’s 
chronic disease division, has 
received two grants for hiv- 
related studies in Africa. With a 
Fulbright-Hays Doctoral 
Dissertation Research Abroad 
Grant and an International 
Dissertation Research Grant from 
Yale’s Center for International 
and Area Studies, Norris will 
spend a year conducting doctoral 
research at the Tanganyika 
Planting Company, a large sugar 
plantation near Mt. Kilimanjaro 
in northern Tanzania. More than 
7,000 adults live and work there, 
and her study aims to under¬ 
stand how life in a “company 
town” influences risk for hiv and 
other sexually transmitted dis¬ 
eases (STDs). Norris’ research will 
describe how and why people 
have sex with partners who 
infect them with hiv, and explain 
who is most at risk for infection 
with HIV and other stds in the 
plantation community. She hopes 
this information will suggest 
ways to reduce the spread of hiv. 
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A surgeon takes aim at 
bias in health care 
A surgeon sees disparities in treat¬ 
ment and a solution in the creation 
of more diverse medical teams. 
By Cathy Shufro 
If you log onto medline and search 
for papers by Augustus A. White III, 
M.D., PH.D., HS ’66, most citations will 
be what you’d expect from a prominent 
orthopaedic surgeon, with titles like 
“Effect of Screw Diameter, Insertion 
Technique and Bone Cement Augmen¬ 
tation of Pedicular Screw Fixation 
Strength.” But among the recent arti¬ 
cles, you’ll also find one with a very dif¬ 
ferent focus, “Our Humanitarian 
Orthopaedic Opportunity.” In the 
March 2002 issue of The Journal of 
Bone el Joint Surgery, White addresses 
topics that have increasingly preoccu¬ 
pied him during four decades as a sur¬ 
geon: the racism that has denied equal 
health care to African-Americans and 
the healing potential of cultural sensi¬ 
tivity among doctors. 
Unless physicians fight their con¬ 
scious and unconscious biases. White 
says, they will widen the gap between 
the quality of health care provided to 
the privileged and what’s offered to the 
marginalized. Infant mortality rates 
show that things are getting worse, says 
White, the Ellen and Melvin Gordon 
Professor of Medical Education at 
Harvard, where he is also a professor 
of orthopaedic surgery. In 2000, 14 of 
every 1,000 black babies died in their 
first year, compared with 5.7 per 1,000 
white babies. That ratio of 2.5 black 
deaths for each white death has increased 
over the past 20 years, from 2.0, accord¬ 
ing to the Centers for Disease Control 
and Prevention. “Bias is thoroughly 
interwoven into the very core of Western 
medical culture,” says White, former 
orthopaedic surgeon-in-chief at Boston’s 
Beth Israel Deaconess Medical Center. 
Even after adjusting for education 
and access to care, studies show simi¬ 
lar gaps. African-Americans are less 
likely than whites to have coronary 
Augustus White says physicians must fight 
their conscious and unconscious biases in 
order to narrow the gap in health care be¬ 
tween the privileged and the marginalized. 
angiography, drug therapy for hiv, kid¬ 
ney transplantation and even routine 
care. Bias even seems to influence the 
decisions of African-American physi¬ 
cians themselves. A 2001 Yale study by 
Jersey Chen, m.p.h. ’98, m.d. ’00, and 
Harlan M. Krumholz, m.d., professor 
of medicine, and others showed that 
after an acute myocardial infarction, 
white patients were significantly more 
likely than blacks to be given cardiac 
catheterization, even when the African- 
American patients were treated by 
African-American doctors. “Does any¬ 
one still have doubts about the momen¬ 
tum for bias in our medical heritage?” 
White asks. 
He says that when the physician 
workforce represents a variety of 
ethnic groups, health care improves 
for those less likely to get good care. 
Physicians from minority groups 
are more likely to set up practices in 
underserved areas; simply including 
them on a team improves care, says 
White, who is African-American. 
“Over time, you’re going to have a 
team that’s less ethnocentric.” 
White believes that awareness 
of cultural differences is slowly emerg¬ 
ing. At Harvard, first-year medical 
students now attend an all-day discus¬ 
sion of cultural differences in medi¬ 
cine. He describes his Yale mentor, 
Wayne O. Southwick, m.d., professor 
emeritus of orthpaedics, as a leader in 
fostering gender and racial diversity. 
Southwick received the 2003 Diversity 
Award from the American Academy 
of Orthopaedic Surgeons for his com¬ 
mitment to achieving greater diversity 
in the field. 
White experienced racism in medi¬ 
cine firsthand when he graduated 
from Brown University in 1957 and 
sought a summer hospital job. At 
the “white” hospital in his hometown 
of Memphis, he would have been 
restricted to a menial job. To find a 
job with responsibility. White had 
to apply to a hospital for nonwhite 
patients; there he was allowed to work 
as a surgical technician. Since then, 
ii 
I “the theme of diversity and the value 
' and importance of diversity” has been 
! “a recurrent theme in my mind, like 
j a Bach concerto. 
White is co-author, with Manohar 
' M. Panjabi, ph.d., a Yale professor of 
■, orthopaedics and mechanical engineer- 
i! ing, of the widely used reference 
I Clinical Biomechanics of the Spine and 
5 author of the popular book Your Aching 
l' Back: A Doctor’s Guide to Relief, 
f Although White no longer performs 
^ surgery, he still does consultations, 
ii writes about orthopaedics and lectures 
I both at Harvard and at national confer¬ 
ences. He has won many awards, 
including the Bronze Star for service 
i as an Army surgeon in Vietnam. A for¬ 
mer Brown University corporation 
trustee and fellow, he was selected in 
( 2000 as one of Brown’s loo most 
i influential 20th-century graduates, 
(I chosen from among 75,000 alumni. 
IV When asked what honor has given him 
the greatest satisfaction. White replied, 
“Whaf s clearly the most gratifying is 
the positive feedback from patients, 
|i spine fellows, professional colleagues.” 
ii He said he was reminded of his pur- 
iti pose when he read The Art of 
li Happiness: A Handbook for Living by 
the Dalai Lama, adding, “Our purpose 
'I here on Earth is to be happy, and the 
; way to be happy is to help others.” 
I White also finds happiness listening to 
i I 
I the music of Duke Ellington, Quincy ! Jones and Nina Simone at home in 
i Weston, Mass., where he lives with his 
. wife, Anita, and two of his three grown 
; daughters. (The third daughter is 
[ working in Sweden, where White stud- 
1 ied and met his wife.) 
, In his article on race and medical 
I care. White asks physicians to 
; approach every patient based on the 
“double E criterion”—that is, to ask 
themselves: “Is this the way I would 
treat my friend or my family?” Do this, 
writes White, “and we make a tremen¬ 
dous contribution toward the elimina¬ 
tion of health care disparities.” 
t, Cathy Shufro is a contributing editor of 
i Yale Medicine. 
For NASA veteran, alumni post 
offers chance to help students 
reach their goals 
when Howard A. Minners, m.d. ’57, 
M.P.H., was a boy growing up in Gar¬ 
den City, N.Y., his parents hoped he’d 
aspire to be a doctor. But Minners had 
other ideas. Living on Long Island near 
Roosevelt field, where Charles Lindbergh 
launched his dramatic flight across the 
Atlantic Ocean, he dreamed of doing 
something related to aviation. Minners 
did succeed in combining the two aspi¬ 
rations, becoming a flight surgeon for 
the astronauts in the early days of the 
space program. (As a flight surgeon, 
Minners took a mandatory jet qualifica¬ 
tion course, but never flew solo.) 
“It was a matter of being in the 
right place at the right time, and hav¬ 
ing the right training,” says Minners, 
who was recently named chair of the 
board of trustees of the Yale Medical 
School Alumni Fund. After graduating 
from medical school he spent a year 
getting a master’s degree in public 
health at Harvard. Next came a year at 
the U.S. Air Force School of Aerospace 
Medicine in San Antonio, followed by 
a year of supervised residency training 
in aerospace medicine, eight months 
of which were spent with the nasa 
Space Task Force, then located at Lang¬ 
ley Air Force Base in Hampton, Va. 
As a flight surgeon for more than 
four years with nasa in Houston, 
Minners tended to the everyday health 
care of the astronauts and their fami¬ 
lies. On launch days he conducted a 
final medical exam and helped the 
astronauts suit up. He also conducted 
immediate postflight medical exams, 
often aboard an aircraft carrier. 
One of his fondest memories is 
of John Glenn’s 1962 Project Mercury 
flight, which had to be temporarily 
scrubbed for technical reasons. After 
lying supine in his spacecraft for 
nearly four hours, Glenn returned to 
the astronauts’ quarters to remove 
his space suit. With yet another mis¬ 
sion postponement, there was public 
concern about the astronaut’s mood. 
“John liked music, and suddenly I 
heard him singing, so I harmonized 
with him,” Minners recalls. “With the 
whole world waiting, there we were 
singing. It was a delightfully private 
experience uncomplicated by all this 
stuff that was going on.” 
But there were also stressful expe¬ 
riences, like the time an astronaut 
missed his landing site. “There’s a 
period during spacecraft re-entry 
when, due to atmospheric ionization, 
you have no communication, so we 
didn’t know where he was,” Minners 
says. “It turned out fine, but for a 
while we were very concerned.” 
While working with the space pro¬ 
gram, Minners researched orthostatic 
hypotension—the lightheadedness you 
may experience if you get up quickly 
after you’ve been lying down—to see if 
it was accentuated after flight in space. 
In part as a result of his early work. 
Howard Minners 
v
a
le
 
M
e
d
ic
in
e
 
w
in
te
r 
2
00
4 
40 Alumni FACES 
exercises have been developed for astro¬ 
nauts to perform while they’re in space 
to maintain cardiovascular fitness. 
After leaving the space program in 
1966, Minners joined the U.S. Public 
Health Service at the National Institutes 
of Health, first in the Office of Interna¬ 
tional Research and two years later at 
the National Institute of Allergy and 
Infectious Diseases. He worked in vac¬ 
cine development, immunology and 
tropical medicine. He went on to 
become chief of the World Health 
Organization’s research office in 
Geneva before serving as an assistant 
surgeon general and deputy director 
of the Public Health Service’s Office 
of International Health. He spent the 
last 10 years of his career as science 
advisor to the head of the Agency for 
International Development, with over¬ 
sight for agricultural, environmental, 
energy and natural resources research, 
as well as biomedicine. 
Minners says his education at the 
School of Medicine prepared him well 
for a career in the sciences. He cites as 
an example the research he did for his 
medical school thesis. “Having been a 
chemistry major at Princeton before 
coming to Yale, I was trying to develop 
a chemical process whereby we could 
accurately and more simply measure 
urinary estrogen levels,” he says. “We 
couldn’t come up with what we were 
trying to do, but that in itself is part of 
the learning process.” 
As chair of the medical alumni 
fund, Minners wants to make the 
kind of education he received at Yale 
more affordable. 
“When I learned that the scholar¬ 
ships we offer aren’t always as competi¬ 
tive as at some other medical schools, I 
decided then and there that we need to 
[do more],” he says. 'Three years ago he 
established the Howard Minners Family 
Scholarship for medical students. “I still 
believe that the education you receive at 
Yale, and notably, under the Yale 
System, is better than anywhere else. 
But it doesn’t come inexpensively.” 
—Jennifer Kaylin 
Working on a broad canvas, 
physician-artist finds perfec¬ 
tion amid life’s many flaws 
It is 5:30 a.m., and the sun hasn’t yet 
risen on this fall day in Providence, 
R.I. On the third floor of an old house 
in the historic East Side of town, 
Cheng-Chieh Chuang, m.d. ’95, holds 
his watercolor brush in his hand. 
This is how Chuang begins each 
day—in his studio. The meditative 
focus of painting prepares him for the 
hectic pace of his solo family practice 
in Taunton, Mass., a blue-collar town 
just across the state line. It allows him 
to work as an artist, a lifelong interest 
and parallel career to medicine. 
Painting also serves as a philosophi¬ 
cal foundation for Chuang. When he 
chooses a subject for his detailed, 
nearly photographic watercolors—usu¬ 
ally something from nature—he does 
not avoid objects that seemed flawed, 
like a maple leaf with a scaly patch. “All 
those scars are beautiful in themselves. 
Nothing is perfect in this world,” says 
Chuang. He tries to retain this per¬ 
spective when meeting with patients. 
“I try to see them as perfect beings, 
despite their imperfections.” 
For four years after his residency 
in family practice at Brown University, 
Chuang’s desire to travel and paint 
while practicing medicine led him 
down an unusual path. He spent half 
his time on the road doing locum tenens 
work and half his time at home in 
Providence, painting. He lived in a 
dozen communities for several months 
each, from Maine to Alaska and from 
Minnesota to New Mexico, where meet¬ 
ing patients gave him a more nuanced 
view than that of a tourist. In the fall of 
2002 he settled full time in Providence 
and has established an Internet site 
to display his paintings and sell prints 
(See http://www.fromearthtosky.com/). 
Chuang also combines his interests 
by teaching a course in art and medi¬ 
cine to Brown medical students. They 
explore how art can improve their pow¬ 
ers of observation and enrich both their 
Sun Rising by Cheng-Chieh 
Chuang 
own lives and those of their patients. 
Chuang wants his students to view 
physicians in the way that he came to 
see them as a child growing up in 
Taiwan (where his adventures some¬ 
times ended with a trip to the doctor): 
not just as scientists but as “renais¬ 
sance men/women.” 
Chuang is looking for a house 
near his practice in Massachusetts, 
where he hopes to combine his office 
with an art gallery and a “healing 
garden.” Having worked much of 
his career in subsidized clinics in 
medically underserved areas, he is 
tempered by the realities of private 
practice, of having to worry about the 
bottom line in addition to simply 
providing quality care. But he’s happy 
with the work. “Family practice 
constantly reminds me to be curious 
about everything in life, including 
the human condition.” 
And he tries to see each day as a 
gift. “There is so much adversity. ... 
But most of us go through daily life ; 
without any big problems. That in i 
itself is a miracle. That’s something we 
take for granted, like the air.” | 
—Cathy Shufro | 
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Online cme site, voted best of 
the Web, reflects the curiosity 
of its creator 
In the mid-1990s, just as the Internet 
was starting to take off, Harry A. Levy, 
M.D., M.P.H. ’82, looked at the infor¬ 
mation available online for physicians 
and saw a virtual desert. “Not much 
was going on in health care on the 
Internet,” says Levy, 59. “I decided I 
could do better.” 
So in 1996 Levy launched the first 
continuing medical education (cme) 
site on the Web and hasn’t looked 
back. His creation, Cyberounds (www. 
cyberounds.com), now has 125,000 
registered users and a potential audi¬ 
ence of more than a half-million physi¬ 
cians, as a result of the cooperative 
arrangements Levy has struck with 
major online publishers and profes¬ 
sional societies. The website offers con¬ 
ferences in 15 disciplines, including 
cardiovascular medicine, geriatrics, 
genetics, psychiatry, rheumatology and 
women’s health. 
Each conference provides a case 
study, diagnostic clues and a discus¬ 
sion by experts, usually highlighting 
emerging treatments. Conferences are 
moderated by faculty members from 
medical schools around the country, 
and physicians who complete the work 
can earn cme credit from the Albert 
Einstein College of Medicine in New 
York, the program’s academic partner. 
(Last year Einstein awarded a total of 
20,000 CME credits to participants in 
Cyberounds courses.) As it approaches 
its eighth birthday, Levy’s brainchild 
has the longest track record in the 
online cme field, and last June it 
received a Nettie award from MD Net 
Guide as best cme provider. 
“Doctors are busy people,” says 
Levy. “What we do for them is provide 
the experts to lead them through the 
information jungle.” 
Levy and his collaborators at Cyber¬ 
ounds have also employed a playful 
approach to cme (Levy calls it “medu- 
tainment”). Two years ago, they 
launched “Cardio Country Club,” a 
Web-based golf game in which physi¬ 
cians compete against each other and 
advance through an 18-hole course by 
correctly answering questions about 
the management of cardiovascular dis¬ 
ease. More than 3,800 online learners 
have played the game. 
An NYU medical graduate. Levy 
trained at New York’s Mount Sinai 
Hospital in preventive medicine and 
studied public health at Yale. After start¬ 
ing and running several health care 
businesses in New York in the 1970s 
and 1980s, he decided he would need to 
make time for at least three careers. He 
sold his companies in 1991 and set a 
goal of writing five novels, then doing 
basic research in neuroscience. 
He’s now at work on his third book 
(his second, a mystery novel titled 
Chain of Custody, was published by 
Random House in 1998), is writing a 
screenplay and expects to be slicing 
brain tissue by the time he turns 65. 
He figures the conventional age for 
retirement will be a good time to begin 
the next chapter in his professional life, 
however unconventional that may seem 
to others. (Levy notes that his great¬ 
grandfather lived to be no and that 
both his grandfathers reached 90.) “I 
think I can stick to my timetable,” he 
says, smiling. “At least I’m crossing my 
fingers that genetics will help me out.” 
As for the future of Cyberounds, 
he says the company will turn its atten¬ 
tion to developing courses serving 
the subspecialties. “We want to drill 
down deeper—beyond the general cat¬ 
egory of endocrinology, for example, to 
have focused modules in diabetes or 
thyroid disease,” he says. “We want to 
do more interactive programming, 
including games and decision-tree pro¬ 
grams, courses customized to the 
user’s individual needs and interests.” 
Currently in the works are a triathlon 
game on rheumatoid arthritis and dis¬ 
ease management software for doctors 
and patients. 
Levy says the business (which 
includes a consumer site, TheDoctor 
Harry Levy 
WillSeeYouNow.com, and an e- 
scheduling site, MakeMyAppt.com) 
has been profitable for the past six 
years despite the bursting of the tech 
bubble. One factor in its success, he 
says, is that the company is doctor- 
driven and doctor-created, and it caters 
to what physicians want. “We owe our 
success to word-of-mouth among 
physicians. We haven’t had to advertise 
and instead were able to invest in 
innovative programs. You grow slower, 
but you become more useful to the 
medical community.” 
—Michael Fitzsousa 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
Yale Medicine, P.O. Box 7612, New Haven, 
CT 06519-0612. 
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New leadership for 
the alumni association 
The AYAM elects its first African- 
American president, a Brooklyn 
physician who makes house calls. 
Hospitals horrified Donald E. Moore, 
M.D. ’81, M.P.H. ’81, beginning the day 
he visited his dying father. 
“ I was able to see him in the state 
of illness before the nurses generally do 
their morning care. It was very ugly,” 
said Moore, who was 14 years old and 
growing up in Jamaica. His police offi¬ 
cer father was in end-stage renal failure, 
the result of uncontrolled hypertension. 
“I remember I left the ward crying. That 
was the first time that it struck me that 
he was dying. I never thought I’d ever 
go back into a hospital.” 
Later, as a student at Pace University 
in Manhattan, Moore majored in sociol¬ 
ogy. When he excelled in an obligatory 
math and science course, his professor 
suggested that he consider medicine. 
“I had no idea what I was getting 
into.” And yet, he says, “There’s 
nothing in my life that would have 
given me as much satisfaction as 
studying medicine.” 
In July Moore assumed the presi¬ 
dency of the Association of Yale 
Alumni in Medicine (ayam). A new 
vice president and secretary were also 
elected, as well as two new execurive 
committee members. 
One of Moore’s goals as president 
is to foster discussion of how managed 
care has harmed the doctor-patient 
relationship. He said a capitated plan, 
which pays a doctor to take care of a 
group with a flat per-patient payment, 
militates against what a physician is 
supposed to do: care for sick people. 
Instead, it encourages the doctor to 
seek healthy patients and see them as 
little as possible. 
Moore, the first African-American 
to serve as ayam president, also hopes 
to convince more minority graduates 
from the mid-yos through the mid-8os 
to attend reunions. He can’t explain 
why, but minority grads from that era 
are “a disaffected group.” He would 
like them to renew their connections to 
Yale because, for most doctors, the medi¬ 
cal school experience “is a defining 
characteristic of them as physicians.” 
The medical school will most likely 
choose a new dean during Moore’s two- 
year term, to replace David A. Kessler, 
M.D., who left in June to become dean 
of the medical school at the University 
of California, San Francisco. Moore 
favors choosing “someone who loves 
the Yale System because of their 
involvement in it, either as a student or 
a faculty member, or someone who 
came, saw and loved.” He and six for¬ 
mer presidents of ayam wrote to uni¬ 
versity President Richard C. Levin in 
July suggeshng that the new dean 
should be either a faculty member or a 
graduate of the School of Medicine. 
They asked Levin to consider appoint¬ 
ing Interim Dean Dennis D. Spencer, 
M.D., HS ’77, permanently to the 
post. Spencer, who did his residency 
at Yale, is a longtime faculty member 
and former chair of the Department 
of Neurosurgery. 
Research into basic immunology 
dominates the professional life of 
Francis M. Lobo, m.d. ’92, ayam vice 
president. An assistant professor of 
medicine at Yale, Lobo studies a pro¬ 
tein messenger, the cytokine CD40 
ligand, which generates normal anti¬ 
body responses to infection but also 
mediates abnormal immunological 
responses, such as those that cause 
lupus, atherosclerosis, asthma and 
rejection of transplanted organs. Lobo 
hopes that a deeper understanding of 
CD40 ligand will provide opportunities 
to treat diseases of deflcient or abnor¬ 
mal immunity. 
In a subtle way, students at Albert 
Einstein College of Medicine in the 
Bronx are beneficiaries of the Yale 
System. As a member of the school’s 
admissions committee, ayam secretary 
Christine A. Walsh, m.d. ’73, looks for 
applicants who show creativity and 
Christine Walsh, Donald Moore and Frank Lobo 
were chosen at the 2003 Reunion to lead the 
Association of Yale Alumni in Medicine. Frank 
Coughlin is past president. 
NOTES 43 
I self-motivation, qualities valued at Yale. 
“I think the Yale System is very success- 
I ful in the type of doctor it produces,” 
: says Walsh, a pediatric cardiologist on 
' the full-time faculty at Einstein. Her 
: research focuses on abnormal heart 
rhythms in children. She directs the 
Pediatric Dysrhythmia Center at the 
' Children’s Hospital at Montefiore 
Medical Center in the Bronx, specializ- 
, ing in cardiac electrophysiology. 
AYAM executive committee member 
Victoria L Holloway, m.d. ’94, m.p.h., 
! may influence what we And in the 
: beauty aisles at the local pharmacy. A 
t dermatologist, Holloway is assistant 
I vice president for research and devel¬ 
opment at L’Oreal, the world’s largest 
!, cosmetics company. In a converted 
Chicago warehouse, Holloway oversees 
I biologists, physicists and chemists 
' working “to understand the differences 
across ethnicities of hair and skin.” 
The findings will be used to design 
hair and skin-care products. 
Executive committee member 
; Robert W. Lyons, m.d. ’64, visits his 
alma mater several times a month to 
I attend conferences. He is chief of 
infectious diseases and epidemiology 
) at Saint Francis Hospital and Medical 
Center in Hartford, professor at the 
University of Connecticut School of 
, Medicine and associate clinical profes- 
. sor of medicine at Yale. In the past 
year he has led seminars for 
Connecticut county medical societies 
on SARS, bioterrorism and smallpox. 
—Cathy Shufro 
Maxine Singer Laurence Boxer David Law Barry Solof 
1940s 
C. Baldwin DeWitt Jr., M.D. ’49, 
presented the commencement 
address and received an honor¬ 
ary doctor of science degree 
from Northeastern Ohio Univer¬ 
sities College of Medicine in May. 
DeWitt continues to work full 
time as scholar-in-residence at 
the Accreditation Council for 
Graduate Medical Education in 
Chicago, pursuing his research 
on the working and learning 
environments of residents. 
1950s 
Maxine F. Singer, ph.d. ’57, retired 
from a i4-year tenure as presi¬ 
dent of the Carnegie Institution 
of Washington and in January 
2003 was named chair of the 
board of directors of the White- 
head Institute for Biomedical 
Research in Cambridge, Mass. 
Singer, who previously served as 
a member of the board, has 
earned a strong reputation in 
science public policy for her stud¬ 
ies of risks from recombinant 
DNA research and her support 
for the Human Genome Project. 
1960s 
Laurence A. Boxer, m.d., hs ’68, 
was named the Henry and Mala 
Dorfman Family Professor of 
Pediatric Hematology/Oncology 
at the University of Michigan. He 
has been director of pediatric 
hematology/oncology for the 
past 21 years. 
David C. Law, M.D. ’66, wrote to 
say that in 1998 he and his wife 
Doris, "at the ripe old age of 58,” 
adopted two girls from the 
Ukraine, Anna, 4, and Ekaterina, 
3. A year and a half later, they 
adopted Natalia, 2.The girls are 
now 9,8 and 5 and the family is 
doing quite well. He adds that 
this may be of interest to mem¬ 
bers of the class, as well as to 
others who might be considering 
adoption or starting a second 
family in their “senior” years. 
Ghulam Rauf Roashan, M.D., 
M.P.H. ’67, who is semiretired 
and teaching and living in Fre¬ 
mont, Calif, was head of health 
planning and international 
health in the Ministry of Public 
Health in Afghanistan in the 
1970s and served on the execu¬ 
tive board of the World Health 
Organization. He has also worked 
as a journalist. Roashan now 
directs the online Institute for 
Afghan Studies and is an advisor 
to Development Gateway, an 
online research group. 
1970s 
Barry S. Solof, M.D. ’74, is national 
chair of the American Society 
of Addiction Medicine’s commit¬ 
tee on Geriatric Alcoholism and 
Substance Use and physician- 
in-charge of addiction medicine 
for Southern California Perma- 
nente Medical Group in West 
Covina, Calif Previously, Solof 
served as medical director of 
adult and adolescent chemical 
dependency treatment pro¬ 
grams at Edgemont Hospital in 
Los Angeles and Tustin Medical 
Center in Orange County, Calif, 
and for Alternatives, a gay 
and lesbian program at Glen¬ 
dale (Calif) Memorial Hospital. 
He spoke recently on the medi¬ 
cal aspects of chemical depend¬ 
ency at a conference organized 
by Save Our Selves, a group that 
encourages a self-empowerment 
approach to recovery from drug 
and alcohol abuse. 
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44 Alumni NOTES 
Marian Hannan David Eduardo Marban 
Mandelbaum 
Murad Alam Joshua Rosenow Chrysalyne 
Schmults 
1980s 
Marian T. Hannan, D.SC., M.P.H. ’81, 
assistant professor of medicine 
at Harvard Medical School and 
a senior research associate at 
Hebrew Rehabilitation Center 
for the Aged in Boston, received 
the 2003 Excellence in Teach¬ 
ing Award from the First Year 
Student Committee on Teaching 
Excellence at Harvard. Hannan 
is a specialist in the epidemiol¬ 
ogy of age-related musculoskel¬ 
etal disorders. 
Robert S.D. Higgins, M.D. '85, 
chair of the department of car¬ 
diovascular/thoracic surgery at 
Rush University in Chicago, was 
appointed the Mary and John 
Bent Chair of Cardiovascular- 
Thoracic Surgery in June at the 
quarterly meeting of the Rush- 
Presbyterian-St. Luke’s Medical 
Center board of trustees. 
David E. Mandelbaum, M.D., PH.D., 
HS ’82, former chief of the divi¬ 
sion of child neurology at the 
Robert Wood Johnson Medical 
School, was appointed chief of 
the division of pediatric neurol¬ 
ogy at Hasbro Children’s Hospital 
in Providence, R.l. Mandelbaum 
is also professor of clinical neuro¬ 
sciences and pediatrics at Brown 
Medical School. His teaching and 
research have focused on child¬ 
hood epilepsy and related neuro- 
developmental disorders. 
Eduardo Marban, M.D. ’80, PH.D. 
’81, chief of cardiology at Johns 
Hopkins Medical Center, is 
the director of The Donald W. 
Reynolds Cardiovascular Clinical 
Research Center at Johns 
Hopkins, established under a 
four-year, $24 million grant in 
May 2003.The multidisciplinary 
center will use novel biological 
therapies and modern imaging 
techniques to try to reduce the 
rate of sudden cardiac death. In 
October, the center held an 
inaugural symposium to high¬ 
light the major projects that 
make up its research efforts. 
1990s 
Murad Alam, M.D. ’96, has started 
his second year as chief of the 
section of cutaneous and aes¬ 
thetic surgery in dermatology at 
Northwestern University in 
Chicago. Alam completed a der¬ 
matology residency at Columbia 
University College of Physicians 
and Surgeons and fellowships in 
laser surgery at Harvard and in 
Mohs micrographic surgery at the 
University of Texas Baylor/M.d. 
Anderson Cancer Center. 
M. Kathleen Figaro, M.D. ’g6, 
assistant professor of medicine 
at the Vanderbilt Medical Center, 
won a Robert Wood Johnson 
Career Development Award for 
her work with underrepresented 
minorities and diabetes care. 
The four-year, $365,000 grant 
was awarded in January 2003. 
Figaro’s project is titled "Disability 
Expectation: Impact on Self-Care 
of Type 2 Diabetes.” 
Kathryn E. Johnson Hoffman, 
M.P.H. ’99, and Eric S. Hoffman, 
PH.D. ’99, were married on July 5 
in Webster, Mass. She is a doctoral 
candidate in clinical neuropsy¬ 
chology at the University of 
London. He is a research analyst 
for biotechnology stocks in the 
London offices of Bear Stearns, a 
New York investment bank. 
Cynthia Lord, PA-C ’91, program 
director and assistant professor 
at the Quinnipiac University 
Physician Assistant Program, was 
elected director-at-large to the 
board of the American Academy 
of Physician Assistants (aapa) for 
a two-year term. Lord is the 
graduate advisor to the Student 
Academy of the aapa. 
Shefali Pardanani, M.D., M.P.H. ’97, 
and Vinod Pathy, m.d., were mar¬ 
ried on May 10 in New Rochelle, 
N.Y.They are medical residents, 
she in obstetrics and gynecology 
at the Jacobi Medical Center and 
he in general surgery at Monte- 
fiore Medical Center, both in the 
Bronx. Pardanani is also a resi¬ 
dent at Jack D. Weiler Hospital, 
Albert Einstein College of Medi¬ 
cine in New York. 
Lisa F. Price, M.D. ’98, a second- 
year child psychiatry fellow in 
the department of child and 
adolescent psychiatry at the 
Massachusetts General Hospital/ 
McLean Hospital in Boston, 
received the 2003 American 
Academy of Child and Adolescent 
Psychiatry Presidential Scholars 
Award for research. Price will 
explore the parent-child rela¬ 
tionship in couples who have 
conceived their child with the 
aid of in vitro fertilization, 
assessing attachment, risk and 
resiliency factors. 
Joshua M. Rosenow, M.D. ’96, has 
completed his fellowship in 
stereotactic and functional neuro¬ 
surgery at the Cleveland Clinic 
Foundation and works as direc¬ 
tor of functional neurosurgery at 
Northwestern University and 
Northwestern Memorial Hospital 
in Chicago. His practice focuses 
on surgery for movement disor¬ 
ders, epilepsy and pain. His 
H. Steven Sims Dina Strachan 
research interests include out¬ 
comes from surgery for move¬ 
ment disorders and pain and 
functional imaging of neuro¬ 
stimulation. Rosenow is also 
investigating novel applications 
of neuromodulation. 
Chrysalyne D. Schmults, m.d. ’98, 
was appointed assistant profes¬ 
sor of dermatology at the Uni¬ 
versity of Pennsylvania Health 
System in July. Her initial research 
will examine the efficacy and 
safety of topical, nonsurgical 
treatments for basal and squa¬ 
mous cell carcinomas. Her clini¬ 
cal responsibilities include Mohs 
surgery, an advanced surgical 
procedure used for recurrent skin 
cancers. Schmults is also an edi¬ 
torial reviewer for The Journal of 
Drugs in Dermatology. 
H. Steven Sims, M.D. ’94, HS ’00, 
was recently named director of 
the Chicago Institute for Voice 
Care, a treatment center dedi¬ 
cated to the care of voice and 
airway disorders. Sims, who com¬ 
pleted a research fellowship in 
neurolaryngology at the 
National Institutes of Health and 
a research fellowship in the care 
of the professional voice at 
Vanderbilt, relocated to Chicago 
after serving on the staff at the 
University of Nebraska. 
Dina D. Strachan, m.d. ’94, writes 
to say that she is an assistant 
clinical professor of dermatology 
at the Columbia University 
College of Physicians and 
Surgeons and has gone into a pri¬ 
vate practice in Manhattan. 
Strachan received a 40-Under- 
Forty Achievement Award 
from The Network Journal at a 
ceremony in June at Columbia 
University, where she is studying 
biomedical informatics part time. 
45 
Stephanie Snitow and 
Daniel Jacoby 
2000S 
DanielJacoby, M.D.'oo, and 
I Stephanie Snitow were married 
on August 31 in Florham Park, N.J. 
Jacoby, son of Robert O. Jacoby, 
D.V.M., PH.D., professor and chair 
of comparative medicine at 
Yale, is a chief resident in inter- 
, nal medicine at Mount Sinai 
Hospital in New York. Snitow is a 
‘ fellow in the Harvard Business 
School Service Leadership 
' Program, working as the special 
. assistant to the president of 
Phipps Houses, a developer of 
, affordable housing in New York. 
Elizabeth V. Harrold Ratchford, 
M.D. 'oo, and Jack Ratchford, M.sc. 
! ’98, were married in Atlanta on 
I May 3. She is an instructor in clini¬ 
cal medicine and on the faculty 
in the division of cardiology at 
; Columbia Presbyterian. He gradu- 
i ated in May from Columbia 
University College of Physicians 
I and Surgeons and will serve a 
i preliminary year in internal 
I medicine followed by a neurol¬ 
ogy residency at Columbia. 
SEND ALUMNI NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
info.med.yale.edu/ymm 
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46 in Memoriam 
Paul A. Bonner, M.P.H. '68, of 
Dewitt, N.Y., died on August 8 at 
the age of 58. He had battled 
diabetes for more than 40 years. 
Bonner worked for the Salvation 
Army Harbor Light Centers, as 
director of grants and contracts 
management in Washington, 
and as associate program direc¬ 
tor in Boston. He was also exec¬ 
utive director of the Addiction 
Treatment Center of New 
England in Brighton, Mass. 
Thomas J. Brennan, M.D. ’82, died 
on July n at the age of 56, at his 
home in Vero Beach, Fla. Born in 
Richmond Hill, N.Y., Brennan 
graduated from the U.S. Military 
Academy at West Point in 1969. 
He was a captain in the Army 
and was awarded the Silver Star 
for Bravery. Brennan was an 
anesthesiologist in Dothan, Ala., 
until 1989, when he moved his 
practice to Vero Beach. He was 
also a member of the Indian 
River County Medical Society. 
Paul Calabresi, M.D. ’55, professor 
emeritus of medicine and 
founding faculty member of the 
Brown University School of 
Medicine, died on October 25 of 
cancer at the age of 73. One of 
the founding fathers of medical 
oncology and cancer clinical 
pharmacology at Yale, Calabresi 
was instrumental in shaping the 
field of modern chemotherapy. 
He developed approaches that 
led to the cure of such diseases 
as Hodgkins lymphoma. During 
his career Calabresi was presi¬ 
dent of the American Society of 
Clinical Oncology, chair of the 
National Cancer Advisory Board 
and a member of the President’s 
Cancer Panel and the National 
Cancer Legislation Advisory 
Committee.The Paul Calabresi 
Lectureship has been created 
in his honor by the Yale School 
of Medicine. 
Miriam McDonald Campbell, 
M.P.H. ’33, of Chilmark, Mass., 
died on July 21 after a short ill¬ 
ness and complications from a 
fall. In 1980 Campbell co-founded 
the Hospice of Martha’s Vineyard, 
where she was admitted during 
her illness. Campbell taught at 
Smith College in Northampton, 
Mass.; Westbrook Junior College 
in Portland, Maine; and the 
University of Maine at Orono. She 
received the Health Education 
Award of Distinction from the 
New England Health Education 
Consortium, the Ira V. Hiscock 
Award from the New England 
Public Health Association and the 
Maine Maternal and Child Health 
Council Health Education Award. 
Irving Cuttenberg, M.D. ’60, an 
otolaryngology surgeon from 
Rochester, N.Y., died on August 17 
at the age of 69. After medical 
school and training, he served as 
a captain in the Air Force at 
Loring Air Force Base in Maine. 
Cuttenberg was a clinical 
instructor in surgery (otolaryn¬ 
gology) at Yale from 1984 until 
his death and chief of surgery 
and chief of ear, nose and throat 
surgery at the VA Connecticut 
Healthcare System in West 
Haven and at MidState Medical 
Center in Meriden. He retired 
from private practice in 2002. 
William C. Harvey, M.P.H. ’65, of 
Tiverton, R.I., died on August 21 
at the age of 71. Harvey was 
the owner/operator of a medical 
consulting firm. Hospital 
Executives, from which he retired 
in 1994. He was a hospital 
administrator in Rhode Island, 
New York and Massachusetts, 
and ran a home health 
care agency in Rhode Island. 
Warren H. Knauer, M.D., HS ’54, 
an oncologic surgeon from 
Naples, Fla., died on June 21 at 
the age of 81. Knauer was co¬ 
director of the Wuester Tumor 
Clinic in Elizabeth, N.J., and 
chair of the division of malignant 
and allied diseases and of the 
cancer committee at the 
Elizabeth General Medical Center. 
He also developed a surgical 
oncology program for fourth- 
year surgical residents, the only 
one of its kind in New Jersey. 
Knauer volunteered for 28 years 
for the American Cancer Society 
(acs) and received the Physicians 
Award and the highest National/ 
Division Bronze Medal Award 
from the acs. 
Myra A. Lappin, M.P.H. ’71, M.D., of 
San Francisco, died from ovarian 
cancer on June 17 at the age 
I of 57. Lappin was director of stu¬ 
dent health services at Cal 
State Hayward and later at San 
t Francisco State University, where 
the program became a model 
for accessible, affordable health 
, care for students. She promoted 
research in the fields of women’s 
health and sexually transmit¬ 
ted infections. 
Dorothy J. Lewis, M.P.H.’72, of 
I Newtown, Conn., died on August 
!■ 7 at the age of 71. Lewis was 
1 professor of dental hygiene at 
the University of Bridgeport. She 
retired in 1985, then joined 
the faculty atTunxis Community 
College in Farmington, Conn., 
f where she focused on commu- 
p nity programs affecting dental 
» care for underprivileged children 
r in the local school systems. 
4 Robert M. Macnab, PH.D., profes- 
I sor of molecular biophysics and 
It biochemistry at Yale, died on 
( September 7 as a result of 
injuries sustained in a fall at his 
home. He was 63. Macnab, an 
expert on the bioenergetics of 
It. motility, joined the faculty at 
Yale in 1973 and served as chair 
I of his department from 1992 
i untih995. 
George A. Nelson, m.d. ’57, of 
Glenview, III., and formerly of 
Northbrook, III., died on 
September 3 at the age of 72. 
Nelson served as chief of staff at 
Lutheran General Hospital and 
during a 45-year career practiced 
at the Fahey Clinic and Holy 
Family Medical Center in Del 
Plaines, III. He also served as a 
flight surgeon on the aircraft 
carrier uss Ranger. 
David A. Page, M.D. ’56, of 
Skidaway Island, Ga., died on 
July 2 at the age of 75. Page 
was an ophthalmologist at the 
North Shore Medical Group in 
Huntington, N.Y., before retiring 
to Georgia in 1994. During World 
War II, he served in the Army 
occupation forces in Japan. 
Robert J. Rice, M.D. ’56, of Punta 
Gorda, Fla., died on June 13 at 
the age of 74. Rice owned and 
directed Camp Montrose in New 
York state for emotionally dis¬ 
turbed children. He also served 
as a consultant to the Nassau 
County special schools and was 
director of child psychiatry 
inpatient services at the Nassau 
County Medical Center. 
Benjamin R. Robinson Jr., M.D. ’43, 
died on June 15 at the University 
Retirement Community in Davis, 
Calif, at the age of 84. Robinson 
practiced for 30 years at the 
Woodland (Calif) Clinic Medical 
Croup and served as chief of 
staff of Woodland Memorial 
Hospital. He was a captain in 
the Army and was also in the 
National Guard Reserves. 
Peter Safar, M.D., FW ’50, a pio¬ 
neer in emergency medicine and 
the development of cardiopul¬ 
monary resuscitation (cPR),died 
on August 3 of cancer at his 
home in Pittsburgh. He was 79. 
Safar was known as the father 
of modern-day cpr for develop¬ 
ing, in the 1950s, a method of 
mouth-to-mouth resuscitation 
which he combined with chest 
compression. He was a founding 
member of the U.S. National 
Research Council’s committee on 
emergency medical service, 
establishing guidelines for ambu¬ 
lance design and emergency 
medical technician and para¬ 
medic training. Safar established 
anesthesiology departments in 
Baltimore, Pittsburgh and Lima, 
Peru. He was chair of anesthesiol¬ 
ogy at the University of 
Pittsburgh Medical Center and 
established the International 
Resuscitation Research Center 
(now the Safar Center for 
Resuscitation Research). 
Thomas E. Shaffer, M.D., HS ’37, of 
Columbus, Ohio, died on July 31 
at the age of 94. Shaffer was a 
clinical instructor in pediatrics at 
Yale until 1942 and had a private 
practice in New Haven and 
Farmington, Conn. After serving 
in the Army Medical Corps 
during World War II, he joined 
the faculty at the Ohio State 
University Medical Center. 
Shaffer also was director of ado¬ 
lescent services at Children’s 
Hospital in Columbus, Ohio, until 
1983, and he was the medical 
director for the Juvenile 
Diagnostic Center in Columbus 
from i960 until 1964. 
SEND OBITUARY NOTICES TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
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48 FOlloW-Up Archives 
Settling down in Pittsburgh 
A little over three years ago, fourth-year students Tanya Smith 
and Jose Prince embarked on a complicated venture and 
entered the residency placement process leading up to Match 
Day as a couple [“A Match Made in New Haven,” Summer 
2000]. It meant finding one desirable location that also had 
two desirable residency programs, in ob/gyn for Smith and 
surgery for Prince. They settled on Pittsburgh and matched at 
the University of Pittsburgh Medical Center, their top choice. 
Now, three and a half years later, they’re convinced they 
made the right decision. “It’s been a really good place to do 
training in ob/gyn,” said Tanya Prince (the couple married two 
years ago). “It has tremendous clinical volume so you get lots 
of experience. It’s a great place in terms of balancing clinical 
research and operating experience.” She’s looking for a private 
practice position in Pittsburgh to join when her residency ends 
in June. 
Jose Prince is temporarily trading the care of humans 
for the study of mice. He recently began a two- to three-year 
research fellowship. "I’m working on a project that looks at 
early molecular signaling that takes place in hemorrhagic 
shock,” he said. After his fellowship, he must complete two 
more years of clinical work. 
Though still earning residents’wages, the couple has 
been able to buy a house, a 1930 red-brick duplex in the 
Squirrel Hill neighborhood just a mile and a half from work. 
For a young couple, Pittsburgh has been a wonderful place to 
live. "It has a small-city feel, but it has all the good things of a 
big city,” said Tanya Prince. City attractions include the local 
symphony and opera and touring Broadway shows. For out¬ 
door enthusiasts, skiing is only 45 minutes away. Sailing and 
hiking are also close at hand. The only downside for the couple 
is the distance from family and ocean. She is from San 
Francisco; he’s from New York City. 
Nevertheless, Tanya concluded, "It was a really good 
choice for us.” They plan to stay in Pittsburgh for the foresee¬ 
able future, but as Jose said,"You never know. We would like 
to be closer to our families.” 
—John Curtis 
OCTOBER 1958 
Alumni Bulletin 
"Discovery of the first hormone 
ever isolated from the pineal 
gland has been reported by Dr. 
Aaron B. Lerner and his associates 
in the Section of Dermatology. The 
new hormone has been named 
Melatonin. 
“The laboratory technique 
developed by the Yale investiga¬ 
tors for isolating Melatonin was 
worked out during three years 
of exhaustive research. More than 
250,000 beef pineal glands were 
supplied by the Armour Labora¬ 
tories. Chemically, the new hor¬ 
mone belongs in the class of 
compounds known as hydroxyin- 
doles. Although the function 
of Melatonin has not yet been 
determined in humans or in 
animals, tests in frogs reveal that 
it lightens the skin shade and 
reverses the darkening effect of 
other hormones.” 
SUMMER 1994 
Yale Medicine 
“At a medical school so steeped 
in tradition. Dean Gerard N. 
Burrow, m.d. ’58, knows full well 
how difficult it is to start a new 
one. But with the dean’s gift of a 
replica of John Radcliffe’s gold¬ 
headed cane, the school now has 
another tradition. 
“ ‘After my first Yale Commence¬ 
ment as dean last year, I realized 
that we were the only school 
within the university not to have 
a standard to carry,’ the dean 
explains. So he presented to the 
school his own gold-headed 
cane, a gift from his chief resi¬ 
dents when he left Toronto 
General Hospital. This cane was 
first carried May 23 at the Yale 
University Commencement. ... 
“The original cane was carried 
by John Radcliffe, an outstanding 
British physician. A year before he 
died in 1714, Dr. Radcliffe passed 
the cane on as a token of friend¬ 
ship to Dr. Richard Mead, a rising 
physician. The tradition of passing 
the cane continued until 1823, 
when the widow of Dr. Matthew 
Baillie presented the cane to the 
College of Physicians in London.” 
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2 Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters to the editor and news 
items to Yale Medicine, P.O. Box 
7612, New Haven, CT 06519- 
0612, or via electronic mail 
to ymm@yale.edu, and include 
a daytime telephone number. 
Submissions may be edited for 
length, style and content. 
VISIT US ON THE WEB 
info.med.yale.edu/ymm 
“I loved medicine but 
do not miss it” 
The following is a response to a 
letter from Howard Spiro, M.D., 
that appeared in the Autumn 
20og issue of Vale Medicine. 
Dear Howard, 
That you should respond to 
my essay with a letter half again 
as long as that to which you 
responded [“Knowing When It’s 
Time to Quit,” Summer 2003] 
brings to mind C.B. Shaw’s coda 
to a letter,“Forgive me for writing 
a long letter but I did not have 
time to write a short one.” My 
response to you will be shorter. 
My two main reasons for 
retiring are relevance to my 
medical community and lack 
of an adequate intellectual 
schema in which to incorporate 
new knowledge. I was bothered 
by the impending irrelevance 
that I had seen afflict older 
physicians. Friends of mine, par¬ 
ticularly doctors and attor¬ 
neys, concur in the recognition. 
Does being troubled by that 
prospect reveal inadequate 
ego strength or simply an accu¬ 
rate perception of reality? 
Choose one! 
The problems of understand¬ 
ing and incorporating new 
knowledge and its effect on how 
I wanted to practice are linked 
to your statements about con¬ 
tinuing to practice in a changed 
capacity and the wisdom that 
comes to some with age. All the 
kindness and wisdom in the 
world are not, in my opinion, 
worth much if not backed by up- 
to-date knowledge. I suspect 
that doctors who practice part 
time in clinics after retiring are 
not offering first-rate medicine. 
You take me to task for not 
being a “mid-r930s liberal.” 
I plead guilty. The implication 
that somehow it was immoral 
to retire and deprive the world 
of my (supposed) talents is a bit 
harder to take. Perhaps I should 
have spelled out my thoughts 
more clearly. For me to continue 
to practice and encounter the 
loss of respect of my colleagues— 
and your colleagues know you 
better than you know—and be 
unable to use new information 
properly would have been to 
practice under false pretenses. 
Do I think everyone should 
retire at a specific age? Of 
course not. With rare exceptions, 
however, there comes a time 
when older physicians should 
make way for younger ones. 
I chose what I chose. I make no 
apologies. I loved medicine 
but do not miss it. I am very 
happy in my current state. 
Your longtime friend and 
student, 
Herbert J. Kaufmann, M.D. 'sg 
Bedford, N.Y. 
For more on this topic, see 
the online Yale Journal for 
Humanities in Medicine at 
info.med.yale.edu/intmed/ 
hummed/yjhm/. 
Strong support from chief 
helped female surgeons 
I read with interest the article 
on the growing number of 
women in surgery [“Closing the 
Gender Cap,” Winter 2004] and 
was pleased that Barbara Kinder 
mentioned William Collins as 
one of those who strongly sup¬ 
ported women in the surgery 
program. As the first woman 
resident in neurosurgery at 
Yale (and the third to be board- 
certified in the country), I was 
fortunate that Dr. Collins literally 
“took a chance” and accepted 
me on the resident staff. I recall 
early in my residency when the 
chairman of one of the major 
neurosurgery departments in 
the country said to Dr. Collins (in 
a voice calculated to reach me), 
“Bill, I thought you came here to 
build a first-rate program. How 
do you expect to do that after 
you bring a woman on staff?” 
Dr. Collins’ support was invalu¬ 
able not only during residency 
and when I was a faculty mem¬ 
ber, but later in my career as well. 
Thanks, Barbara, for remembering. 
I would also like to echo Dr. 
Kinder’s reservations about the 
reduction in resident duty hours. 
As one who attended a medical 
school in New York with a county 
hospital affiliation, I know it 
was not necessarily the fatigue 
of house staff that caused the 
errors that aroused the concern 
of legislators, but the inability 
to get senior staff to respond to 
night call. For example, in my 
third-year obstetrics rotation 
I delivered more than 30 babies, 
and I was “taught” to do puden¬ 
dal blocks (among other things, 
like breaking a clavicle for a 
shoulder dystocia) by the night 
nurse. I agree with Dr. Kinder 
that the diffusion of respon¬ 
sibility that occurs with the 
shortened hours is a significant 
negative. And perhaps more 
importantly, it will do little to 
solve the problem. 
Joan Venes, m.d., hs ’67 
Sacramento, Calif. 
Cos, not Ephesus, was 
Hippocrates’ birthplace 
In reference to the caption under 
the photo of a sycamore tree on 
Harkness Lawn [“A Nurturing 
Vision,” Winter 2004], Hippocra¬ 
tes was not born in Ephesus, but 
rather on the island of Cos off 
the Ionian coast. 
William B. Radcliffe, m.d. ’58 
MItchellville, Md. 
Dr. Radcliffe is correct. Due to an 
editing error we stated the Incor¬ 
rect birthplace for Hippocrates. 
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Connective tissue 
I still have vivid memories of my first day of dorm life. The year was 1977, the city was 
Baltimore and the weather was what you’d expect in late August: hot and very humid. 
Music fdled the quad, and there was a communal air that endured long after we had 
moved off the Hopkins campus for the thrill of living on our own. 
That was Maryland, not Connecticut; college, not med school; but the experience 
held the same charm for me that Jenny Blair conveys in her memoir of life in Harkness 
Hall (“That College Feeling,” page i8). Dorm life has its downside, but it’s the one time 
many of us will live elbow to elbow with so many of our peers. 
The “connective tissue” linking physicians is a thread in our cover story about the 
dilemmas doctors face. The values instilled by institutions such as Yale and reinforced 
by the relationships that begin here form the basis for ethical decision making for years 
to come. Our third feature describes yet another kind of connection, this one a collabo¬ 
ration between physicians in New Haven and Tehran that revealed the genetic cause of a 
cardiac disorder. 
To meet our goal of keeping the Yale family in touch, we rely on you, our readers, 
to share stories of interest to your colleagues, friends and former classmates. Whether 
it’s a brief note for the Alumni section, a profile suggestion for Faces or a larger story, we’d 
like to hear about it. Drop us a line the next time you feel like connecting. 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
SECOND OPINION BY SIDNEY HARRIS 
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4 chronicle news from cedar street 
Health care van rides 
a road less traveled 
For city residents with limited 
access to medical services, Yale’s 
mobile clinic fills a critical void. 
Tlie Community Health Care Van parks 
in front of an apartment house with ply¬ 
wood nailed over the windows. Orange 
spray paint on the Congress Avenue 
tenement demands, “Whose Livable 
City Is This?”—a reference to New 
Haven’s anti-blight initiative. It is cold 
and rainy, the kind of weather that dis¬ 
courages patients from venturing out 
to die mobile clinic. But enough people 
show up to make for tight quarters. 
loel stoops to walk inside. 
“It's a good day because we’re alive to 
see it,” the lanky man says with a grin 
as he brushes raindrops from his jacket. 
Tliis is an optimisdc time in Joel’s 
life; with the assistance of the van staff, 
he has just signed up for substance 
abuse treatment. But first he needs a 
physical and a tuberculosis test, and 
the van takes walk-ins. Waiting weeks 
or even days for an appointment at a 
clinic would be difficult and risky for 
a man who says he is “just trying to 
find the strength one day at a time.” 
Entering its loth year of service to 
New Haven, the van has always empha¬ 
sized free, immediate and dignified 
care, says Frederick L. Altice, m.d., hs 
’89, associate professor of medicine 
(aids Program) and director of the 
Community Health Care Van initiative. 
Altice got the idea for a mobile clinic 
a decade ago while working with New 
Haven’s needle exchange program. He 
saw people come in with abscesses tliat 
went untreated until they were acute 
enough to land the client in the emer¬ 
gency room. 
With a small van borrowed from 
Yale-New Haven Hospital’s Primary 
Care Center, Altice began following 
the needle exchange van once a week. 
Along with a social worker and hiv 
counselor, Altice provided primary 
care, mostly to injecting drug users. 
Today, a newer, 36-foot van serves 
patients ii hours a day, five days a 
week throughout the city. The rotating 
staff includes senior physicians, resi¬ 
dents, HIV specialists, a nurse practi¬ 
tioner, a physician associate, an hiv 
counselor, a drug treatment coordina¬ 
tor, a case manager, outreach workers 
and a number of volunteers. Usually 
four staff members ride on most trips. 
Many others are immediately available 
by cellular telephone. 
The van’s impact on the community 
is well-documented: a 41 percent reduc¬ 
tion in emergency department visits 
for clients who are injecting dnig users, 
a 66 percent success rate in getting 
drug users to complete all three shots 
in the hepatitis B series, and promising 
results using buprenorphine to reduce 
heroin cravings. For clients who do not 
qualify for entitlements, the van may 
be their only treatment option. Where 
possible, the aim is to move the patient 
toward a community health center 
or some other fixed source of primary 
care. In 41 percent of the cases, that 
transition is successfully made. The 
van has done promising work on TB 
screening with undocumented resi¬ 
dents, says Altice, which he expects to 
publish soon. Similar work is going 
on with the homeless. 
About half of the 500 to 600 
patients who visit the van each month 
arrive with issues unrelated to drugs. 
On the same morning that Joel needs a 
physical to get into treatment, a teenage 
girl with seashells braided into her hair, 
powder-blue tennis shoes and a hand¬ 
bag that says “Princess” takes a seat in 
the van. “I’m here for two reasons,” she 
announces with studied nonchalance, 
“a pregnancy test and an hiv test.” 
Within minutes, she has seen a men¬ 
tal health counselor, a physician and 
an HIV counselor. She is relieved to get 
test results quickly and without a lecture. 
As she leaves with condoms she smiles 
and says, “I’ll be seeing you.” 
“Everybody I meet on the van is 
always nice,” says Michael, 28, who 
takes his daily hiv medications here. 
“This gets my morning going.” 
Much of the ongoing care the van 
provides also is the basis for research 
5 
that might help patients far beyond 
New Haven. Some clients take their 
HIV medications in the van as part of 
an effort to increase adherence. Data 
collected so far show that the directly 
observed medication program works, 
according to Robert Douglas Bruce, 
M.D., clinical instructor of medicine. 
Some patients, he says, have seen their 
viral loads fall and their T cells rise 
substantially. The research project is 
funded by the National Institute on 
Drug Abuse. 
Research funding has largely sus¬ 
tained the van, says Altice. The mobile 
clinic is an ideal setting for many other 
investigations. For example, he is eager 
to monitor hiv therapy for inmates 
released from prison, hiv tends to be 
well-managed in prison, but viral loads 
often rise after release. 
Aside from research grants, fund¬ 
raising efforts have been difficult, 
Altice says, in part because the clientele 
arouses little public sympathy. It is 
precisely that lack of sympathy that the 
van staff is determined to combat. For 
example, many patients say they have 
been treated terribly by other health 
care providers, which makes them 
reluctant to seek treatment. Charly 
began coming to the van for primary 
care after her release from prison. 
Though she found work immediately 
after returning to New Haven, her job 
provides no health benefits. Charly 
says that on the van she gets a measure 
of respect she rarely finds elsewhere: 
“You don’t have to be afraid to tell them 
about nothing,” she says. Perhaps that’s 
the secret of the van’s success. 
—Colleen Shaddox 
Biomedical engineering 
becomes a department, 
uniting several disciplines 
In eight years, biomedical engineering 
at Yale has grown from a fledgling 
undergraduate major to the univer¬ 
sity’s newest department. 
The Yale Corporation approved the 
formation of the interdisciplinary 
Department of Biomedical Engineering 
last summer with the participation of 
the medical school as well as the facul¬ 
ties of engineering and arts and sci¬ 
ences and the John B. Pierce Laboratory. 
Yale has offered an interdisciplinary 
program in biomedical engineering 
since 1996, led by James S. Duncan, 
PH.D., professor of diagnostic radiol¬ 
ogy, biomedical engineering and elec¬ 
trical engineering, but the decision to 
create a department signals how far the 
field has come. “I see a whole new set 
of symbiotic capabilities coming out of 
this partnership,” said Paul A. Fleury, 
PH.D., dean of the Faculty of Engineer¬ 
ing. These include the marriage of 
computer modeling of tissue mechan¬ 
ics with clinical practice, the applica¬ 
tion of computer technology to enhance 
imaging data from mri, and tech¬ 
niques for using biologically compat¬ 
ible materials to deliver drugs or cells. 
The department already has 70 
undergraduate and 30 graduate stu¬ 
dents. There are nine primary and four 
secondary faculty members, with 
plans to fill three more primary faculty 
positions. Ongoing research projects 
include bioimaging and intervention in 
neocortical epilepsy, modeling of drug 
transport for brain tumor therapy, 
motor control in low-back injuries, and 
fMRi for neurosurgical planning in 
epilepsy. The department is now 
housed in the Becton Science Center, 
but ground was broken in December 
for its new home in the Engineering 
Research Building on the corner of 
Prospect and Trumbull streets. 
Fleury says the department is fully 
interdisciplinary, with several faculty 
members appointed in both the medi¬ 
cal school and the Faculty of Arts and 
Sciences. “We expect that this arrange¬ 
ment will enable seamless relation¬ 
ships among the departments,” he said. 
W. Mark Saltzman, ph.d., chair of 
the new depaitment, says tlie inter¬ 
disciplinary environment and potential 
for collaboration are what drew him 
to Yale. Saltzman, who was previously at 
Cornell University, is worlcing on dmg 
delivery and tissue engineering. He says 
his top priorities as chair are to enlarge 
tlie faculty and to add new courses. 
Fleury says the Yale program will 
succeed because it is closing a cultural 
gap. “Medical doctors often see engi¬ 
neers merely as gadgeteers who can 
supply methods or devices, but are not 
interested in or capable of engaging 
in the deeper roots of clinical and 
medical challenges,” he said. “Con¬ 
versely, engineers are often skeptical 
of doctors’ scientific interests and 
depth. I am glad to say that these gap 
characteristics are vanishingly small 
here at Yale.” 
—Jennifer Kaylin 
W. Mark Saltzman, chair of the new bio¬ 
medical engineering department, and 
Erin Lavik, an assistant professor, with a 
sample of a polymer wafer capable of 
delivering therapeutic agents in the brain 
after surgery. 
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6 chronicle 
Renewed “vows” herald 
a stronger link between 
Yale and London 
when a trans-Atlantic group of psychia¬ 
trists and psychologists gathered at 
Yale in early December, it was as much 
a reunion of old friends as an academic 
symposium at the Child Study Center. 
Many in the group have known each 
other for years. They have written papers 
together, mentored and trained each 
other and collaborated on research 
and interventions. 
The reason for the symposium, 
“Developmental Science and Psycho- 
A symposium in December at the Child Study 
Center brought together an international 
group of psychologists and psychiatrists. 
Peter Fonagy, Mary Target and Yale professor 
Linda Mayes are the new directorial team at 
the Anna Freud Centre in London, which has 
long-standing ties to Yale’s Child Study Center. 
analysis: Integration and Innovation,” 
was to formalize three decades of 
largely informal ties between Yale and 
the Anna Freud Centre in London. 
The symposium also celebrated the 
launching of the Anna Freud Centre 
Program at Yale and a revitalization 
of the Centre in London. 
Alan E. Kazdin, ph.d., director of 
the Child Study Center, likened the cel¬ 
ebration to the renewal of wedding 
vows. “There has already been a very 
enduring marriage that has worked out 
very well,” he said. “Let’s go through 
the ceremony and vows again and 
chart the future.” 
What the future holds for Yale’s 
participation in the program is a series 
of exchanges that will bring students 
and scholars across the Atlantic for 
training, research and study. Linda 
C. Mayes, m.d., the Arnold Gesell 
Professor of Child Psychiatry, Pediatrics 
and Psychology in the Child Study 
Center, will head the program at Yale 
and is one of three members of a 
new directorial team that will lead the 
Freud Centre. 
According to Mayes, the program 
at Yale will offer training that includes 
exchanges for scientists and scholars, 
a master’s program, an undergraduate 
program and an international visiting- 
scholar program. The program will 
also include joint research projects 
focused on the science of early attach¬ 
ments and emotional development. 
“The idea is to have a continual 
exchange of ideas and very active col¬ 
laborative clinical research,” she said. 
The exchanges between London 
and New Haven go back three decades. 
In the early 1970s, the late Albert J. 
Solnit, M.D., HS ’52, who headed the 
Child Study Center from 1966 until 
1983, forged a strong friendship with 
Anna Freud and introduced his Yale 
colleagues to her. 
The Anna Freud Centre, which was 
established during World War II as the 
Hampstead War Nurseries to treat 
traumatized children, had become one 
of the leading centers for the treatment 
and study of children with a range of 
serious developmental and psychologi¬ 
cal disorders. The Centre’s collabora¬ 
tions with Yale involved professors at 
the medical and law schools as well as 
colleagues in the community and on 
the clinical faculty. The ties between 
these two institutions continued with 
the leadership of Donald J. Cohen, 
M.D. ’66, who led the Child Study 
Center from 1983 until his death in 
2001 and who, like Solnit, served on 
the Centre’s board of trustees. 
Last July, the Centre appointed a 
new directorial team that includes, 
in addition to Mayes, Peter Fonagy, 
PH.D., and Mary Target, ph.d. Fonagy 
is the Freud Memorial Professor of 
Psychoanalysis and Director of the 
Sub-Department of Clinical Health 
Psychology at University College 
London. Target is a senior lecturer in 
psychoanalysis, also at University 
College London. 
—John Curtis 
An i8io issue of the Connecticut Mirror 
announces the establishment of the Medical 
Institution of Yale College. 
Newspaper heralds a new day 
in medical education— 
almost two centuries ago 
Stop at medical grand rounds on any 
given Thursday morning and you’re 
likely to encounter Samuel D. Kushlan, 
M.D. ’35, HS ’37, a retired gastroenter¬ 
ologist who has served on the faculty 
for 65 years and who turned 92 in 
February. Kushlan graduated from Yale 
College in 1932 and from the School of 
Medicine three years later, and his view 
of the school’s history is a long one. 
Kushlan’s appreciation of the 
medical school’s earliest days recently 
grew larger, however, when he was 
given a copy of a 19th-century news¬ 
paper documenting the school’s estab¬ 
lishment by an act of the Connecticut 
legislature. 'The slightly yellowed but 
well-preserved copy of the Connecticut 
Mirror, from November 5,1810, includes 
the text of the act creating the Medical 
Institution of Yale College. The new 
school was the joint responsibility 
of Yale College and the Connecticut 
Medical Society, which today has its 
headquarters on St. Ronan Street in 
New Haven. 
Yale’s first medical students could 
expect to draw on the expertise of an 
initial faculty of four and core facilities 
consisting of “a Cabinet of anatomical 
preparations,” “a collection of speci¬ 
mens, in the Materia Medica” and a 
botanical garden to be planted “as soon 
as the funds of the college can afford 
such establishment.” Medical students 
who had finished college were required 
to study medicine for two years before 
entering the profession; those who 
hadn’t would spend three years in 
class. In addition to attending lectures, 
the students were expected to appren¬ 
tice under a local physician or surgeon 
in good standing. 
Kushlan came upon the newspaper 
through the good graces of Richard 
Lodish, principal of the lower school at 
Sidwell Friends in Washington, D.C., 
where Kushlaris granddaughter chairs 
the school’s parents’ organization. A 
collector of education memorabilia, 
Lodish thought of Kushlan when he saw 
the copy of the Mirror advertised on the 
Internet. Lodish has another New Haven 
connection: his daughter, Maya B. 
Lodish, M.D. ’03, received her medical 
degree from Yale last May and is now a 
resident in pediatrics at Johns Hopkins. 
While some early features of aca¬ 
demic medicine remain unchanged 
(the act describes in detail the respon¬ 
sibilities of various committees, for 
example), recent graduates will be 
amused and possibly dismayed by one 
provision of the 1810 legislation noted 
below its description of the curricu¬ 
lum: “The price of the ticket for the 
whole of the above courses of lectures 
shall be fifty dollars,” the act stated. 
But students had other expenses to 
take into account as well. Before pass¬ 
ing their exams, they were required to 
pay $10 to the treasurer of the medical 
society, $4 to each of their examiners 
and $8 to the president of the univer¬ 
sity. Full freight is likely to be a great 
deal more when the medical school 
marks its 200th anniversary six years 
from now. 
—Michael Fitzsousa 
rUGLiC ACTS, 
Of October Soacion, 1810. 
An Act in addition to and alteration ol 
un Act, t‘i\iitlcd “ An Act to incui po- 
latc the Mediail S(!Ciety.” 
J'. it tr.act,:d by the Governor, 
and Couneii,und Hvuoe of Re- 
fres' eTitriiivei-, in General Court aescni- 
bled, 'I'hut the President aiul F'tlluws ol 
the Medical Soricty be empowered, to 
unite with the President atid Fellows of 
Yale-Collcj’c, for the purpose of forming 
u Medical Seminary, to he styled The 
Medical Institution of Yaie-Collcgc; 
agreeably to liie following article^, a- 
greed upon by and Iretween the commit¬ 
tee of the cerporation of Yale-Collcge,, 
and the Medical Society of the State of 
Connecticut ; as follows, viz. 
Aut. 1. That there shall be a medi¬ 
cal institution established in Yale-Col- 
lep;e, to l)e known and acknowledged bv 
the name of The IMcdicai Insiitiuion of 
Yale-College. 
2. Tiuit said insiitiuion, to include a 
complete circle ot n edictil science, con¬ 
sist of four Professors. F'irst, of Che¬ 
mistry and Plvarniat V : Secorci, of tin 
theory and preciice id meaiciric : 'i'hird. 
of Anatomy- Mtn'gciy, and ^ii:l\vifery : 
F'ourlii, of .alatei ill Medica, and Botany. 
And tliat '.here- rdia!! be a joint conimii- 
tee of an etp!ai number of iversons, ap¬ 
pointed hv the convention of ihe -Medi¬ 
cal Society and corper-aion cf Vale-Col¬ 
lege, who will make a nomination ; froni 
which noniination, the -foresaici Profes¬ 
sors s'.iall he ciiosen by il'.e corporation. 
3. That a Cabinet of anatomical pre¬ 
parations, including all things usually 
found in collections of this nature, be 
proviiied as speedily as the college funds 
will allow. 
4. That there be a collection of spe¬ 
cimens, in the Materia Medica; And 
that a botanical garden.be established, as 
soon as tlie funds of tlie college can af¬ 
ford such establishment. 
5. That every medical student be re¬ 
quired to attend to the study of physic, or 
surgery, with some medical orchirurgi- 
cal professor, or practitioner, who is in 
respectable standing, for two years ; pro¬ 
vided he shall have been graduated at 
some college : otherwise to study three 
years ; and to have arrived to tlie age of 
twenty-one years. And that every me¬ 
dical student, who shall commence the 
study of physic, or surgery, after the 
foregoing articles shall be complied with, 
and lectures commenced, u|)on the seve¬ 
ral branches abovemenuoned, shall at- 
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8 chronicle 
For undergrads, mentor 
program offers a glimpse 
of a physician’s life 
Limits on stem cell research 
may preclude development of 
key therapies, panelists say 
Nobody knows whether stem cells, the 
body’s so-called “master cells” that 
can differentiate into other cells, will 
ultimately be useful for repairing dis¬ 
eased or damaged tissue. Current 
knowledge about possible therapeutic 
uses remains so limited, according to 
speakers on a panel on potential appli¬ 
cations of the technology, that com¬ 
mercial development remains a distant 
hope in most cases. And panelists 
warned that medical applications may 
never occur because of current restric¬ 
tions on research involving human 
embryonic stem cells. 
According to Marc D. Beer, chief 
executive officer of ViaCell, a Boston- 
based company that banks stem cell- 
rich blood from umbilical cords for 
study and possible therapeutic use, 
“Stem cells have the potential to cure.” 
But because of federal limits on the 
use of human embryonic stem cells, 
he said, “research is being curtailed. 
I’m watching basic research leave 
this country.” 
Beer was one of the panelists taking 
part in the third annual Yale and 
New Haven Biotechnology Reception 
in October. He pointed to recent suc¬ 
cesses in experimental clinical trials 
in which insulin-producing islet stem 
cells from donor pancreases have com¬ 
pletely cured type 1 diabetes in some 
patients. “Lack of cells,” said Beer, “is 
the biggest problem” for wider applica¬ 
tion of the transplant procedure. 
Panel moderator Erin Lavik, sc.d., 
assistant professor of biomedical 
engineering, studies the use of stem 
cells for repairing damaged spinal 
cords. She said government restric¬ 
tions, coupled with a possessiveness 
on the part of those who developed a 
few approved stem cell lines, are ham¬ 
pering research despite the fact that 
“we do not know the potential of 
these cells.” 
“When you don’t know,” said fellow 
panelist Earl M. Collier Jr., execu¬ 
tive vice president of Genzyme Corp., 
“that’s not the time to legislate.” 
—Marc Wortman 
Eive times during the fall semester. 
Shannon Gulliver, a Yale College senior 
majoring in microbiology, traveled from 
central campus to the medical school 
to observe Ali K. Abu-Alfa, m.d., as he 
tended to his patients. And her role at 
times went beyond mere observahon. 
After palpating for edema on a dialysis 
patient’s ankle, for example, he turned 
to Gulliver and asked: “What is the sig¬ 
nificance of this finding?” 
The pairing of Gulliver and Abu- 
Alfa, an associate professor of medi¬ 
cine and director of the Peritoneal 
Dialysis Program, came as part of a 
new program, Yale Medical Profes¬ 
sions Outreach (ympo), designed to 
introduce undergraduates to the world 
of medicine. “I’ve always been very 
interested in science, but I didn’t know 
much about patient relations,” said 
Gulliver. “ I was lucky enough to get 
a doctor who could talk about what 
aspects are fun, what aspects are 
harder, lifestyle sacrifices you have 
to make, time commitment and 
emotional commitment. I asked him 
very direct questions, and he was 
really into explaining.” 
YMPO was launched by students in 
January 2003 to create opportunities 
for undergraduates to observe physi¬ 
cians in their daily activities. “It’s 
absolutely one of the most important 
things we can do for undergraduate 
students,” said neurosurgeon Dennis 
D. Spencer, m.d., hs ’77, the medical 
school’s interim dean and a ympo par¬ 
ticipant. Eor years as a Yale Gollege 
freshman advisor, Spencer invited his 
advisees to observe his interactions 
with patients, but it was always “hit-or- 
miss” for other undergraduates seek¬ 
ing physician contact, he said. 
Yale seniors Steven Hsu and Jason 
Choi started ympo to fill what they saw 
as a lack of premed preparation for 
undergraduates. “Yale has so many pro¬ 
grams for students but nothing like 
9 
this,” said Hsu, who contacted Under¬ 
graduate Career Services and the 
medical school for guidance. A previ¬ 
ous attempt at such a program ended 
when the founding students gradu¬ 
ated. YMPO’s new leadership includes 
students from all classes to ensure 
continuity and growth, ympo also 
started a lecture series, and in Sep¬ 
tember added a Big Sibling/Little 
Sibling program that matches under¬ 
graduates with medical students, ympo 
students must fill out an application 
and write an essay, and those selected 
are trained to comply with federal 
HiPAA regulations on patient confiden¬ 
tiality. Each student-physician pair 
sets its own meeting times for the 
semester. Sixty physicians are signed 
up, and last fall 70 students participated. 
“I was immediately attracted to 
the program," said Abu-Alfa. “Under¬ 
graduates are a body of students we 
don’t usually get to interact with. If 
you’re in love with what you do, to 
transmit that to a new generation is 
very exciting.” 
—Mary Anne Chute Lynch 
Yale College senior Shannon Gulliver 
shadowed nephrologist Ali Abu-Alfa over the 
course of the fall semester to learn about 
careers in medicine. 
YALE RANKED AMONG BEST PLACES TO WORK 
It’s often said that Yale is a highly collaborative institution, but 
how does one measure collegiality? The Scientist magazine did 
just that last fall In an international survey of 38,000 full-time 
U.S. faculty and researchers and found Yale among the best places 
to work in academia—third, actually, just behind Fox Chase 
Cancer Center in Philadelphia and Purdue University. Relationships 
with colleagues and the availability of resources were among the 
most important criteria for Yale respondents. “It is greatly reward¬ 
ing to see our culture and investments acknowledged,” Provost 
Susan Hockfield, ph.d., said of the October 20 report, which can 
be viewed online at www.the-scientist.com. 
—Michael Fitzsousa 
NEW PARTNERSHIP IN CHINA 
On a recent trip to China, President Richard 
C. Levin and other university officers 
cemented a program of exchanges between 
Yale and Fudan University in Shanghai. The 
Fudan-Yale Center for Education Cooperation, 
one of several programs between Yale and 
Chinese universities, will build on educa¬ 
tional exchanges that began in 1996. 
The new center will promote exchanges 
among scholars in history. East Asian lan¬ 
guages and literature, genetics, biology, 
law, medicine and management. The center- 
piece of the agreement is the Fudan-Yale 
Biomedical Research Center. Tian Xu, ph.d. 
’90, vice chair of genetics and special advisor 
to Levin on science and higher education in 
China, will direct both the education center 
and the biomedical center. Xu received his 
undergraduate degree at Fudan and his 
doctorate at Yale. 
Xu said Yale has three goals—to help 
establish a world-class research center, to 
help Chinese educators reform their educa¬ 
tional system and to promote understanding 
between the two countries. 
—John Curtis 
ONE PAPER, MANY IMPLICATIONS 
A Yale geneticist is among the authors of an 
article deemed by The Lancet last winter to 
be the most important biomedical research 
paper of the previous year. 
The authors of the article, “Genetic 
Structure of Human Populations,” published 
in Science in December 2002, used genotypes 
of more than 1,000 people from 52 popula¬ 
tions around the world to study human 
population structure. "The paper quantifies 
the degree to which biomedical research 
findings based on one group of individuals 
may be applicable to individuals from other 
populations,” said co-author Kenneth K. 
Kidd, PH.D., Yale professor of genetics, psy¬ 
chiatry and biology. Kidd and colleagues in 
the United States, France and Russia identi¬ 
fied six main genetic clusters and additional 
subclusters. They concluded that genetic 
risks of disease can be assessed with stan¬ 
dard study designs if self-reported ethnic 
background is also considered. 
—J.C. 
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Rounds MEDICINE AND HEALTH AT YALE 
At Liver Center, a vital 
organ gets its due 
The nation’s oldest liver research 
center sees a five-year renewal and 
expanding targets for therapies. 
Poets and philosophers may rhap¬ 
sodize about the human heart, but 
lames L. Boyer, m.d., hs ’67, says 
it’s actually the liver that is the body’s 
most fascinating organ. 
“The ancients thought of the 
liver as the seat of the soul,” says 
Boyer, director of the Liver Center at 
the School of Medicine and Ensign 
Professor of Medicine. “Babylonians 
would consult a sheep’s liver before 
going into battle, and even today, a 
Frenchman who is not feeling well is 
said to have mal aufoie. European 
societies have much more respect for 
the liver than we do.” 
But at the Liver Center, the oldest 
research facility in the country devoted 
exclusively to liver research, this essen¬ 
tial and complex organ gets its due. 
Roughly 40 scientists, all with inde¬ 
pendent funding totaling about $15 
million, study the liver. 
The value of the 20-year-old center 
was confirmed in December, when the 
National Institutes of Health (nih) 
renewed the center’s funding for a 
fourth consecutive five-year term start¬ 
ing in September 2004. “We received 
the highest score in the history of the 
center,” Boyer says of the nih’s evalu¬ 
ation. The center will receive $3.75 
million, with the university getting an 
additional 62 percent of that in indi¬ 
rect NIH support. 
Hepatology has existed as a medi¬ 
cal subspecialty for only 50 years, and 
as recently as 20 years ago there were 
still very few treatments for liver disor¬ 
ders. But Boyer says that is changing. 
He points out that hepatitis B and C 
and biliary cirrhosis can now be treated 
with medications. There is a vaccine 
for hepatitis A and B, and liver trans¬ 
plantation is now a viable option. In 
fact, Yale is expanding its transplant 
program with the recent arrival of 
David Cronin, m.d., a liver specialist, 
in the Department of Surgery. 
But while some liver disorders are 
treatable, new challenges loom. The 
biggest, Boyer says, is fatty liver 
disease related to obesity. Gerald 1. 
Shulman, m.d., ph.d., is a researcher 
in the Liver Center who has been 
studying liver diseases associated with 
insulin resistance. “Our work suggests 
that one of the earliest findings in type 
2 diabetes is the presence of insulin 
resistance,” Shulman says. “That starts 
to happen years before the develop¬ 
ment of diabetes.” 
Shulman’s research has also found 
that insulin resistance occurs in the 
liver and the muscles, and that it is 
caused by a transport deficit triggered 
by the presence of fatty acids. “Fatty 
acids build up in the liver and lead to 
deficits in insulin signaling,” he says. 
OBESITY BIAS A PROBLEAA FOR DOCTORS 
Shulman is now looking into the corre¬ 
lation between age and the onset of 
type 2 diabetes, even in adults who are 
not sedentary or overweight. “I’d say 
every third or fourth patient I see has 
adult-onset diabetes, which can have 
devastating complications,” Shulman 
says. “We’re working hard to sort it 
out.” Many of these patients have fatty 
liver disease. 
Other groundbreaking work 
being done by researchers at the Liver 
Center includes: 
Discovery of the gene responsible for 
isolated autosomal dominant polycys¬ 
tic liver disease and description of the 
clinical characteristics of this inherited 
disorder, by a group led by Stefan 
Somlo, M.D., Fw ’91. 
Fundamental discoveries made by 
a team led by Roberto J. Groszmann, 
M.D., at the VA Connecticut Health¬ 
care System in West Haven and 
William C. Sessa, ph.d., which have 
paved the way for therapies that will 
control the complications from portal 
hypertension in cirrhosis, such as 
intestinal bleeding. 
Demonstration that bone marrow cells 
are capable of migrating and establish¬ 
ing themselves in other tissues, such 
as the liver, by Diane S. Krause, m.d., 
PH.D. This pioneering work is central 
to the future of gene therapy for genetic 
liver disorders. 
“When I started out, we were mainly 
diagnosticians. We couldn’t cure many 
liver diseases,” Boyer says. “The changes 
have been enormous. It’s an exciting 
time to be working in this field.” 
—Jennifer Kaylin 
Spike in blood pressure may 
make weight lifters vulnerable 
to aortic aneurysm 
In a research letter published in JAMA: 
The Journal of the American Medical 
Association in December, a team of Yale 
researchers reported that some weight 
lifters may be at risk of rupturing the 
aorta’s inner lining. 
“We had seen a couple of patients in 
a row who had been weight lifting when 
this phenomenon occurred,” said John 
A. Elefteriades, m.d. ’76, hs ’81, fw ’83, 
chief of cardiothoracic surgery. Looking 
through his research projects, he found 
other cases. “I noticed that two or three 
of them were young people who other¬ 
wise wouldn’t have been expected to 
have an aortic dissection and were lift¬ 
ing weights at the time.” 
They found that systolic pressure 
during heavy weight lifting can rise 
from a normal reading of 120 to highs 
of 280 and even 300. “If your aorta 
is weak due to your genetics and if it is 
mildly enlarged, weight lifting might 
be what puts you over the brink,” 
Elefteriades said. 
The danger of a potentially fatal aor¬ 
tic dissection, which splits the artery in 
two, results from a confluence of events, 
starting with that genetic predisposition. 
Elefteriades is working to pinpoint 
the genetic links in association with 
Celera Genomics, the company involved 
in the mapping of the human genome. 
Those at risk include people with 
aneurysms, connective-tissue diseases 
and hypertension, as well as people with 
a family history of aneurysms or dissec¬ 
tions and those above age 40. 
—John Curtis 
Health professionals surveyed at an obesity 
conference in Quebec last year learned 
something surprising about themselves. The 
survey revealed a significant bias against 
overweight people among almost 400 physi¬ 
cians, researchers, pharmacologists and 
psychologists who treat and study obesity. 
“The stigma of obesity is so strong that 
even those most knowledgeable about 
the condition infer that obese people have 
blameworthy behavioral characteristics 
that contribute to their problem, i.e., being 
lazy,” said Marlene B. Schwartz, ph.d. ’96, 
a research scientist in the Department 
of Psychology and lead researcher of the 
study published in September in Obesity 
/Jeseorcb. “Furthermore, these biases extend 
to core characteristics of intelligence and 
personal worth.” 
For the study 389 clinicians and researchers 
took the implicit Association Test and filled 
out a questionnaire that assessed attitudes, 
personal experiences with obesity and demo¬ 
graphic characteristics. The results were not 
all dispiriting, however. Those who work 
directly with obese patients showed less bias 
than those who do not. 
—J.C. 
SAME CHEMICAL, DIFFERENT REACTION 
Drugs designed to improve memory consoli¬ 
dation in the elderly may also worsen work¬ 
ing memory, according to a study by Yale 
researchers published in the journal Neuron 
in November. 
The difference stems from the brain 
regions needed for different kinds of memo¬ 
ry processing, according to Amy Arnsten, 
PH.D., associate professor and director of 
graduate studies in neurobiology. The hippo¬ 
campus handles long-term memory, while 
the prefrontal cortex is responsible for work¬ 
ing memory. The two brain areas, Arnsten 
found, respond to chemicals differently. 
Medications in development to improve 
long-term memory often try to enhance 
the activity of protein kinase A (pka), an 
enzyme inside of cells. Arnsten and her col¬ 
leagues found that when this protein 
was activated in the prefrontal cortex it 
worsened working memory. 
—J.C 
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Findings from the bench 
A partnership that aids 
cancer’s migration 
when Ras teams up with cell 
polarity genes, mutations are found 
to produce metastatic tumors. 
In the world of cancer-causing genes, 
Ras is a celebrity. Mutated versions of 
this gene appear in more than half of 
all human cancers, including metasta¬ 
tic cancers, in which cells from a pri¬ 
mary tumor disperse to other organs 
or systems of the body and there give 
rise to new tumors. Clearly, Ras is a 
cidprit in many terminal cases. But 
since a large number of Ras-based 
tumors are benign and never spread 
beyond their original site, it was 
thought that the oncogenic Ras triggers 
only tumorigenesis. Now, research 
demonstrates that Ras also contributes 
to metastasis and it collaborates 
with a partner to do so. Tian Xu, ph.d. 
’90, professor and vice chair of the 
Department of Genetics and an associ¬ 
ate investigator for the Howard 
Hughes Medical Institute (hhmi), has 
identified five genes that interact with 
Ras to cause metastasis. 
Each of these “cell polarity genes” 
normally fills an important role in 
maintaining the orientation of the cell 
with regard to the inside or the outer 
surface of the body. The normal ver¬ 
sion of Ras, meanwhile, transmits 
signals that aid in development by 
controlling the rate at which various 
cells reproduce and differentiate. 
Although neither a mutation in a cell 
polarity gene nor a mutation in Ras 
leads to malignancy on its own, 
Xu and graduate student Raymond 
Pagliarini have shown in an animal 
model that when tumor cells have 
both mutations, they invariably pro¬ 
duce metastatic tumors. 
The scientists arrived at these find¬ 
ings by creating a genetic screen in 
Drosophila melanogaster, the fruit fly. If 
Drosophila seems at first to be an 
unsuitable model for humans, it is only 
because our outer forms look so differ¬ 
ent. Inside we have a great deal in 
common: for instance. 70 percent of 
the disease-causing genes in humans 
also appear in the fruit fly. Xu and 
Pagliarini first used fruit flies with 
mutant Ras genes to create noninva- 
sive tumors in developing larvae, then 
added other mutations to see whether 
the tumors become metastatic. Although 
only a handfid of these combinations 
produced the results they were looking 
for, Xu and Pagliarini’s observations 
are likely to spur the development of 
new drugs for cancer treatment, target¬ 
ing genes that collaborate with Ras to 
deadly effect. 
As for Ras itself this gene has been 
in the sights of pharmaceutical compa¬ 
nies for some time rrow, and Xu points 
out that it still represents a good target 
for anti-cancer drugs. “Inactivating the 
tumor-producing effect of mutant Ras 
genes,” he says, “will likely be simpler 
than re-creating the tumor-suppressing 
effect of genes that are no longer nor¬ 
mal, but mutated.” 
As Xu sees it, “cancer is generally 
a late-stage disease—but in most of 
human history, longevity was much 
lower than it is now. People didn’t live 
long enough to get cancer.” What then 
was the original function of these 
genes? “We believe they are normally 
involved in regulating development, 
especially the size of cells and tissues, 
and ultimately the size of whole 
animals,” Xu says. 
The most exciting aspect of Xu’s 
work on the metastatic partners of Ras 
is undoubtedly its clinical potential, 
but in Xu’s eyes this series of experi¬ 
ments offers another far-reaching ben¬ 
efit as well. “This work really showed 
the power of model organisms like 
fruit flies, because we can use them to 
do a lot of experiments that would 
not be possible in humans,” he says. 
It was this painstaking, gene-by-gene 
screening that allowed researchers 
to find the specific gene interactions 
that lead to metastasis, and thus to 
identify the drug targets that look so 
promising today. 
—Sandra J. Ackerman 
GENE MUTATION LINKED TO OCD 
Divining the scent of a 
human: for mosquito, it’s 
a molecular event 
I To most people perspiration ranks 
I low on lists of attractive features, 
but one creature finds the smell of 
I human sweat irresistible: the female of 
I Anopheles gambiae, commonly known 
i as the mosquito. Just what makes our 
! perspiration so alluring to this ruthless 
; predator is a question that intrigues 
; not only the companies that make 
, insect repellents and the people who 
use them, but most of all the epi¬ 
demiologists trying to reduce the toll 
of mosquito-borne diseases. 
Now scientific research is begin- 
I ning to reveal an answer. John R. 
t Carlson, ph.d., professor of molecular, 
I cellular and developmental biology, 
^ ' Elissa Hallem, a graduate student in 
; the Interdepartmental Neuroscience 
1 Program, and colleagues have developed 
' a transgenic technique that allows 
them to identify the functions of spe¬ 
cific odor receptors in the mosquito 
antenna. Their paper, published in the 
January 15 issue of Nature, describes 
how the researchers pinpointed the 
receptor gene, AgOri, and the com¬ 
pound to which this receptor responds, 
the odorous molecule 4-methylphenol. 
The scientists used a “knockout” 
fruit fly lacking one if its odor-receptor 
genes. They substituted the mosquito 
gene AgOri and then measured the 
animal’s response to various odors; 
the only molecule to produce a strong 
response was 4-methylphenol. A simi¬ 
lar gene, AgOr2, used as a control, 
showed no such response. This obser¬ 
vation, together with previous flndings 
that AgOri is present only in female 
mosquitoes and that the expression of 
this gene tends to diminish after the 
mosquito has had a blood meal, sug¬ 
gests that the AgOri receptor plays an 
important role in the mosquito’s hunt¬ 
ing and feeding behavior. 
According to Carlson, this work puts 
researchers “on the right track” toward 
developing a truly effective mosquito 
repellent. “If we can find each of the 
odor receptors and identify the specific 
compounds they’re responding to, the 
next step would be to come up with 
inhibitor or blocker compounds, which 
would bind to the receptors but not 
activate them,” he explains. The mos¬ 
quito would thus be unable to perceive 
the odors that normally lead it to a 
human banquet. Large numbers of peo¬ 
ple might be protected from bites, or 
from life-threatening infections. (The 
mosquito-borne disease malaria kills an 
estimated one million people each year, 
most of them children.) 
The research on odor receptors may 
also have a direct application in insect 
control: the odors most attractive to 
mosquitoes could be used to lure the 
insects away from human populations 
and into traps where they could be 
destroyed. In principle, says Carlson, 
the same techniques might even be 
used against crop pests. But he cau¬ 
tions that “the system we have created, 
a system that can identify odor-receptor 
genes, has not yet been applied in 
other insects.” With the work on mos¬ 
quitoes yielding such promising 
results, progress on dealing with other 
insects is probably not far behind. 
S.J.A. 
A mutated gene’s link to a rare form of obses¬ 
sive compulsive disorder (ocd) is the strongest 
proof yet that neuropsychiatric disease can 
result from a malformed neuronal protein. 
In studies published last October and 
August in Molecular Psychiatry and Molecular 
Pharmacology, researchers at Yale and the 
National Institute of Mental Health found 
that a rare form of ocd is associated with 
a mutation in the serotonin transporter 
gene that disrupts the normal regulation 
of transport. 
“There are not a lot of established con¬ 
nections between genes and behavior,” 
said Gary Rudnick, ph.d., professor of phar¬ 
macology, who conducted the research 
with Fusun Kilic, ph.d., of the University of 
Arkansas for Medical Sciences. “Our find¬ 
ing focuses on the role of the serotonin 
transporter in mood and behavior and ties 
it to a specific behavioral disorder." 
The researchers found in two unrelated 
families a gene mutation that increases up¬ 
take of serotonin by the transporter. Further 
study could lead to a better understanding 
of how OCD develops and how medications 
might affect the serotonin transporter. 
—John Curtis 
HONORS FOR IMMUNOLOGIST 
Scientists from around the world gathered 
in November to honor the late Richard K. 
Gershon, m.d. ’59,20 years after his death 
and 30 years after his discovery of suppres¬ 
sor! cells. 
Gershon started his career as a patholo¬ 
gist and switched his focus to immunology 
when he began working on a tumor model 
in hamsters. His discovery was initially 
greeted with skepticism, but suppressor 
T cells, which reduce the immune response 
of other cells to antigens, are now seen as 
vitally important in a variety of diseases. In 
recognition of his work, Gershon was elected 
to the National Academy of Sciences in 1980. 
A lecture has been held in his honor each 
year since his untimely death in 1983, but 
this year the Section of Immunobiology and 
his family noted his passing with a sym¬ 
posium that featured leaders in suppressor 
T cell research. 
—J.C. 
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14 Books 
Suicide in Children and 
Adolescents 
edited by Robert A. King, m.d., 
professor of psychiatry and 
a member of the Child Study 
Center, and Alan Apter 
Cambridge University Press 
(Cambridge, United Kingdom) 
200j;3J4 pages 
Experts from psychiatry, epi¬ 
demiology, neurobiology, genet¬ 
ics and psychotherapy bring 
together the most recent find¬ 
ings in their fields to address 
important questions about sui¬ 
cide. How can these deaths be 
prevented? Can they be antici¬ 
pated? Are there perceptible 
patterns? What role do families 
and gender play? What are the 
treatments for and outcomes of 
suicide attempters? 
Treatment Planning for 
Psychotherapists: A Practical 
Guide to Better Outcomes, 
2nd ed. 
by Richard B. Makover, m.d., 
lecturer in psychiatry 
American Psychiatric Publishing 
(Washington) 2004; 208 pages 
This handbook offers a clear, 
concise explanation and clinical- 
case examples of practical 
treatment plans from initial 
assessment, through diagnosis 
and formulation, to the critical 
decisions about objectives, 
methodology and technique. 
Dementia: A Practical Guide 
by Marc E. Agronin, m.d. ’91 
Lippincott Williams Wilkins 
(Philadelphia) 2003; 272 pages 
This latest addition to the 
Practical Guides in Psychiatry 
series is a pocket manual 
written for everyone from 
medical students to fellows to 
psychiatrists, neurologists 
and internists in practice who 
want a concise guide to demen¬ 
tia at their fingertips. 
A Practical Approach to Trans¬ 
esophageal Echocardiography 
by Bessie L. Marquis; edited by 
Scott T. Reeves and Albert C. 
Perrino Jr., M.D., HS ’87, associ¬ 
ate professor of anesthesiology 
Lippincott Williams ei Wilkins 
(Philadelphia) 2003; 332 pages 
This text offers a concise guide 
to the current practice of trans¬ 
esophageal echocardiography 
and includes discussions on 
its uses in surgical procedures 
and on data derived from 
Doppler studies. 
Clinical Neuroanatomy, 25th ed. 
by Stephen G. Waxman, m.d., 
PH.D., chair and professor of 
neurology and professor of 
pharmacology and neurobiology 
McGraw-Hill/Appleton K. Lange 
(New York) 2002; 400 pages 
This text links basic concepts 
in neuroanatomy with clinical 
correlations. The new edition 
reflects the state-of-the-art in 
the pathophysiology, diagnosis 
and treatment of neurological 
disorders and discusses the 
latest advances in molecular and 
cellular biology in the context 
of neuroanatomy. 
Ellenberg and Rifkin’s Diabetes 
Mellitus, 6th ed. 
by Daniel Porte Jr., Robert S. 
Sherwin, m.d., C.N.H. Long 
Professor of Medicine, and 
Alain Baron 
McGraw-Liill Professional 
(New York) 2002:1,043 ptiges 
This text is a comprehensive ref¬ 
erence on diabetes mellitus, cov¬ 
ering basic biochemistry, 
physiology and pathogenesis, as 
well as clinical diagnosis and 
treatment. The sixth edition 
includes five new chapters, plus 
new material on the genetic 
basis of the disease, new hypo¬ 
glycemic drugs, mechanisms of 
hormone action and regulation 
of hormone secretion. 
Child and Adolescent Psychiatric 
Clinics of North America: 
Psychological Aspects of Chronic 
Disease 
by Lawrence A. Vitulano, ph.d., 
and Melvin Lewis, m.b.b.s., 
F.R.C.psych., HS ’59 
W.B. Saunders Co. 
(New York) 2003; jg8 pages 
Chronic illness in childhood 
presents many challenges for 
the child and adolescent 
mental health clinician.This 
book examines several major 
chronic illnesses in depth to 
provide a better understanding 
of the physical demands, medi¬ 
cal treatment requirements, 
social limitations and general 
prognosis for the child. 
Why Smart People Can 
Be So Stupid 
edited by Robert J. Sternberg, 
ph.d., IBM Professor of 
Psychology and Education 
Yale University Press 
(New Haven) 2003; 272 pages 
This book investigates the psy¬ 
chological basis for stupidity in 
everyday life. Experts shed light 
on the nature and theory of 
stupidity, whether stupidity is 
measurable, how people can 
avoid stupidity and its conse¬ 
quences and more. 
The Perfect Fit Diet: Combine 
What Science Knows About 
Weight Loss With What You 
Know About Yourself 
by Lisa Sanders, m.d. ’97, hs ’00, 
clinical instructor in medicine 
Rodale Press 
(New York) 2004; 338 pages 
Building on her research analyz¬ 
ing more than 700 weight-loss 
programs, Sanders has "uncov¬ 
ered a fundamental truth about 
dieting,” according to the pub¬ 
lisher, that “sustainable weight 
loss is only possible on a diet that 
fits [one’s] food preferences, sati¬ 
ety signals, lifestyle and medical 
profile.” Sanders, who also writes 
the monthly “Diagnosis” column 
in The New York Times Magazine, 
offers a plan for tailoring eating 
habits and activities to lose 
weight and keep it off. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryLviolante@yale.edu 
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In global cooperation every 
human being counts” 
Long-term stability for the 
! United States depends on fos- 
1 tering international cooperation, 
not as a last resort but as a 
priority, former President Bill 
Clinton told an enthusiastic 
crowd of more than 2,000 at 
Woolsey Hall last fall. In an 
explicit critique of the Bush 
Administration’s foreign policy, 
Clinton said Americans should 
"cooperate whenever we 
can and act alone only when 
I we have to, and not the other 
[ way around." 
A multilateral approach is 
vital to combat aids and other 
. diseases; “You cannot zap a 
microbe with a missile,” said 
Clinton, who was in New Haven 
for his 30th law school reunion 
in October. And by reaching out 
to help struggling nations, the 
United States also serves its 
own interests. "This is not rocket 
' science, but every time we do it, 
we build a world with more 
friends and fewer terrorists." 
The foundation of global 
cooperation, Clinton said, is the 
idea that every human being 
counts. And that means leaving 
ideology aside, he said. "Because 
once you believe you have the 
absolute truth, then it’s not pos¬ 
sible for everyone to count....” 
—Cathy Shufro 
Encouraging physicians to speak 
“the appropriate language” 
Media consultant Andrew 
Gilman once coached a NASA 
engineer who was part of the 
effort to repair the Hubble 
Space Telescope. Preparing him 
for a television interview, 
Gilman winced at the engineer’s 
description of the evening’s mis¬ 
sion: “At 23:50, we’i! effect an 
EVA and recalibrate the module.” 
Did that mean, Gilman asked, 
that an astronaut would take a 
space walk at 10 minutes to 
midnight and adjust the tele¬ 
scope by a few millimeters? 
"Yes,” the engineer said. 
"Jheesh,” replied Gilman. “No 
wonder you can’t get money 
from Congress!" 
Speaking at psychiatry grand 
rounds in October, Gilman 
advised faculty members who 
speak to the press to keep their 
messages simple and focused. 
Three points repeated three 
times during an interview com¬ 
municate more than nine points 
made once, he said. It also pays 
to find out a little about the 
reporter and the story angle 
before launching into an inter¬ 
view, and to keep the school’s 
media relations staff in the loop. 
Gilman also dismissed the 
notion that science is too com¬ 
plex to be conveyed to the pub¬ 
lic. Citing the example of the 
NASA engineer, he urged his 
audience to use plain English. 
“It’s not dumbing down,” he 
said, “it’s speaking the appropri¬ 
ate language.” 
—Michael Fitzsousa 
Keeping hope alive for the 
seriously ill 
As a physician caring for seri¬ 
ously ill AIDS and cancer 
patients, Jerome E. Groopman, 
M.D., has learned that doctors 
need to temper their prognoses 
with humility, regardless of how 
bleak the patient’s outlook may 
appear."We should not sit like a 
Judge and hand down a death 
sentence,” he said during a visit 
to Yale in November. “Never 
write someone off a priori.” 
Delivering the Iris Fischer 
Lecture, the bestselling author. 
Harvard Medical School profes¬ 
sor and chief of experimental 
medicine at Boston’s Beth Israel 
Deaconess Medical Center 
recounted some of the stories 
and themes from his recently 
published book. The Anatomy of 
Hope: How People Prevail in the 
Face of Illness. In the context of 
illness, he said, hope and science 
are often in conflict.“There’s a 
tension in how to be truthful to 
patients and ourselves and not 
take away hope,” he said. “We 
have to be careful about slam¬ 
ming the door on hope.” 
His patients’ efforts to derive 
meaning from their illness, he 
said, offered a lesson about 
hope. “Hope arrives,” he said, 
“when you believe you have real 
choices to make, when you 
believe the future can be differ¬ 
ent than the present.” 
—Marc Wortman 
Examining how a chemical 
enters the food supply 
Health and safety experts are 
trying to solve a fast-food mys¬ 
tery: why does a probable 
human carcinogen appear in 
such foods as French fries and 
potato chips, and how much of a 
health risk does it pose? Nga 
Lien Tran, dr.ph., m.p.h. ’85, sen¬ 
ior managing scientist at 
Exponent and adjunct assistant 
professor at the Bloomberg 
School of Public Health at Johns 
Hopkins University, discussed 
the puzzle at the November 2003 
Interdisciplinary Risk Assessment 
Forum sponsored by the 
Institution for Social and Policy 
Studies at the Peabody 
Museum. According to Tran, 
studies conducted by the Swedish 
National Food Administration 
and researchers from Stockholm 
University confirmed in April 
2002 that unexpectedly high 
levels of acrylamide—a chemi¬ 
cal used in making cosmetics, 
plastics and adhesives—were 
found in some starchy foods 
after frying or baking at high 
temperatures.The darker and 
crispier the food, the more 
acrylamide was present. 
The good news,Tran said, 
is that neurotoxicity resulting 
from acrylamide exposure— 
which has been known to kill 
fish and paralyze cows—doesn’t 
appear to be a concern. However, 
people who consume a lot of 
these foods may increase their 
lifelong cancer risk by an order 
of one in a thousand. “We’ve 
let the public know, and we’re 
continuing to monitor and 
measure,” she said. ‘At this point 
that’s all we can do.” 
—Jennifer Kaylin 
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Marie Curie at Yale 
Despite her scientific eminence, a warm welcome and an 
honorary degree, the Nobel laureate endured a few slights during 
her 1921 visit to New Haven. 
By John Curtis 
M E LON EY-CU R I E PAPERS. RARE BOOK AND MANUSCRIPT LIBRARY. COLUMBIA UNIVERSITY LIBRARIES 
Although Marie Curie tended to shy away 
from journalists, she hit it off with Marie 
(Missy) Mattingley Meloney, left, editor of a 
women’s magazine called The Delineator. 
Meloney organized Curie’s 1921 American tour 
and promised to raise $100,000 to buy a 
gram of radium. Curie’s daughters Irene and 
Eve, right. Joined her on the tour. 
When Marie Curie came to Yale in 1921 
to receive an honorary degree, opinions 
among the faculty were decidedly 
mixed. Although six women had 
already received honorary degrees from 
Yale, she was the first to receive an 
honorary sc.d. Her nomination had 
come not from the Faculty of Arts and 
Sciences, but from physicians at the 
School of Medicine, who had corre¬ 
sponded with the Nobel laureate about 
the uses of X-rays and radium. Some 
chemists and physicists on the faculty 
thought the award was a mistake. 
Among them was Bertram B. 
Boltwood, PH.D., a Yale professor and 
a leading radiochemist, who felt that 
the physicians’ recommendation was 
a bit hasty. “When he learned Curie 
wished to visit him, he told the Yale 
administration he had no desire to 
have the honor thrust upon him,” said 
Daniel J. Kevles, ph.d., the Stanley 
Woodward Professor of History. “He 
considered it the duty of the institu¬ 
tion to entertain her.” 
Kevles was one of three panelists to 
discuss the “Intellectual Journeys of 
Marie Curie” at a three-day symposium 
in November to celebrate the centennial 
of Curie’s first Nobel Prize and to honor 
women in science. An exhibit at the 
Cushing/Whitney Historical Library 
also examined Curie’s life and legacy. 
Curie seems to have been destined 
to lead an unconventional life. She was 
born into a Polish family that included 
a grandfather who harbored the revolu¬ 
tionary notion that the children of peas¬ 
ants and nobles should go to school 
together. Her father was demoted from 
his job as a school headmaster for con¬ 
sorting with “radicals.” Marie Curie 
herself was illegally taught the Polish 
language, history and literature as a 
child and got around the ban on higher 
education for women in occupied 
Poland by attending an illegal, clandes¬ 
tine university. She later courted exile 
to Siberia for the crime of teaching 
peasant children to read and write. 
Years later in Paris she would meet 
and marry an equally unconventional 
17 
man. Pierre Curie was an outsider to the 
French scientific establishment who 
had not attended the right schools. In 
1903, when he and a colleague were 
under consideration for a Nobel Prize, 
his sense of fairness demanded that a 
third collaborator in their studies of radi¬ 
ation also be included. So it was that 
Marie Curie received her first Nobel 
Prize, in physics. Her second, in chem¬ 
istry for the discovery of radium and 
polonium, came in 1911, several years 
after her husband died in an accident. 
Their strongly held beliefs would 
not allow the Curies to profit from their 
discoveries. “They made a deliberate 
decision not to patent the process for 
purifying radium, believing it belonged 
to the public,” said Sara Roclcwell, 
PH.D., professor of therapeutic radiol¬ 
ogy and director of the office of scien¬ 
tific affairs at the medical school, who 
also spoke at the symposium. 
The United States that Curie visited 
in 1921 offered a bleak landscape for 
women in science. They were paid less 
than men and promoted more slowly. 
Most found jobs in women’s colleges 
that lacked the resources of larger 
schools. “Coeds could celebrate Marie 
Curie, but in the 1920s, few wanted to 
emulate her.” Kevles said. 
Her tour culminated in a visit to the 
White House, where President 
Harding presented her with a gift of a 
gram of radium. 
Yet even as a Nobel laureate and 
guest at the White House, Curie was 
not immune to discrimination on her 
American tour. The physics department 
at Harvard blocked an honorary degree 
for her, and rather than address the 
question of whether to admit women, 
the National Academy of Sciences 
declined to accept her as a member. 
And there was her reception at Yale. 
Despite Boitwood’s antipathy toward 
her, the citation that accompanied 
Curie’s honorary Yale degree was warm 
and effusive. “It is superfluous to men¬ 
tion her discoveries in science and now 
she has discovered America. She has 
often encountered dangers in scientific 
experiments, but nothing so dangerous 
as American Hospitality; it is to be 
hoped that she will not be a Woman 
Killed with Kindness. She is unique. 
There is only one thing rarer than 
genius, and that is radium. She illus¬ 
trates the combination of both.” 
And eventually. Curie won over 
even Boltwood. 
“In the end,” Kevles said, “Boltwood 
did receive Curie in his laboratory and 
was in fact impressed by her keenness 
in scientific matters and also her per¬ 
sonal amiability.” 
John Curtis is the associate editor of Yale 
Medicine. 
MANUSCRIPTS & ARCHIVES, YALE UNIVERSITY LIBRARY (2) 
THE V,\LE .-\LUMNI WEEKLY 
MADAME CURIE RECEIVES HER YALE DOCTORATE OF SCIENCE. 
I lOI 
Although six women had previously received 
honorary degrees from Yale, at the 1921 
Commencement Curie became the first to 
receive an sc.D. 
Bertram Boltwood, a leading radiochemist, 
initially balked at a request to receive Curie 
in his laboratory at Yale. When Curie did 
visit him, he was impressed by her keenness 
in scientific matters. 
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of an old friend. The bathroom 
door sticks, layers of paint 
cover everything and her oven 
overheats by 100 degrees. 
But, she says,"these are all part 
of the charm of the place.” 
1 
By Jenny Blair j 
Photographs by Terry Dagradi l 
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**That college feeling” 
What student in her right mind would choose to live in a dorm for all four 
years of medical school? Ask Jenny Blair, who enjoyed a gym in the basement, 
a piano in the Harkness ballroom and snowball fights right outside the door. 
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idtown, Hyde Park, Brook¬ 
line. Match Day is upon 
us, and I am looking for a 
neighborhood in the cities 
whose hospitals I’ve 
applied to. Soon I will be 
looking for an apartment. 
Strange though it sounds, 
it will be hard to improve upon the one I have on the 
medical school campus. 
Our class moved into Harkness Dormitory in August 
2000, after renovations had polished it back to new. The 
doors swung smoothly. The floors were so clean that it felt 
like sacrilege the first time your bare feet felt the crunch of 
dirt on them. The low-pitched, constant whoosh of building 
ventilators coming from the courtyard—or the ripping deci¬ 
bels of motorcycles on the Frontage Road side—became our 
lullabies. We had sinks in our rooms, clean tiled bathrooms 
down the hall and windows generous enough to help the 
building shed its old nickname (“You don’t live in Darkness 
Hall, do you?” asked a smart aleck I met through an online 
dating service). 
Though I’d known the freedom of apartment life 
during my years at Yale College, I initially opted for the 
dormitory for social reasons. Ask almost anyone who 
chooses Harkness and they’ll say the same thing, though 
they’ll mention the location and the in-house cafeteria 
and the relief of not needing to look for an apartment in 
a strange city. New Haven was no novelty to me; I could 
have picked out a porch-and-yard in the Grad Ghetto 
in the East Rock neighborhood or on Prospect Street with 
English and physics students as neighbors. But I wanted to 
start medical school with my very own class. So I wedged 
belongings from the three-bedroom shared apartment I’d 
occupied during a post-college year into a tiny room beside 
the elevator, on the eighth floor. It was small, but near 
everybody else, including students from the other health 
schools, and you couldn’t beat the commute—though that 
didn’t keep us from trotting down Gedar Street late for 
morning lectures, slinking into the back of Hope no with 
coffee in hand. 
A room with a view 
I nested quickly, decorating the door with photos from maga¬ 
zines and the obligatory message board, and coming to 
relish the view from my window: food-cart picnickers on the 
grass, day-care kids playing and always the stately Sterling 
Hall of Medicine, with odd windows lit at night. The eighth 
floor was all-female, and peaceful. The happenin’ floor was 
the ninth. It was there that we threw our parties; people 
strung black bags over the ceiling lights, and someorre DJ’d 
with his own equipment and we all felt like college fresh¬ 
men again, only much cooler. These days, first-year students 
use the ninth floor’s kitchen to get together for a weeldy 
dinner they cook themselves. 
But no one, it seems, wants that college feeling for 
long. My classmates, almost to a person, stopped living 
on the med school campus after their first year. The many 
perks—Tuesday-night Queer Eye for the Straight Guy (or, 
when we were first-years, Temptation Island), instant access 
to food carts, laundry machines, Ethernet, even the lack of 
any commute to Yale-New Haven Hospital (which can mean 
an extra half-hour of sleep during tough rotations)—don’t 
seem to overcome the stigma of a dormitory. Most people 
moved into high-rises two blocks away, or up to the Science 
Hill neighborhood, where they walk their dogs and jog past 
lawns, bushes and postdocs out with spouse and stroller. 
After four years, though. I’m one of the few die-hards still 
living here, though I switched to the apartment side of 
Harkness during second year. (Harkness Apartments 
is Harkness Dormitory’s endearingly scruffy neighbor. 
Whether for reasons of convenience, aesthetics or 
sociability, Harkness has always lent my medical school 
experience something inimitable. 
21 
Living in an apartment overlook¬ 
ing Harkness Lawn keeps Blair 
connected to the school and class¬ 
mates. “Friends walk by and 
wave for me to let them in, and 
I always know when impromptu 
snowball scrimmages are on.” 
Edward S. Harkness Hall turns 50 
in 2005; see Archives on page 48. 
Positioned at right angles to the dormitory—the two build¬ 
ings hug the courtyard—it is only four stories high, and its 
units are one-bedroom apartments instead of studio-style 
dorm rooms. Together they are Edward S. Harkness Hall.) 
Whether for reasons of convenience, aesthetics or sociability, 
Harkness has always lent my medical school experience 
something inimitable. 
On the happenin’ floor, communal meals 
I wondered how other students felt about it. On a recent 
Sunday evening I revisited the ninth floor to check out the 
fabled communal meals. When I arrived, a dozen or so 
students were watching football on TV and eating a pepper- 
speckled Caesar salad from a big bowl. Two women hovered 
over great pots of chili on the stove. Empty cans and pack¬ 
ages of guacamole littered the counter. A keg waited expec¬ 
tantly in a corner. 
Eyeing the generous bowls of corn chips, I sat down 
beside a first-year named Brendan Jackson who, as it turned 
out, was a member of a mysterious sixth-floor Erat. “It’s 
very unofficial—Ru-Rah-Rigma,” he explained mysteriously. 
“There’s a fraternity on the sixth floor?” asked a classmate. 
(It’s an all-male floor.) “Yeah. Live on the sixth floor and 
you’re in.” Jackson is also the Harkness Dorm Liaison. He 
had recently been elected by his classmates, though he ran 
unopposed. His duties include presenting the dorm dwellers’ 
complaints to the Powers That Be. Complaints like what? 
“The water pressure!” he answered. “None of the TVs work 
except the one on the ninth floor,” put in a woman who was 
standing by. Maybe that’s how the ninth floor got so popular. 
The home-cooked dinners began because the dining 
hall is closed on weekends. They were the brainchild of 
first-years Caryn St. Clair and Misaki Kiguchi. When I first 
saw Misaki, words like “brisk” and “efficient” came to mind. 
As students slipped into the lounge, she swung between 
kitchen and tables as if on a hinge, handing off bowls of chili 
topped with blue corn chips, purple onions, guacamole, sour 
cream and shredded cheese to one eater after another. The 
room grew happy and noisy, and soon people were wading 
through the crowd to the keg and helping themselves. 
I stretched like a cat and enjoyed the atmosphere. 
Tired of eating at Subway every weekend, Misaki con¬ 
vened a group of students willing to take turns catering 
for each other. She makes up the schedule and e-mails it to 
everyone involved. When people who aren’t part of the cir¬ 
cuit show up to mooch, she publicly assigns them a night to 
cater for the group, trusting in the potential wrath of 40 
hungry classmates to exert the necessary social pressure. 
Dishes served in weeks past have included chicken Marsala, 
pancakes and caramel apples. As I chatted with the diners, 
an arm reached into our midst and set down a big pan of 
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22 'That college feeling' 
sliced blueberry cornbread. 1 took a piece, ate it, then took 
another. Though I was too afraid of being forced to cater for 
40 people to sneak a bowl of chili, resistance to cornbread 
was futile. 
Remembering what it was like trying to fit my compli¬ 
cated mess into one room, I asked the general assemblage 
if anyone had decorated really creatively. One of their num¬ 
ber was pushed forward, protesting feebly. “You’ll see what 
can be done with a Harkness room,” they promised me. 
The student in question, willing but abashed, led me to his 
room and unlocked it. 
This man had a gift. Red curtains, sleek pine book¬ 
shelves, delicate fabric lamps shaped like Platonic solids, a tidy 
futon, a patterned rug instead of the standard ratty Persian 
knockoff, a graceful easy chair. It was Urban Outfitters, it was 
Ikea, it was glorious. It even smelled good. 
Yet even he is planning to leave, as is every current 
first-year I asked. 
I stayed. I love living in Harkness. Friends walk by the 
window and wave for me to let them in, and I always know 
when impromptu snowball scrimmages are on. The base¬ 
ment gym is too close for excuses. I can walk downstairs with 
a folder of music and practice the piano in the ballroom. In 
late evening I can slip across the lawn to the computer lab or 
library—the lack of psychological distance between work and 
home life doesn’t bother me, for some reason. Here on the 
apartment side, the dormitory gods even provide free furni¬ 
ture. My couch and easy chair began life as seating for inter¬ 
viewees in the Office of Student Affairs. Tacit neighborly 
trades go on all the time, as when a bookshelf or night table 
turns up in a hallway and a day later is eased, skittering, into 
someone else’s room. 
I prefer the apartments for a few reasons. For one 
thing, I’m not an elevator person. As anyone who has 
watched me can tell you, I tend to stride purposefully toward 
my destination. Elevators interrupt the vector. The Harkness 
elevators were particularly irksome because they were often 
out of order. This happened so often that I learned to build 
it into my day, leaving extra time to get up and down the 
stairs on days when the building was competing for a single 
elevator. Living on the eighth floor, it was just barely worth 
it to wait rather than take the stairs, but I never learned 
patience. Apologetic signs appeared on the elevator doors 
over and over again, and soon we all knew where the first- 
floor stairwell door was. When I moved into Harkness 
Apartments, I chose a second-floor unit. Suddenly it was 
possible to run home from the hospital and pick up a 
forgotten stethoscope or heat up some lunch. 
A decided advantage to the apartment side of 
Harkness, indeed, is the kitchenette. Though I’m no chef, 
it can be hard to transition back to a meal plan after having 
lived in an apartment. The dormitory’s common-room 
kitchens come complete with sink, stove, microwave and 
freezer (“not a refridgerator [sic],” a sign reminds us). 
But their public location creates a certain tension between the 
shared and the owned. Some people take their chances and 
leave things there. When 1 was a first-year, one student used 
to leave her carton of eggs out on a shelf I doubt anyone 
stole an egg, but 1 remember slices gone missing from the 
loaves of bread I stored in the freezer. Annoyed, 1 piled break¬ 
fast fixings onto a cart every morning—pot, oatmeal, eggs, 
plate, fork, spatula—and wheeled it into the elevator to ride 
one floor up. Ding. But the dumpy little cart dampened any 
culinary ambitions I might have had after managing break¬ 
fast. Now that 1 have a kitchen of my own. I’ve upgraded to 
soups and stir-fries. 
Like an old friend 
It’s taken some practice, though. In contrast to the spanking- 
clean Harkness dorm rooms, the apartment side hasn’t been 
renovated. I like it that way; my apartment’s quirks are like 
an old friend’s. If s the type of place where everything is cov¬ 
ered with layers of paint—radiators, light switches, coat 
hooks. Every piece of furniture is an orphan. Several genera¬ 
tions of curtain rods grace each window. The window in the 
bedroom is stuck slightly open year-round, while the bath¬ 
room door, if fully closed, traps guests inside (if I forget to 
warn them, I have to kick it open while they cower behind 
the sink). The oven reliably overshoots by 100 degrees, and 
the markings wore off the burner dials ages ago. But these 
are all part of the charm of the place, and I’ve mastered the 
workarounds. With vigilance and a thermometer, I can even 
wrest pie from the oven. 
Do fourth-year medical students get “senioritis"? As 
part of final-semester lassitude, I spend a lot of time day¬ 
dreaming about my next place, as well as reminiscing. I’ve 
lived in a lot of apartments. There was a New Haven summer 
sublet on Bishop Street, with hardwood floors that sloped 
and roaches so ubiquitous that I kept dishes buttoned into 
Tupperwares to keep them clean. There was a carpeted one in 
Ann Arbor, an easy walk from downtown, that smelled of the 
downstairs neighbor’s ferrets. At night a freight train hustled 
by, waking me, then soothing me back to sleep. There was 
a flat in Eort Lauderdale that huddled in a patch of downtown 
jungle. I remember wet heat, ants streaming across the win¬ 
dowsill to the spot of jelly on the counter, peacocks strolling 
outside. The year after graduating from Yale College, 1 lived 
in New Haven in a place memorable more for its room¬ 
mates—a bread-baking astrophysicist, an Orthodox Jew who 
knew six languages and a geologist obsessed with bunnies 
and Renaissance Fairs—than for its physical plant. Then I 
was accepted to Yale Med. For four years, Harkness has wel¬ 
comed me home, and 1 could hardly ask for better, ym 
Fourth-year student Jenny Blair will begin a residency in emergency 
medicine this summer at University of Chicago Hospitals. 
A bed at Ma Levin’s, 
dinner at Nick’s and nary 
an e-mail in sight. 
It’s been more than half a century 
since Arthur C. Crovatto, m.d. ’54, 
HS ’6i, was a first-year Yale 
medical student living in Ma Levin’s 
boarding house on Howard 
Avenue, but he can tick off the 
names of his housemates as eas¬ 
ily as if he were telling you who 
was at last Saturday night’s poker 
game: "Let’s see, there were n of 
us.! roomed with Bob Joy. Buzz 
Lind, John Rose and Lowell Olson 
were down the hall. Then there 
was Harry Miller... Bill Elliott.... ’’ 
Residential life for medical stu¬ 
dents in the early 1950s fostered a 
camaraderie that has endured well 
beyond that triumphant moment 
when they received their diplo¬ 
mas. Despite, or perhaps because 
of, arduous studies and living con¬ 
ditions that can best be described 
as austere, graduates of 1954 recall 
those days with the warm affec¬ 
tion of soldiers bonded by the rig¬ 
ors of boot camp. 
Recollections of that time, 
which ended with the opening of 
the Edward S. Harkness Memorial 
Residence Hall in the fall of 1955, 
live on in a class book assembled 
by the Class of 1954 in preparation 
for their 50th reunion next spring. 
Robert P. Hatch, M.D. ’54, edited 
the class book. 
“We loved the place,” Crovatto 
says of his first New Haven domi¬ 
cile. (When her boarders told 
her about a broken toilet seat, Ma 
Levin responded that it was for 
“half-assed doctors. The name— 
‘home for half-assed doctors’—■ 
stuck.”) Ma Levin’s boarders may 
not have known their host’s first 
name, but the house rules were 
never in doubt. “She wouldn’t tol¬ 
erate women. Wouldn’t let them 
in the front door,” Crovatto 
recalls. Everyone knew Ma hoped 
her niece Jackie would marry a 
medical student, so whether this 
prohibition was a reflection of 
her moral code or just a desire to 
lessen Jackie’s competition was 
i not known. “Only once in my life 
have I found a bottle of wine so 
bad that I couldn’t drink it. It was 
a bottle of something Ma Levin’s 
niece tried to share with us,” 
; recalls Lowell E. Olson, M.D. ’54. 
' “But it was a nice place to live. 
! We all got along well.” 
Members of the Class of 1954 
gathered outside a rooming house 
on Howard Avenue, sometime in 
the 1950s. 
For $8 a week, Levin’s tenants 
got a room, housekeeping service, 
clean sheets and Sunday breakfast. 
They ate the rest of their meals 
at Nick’s or one of the other greasy 
spoons that lined Congress Avenue. 
Dinner cost about 50 cents, and 
students often worked in the 
restaurant in exchange for food. 
But the big treat for those 
who stayed at Ma Levin’s was 
access to something rare and won¬ 
derful—television on Sunday 
evenings. “I’d never seen TV 
before. We’d all get together and 
watch Your Show of Shows with 
Sid Caesar,” recalls Harry C. Miller 
Jr., M.D. ’54. “She was like a surro¬ 
gate mother to us.” 
Although Ma Levin’s boarders 
enjoyed the homey atmosphere, 
they were usually eager to move 
into one of the medical school 
dormitories farther down Howard 
Avenue (where the children’s hos¬ 
pital now stands). The cost was 
between $5 and $8 per week for a 
single room and between $3 and 
$5 per person for a double. But 
the main allure was a chance to 
interact with the more advanced 
students and to learn from their 
experiences. Plus, there were fewer 
rules. “I liked it better,” says 
Crovatto. "You were absolutely free 
to do what you wanted, as long as 
you didn’t burn the place down,” 
which probably wouldn’t have been 
hard to do. Adds Miller: “I remember 
a guy was locked out of his room, 
so he just broke through the wall.” 
Some students had radios or 
phonographs for entertainment. 
“I brought a stack of very precious 
first-edition 78s I’d collected: 
Glenn Miller, Tommy Dorsey,” says 
Miller. “When I left med school 
I foolishly didn’t take them with 
me. Somebody probably used 
them as Frisbees.” As for access to 
telephones,“It wasn’t a big deal in 
our lives,” says Miller. “I can’t even 
remember. There may have been a 
pay phone somewhere.” One thing 
everybody remembers vividly was 
the formal tea hosted by faculty 
wives four days a week. “The tea 
was poured from a samovar, with 
cups, saucers, spoons, little cakes, 
the whole bit,” says Crovatto. 
“Everyone came—faculty, nurses, 
students, house staff. It was a 
wonderful tradition.” Less charm¬ 
ing, but arguably more timeless, 
were the loud parties on the back 
porch of the dorm. Crovatto recalls 
a particularly boisterous gala 
involving fireworks after the board 
exams. “There was a convent right 
behind us. Usually the sisters were 
very tolerant, but this time they 
called the police.” 
The Class of 1954 included 
three women. Two lived off cam¬ 
pus, and one, Eva H. Henriksen, 
M.D. ’54, lived with women from 
the public health program in a 
dormitory next to the men’s build¬ 
ing. Consequently, dormitory life 
for her was significantly different 
than it was for the men. 
“We were allowed to study 
together, to help each other, so 
the guys would get together in 
their dorm,” Henriksen says. “But I 
wasn’t going to go next door to 
study with them. You just didn’t 
do that in those days. I wasn’t 
a great med student, but I did it 
alt myself.” Henriksen did find 
a way to “visit” with one student 
in the men’s dorm. “The space 
between his window and mine 
was just close enough that if 
we both leaned out, I could hand 
him a cup of tea,” she recalls. 
“Then he’d hand me his mother’s 
home-baked black walnut cookies.” 
Also outside the mainstream 
housing experience were World 
War II veterans, who lived with 
their wives and children in 
Armoryville, a village of metal 
half-cylinder Ouonset huts built 
by the Army near the Yale Bowl. 
Two couples occupied each hut, 
one couple at each end, with the 
two apartments separated by a 
thin wall. “In the winter, whether 
you were warm or cold depended 
on which way the wind was blow¬ 
ing,” says Richard D. Pullen, m.d. 
’54, a Navy veteran. The apart¬ 
ments, which rented for $37 a 
month, were heated with a pot¬ 
bellied coal stove and cooled 
by a sprinkler on the roof. “Silvia 
Heap, the wife of Walker Heap, put 
a can of frozen orange juice on the 
counter to thaw,” recalls Hatch. 
“When she came back a few hours 
later, it had exploded in the heat.” 
Hatch’s other vivid recollection is 
that “the walls were quite thin, so 
you pretty well knew what activity 
was going on next door. It was 
kind of intimate that way.” 
While football games at the 
Bowl provided entertainment for 
veterans and their wives, they 
could also be a hardship. Either the 
couples were hounded by tail- 
gaters wanting to use their bath¬ 
rooms, or the roads leading to 
their homes were blocked off by 
traffic police. Getting to and from 
the medical school was also a 
challenge. Hatch remembers com¬ 
muting for a while on an "old 
rusty bike I’d picked up some¬ 
where.” Armoryville couples usually 
walked, hiked, took the bus or 
used vintage Plymouths or Fords. 
“It might have been hard, but I 
remember it as a happy and fulfill¬ 
ing time,” Hatch says. 
Indeed, whether home was a 
Ouonset hut, a dormitory or a 
rooming house, the memories of 
former occupants have acquired 
the patina of nostalgia. “Things 
happen in your life that are life¬ 
changing. My going to the Yale 
Medical School was one of them,” 
says Crovatto. 
—Jennifer Kaylin 
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By Trisha Gura 
Children in Iran face an elevated 
risk of patent ductus arteriosis, 
a congenital heart defect In which 
a critical blood vessel in the heart 
does not fully seal after birth. 
A collaborative bridge between Yale and Wi 
Iran spanning the genetics of cardiovascular 
disease is a two-way street for science. 
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26 Journey of the heart 
Researchers from Yale and the Iran 
University of Medical Sciences in 
Tehran believe a gene mutation on 
chromosome 12 causes at least 
one-third of patent ductus arterio- 
sis cases in Iran and may be respon¬ 
sible for as many cases in other 
populations throughout the world. 
Every medical student must struggle to fight off distractions, 
but Arya Mani, m.d., had to contend with more than his 
share. )ust before he began medical school in his native Iran 
in the late 1970s, the nation’s capital, Tehran, was rocked by 
a massive, student-led uprising that made headlines around 
the world. The Ayatollah Khomeini ousted Mohammad 
Reza Pahlavi, who had ruled the nation as the Shah of Iran 
for nearly 40 years. Khomeini rose to power on the wings of 
an impassioned revival of Islamic fundamentalism, and 
toward the end of 1979 he began a nail-biting 444-day stand¬ 
off with the United States over the capture of hostages from 
the American embassy, an incident which continues to have 
profound political repercussions today. 
Mani did his best to keep his mind on his studies 
against the increasingly tense political backdrop in Iran, but 
in the midst of the upheaval his university was closed, and he 
fled to the Johannes Gutenberg-University of Mainz in 
Germany to complete his training. In the last leg of a long 
journey, he arrived at Yale as a hospital resident in 1992, and 
he has made New Haven his home ever since. 
Mani, now a cardiologist and assistant professor of 
medicine, had long been convinced that genes play a critical 
role in many forms of heart disease, but he hadn’t had an 
opportunity to do serious research in the area until he 
became a chief resident at Yale in 1993. He then found an 
enthusiastic and like-minded mentor in Richard P. Lifton, 
M.D., PH.D., who has spearheaded an innovative series of 
genetic research projects around the world, including 
groundbreaking research on the genetic basis of hyperten¬ 
sion. Mani returned to his homeland in 1998 as part of a 
globe-spanning collaboration between New Haven and 
Tehran. By bringing Yale’s state-of-the-art genomics initia¬ 
tives to bear on the time-honored marriage customs of Iran, 
Mani’s work has put the Lifton lab within striking distance 
of an elusive gene or genes that act to cause a common con¬ 
genital heart condition. 
A novel approach 
In his science, Lifton, the chair and Sterling Professor 
of Genetics, believes in going to extremes. Lind genetic cul¬ 
prits at the pathological and geographical edge, he says, 
and you can apply your insights to the norm. Thus he has 
investigated families with the very highest and lowest 
blood pressure to find clues to treat the everyday hyperten¬ 
sion that affects the rest of us. 
Populations in which marriages between close relatives 
are common are particularly ripe for study, says Lifton, a 
Howard Hughes Medical Institute investigator, because inter¬ 
marriage keeps the same genes circulating within the group, 
and genetic diseases occur more frequently, for example, 
first cousins are much more likely to carry identical defective 
recessive genes passed down from a grandparent. If these 
cousins marry, their children run a higher risk of genetic dis- 
ease than children in more diverse populations. And the 
more such illnesses arise in a small, discrete population that 
practices intermarriage, the easier it is to spot recessive 
genes that may be responsible. On any given day in his third- 
floor lab in Yale’s new Anlyan Center, Lifton might be found 
poring over pedigrees of a Saudi Arabian village, a family 
in the Italian Alps or a close-knit clan in the South Pacific. 
The approach has paid off: to date, members of Lifton’s 
lab have unearthed more than a dozen genes involved in the 
regulation of blood pressure and several other genes underly¬ 
ing conditions ranging from osteoporosis to vascular disease 
of the brain. 
Mani knew that 25 percent of live births in Iran arise 
from parents who are closely related, so he thought that the 
country could provide a uniquely valuable setting to apply 
Liftoris methods. He proposed to travel to Iran to conduct a 
systematic study of disease patterns in families with closely 
related marriage partners. Lifton advised Mani to first iden¬ 
tify any diseases that are markedly more common in the 
general Iranian population than would be expected from 
his clinical experience at Yale, and to then look for a subset 
of those illnesses that occurs frequently among children 
of closely related parents. 
To prepare for the journey, Mani searched the medical 
literature and discovered a research paper written by Shahrokh 
Naderi, m.d., an Iranian gynecologist, in 1979. Naderi 
had catalogued several diseases that were more common in 
Iranian children of closely related parents, including con¬ 
genital heart disorders. Neither Mani nor Lifton was aware 
of any other reported association between intermarriage and 
cardiovascular disorders, so Mani contacted Naderi, who has 
also emigrated to the United States, for advice on following 
up this work in Iran. Mani also consulted with Iranian-born 
Tayebeh M. Rezaie, m.sc., at the University of Connecticut 
Health Center in Farmington, who had been studying geneti¬ 
cally based illnesses in Middle Eastern populations. Rezaie 
provided Mani with a list of candidate illnesses, including the 
congenital heart defect called patent ductus arteriosis, or pda. 
The ductus arteriosis is a normal fetal structure that 
joins the aorta to the pulmonary artery; since the fetus 
obtains oxygen from the placenta, the ductus arteriosis allows 
blood to bypass the lungs to supply the rest of the body. In 
PDA, the ductus arteriosis does not fully seal off after birth, 
and some oxygenated blood in the aorta returns to the lungs 
via the pulmonary artery instead of entering the general cir¬ 
culation. Many children with pda experience nothing more 
than a mild heart murmur or tiredness and are not properly 
diagnosed for two years or more, but some infants with pda 
must be rushed to emergency rooms, where surgeons repair 
the defect to prevent congestive heart failure. 
Mani had seen patients with severe pda symptoms in 
his rounds at Yale. But American physicians weren’t certain 
that the condition had a genetic cause because it appears so 
sporadically in the United States and, more often than not, 
does not seem to affect pda patients’ relatives. Though this 
clinical picture is typical of recessive illnesses masked by a 
genetically diverse population, the consensus was that pda is 
caused by unknown environmental triggers. 
Politics often trumps science, and there were particu¬ 
larly worrisome political hurdles facing Mani in his quest to 
do research in Iran. Relations between the United States and 
Iran were severely strained by the 1979 hostage crisis, and 
have been mixed at best since then. Though there have been 
instances of cooperation, such as the recent U.S. aid to Iran 
in the aftermath of the earthquake in the city of Bam (See 
sidebar, page 29), President Clinton instituted a strict trade 
embargo against the country in 1995. and President Bush 
famously named the country in his 2002 State of the Union 
address as part of an “axis of evil.” Fortunately for Mani, 
Asghar Rastegar, m.d., associate chair for academic affairs in 
the Department of Internal Medicine, had been building 
medical partnerships between Yale and countries in need, 
including Iran, for a dozen years. 
After the fall of the Soviet Union, Rastegar, an Iranian 
by birth, organized collaborative efforts with Russian educa¬ 
tors, arranging faculty exchanges and trips to Russia for 
Yale researchers. With the announcement of Clinton’s trade 
embargo, Rastegar again sought to build scientific bridges. 
“I felt that Iran was being isolated politically,” he says, “but 
that such isolation should not extend academically.” For 
example, Rastegar has sponsored Iranian faculty members to 
spend sabbaticals at Yale and more recently he has helped 
to set up partnerships between Iranian physicians and two 
Yale researchers—Richard S. Schottenfeld, m.d. ’76, profes¬ 
sor of psychiatry and master of Davenport College, and 
David A. Fiellin, m.d., associate professor of medicine—to 
study issues related to substance abuse and hiv in Iran. 
Introductions in Tehran 
Rastegar, who had known Mani from his student days dur¬ 
ing the Iranian revolution, acted as Mani’s go-between with 
Iranian physicians and scientists, so when Mani arrived 
in Iran he was able to quickly team up with internist and 
nephrologist Behrooz Broumand, m.d., at the Iran University 
of Medical Sciences in Tehran. Broumand was keenly inter¬ 
ested in genetically based kidney diseases and was eager 
to learn techniques to ferret out the precise genetic defects 
underlying these conditions. However, he says that he and 
other physicians at Iran’s top hospitals are handicapped by 
the country’s economic struggles and political isolation. 
“We have a shortage of basic science knowledge in Iran 
because of the lack of facilities,” Broumand says. 
According to Broumand, only about 5 percent of Iran’s 
gross national product goes toward health care (compared 
to 13 percent in the United States), and many hospitals do 
not have essential medical equipment such as CT or mri 
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machines, let alone facilities for basic research. The physi¬ 
cians who staff Iran’s hospitals carry very heavy patient loads 
but are usually paid only about one-tenth the salary of their 
colleagues in private practice. 
“They really had to be devoted to work in the hospital,” 
Mani says. But the doctors he met at Tehran's Shahid-Rajai 
Cardiovascular Medical Center at the Iran University of 
Medical Sciences were anxious to help him with his work, 
and appeared to be motivated more by a thirst for knowledge 
and a desire to train with new technology than by financial 
compensation. Such physicians formed the Iran-based part of 
Mani’s team, and once they provided him with patient 
records and recounted their clinical experience with Iran’s 
close-knit families, it didn’t take long for him to conclude 
that the University of Connecticut’s Rezaie was right—pda 
in Iran had all the earmarks of a promising candidate illness 
for genetic analyses, 
Lifton still recalls a phone call Mani made to Yale from 
Tehran, “He told me, ‘I have seen 20 cases of pda here in 
two weeks but only half a dozen in my entire clinical experi¬ 
ence at Yale.’” The patient records painted a startling picture: 
at Shahid-Rajai, pda accounted for 15 percent of 13,000 con¬ 
genital heart defects, while the best estimates say that pda 
makes up only 2 to 7 percent of congenital heart disorders in 
the United States. And the disease showed up far more fre¬ 
quently in children whose parents were first cousins. When 
the researchers looked closely at 338 recent cases of babies 
born with pda, nearly two-thirds had closely related parents. 
These data indicated that, at least in Iran, the disease is almost 
certainly caused by a defect in one or more recessive genes. 
Mani collected blood samples from 21 pda patients 
born to parents who were first cousins for genetic analysis 
back at Yale. Members of Lifton’s lab combed through the 
patients’ dna and compared it to samples from unaffected 
children, performing analyses that mark stretches of the 
genome where genetic defects might lie. The lab’s prelimi¬ 
nary analyses pointed toward three chromosomes as culprits, 
but more intensive number crunching eventually steered the 
group toward a section of chromosome 12; nine pda patients 
had sequences in this region that were so similar that the 
odds of the matches occurring by chance are less than one in 
a million. In a November 2002 paper in the Proceedings of 
the National Academy of Sciences, Mani and Lifton proposed 
that a gene mutation somewhere in this section of chromo¬ 
some 12, which they have christened pdaI, causes at least 
one-third of the pda cases in Iran, and may be responsible 
for as many cases in other populations throughout the 
world. The study is further vindication of the cross-cultural 
methods that Lifton has so profitably used thus far. 
“This is a very interesting approach, and one that will 
be even more powerful in the near future,” says molecular 
geneticist David M. Altshuler, m.d., ph.d., of the Broad 
Institute in Cambridge, Mass. In particular, Altshuler says 
that the approach of Mani and Lifton benefits from a new 
genetic tool called a haplotype map—in essence, an exhaus¬ 
tive inventory of common dna variations within human 
LEFT TO RIGHT Arya Mani 
returned to his native Iran to 
seek out diseases with a genetic 
cause. Back at Yale, Richard 
Lifton’s analysis of dna led to a 
section of chromosome 12. 
Behrooi Broumand teamed up 
with Mani in Iran to seek out 
genetic underpinnings of disease. 
populations. Knowing those variations will give geneticists 
such as Lifton a head start in identifying dna patterns that 
might be linked to diseases. 
Putting science over politics 
Members of the Yale-Iran pda collaboration still work 
together, but they are also heading in different directions. 
Lifton and his colleagues are whittling away at millions of 
base pairs on chromosome 12 to find the gene that carries 
the mutation that causes pda. So far, they have ruled out 
three promising candidates, but there are 31 more to test. 
Lifton is also applying his methods to other diseases found 
in different isolated populations; for example, he is now on a 
hunt for the genes that confer a high risk of heart attack 
among the people of the Kosrae Islands in the South Pacific. 
Meanwhile, Mani and Lifton have begun work to uncover 
the genetic underpinnings of the high risk of early heart 
attack in Indian men, which seems to persist even if these 
men leave India to live elsewhere. 
As for Broumand and his Iranian colleagues, they are 
building on the training Mani gave them by collecting tissue 
samples from adidt heart disease patients born of closely 
related parents in the hopes of finding genes related to that 
ailment. In the end, the New Haven-Tehran collaboration 
was a win-win situation, Broumand says—America has 
cutting-edge genomic technology, and Iran has unique study 
populations. If the two countries continue to join forces, he 
says, science can more rapidly find the treatments that 
patients so desperately need. 
But Broumand does voice one note of caution. Many 
of the Iranian patients who participated in the study did 
so, he says, because they hope that they or their descendants 
will eventually benefit from any treatments that emerge. 
Similarly, Iranian physicians donated their time to expand 
their knowledge and to better treat their patients. Broumand 
fears that those in poorer nations who help to make cross- 
cultural medical collaborations possible could be forgotten 
once the necessary data are gathered. “If the studies stop at 
the point when the paper is published, then the fruit is dead 
and nothing else will happen,” he says. For his own part, 
Lifton has been inviting researchers from Iran and other 
countries to spend time training in his lab and to take knowl¬ 
edge back to their home countries. 
Broumand believes that everyone can benefit if 
Western researchers maintain strong contacts with col¬ 
leagues in other regions, not simply by reading each others’ 
papers, but by engaging in regular discussions with each 
other. And this is particularly true where the United States 
and Iran are concerned. “I believe that if we go through 
cooperation in science,” he says, “we will create an environ¬ 
ment to soften the politics and the violence, which is based 
on politics. That is the hope.” ym 
Trisha Cura is a science writer in Brookline, Mass. 
In earthquake’s aftermath, 
Yale physician makes a 
journey back to Iran 
Five days after an earthquake dev¬ 
astated the Iranian city of Bam in 
December, Asghar Rastegar, M.D., 
professor of medicine and associ¬ 
ate chair for academic affairs in the 
Department of Internal Medicine, 
was on an AmeriCares cargo plane 
carrying 80,000 pounds of emer¬ 
gency supplies. His mission was to 
help deliver the supplies and assess 
the city’s medical needs for the 
next two to three months. Rastegar 
was asked to help because he is 
originally from Iran and had worked 
with AmeriCares on relief efforts 
after a 1990 earthquake there. And 
he’s familiar with the area, having 
taught at the medical school in 
Kerman, the provincial capital 120 
miles from Bam. 
“It was a very peculiar feeling,” 
he said of the approach to Bam. 
Roads were open and there were 
no immediate signs of devastation. 
“You enter the city and after two 
blocks everything is destroyed.” 
The earthquake, which struck 
at 5:30 a.m. on December 26, 
destroyed most of the city, includ¬ 
ing its two hospitals. The death 
toll was at least 43,000. Most of 
the city’s health workers were 
killed, leaving no one to treat the 
injured during the crucial eight 
hours following the earthquake. 
Although physicians and nurses 
from Kerman and other nearby 
cities filled the gap heroically, 
Rastegar said national planning 
for the earthquake was missing. 
“Iran sits on a major earthquake 
fault,” he said. “This is going to 
happen again.” 
Now Iranian officials, working 
with Iranians who live in the 
United States, are planning meet¬ 
ings to prepare an emergency 
response plan. 
—John Curtis 
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Two alternatives, 
each a little wrong 
With that definition of a dilemma in mind, 
Yale’s cadre of bioethicists wade into our 
mailbag and weigh in on readers’ questions 
from the front lines of medicine. 
By Marc Wortman 
Illustrations by Serge Bloch 
In the 1980s, neurosurgeon Dennis D. Spencer, m.d., hs '77, was a 
leader in an investigational effort at Yale to transplant fetal 
cell tissue in the brains of Parkinson's disease patients. Animal 
studies had shown that implanting the cells might reverse 
the tremors and other neurological problems caused by the 
disease. His research team applied for a grant from the 
National Institutes of Health (nih) to carry out some of the 
first studies in humans. Unlike other teams applying for the 
grants, Spencer’s group refused to include placebo surgery as 
part of their study.The sham surgery would have required him 
to carry out all the steps of the transplant surgery—drilling 
a hole through a patient's skull and inserting a needle into the 
hole—but without delivering any fetal cells. "My reading of 
the literature,” he now says,"showed that any placebo effect 
from surgery would have been short-lived. We believed that 
over time you could clearly judge the efficacy of the procedure 
without subjecting patients to an unnecessary risk. We felt to 
do so would be unethical.” nih insisted on the placebo surgery. 
"We didn't get funded.” 
For Spencer, who is now interim dean of the School of 
Medicine, that experience marked the beginning of his need 
to study bioethics in a more focused way."I started reading 
the literature on the ethics of using surgery as placebo. I read 
what happened in the past and that helped crystallize the 
issue for me.” He and his colleagues began a series of debates 
on the subject at nih and neurosurgical society meetings.“For 
scientists, study controls and placebos are important, but you 
need to consider the ethical issues.” While no formal policy on 
placebo surgery resulted,“We got people to think about it.” 
The need to think about, explore and, when possible, 
resolve such complex issues has increased at Yale and else¬ 
where as medicine has become more complex. Spencer is 
one of many Yale physicians who regularly encounter ethical 
challenges in their work. They have a number of resources 
available to advise them when necessary. The Yale-New Haven 
Hospital Bioethics Committee—a panel of physicians, nurses, 
lawyers, social workers, clergy, ethicists and community mem¬ 
bers—reviews dilemmas, sets guidelines for care and also 
looks into issues about the quality of hospital services and 
physician conduct. “As professionals," says Thomas P. Duffy, 
M.D., professor of medicine and a founding member of the 
Bioethics Committee,"we have an obligation to monitor 
how all of us are performing as physicians. The actions of 
one reflect on all of us.” 
When urgent bioethical dilemmas requiring swift, high- 
level decision making arise, physicians can turn to the hospital's 
chief of staff, Peter N. Herbert, m.d.’67, hs '69, and attorneys 
for final arbitration. Any Yale investigator seeking to carry out 
experiments involving human subjects must file an application 
with one of four university institutional review boards that 
oversee the studies, based on federal guidelines. A variety of 
other departmental committees and individual experts are also 
available to help resolve disputes when they occur."Ethics,” says 
Robert J. Levine, m.d., hs ’63, professor of medicine and a co¬ 
founder of the hospital ethics committee, “is civilized society’s 
alternative to violence in dispute resolution.” 
Levine is co-chair of Yale’s Interdisciplinary Bioethics 
Project and director of the Donaghue Initiative in Biomedical 
Dilemma i 
and Behavioral Research Ethics at Yale. He points to the Greek 
origins of medical ethics as what he terms "a field for devel¬ 
oping standards for behavior that is praiseworthy or blame¬ 
worthy." However, he also defines an ethical dilemma as one 
in which there are "two alternative courses of action, each of 
which is a little wrong.” 
Disputes arise because opposing responses are possible. 
Nonetheless, dilemmas require resolution if the needs of indi¬ 
viduals and society are to be met. Last autumn, Yale Medicine 
invited its readers to submit biomedical dilemmas they have 
encountered in the course of their work, and many of you 
responded with issues where a proper course of action was 
not necessarily obvious. Issues ranged from a family that 
insisted for religious reasons that a loved one who was suffer¬ 
ing not receive pain medication to concerns about the pro¬ 
fessionalism of colleagues. 
Working with Levine, Contributing Editor Marc Wortman 
and the editors of Yale Medicine selected four provocative and 
difficult-to-resolve dilemmas. Individual faculty members with 
relevant expertise were invited to reflect on one of the dilem¬ 
mas and to present their views of the logic of a resolution. The 
dilemmas are presented anonymously but are based on real 
situations described by readers from around the country, ym 
Marc Wortman is a contributing editor of Yale Medicine. 
Is it ethical to help a patient 
against his will or when he 
doesn't know or understand 
his situation? 
A young man with schizophrenia and a history of non- 
compliance with treatment was admitted to my outpatient 
practice in a severely psychotic condition. He was completely 
lacking insight into his condition, and all approaches to gain 
compliance—most importantly, taking medications that could 
reduce his psychotic state—failed. His mother convinced 
me to prescribe medication, which she secretly placed in the 
patient’s food for nearly two years. I saw the patient for 
medication checks regularly, but he was unaware of his “com¬ 
pliance” throughout this time. This strategy resulted in slow, 
steady and quite remarkable improvement in all areas of func¬ 
tioning. The only untoward event, if you will, was the patient’s 
return to a pattern of partial compliance and eventual return 
of some symptoms several weeks after I chose to tell him the 
entire story. I had simply grown too uncomfortable with the 
situation, realized that this could not go on forever, and hoped 
that his clinical improvement just might allow him to embrace 
a proven, efficacious treatment (which was the ultimate plan 
discussed with his mother prior to embarking on treatment). 
Despite some decline in his condition and only partial compli¬ 
ance, the patient continues today improved from admission 
and much more amenable to inducements to adhere to his 
regimen. I believe I have given this individual a fighting chance 
where there was none—yet 1 have been acutely aware of the 
ethical dilemmas in his treatment along the way. Was I right 
to pursue this course? “A person with schizophrenia, such 
as this patient during psychotic exacerbations, may not be 
capable of making a variety of decisions and may require 
guardians to look after their interests. Guardians, however, 
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may not force medications on outpatients in Connecticut,” 
says Howard V. Zonana, m.d., professor of psychiatry and 
head of that department’s forensic psychiatry resideircy pro¬ 
gram. “Patients frequently don’t like to take medications. 
They have some unpleasant side effects. As part of their ill¬ 
ness, some patients don’t believe they’re sick." Zonana 
chaired the ynhh Bioethics Committee from its inception in 
1985 until 1999. 
He notes that psychiatrists are not alone among 
health care providers in receiving requests from one family 
member that they deceive another about care being given. 
For instance, physicians in family practice may encounter 
patients with sexually transmitted diseases who request that 
the doctor treat their spouses surreptitiously because they 
are afraid of threatening their marital situation. To hide infor¬ 
mation from one patient for the sake of another, he says, 
“is putting the needs and beliefs of the person who wants to 
keep the secret first and is conspiring in a deception. The 
doctor who does so is making complicated value judgments 
and is being co-opted. Sometimes, as in a case like this, it 
may work out, but there are many more times when it won’t, 
and the price for a betrayal of trust is very high, threatening 
both the present and future physician-patient relationships.” 
Zonana, medical director for the American Academy 
of Psychiatiy and the Law, helped to write the state of 
Connecticut’s civil commitment statutes. Psychiatrists, he 
points out, operate under extensive legal regulation because 
they have powers akin to those of the police to detain a 
mentally ill person involuntarily. He says, “There are many 
chronic schizophrenics on the street, and we don’t go around 
surreptitiously injecting theiu with syringes of medications. 
There’s always a balance between individual autonomy and 
social needs and health. If somebody becomes gravely dis¬ 
abled or dangerous, the person loses some autonomy. There 
is always a dilemma about what values the individual and a 
community hold more primary. In this case, I don’t see the 
clinical situation compelling enough to justify this deception.” 
He contends that there are other ways to help someone gain 
insight into his or her condition. “The doctor’s intent was 
clearly humane, but I think in the long run honesty trumps 
health outcomes. I would not have been willing to do this.”* 
Dilemma 2 
Human subjects research: 
when is use of a placebo 
ethical? 
There are several standard drug therapies that can help pre¬ 
vent vertebral fractures in some women with osteoporosis, a 
potentially serious problem associated with a condition com¬ 
mon among aging women. A pharmaceutical company asked 
me to design and direct a study of a new medication that 
shows promise of preventing fractures in many more women. 
I designed the study to compare the new drug with placebo, 
j in which neither the clinician nor the patient would know 
whether she was receiving the drug or a pill having no effect. 
Based on statistical analysis, the proposed trial could not 
show the new drug's effectiveness until the number of new 
fractures in the placebo group exceeded by 150 the number in 
the group receiving the new drug. 
Our hospital’s institutional review board, or IRB, rejected 
the study, claiming it would be unethical to treat patients 
with a placebo when there are standard therapies that are 
known to be at least partially effective. The review board sug 
gested that, instead of placebo, we give the control group onr 
of the standard therapies, i disagreed because most women 
who have osteoporosis do not receive such treatment, par¬ 
ticularly when they have no symptoms. (The women to be 
recruited for this study will have no symptoms of osteo¬ 
porosis.) Furthermore, most vertebral fractures complicating 
osteoporosis have no symptoms, and the women who have 
such fractures often don’t even know it; it’s not as if they have 
serious pain or disability. Moreover, it will still be necessary 
to continue the trial until the number of new fractures in the 
control group exceeds by 150 the number in the group receiv¬ 
ing the new drug. The same number of women will experi¬ 
ence this injury; it will just take a lot longer to reach that 
number. In other words, there would be a substantial loss in 
efficiency of the trial with no compensating benefit. Was the 
n;view board’s action right in this case> As chair of the 
Human Investigation Committee at the School of Medicine 
for 30 years until 2000, Professor of Medicine Robert f. 
Levine, m.d., hs ’63, was called upon to review hundreds 
of applications for testing new therapies. He is the author 
of the widely used book Ethics and Regulation of Clinical 
Research and founding editor of the journal IRB: A Review of 
Human Subjects Research. He agrees with the review board’s 
decision. “When a therapy known to be effective already 
exists, even if only partially beneficial, and withholding the 
effective standard may result in serious complications, it is 
unethical to use placebo.” 
Levine suggests that the physician consider an alterna¬ 
tive study using what he terms an “add-on” design for the 
trial. This is possible when a new drug acts by a different 
mechanism than the standard drugs currently used in medi¬ 
cal practice. In osteoporosis, one of the standard therapies, 
a combination of vitamin D and calcium, is partially effective 
in the prevention of new fractures, according to Levine. 
Since vitamin D/calcium works differently in the body than 
the new drug, he believes it would be appropriate to give this 
combination to all patients and also give half of the patients 
the new drug and the other half the placebo. “In this 
way,” he says, “the trial has the advantages of being a placebo- 
controlled study without depriving the women of a known, 
partially effective therapy.” Although it will still be necessary 
to continue the trial until the number of new fractures in 
the control group exceeds by 150 the number in the group 
receiving the new drug, Levine believes the loss of efficiency 
will be compensated by the therapeutic benefits to the 
participants getting the placebo. “If I were on that irb, I 
would approve such a study.” ■ 
Reunion program highlights ethics 
"Bioethics in the 21st Century,” a discussion focusing on 
the contributions of alumni, faculty and students at 
the School of Medicine, will be the subject of an Alumni 
Reunion Weekend program June 5 from 9 to n a.m. in 
the Aniyan Center Auditorium, 300 Cedar Street. The 
panel will be moderated by Robert J. Levine, m.d., hs '63, 
co-chair of the Interdisciplinary Bioethics Project at Yale. 
The panelists and their topics are:Thomas P. Duffy, m.d., 
"Ethical Aspects of Medical Professionalism in the 2ist 
Century”; Rupali Gandhi, j.d. '00, m.d. '04,'‘Children as 
Research Subjects: Ethical and Legal Issues”;Tia Powell, 
M.D. '87,"Cultural Competence in Medical Ethics: Notes 
from Japan”; and Philip R. Reilly, J.D., M.D. '8i,"Emerging 
Ethical Issues in Genetic Medicine.” 
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Dilemma 3 
when is extraordinary life¬ 
saving care appropriate? 
A baby boy was born at full term but via an emergency 
Cesarean section, with a mysterious, intense skin reddening. 
Immediately following birth, he was put into the pediatric 
intensive care unit in the hospital where I work. Over the next 
three days, he had multiple organ failures—of the myocardium, 
lung and liver. On his fourth day of life he had a major seizure. 
Studies showed intracranial bleeding, described by the pediatric 
neurologist called in to see him as “the worst I’ve ever seen.” 
The baby was transferred to a medical center where he 
received extensive evaluation and supportive care. The family 
decided on a "No Resuscitation, No Extraordinary Measures” 
order and made that clear to the doctors. No cause for the 
bleeding or other aspects of his condition was ever found. The 
outlook presented to the family by pediatricians was very grim, 
and he was not expected to leave the hospital. 
Still in the first week of life, the boy was not swallowing 
well and was regurgitating so often that a Nissan operation 
was considered. This procedure cinches up the esophageal- 
gastric junction to prevent gastric reflux. The family approved 
the surgery, but unknown to the family, the surgeon also 
inserted a gastric feeding tube brought out through the upper 
abdomen. Given nourishment via the feeding tube, the child 
began to hold his own and gradually improve over a period of 
several weeks. 
Today the child is a couple of years old and weighs 
around 30 pounds. He is still fed through the tube, never swal¬ 
lows, has no excretory control, has never rolled over, cannot 
sit up, receives anti-seizure medication, makes no purposeful 
movements other than occasional random arm waves, does 
not crawl, does not speak or respond to commands and basi¬ 
cally has an 10 of zero. His medical bills have totaled nearly $1 
million so far, with the local county government bearing most 
of that cost. The family is responsible for the insurance copay¬ 
ments, incidental care and other costs amounting to more than 
a third of the family’s income. 
A young family is blessed with a son, but burdened 
with that son being a clearly nonfunctioning human being. 
“Miracles” do occasionally happen in medicine, but there is no 
miracle for this unfortunate family. The question is, what 
should have been done and what should not have been done?, 
“There is no legal or theological basis, in Catholicism, 
Judaism or the majority of Protestant faiths, for keeping alive 
by artificial means someone for whom there is no possibility, 
of recovering,” says Sherwin B. Nuland, m.d. ’55, HS ’61, 
At Yale, a growing focus 
on bioethics 
A biting wind blows through the 
darkened Yale campus on a cold 
December night. The irony of the 
end-of-the-year gloom is not lost 
on the 25 members of the End-of- 
Life Issues working research group 
meeting in a seminar room at the 
Institution for Social and Policy 
Studies (iSPS). This night, four staff 
members from the Connecticut 
Hospice in Branford speak about 
the stresses faced by caregivers for 
the dying. The audience is com¬ 
posed of students; faculty from 
the medical, divinity and nursing 
schools, as well as faculty from 
other academic institutions; and 
local community members. 
During the discussion that fol¬ 
lows, Fred A. Flatow, M.D., a former 
oncologist who is now a hospice 
physician, notes the challenge that 
doctors newly arrived from tradi¬ 
tional hospital settings frequently 
encounter switching from one 
mode of care to another. “They are 
always looking to treat a disease,” 
he said. "We tell them they have 
to treat the patient, not the dis¬ 
ease.” The group then launched 
into a debate over the differing and 
sometimes conflicting emotional 
qualities and approaches to 
patients that caregivers need to 
succeed in each medical setting. 
That sort of investigation 
into the nature and impact of 
medical care and research goes on 
somewhere on campus almost 
every day. The group meeting this 
evening is just one of 15 different 
working research groups, in bio¬ 
ethics that hold monthly meetings 
on topics ranging from technology 
and ethics to allocation of health 
care. The various groups as well as 
publications, seminar and speaker 
series and visiting professors, are 
part of the burgeoning Interdisci¬ 
plinary Bioethics Project at Yale. 
Launched in the summer of 
1997 by the tSPS to bring together 
the swelling numbers of people 
interested in the field, the bioeth¬ 
ics project has drawn more than 
500 participants to its programs 
from departments across the uni¬ 
versity, the local community and 
the larger world of academia and 
health care. “The project is fluid 
and that accounts for its popular¬ 
ity,” says Carol A. Pollard, associate 
director of the bioethics project 
at the ISPS, who coordinates the 
project’s many activities. “People 
come to ask why we don’t do 
something in an area with an 
underlying ethical question. They 
can then work with us to make 
it happen.” 
Those efforts received a major 
boost last year when the Patrick 
and Catherine Weldon Donaghue 
Medical Research Foundation 
awarded the Bioethics Project a 
five-year, $2.1 million grant. 
According to Robert J. Levine, m.d., 
HS ’63, professor of medicine, and 
Divinity School Professor Margaret 
A. Farley, ph.D., co-chairs of the 
Bioethics Project, part of those 
funds will go toward community 
outreach, including a statewide 
network of institutional review 
boards, the hospital and medical 
center ethics watchdog commit¬ 
tees that oversee biomedical and 
behavioral research. The grant 
also helps to bring a prominent 
bioethicist-in-residence to Yale 
each school year.This year’s visit¬ 
ing faculty member is David H. 
Smith, PH.D., a professor of reli¬ 
gious studies at Indiana University, 
where he is immediate past direc¬ 
tor of the Poynter Center for 
the Study of Ethics and American 
institutions. He is currently at 
work on a book on religion and 
the morality of care for the dying. 
At Yale, he is teaching popular 
courses to undergraduate and 
graduate students on bioethics 
and also directs the End-of-Life 
Issues working research group for 
the year. 
Many of the working groups 
focus on policy issues and have 
become voices in wider public 
debates. "It is in the nature of bio¬ 
medical ethics,” says Levine, “that 
almost anything is potentially 
related to public policy.” 
Several of the Bioethics Pro¬ 
ject’s groups have taken on a life 
of their own, developing their 
own visiting-speaker series and 
seeking outside support for their 
efforts. One of the larger groups, 
the Stem Cell Interest Group, was 
founded in May 2002 by medical 
student Rajesh Rao with stem cell 
scientist Diane S. Krause, m.d., 
PH.D., associate professor of labo¬ 
ratory medicine and pathology, 
as an advisor. The group has 
grown from 15 to 150 members 
from a wide range of disciplines. 
It has brought speakers to Yale 
including leading stem cell inves¬ 
tigators and Christopher Reeve, 
an advocate for more research in 
the field. The group now hopes 
to establish a multidisciplinary 
program, with medical and ethi¬ 
cal research and education as 
components. 
Most of those involved in the 
working groups are not formally 
trained as bioethicists. Interim 
Dean Dennis D. Spencer, M.D., HS 
’77, who attends meetings of vari¬ 
ous study groups, has spoken on 
bioethics as part of an annual 
guest lecture series on the field 
held at the Joseph Slifka Center for 
Jewish Life at Yale. “I am not a 
bioethidst per se,” he says, "but 
as a neurosurgeon, I’m engaged in 
it in the trenches. Most of us con¬ 
sider ethics to be common sense. 
All you need to do is ask a resident 
a tough ethical question and you 
see that it is not just common 
sense. We all bring baggage and a 
set of beliefs that you have to get 
rid of in approaching these issues. 
You have to acquire a basis to 
argue your views rationally.” 
A member of the End-of-Life 
Issues group, Stanley H. 
Rosenbaum, aa.d., professor of 
anesthesiology, medicine and sur¬ 
gery, agrees. “I spend so much 
energy dealing with acute medical 
problems. This helps me step back 
and consider the justice and ethi¬ 
cal aspects of what we do.” 
—Marc Wortman 
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36 Two alternatives, each a little wrong 
clinical professor of surgery and author of How We Die: 
Reflections on Life’s Final Chapter. He points out that in the 
landmark 1976 Supreme Court case of Karen Ann Quinlan, 
who was in a persistent vegetative state and whose par¬ 
ents had sought for her to be removed from life support, 
her priest and the local bishop believed that she should be 
allowed to die. (Removed from life support, she lived on 
in that state until her death in 1985.) 
A founding member of the Yale-New Haven Hospital 
Bioethics Committee, Nuland notes that fear of legal ramifi¬ 
cations often drives doctors to pursue extraordinary means 
to keep their patients alive, sometimes even in violation of 
expressed patient and family wishes. The courts have consis¬ 
tently supported patients, their families and physicians 
who choose not to have “heroic” measures taken to keep a 
loved one alive. “I think fears of legal repercussions are 
unfounded,” he says. “The medical team needs to make clear 
the various scenarios if they do or do not intervene. Then it 
all gets down to the wishes of the patient or the closest kin. 
This was a violation of the family’s hope, and of their inten¬ 
tions for their child.” 
He believes that the physicians erred at many levels. 
“There is no way for people of any knowledge to disagree 
about what this child’s outcome would be. There is no possi¬ 
bility that the physicians did not know this.” Nuland believes 
that, by pursuing surgical procedures, the pediatric surgeon 
violated several moral and ethical principles. “The only criteri¬ 
on for a treatment decision should be the patient’s welfare.” 
He suspects that the surgeon may have operated on the 
patient because the “case was a rare opportunity to improve 
his or her technical skills in operating on a tiny baby. He 
was prolonging this poor child’s life by carrying out proce¬ 
dures that make no sense whatsoever. The physicians knew 
this. This seems morally and ethically reprehensible.” 
He believes that a physician must look at the goals of 
any therapy he or she undertakes. “They seem to have 
decided the goal was to discharge the patient from the hospi¬ 
tal. To me the goal is what makes most sense for this family 
and this child.” ■ 
Dilemma 4 
Is it ethical to continue life 
support in brain-dead 
patients so others may live? 
I I was working in a trauma room. A patient was brought in 
I who had been shot through the head. Although he had vital 
[ signs, he was hemorrhaging rapidly through the wound. There 
was wide destruction of his brain tissue; much of it had spilled 
out on the stretcher. My immediate reaction was, “This poor 
person has died.” Any intervention at that point seemed futile. 
Then another doctor who was present ordered blood. I was 
shocked and asked, “Why?” The doctor replied, “Perhaps he 
will be an organ donor.” 
We aggressively resuscitated a person who was demon¬ 
strably beyond saving with large volumes of blood, ventilator 
support and other means on the chance that we would find a 
family member in time to ask if he would be a donor. Was it 
right to treat the patient in front of us—who was functionally 
dead and moments from being without vital signs—as a 
: potential source for an organ harvest? If the two physicians 
agreed that the patient could clearly not be saved, it would be 
ethically acceptable to stop treatment, according to Mark R. 
Mercurio, m.d., hs ’85, co-chair of the Yale-New Haven 
Hospital Bioethics Committee and associate clinical profes¬ 
sor of pediatrics, who also co-directs a bioethics seminar 
series for pediatrics residents. “However,” he adds, “that does 
I not mean that conrinuing aggressive treatment with the goal 
of enabling possible organ donation was unethical.” 
According to Mercurio, there are several ways of look¬ 
ing at the question. The patient-centered approach is perhaps 
the one most widely favored by medical ethicists. It holds 
that in the absence of any knowledge of the patient’s wishes, 
decisions should be guided by his or her best interest. To 
determine this, physicians must weigh the relative benefits 
and burdens imposed on the patient by a particular course of 
action. “Pain should always be considered as a potential bur¬ 
den,” he says. “Also, perhaps his family will be left with a 
much larger financial burden, which might be viewed indi¬ 
rectly as a burden to him.” 
It may also be valid to consider the interests of others, 
including family members or society at large. While it may 
seem wrong to treat the patient just to serve someone else’s 
interests, keeping the patient alive for a period of time while 
important information is gathered might be appropriate. 
“Some ethicists feel that we do not need to restrict the analy¬ 
sis to the patient,” Mercurio states, “but can consider the 
interests of others affected by those decisions as well. Perhaps 
his family will draw some measure of comfort from organ 
donation, and just as their cost may be perceived as his cost, 
their consolation may be seen as a benefit to him.” Such an 
analysis could, he suggests, be expanded still further to 
incorporate potential organ recipients or even a much wider 
set of people. “It seems the questioner sought adherence to 
a patient-centered ethic, but perhaps the other physician 
thought it reasonable to consider the interests of others. 
Ultimately it is a matter of opinion, not medical fact, which 
approach is more appropriate.” 
Mercurio concludes that while the physicians may not 
have been ethically required to continue the treatment, “I do 
think it was ethically permissible for them to do so, at least 
until the patient’s status as a possible organ donor could be 
clarified. If they learn that he had not chosen to be an organ 
donor, and the family did not choose that for him, at that 
point I would then recommend ceasing further efforts to 
maintain vital signs.” 
One final point: “When the correct course between 
two options is not clear, it seems to me the wiser choice is 
the one that is potentially reversible when more information 
becomes available,” says Mercurio. “This would also favor 
attempts to maintain vital signs until the patient’s and fami¬ 
ly’s wishes regarding organ donation could be clarified.” ■ 
What do you think? 
The responses provided here by Yale faculty members 
address four problems that troubled readers of Yale 
Medicine because a proper course of action was not 
easily decided. What would you have done, faced with 
the same dilemmas? Send your thoughts to Letters, 
Yale Medicine, P.O. Box 7612, New Haven, CT 06519-0612, 
or via e-mail to ymm@yale.edu. 
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Myron Cenel James Jamieson 
Pietro de Camilli 
Steven Hebert 
- j 
Stefan Somlo 
Daniel DiMaio 
Arthur Norwich 
Five faculty members 
honored with endowed 
professorships 
PIETRO DE CAMILLI, M.D., FW 
’79, professor of cell biology, has 
been named the Eugene Higgins 
Professor of Cell Biology. De 
Camilli, who is also a Howard 
Hughes Medical Institute investi¬ 
gator, leads a research program 
exploring the molecular basis for 
synaptic transmission. 
DANIEL C. DIMAIO, M.D., 
PH.D., professor of genetics, 
has been named the Waldemar 
Von Zedtwitz Professor of 
Genetics. DiMaio is vice chair of 
the genetics department and 
director of the Yale Cancer Center’s 
Molecular Virology and Oncology 
Training Program. 
STEVEN C. HEBERT,M.D., 
chair and professor of cellular and 
molecular physiology and profes¬ 
sor of medicine, has been named 
the C.N.H. Long Professor of 
Cellular and Molecular Physiology. 
Hebert studies the mechanisms 
and regulation of potassium, 
sodium and chloride transport 
by cells. 
ARTHUR L. HORWICH, M.D., 
HS ’78, professor of genetics and 
pediatrics, has been named the 
Eugene Higgins Professor of 
Cellular and Molecular Physiology. 
Norwich, a Howard Hughes Medical 
Institute investigator, studies pro¬ 
teins known as molecular chaper¬ 
ones and the mechanisms by 
which they assist in protein fold¬ 
ing in the cell. 
STEFAN SOMLO, M.D., FW’91, 
professor of medicine and genetics 
and chief of the Section of Nephrol¬ 
ogy, has been named the C.N.H. 
Long Professor of Medicine. Somlo 
heads a multidisciplinary research 
center at Yale that investigates 
polycystic kidney disease. 
Myron Cenel, M.D., professor 
emeritus of pediatrics, has 
received the Joseph W. St. Ceme 
Jr. Leadership Award, presented 
annually by the seven societies 
that constitute the Federation 
of Pediatric Organizations.The 
international award recognizes 
Genel’s contributions to pedi¬ 
atrics and to the advancement 
of national health policy for 
children. Last year Gene! was 
named chair of the Governing 
Council of the American Medi¬ 
cal Association’s Section on 
Medical Schools.The section, 
which has 600 representatives, 
gives U.S. medical schools a 
voice in the formulation of the 
association’s policies. It has 
been involved in recent discus¬ 
sions on implementing the 
new clinical-skills portion of the 
national board exams. 
James D. Jamieson, M.D., PH.D., 
was awarded the William 
Go Award by the American 
Pancreatic Association. The 
award is given to individuals 
who have made outstanding 
contributions to pancreatic 
studies. Jamieson, professor of 
cell biology and director of the 
M.D./PH.D. program at Yale, 
was honored for his leadership 
in national organizations, his 
academic achievements and his 
abilities as an educator. 
Keith A. Joiner, M.D., M.p.h.’ob, 
the Waldemar Von Zedtwitz 
Professor of Medicine, became 
dean of the University of 
Arizona College of Medicine, on 
March 1. At Yale Joiner was the 
associate chair of medicine, 
chief of the Section of Infectious 
Diseases and director of the 
Investigative Medicine Program. 
Joiner’s group studied two para¬ 
sites, one that causes central 
Keith Joiner Becca Levy 
nervous system infections in 
patients with aids and another 
that causes malaria. He joins the 
University of Arizona at the start 
of a major expansion, including a 
bioresearch institute and a medi¬ 
cal research building. 
Becca R. Levy, ph.d., assistant 
professor of gerontology, was 
named the 2003 recipient of 
the Margret M. Baltes Early 
Career Award in Behavioral and 
Social Gerontology by the 
Gerontological Society of America. 
This annual award recognizes 
outstanding early career contri¬ 
butions to the field. Levy’s 
research focuses on psychosocial 
influences on aging. 
Robert W. Makuch, PH.D., profes¬ 
sor and former head of the 
Division of Biostatistics in the 
School of Public Health, was 
named a fellow of the American 
Statistical Association in June. 
Makuch was honored for his sta¬ 
tistical consultations to govern¬ 
ment and the pharmaceutical 
industry, for his contributions to 
the design and analysis of clinical 
trials and for his administration of 
an academic biostatistics division. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
students syllabus 39 
The bigger questions 
in science 
For a whopping 360 students, 
bioethics course tackles problems 
at “the core of our existence.” 
By Cathy Shufro 
When Political Science 309b — 
“Leading Issues in Bioethics”—met for 
the first time a year ago, Arthur W. 
Galston, ph.d., the Eaton Professor 
Emeritus of Botany and lecturer in 
political science, expected that the 125- 
seat Mason Laboratory would be 
the right size for the undergraduate 
course. But on Day One students were 
“hanging from the rafters,” said 
Galston. The class moved to the 250- 
seat auditorium in the Whitney 
Humanities Center, but even there, a 
hundred students were left standing 
in the aisles. The course had to move 
again, this time to the cavernous 
law school auditorium. Class size: 360 
students, making Poli Sci 309b one of 
the largest courses offered at Yale 
College last spring. 
Although Galston was surprised 
by the huge turnout, he’d known that 
there was “pent-up demand” for 
a course in bioethics, the study of the 
ethical consequences of advances 
in biology. For 12 years, he had turned 
away 60 students each time he’d 
offered a bioethics seminar that was 
limited to 18. 
“These are human interest prob¬ 
lems. They get to tine very core of our 
“Syllabus” is an occasional feature in 
Yale Medicine profMng courses of 
special interest at the School of Medicine 
and throughout the university. 
existence,” said Galston, a member of 
the Institution for Social and Policy 
Studies. Galston assembled his course 
by calling in experts from every corner 
of campus—from the law school to 
the divinity school, from forestry to 
genetics—and including what he called 
“the superstars from the medical 
school.” They gave 26 lectures on top¬ 
ics ranging from the ethics of stem 
cell research, to the Judeo-Christian 
attitude toward nature, to why Jehovah’s 
Witnesses seek the right to deny blood 
transfusions to their children. 
“You have some large questions,” 
said Galston. “Is it fair that Mickey 
Mantle got a liver when he ruined his 
liver through excessive alcohol? Does 
nature have intrinsic value? Does it 
matter if a species goes extinct?” 
“The best thing about the course 
was all the different voices we heard,” 
said Robert Fisher, a divinity school 
student who has worked as a hospital 
An undergraduate course in bioethics has 
become one of the most popular classes at Yale. 
chaplain. Among the voices were those 
of Kenneth K. Kidd, ph.d., professor 
of genetics, who discussed ownership 
of the human genome sequence and 
whether, from a geneticist’s perspec¬ 
tive, race exists; author Sherwin B. 
Nuland, m.d. ’55, hs ’61, clinical pro¬ 
fessor of surgery, talking about the 
end of life; and Marc I. Lorber, m.d., 
professor of transplant surgery, on the 
ethics of obtaining organs for trans¬ 
plantation. Other speakers discussed 
topics ranging from world population 
growth to the potential hazards of 
genetically modified foods. 
Suzana Zorca, a Yale College senior 
last spring who is now attending medi¬ 
cal school, said the course comple¬ 
mented her biotechnology course. “You 
can’t help but be in [biotech] class and 
think of the ethical controversies that 
must be raging around these issues.” 
“The course attracted people of lit¬ 
erally every conceivable major,” said 
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40 students 
Andrew f. Read, a biology major. (The 
course is cross-listed as Molecular, 
Cellular, and Developmental Biology 
130b.) Although Read said that in 
some courses discussion sections can 
be tedious, the give-and-take was lively 
in his bioethics section, led by genetics 
doctoral student Stacey Thompson. 
“People were very much awake, with 
the discussions becoming so heated 
that we almost didn’t want to leave 
when the buzzer signaled the end. ... I 
found myself re-evaluating some of my 
own opinions on the subjects, with the 
realization that most ethical dilemmas 
have no clear-cut answers.” 
Galstoris interest in bioethics dates 
to the mid-1960s, when a chemical 
Arthur Calston led a fall course on issues In 
bioethics that ranged from the ethics of stem 
cell research to the Judeo-Christian attitude 
toward nature. 
he’d developed to improve soybean 
production was combined with 
another and used as a defoliant in the 
Vietnam War. Galston was alarmed: 
the defoliant, the infamous Agent 
Orange, could cause birth defects. He 
and some colleagues eventually man¬ 
aged to convince President Richard 
Nixon to suspend the use of Agent 
Orange. “This is what catapulted me 
into activism and started me into bio¬ 
ethics,” said Galston. 
The course was offered again this 
spring, and this time Galston reserved 
a large auditorium. 
Reading list: Poll Sci 309B/AACDB 130b 
Students taking the course bought 
three textbooks: Ethical Issues in 
Modern Medicine, sixth edition, edited 
by Bonnie Steinbock, John D. Arras 
and Alex John London (McGraw- 
Hill); Environmental Ethics: Readings 
in Theory and Application, third 
edition, edited by Louis P. Pojman 
(Wadsworth); and The Human 
Embryonic Stem Cell Debate: Science, 
Ethics, and Public Policy, edited by 
Suzanne Holland, Karen Lebacqz and 
Laurie Zoloth (mix Press). Students 
also read “The Oath of Hippocrates” 
and articles including “Dying Words” 
by Jerome E. Groopman (The New 
Yorker, Oct. 28, 2002); “Financial 
Compensation for Cadaver Organ 
Donation: Good Idea or Anathema,” 
by A.L. Caplan, C.T. Van Buren 
and N.L. Tilney (Transplantation 
Proceedings, Vol. 25, No. 4, 1993): 
and “Psst! Sell Your Kidney?” by 
Nicholas D. Kristof (The New York 
Times, Nov. 12, 2002). 
A week of fund-raising 
nets $20,000 for the hungry 
and homeless 
Thursday usually finds Interim Dean 
Dennis D. Spencer, m.d., hs ’77, in 
the operating room. But last November 
20, he was on the stage in Harkness 
Auditorium, trying to raise money for | 
the nth annual Hunger and Home¬ 
lessness Auction. 
“I grew up on a farm,” he said. “I’m 
used to auctioning off cattle. We started 
at $2,000.” 
Rather than cattle on the block that 
day, bidders could vie for weeklong 
stays at Vermont ski condos, dinners 
with deans, afternoon sloop sails in 
New Haven Harbor, or airplane rides 
over Connecticut. 
Among the more offbeat items this 
year were break dance lessons by 
second-year student Edward Teng and 
a polar bear swim offered by second- 
year student Duncan Smith-Rohrberg, 
who agreed to plunge into the bidder’s 
choice of body of water and stay in for 
five minutes plus another minute for 
each $2 donated—to a maximum of 
$20. A group of his classmates offered | 
$100 if he went in naked. j 
i 
The auction has expanded over the ] 
years. What was once concentrated j 
in a rowdy two hours in the auditorium | 
now takes place over a week and ; 
includes several new events. First- and ,, 
second-years hold a fund-raising football j 
game on Harkness Lawn; there’s a ; 
“hunger banquet” to introduce people to | 
the world of the food-deprived; a party j 
at the weekly “Club Med” gathering in 
Harkness Dormitory benefits the auc¬ 
tion fund; and for three days preceding 
the live auction there’s a silent auction 
in the Sterling Hall of Medicine. 
This year’s auction netted more than 
$20,000, which will go to Loaves and 
Fishes, LifeHaven, Youth Continuum, 
New Haven Home Recovery, Commu¬ 
nity Health Care Van, Downtovm Even¬ 
ing Soup Kitchen and St. Thomas More, 
the Chapel and Catholic Center at Yale. 
—John Curtis ; 
TOP Natasha Archer, one of the emcees from 
the second-year class, urged students and 
faculty to spend money at the Hunger and 
Homelessness Auction in November. 
ABOVi Interim Dean Dennis Spencer enjoyed 
his debut as an auctioneer at the annual event. 
Art class gives students 
of medicine, anatomy another 
resource to draw upon 
On occasional Thursday afternoons 
throughout the academic year’s first 
semester, students returned after 
hours to the gross anatomy lab armed 
not with scalpels, but with brushes, 
paints, sketch pads and cameras. 
There, Mark R. Depman, m.d., a clini¬ 
cal instructor in medicine who works 
part time in the emergency room at 
Lawrence & Memorial Hospital in 
New London and spends part of each 
week in his Fair Haven art studio, 
encouraged the students to examine 
the human body with an artist’s eye. 
This was not a drawing class—he 
offered no instruction on the fine 
points of charcoal or watercolors. 
Students could, he said, “use drawing 
and photography as a tool to stop and 
look again” at the human body. 
Erin Kiehna, a second-year student, 
said the art class gave her a renewed 
appreciation for not only the body but 
the spirit that once occupied it. “It’s 
nice to sit in silence with a sketch pad 
in hand and really appreciate the 
donor,” she said. In anatomy class, she 
added, “You feel like you’re ransacking 
it, as you try to find everything.” 
Depman, a member of the arts sub¬ 
committee of the Program for Humani¬ 
ties in Medicine, proposed the elective 
course last year and opened it to stu¬ 
dents at all levels of study. “I am hoping 
that over the coming year,” Depman 
said, “students 'will use this as an oppor¬ 
tunity to look at the history of how we 
examine the body and how technology 
has changed the learning process.” 
Although he started painting with 
oils and watercolors in his youth, 
Depman now creates images on film. 
(Depmaris latest work, two series of 
Cibachrome photographs and one of 
digital photographs, opened at the 
Nancy Hoffman Gallery in Manhattan’s 
Soho district in December.) 
In the Thursday afternoon art class, 
students cluster around a cadaver or 
skeleton and draw with charcoals, 
paint with watercolors or set up cam¬ 
eras as they pursue an image. They 
come to the class with a mix of goals. 
“After you’ve gone through the 
wards and spent time with patients 
you’re able to look at anatomy in a dif¬ 
ferent way,” said Vernee Belcher, a 
fourth-year student who found the 
course an artistic way to become reac¬ 
quainted with the human body two 
years after taking the gross anatomy 
class. Said Tina Dasgupta, in her third 
year of the m.d./ph.d. program, “Every 
patient has a story. There is something 
more to a patient than a chief com¬ 
plaint and history of present illness.” 
She also found the course a way to take 
a fresh look at the human body. “Form 
meets function in a fantastic way.” 
Depman, a Cornell medical gradu¬ 
ate who studied drawing at Oxford, is 
fine-tuning the course and, sometime 
in the future, may also teach technical 
skills. For now, though, he’s satisfied 
to let students pursue their own ideas. 
“It is a very important message for 
the medical school to put out there— 
that this is available and it can help you 
mature as a health care professional 
and a human being who practices medi¬ 
cine,” he said. “There is such a danger 
of losing the human impetus and 
human contact in practicing medicine.” 
-J.C. 
Joyce Kaufman, a second-year student, chose 
photography as her medium for the study of 
the skeleton. 
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42 Alumni FACES 
As chief of California’s Division of Chronic 
Disease and Injury Control, Donald Lyman has 
successfully campaigned to reduce tobacco 
use. His next target is obesity. 
Speaking the language 
of prevention 
Building on success with smoking, 
California’s top public health official 
turns state’s attention to obesity. 
When Donald O. Lyman, m.d. ’68, over¬ 
sees a media blitz against smoking 
in California, he draws upon his train¬ 
ing in medicine, his years in public 
health and his knowledge of the differ¬ 
ences between Spanish dialects. In 
California, you have to know whom 
you’re talking to: an anti-smoking ad in 
the dialect spoken in El Salvador won’t 
go over big with Mexican-Americans. 
And vice versa. 
Lyman picked up a sensitivity to lin¬ 
guistics along the way as chief of the 
Division of Chronic Disease and Injury 
Control, a post that his colleagues say 
is California’s equivalent of surgeon 
general. “California has become to this 
nation what New York was a century 
ago. It’s the port of entry to immi¬ 
grants,” says Lyman. “You drive down 
the street in LA with the windows 
open and smell the wonderful smells 
that change from block to block.” He 
describes the state’s 36 million resi¬ 
dents as “a wonderful collection of 
well-motivated people who came here 
looking for a better life.” Helping 
to provide that life is Lyman’s mission 
as the state’s highest-ranking civil 
service physician. Under Arnold 
Schwarzenegger, he’s serving his fifth 
governor since taking the job in 1978. 
This year he heads a staff of 375 
employees and oversees a $200 mil¬ 
lion budget. 
His agency’s biggest victory has 
been its anti-smoking campaign, which 
reduced cigarette consumption in 
California by 64 percent between 1988 
and 2003, based on cigarette sales, 
according to California and federal data. 
(During the same period, consumption 
fell 36 percent nationwide, excluding 
California.) “It’s huge,” says Lyman. 
A 2000 analysis in The New England 
Journal of Medicine found that Cali¬ 
fornia’s anti-smoking program resulted 
in 33,300 fewer deaths from heart dis¬ 
ease between 1989 and 1997 than 
would otherwise have been expected. 
That $i billion program was funded 
by California’s Proposition 99, a 1988 
law that increased the cigarette sales tax 
to fund the nation’s largest-ever tobacco 
control program. Lyman claims its 
success cost the tobacco industry $2.9 
billion in California sales in the decade 
beginning in 1989, and he cheerfully 
reports that the industry views California 
as “Public Enemy Number One, with a 
well-funded program that works.” 
How did they do it? As in all public 
health campaigns, from promoting 
seat belts to discouraging teen drink¬ 
ing, they did it partly by changing soci¬ 
ety’s “ethos.” They challenged the 
assumption that smoking is a neutral, 
strictly personal choice, both “from 
the top down,” with anti-smoking bill¬ 
boards and public service announce¬ 
ments, and also from the ground up, 
by approaching community groups 
and civic leaders. This grass-roots strat¬ 
egy aimed to get communities to adopt 
the battle against smoking as their 
own. The Division of Chronic Disease 
and Injury Control hired public 
health educators to visit neighborhood 
groups, schools, city councils and 
workplaces to discuss how smoking 
contributes to disease. 
Lyman explains that although pub¬ 
lic service announcements and educa¬ 
tional campaigns have clearly conveyed 
the dangers of smoking, “very few peo¬ 
ple come together and sit down and 
talk about smoking. ...When you actu¬ 
ally sit down and look someone in the 
eye and ask, ‘What can we do about 
this.^’ you’re likely to get a response.” 
Billboards and other anti-smoking ads 
make people receptive, but “you’ve got 
to engage people personally. That’s the 
key to the program.” That process 
would be called “community norm 
change” by liberals or “social engineer¬ 
ing” by conservatives, “but... it’s all the 
same,” says Lyman. The health educa¬ 
tors introduce a shift in perspective by 
explaining how tobacco companies 
cynically target vulnerable preteens 
and young teens. “The smoker is no 
longer portrayed as the villain,” says 
Lyman. “The smoker’s the victim.” 
Lyman is unperturbed by Gov. 
Schwarzenegger’s penchant for cigars. 
“I worked with him when he was 
our chair of the Governor’s Council 
on Physical Fitness and Sports, and 
he was consistently supportive of all 
the ‘health stuff we did,” recalls 
Lyman. “The other council members 
ribbed him about the cigars, and he 
was appropriately sheepish in reply.” 
Young people have proven the most 
resistant to anti-smoking efforts, and 
Lyman credits tobacco industry adver¬ 
tising with creating “the Joe Camel 
generation,” in which nationally one in 
four i8- to 25-year-olds smokes. But the 
end result—which is the point for a 
utilitarian like Lyman—is that smok¬ 
ing among California adults dropped 
from 23 percent to 17 percent between 
1985 and 2002, and the California 
rates among teens are now among the 
lowest in the nation. Lyman’s depart¬ 
ment kept track of smoking rates using 
a series of surveys overseen by the 
University of California, San Diego. 
The American Cancer Society’s 
California division, of which Lyman is 
the current president, reported that the 
state lung cancer rate dropped 14 per¬ 
cent from 1988 to 1997, based on the 
records of the state’s cancer registries. 
That compares to declines of 2 to 3 
percent nationally, according to data 
collected by the National Cancer 
Institute. “To see the lung cancer rates 
go down is really quite amazing,” says 
Diane J. Fink, m.d., medical director of 
the California cancer society. “Doris 
leadership has been paramount.” 
His agency’s biggest failure? “We’ve 
been doing a miserable job on nutri¬ 
tion and physical activity,” he says. Like 
smoking, says Lyman, obesity, bad 
food choices and sloth all contribute to 
cancer and cardiovascular disease, 
which account for two-thirds of deaths 
and illnesses in the state. “We have 
an epidemic of obesity and a startling 
lack of physical activity,” says Lyman. 
Lyman said the adult obesity rate in 
the state (a body mass index of 30 or 
more indicates obesity) rose from 10.6 
percent in 1991 to 18.9 percent in 
2000, and type 2 diabetes in children 
is burgeoning. 
Lyman says his agency is using the 
same “sandwich approach” (a low-fat 
sandwich, no doubt) that it used suc¬ 
cessfully against smoking: pairing 
a top-down media campaign with a 
foundation of grass-roots policy 
changes. In the policy realm, the mam¬ 
moth Los Angeles school district voted 
in 2002 to ban soft drink sales to its 
748,000 students by this year. Sensitive 
planning, like linking bicycle trails to 
subway lines, can make exercise more 
convenient. Messages to eat well derive 
in part from the state’s huge agricul¬ 
ture industry and its grocery store 
chains, which push produce with the 
catch phrase “five a day.” 
As for Lyman himself, living a busy 
life that includes a third of his time 
on the road, he manages to eat “four 
or four and a half” of the five recom¬ 
mended daily servings of fruits and 
vegetables and to fit in an hour of com¬ 
bined aerobics and weight training 
five days per week. He and his wife, 
Elisabeth Blakeslee Hall Lyman (who 
also works in public health, as 
California’s assistant administrator for 
health services for children), both have 
centuries-old ties to Connecticut, 
including to Connecticut’s well-known 
Lyman Orchards. Elisabeth spent her 
childhood in South Hadley, Mass., 
down the street from the Giamattis, 
whose son grew up to be president of 
Yale. Despite Yankee roots, the Lymans 
and their two children consider them¬ 
selves Californians. 
Lyman finds inspiration by viewing 
his job as the promotion of social jus¬ 
tice. He is fond of an aphorism from 
the Talmud that he remembers hearing 
in a speech by former Yale President A. 
Bartlett Giamatti: “You are not required 
to complete the work, but neither are 
you free to desist from it.” 
—Cathy Shujro 
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For another public health 
trailblazer, a tobacco control 
milestone in the Bay State 
Howard K. Koh, m.d. ’77, m.p.h., is 
another Yale medical alumnus who has 
won a major battle in the tobacco wars 
as a top state health official. When asked 
to name the most memorable moment 
in his five-and-a-half-year stint as 
Massachusetts commissioner of public 
health, Koh barely hesitates. “I’ll never 
forget pulling down the last tobacco bill¬ 
board in Massachusetts with the attorney 
general, Tom Reilly,” Koh says. “That 
was a very public, concrete example of 
how much progress we had made.” 
Koh’s experience as a clinician (he’s 
board-certified in internal medicine, 
hematology, medical oncology and der¬ 
matology) inspired him to join Massa¬ 
chusetts’ fiedgling anti-tobacco campaign 
iir 1992 as a volunteer for tire American 
Cancer Society and the Massachusetts 
Coalition for a Healthy Future. “I saw 
for myself what happens when preven¬ 
tion isn’t addressed or is overlooked, 
particularly with respect to cancer,” he 
says. During his watch as commis¬ 
sioner, he saw the state’s aggressive 
efforts pay off: Massachusetts reported 
the fastest decline in cigarette smoking 
in the nation—adult cigarette consump¬ 
tion dropped 4 percent per year while 
most states saw a i percent annual 
decline. “People said the industry was 
too strong and the addiction was too 
strong, and it was impossible to make a 
difference,” Koh says. “We showed that 
we could change the social norm and 
prevent addiction, especially for kids.” 
For Koh, who left his post in 
January 2003 to become professor and 
associate dean for public health prac¬ 
tice at the Harvard School of Public 
Health, the victories in the tobacco 
wars are part of a larger legacy. “Just 
before I stepped down, a national 
report ranked Massachusetts as the 
third healthiest state in the country,” 
Koh recalls. “We had risen from num¬ 
ber 10. It was a tremendous honor to 
be commissioner and see that level of 
progress being made.” 
However, the events of September 
II, 2001, presented Koh and other state 
public health officials with an unex¬ 
pected and daunting set of challenges; 
foremost among his goals at Harvard 
is to prepare students to grapple with 
bioterrorism and other 21st-century 
hazards. “The essence of public health 
is protecting people from threats and 
preventing suffering,” he says. “In the 
post-9/11 age, public health has been 
broadened dramatically in its scope, 
and we have a critical function.” 
Howard Koh, former commissioner of public 
health for Massachusetts, saw tobacco use 
decline dramatically in his state. He also had 
the chance to throw out the first pitch at a Red 
Sox game at Fenway. Koh now teaches public 
health and is an associate dean at Harvard. 
Accomplishment and a dedication 
to public service run in Koh’s family, 
along with strong ties to Yale. Koh’s 
brother, Harold H. Koh, j.d., a 
renowned expert on human rights, was 
recently named dean of the law school, 
where his sister, Jean Koh Peters, j.d., 
is a clinical professor. Koh’s mother, 
Hesung Chun Koh, ph.d., one of the 
world’s leading East Asian scholars, 
retains an emeritus appointment at 
Yale. She and her late husband, Kwang 
Lim Koh, ph.d., a lawyer and democ¬ 
racy activist, founded in 1952 what is 
now known as the East Rock Institute, 
the oldest Korean cultural institute in 
the United States. (Howard and 
Harold Koh and their parents have 
been named to the Kioo, a list of 100 
leading Koreans and Korean- 
Americans in the first century of 
Korean immigration to the United 
States.) Koh says his parents were an 
inspiration to all of their children. 
“Both of them viewed life in a very 
broad, societal way, if not a global 
way,” he says. “When people ask where 
this commitment to serve came from, 
I tell them—it’s in my blood.” 
For his Boston-area neighbors, 
though, one honor among the many 
listed on Koh’s CV surely arouses 
the greatest envy. After being named 
a “Medical All-Star” by the Boston 
Red Sox for his work on melanoma, 
Koh, with his wife and three children 
standing by, threw the first pitch 
in a game at Fenway Park last May. 
“That,” Koh says, “was a magical 
public health experience.” 
—Peter Farley 
45 
Michael Viola traveled to Iraq in the 1990s, 
where the organization he leads, Medicine for 
Peace, trained Iraqi physicians, delivered medi¬ 
cine and studied children’s nutritional needs. 
Roaming the world’s hot 
spots, ensuring that care 
reaches those who need it 
Almost two decades after completing 
his residency in internal medicine 
at Yale, Michael V. Viola, m.d., hs ’66, 
was doing the kinds of things that 
serious-minded doctors do: treating 
patients, teaching students, heading 
the cancer center at the State University 
of New York at Stony Brook. But then 
something happened to alter his sure¬ 
footed career path. 
While he was at Stony Brook in 
the early 1980s, a large influx of Salva¬ 
dorans and Guatemalans arrived to 
escape homelands rocked by civil wars. 
“It was an extraordinarily unfortunate 
situation,” recalls Viola, who received 
his medical degree from McGill in 
1964. “Most of them were illegal, and 
they had no health care. They weren’t 
designated as refugees escaping an 
oppressive government, because the 
United States was supporting their 
governments.” 
Viola started collecting and sending 
medicine to villages in El Salvador. As 
that effort grew, he was joined by other 
doctors, and a small nongovernment 
relief organization was born. The group 
crystallized into Medicine for Peace, 
with Viola as its founder and director. 
He continues to direct the group from 
his home in the Washington area. 
Today, Medicine for Peace, an all¬ 
volunteer organization run by a five- 
member executive board, has about 50 
affiliated physicians and nurses from 
around the country. During and after 
the first Gulf War, members of the 
group spent five years in Iraq, filming 
the destruction, teaching Iraqi physi¬ 
cians, studying children’s nutritional 
needs and delivering medicine. In 1993, 
members helped negotiate the release of 
American oil executive Ken Beaty, who 
was arrested by Iraqis after he strayed 
across the border from Kuwait. The 
group’s involvement in the rescue put 
an end to their efforts in Iraq. 
“Once that happened, the Iraqis 
never quite looked at us the same way 
again,” Viola said. “We’d done a lot of 
work with children, so they kind of 
trusted us. But once we were critical of 
their government, and it looked like 
we were working with the U.S. govern¬ 
ment, things changed, and we were 
kicked out in 1995.” 
While Medicine for Peace maintains 
a presence in Haiti and Bosnia, its 
involvement in the current war in Iraq 
has been minimal because of the dan¬ 
ger and restricted access. “There’s not 
much we can do,” Viola said. “We were 
told we need to have armed escorts 
at all times. We can’t operate like that.” 
The group hopes to send a team to 
Baghdad “to locate a large group of Iraqi 
children we brought to the U.S. for 
surgery in the 1990s. We hope they 
have survived all of the violence.” 
Unlike larger, better-known relief 
organizations, such as Doctors without 
Borders, Medicine for Peace (www. 
medpeace.org) won’t take government 
funding (it relies on private donations) 
and will criticize U.S. policy. “We’re 
smaller and more freewheeling,” Viola 
said. “We tend to go to controversial 
places and take controversial stands.” 
But that renegade approach has risks. 
Noting that by the end of 2003, 57 
relief and diplomatic workers had been 
killed since the current Iraq war began 
in March 2003, Viola said, “Humanitar¬ 
ian workers used to be protected, but 
the nature of war has changed. Now 
civilians are targeted. If belligerents 
kill civilians, they certainly don’t mind 
killing relief workers.” In August a 
bomb at United Nations headquarters 
in Baghdad killed 17 people. 
Still, despite the danger, Viola, who 
runs the U.S. Department of Energy’s 
Medical Sciences Division, spends 
as much time as possible working for 
Medicine for Peace. “I’m not saying 
you get an enormous reward. There’s 
nothing rewarding about mass graves 
or large numbers of children dying 
of starvation, but you realize you’re 
having an impact in some small way.” 
—Jennifer Kaylin 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
Yale Medicine, P.O. Box 7612, New Haven, 
CT 06519-0612. 
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Three Yale alumni elected 
to Institute of Medicine 
Three Yale alumni were among 65 
new members elected to the 
Institute of Medicine in October. 
They are JOHN D. Baxter, 
M.D. ’66, professor of medicine 
in the Department of Medicine 
and Diabetes Center, University 
of California, San Francisco; 
DOUGLAS R. LOWY, M.D., HS 
’75, chief of the Laboratory of 
Cellular Oncology and deputy 
director of the division of basic 
sciences and Center for Cancer 
Research, at the National Can¬ 
cer Institute; and shelley E. 
TAYLOR, PH.D. ’72, professor 
of psychology at the University of 
California, Los Angeles. 
Baxter uses the tools of struc¬ 
tural and molecular biology to 
determine the workings of nuclear 
receptors in health and disease 
and to design ligands with selec¬ 
tive actions on nuclear receptors. 
Lowy studies the molecular 
biology of tumor viruses, onco¬ 
genes and tumor genes. Taylor’s 
research explores the interaction 
of biology and behavior as they 
affect mental and physical health. 
1940s 
Robert W. Frelick, M.D. ’44, of 
Wilmington, Del., liaison to 
the National Cancer Advisory 
Board for the Association of 
Community Cancer Centers, 
received the Christiana Care 
Health System’s annual com¬ 
mendation for excellence in 
October. The award recognizes 
a current or former member 
of the medical-dental staff of 
Christiana, Delaware’s largest 
health care provider, for out¬ 
standing clinical care and com¬ 
passion and for distinguished 
achievement in education, 
research, community service or 
leadership. Frelick, a medical 
oncologist since the specialty’s 
earliest days, was honored for 
more than five decades of serv¬ 
ice and leadership. Frelick and 
his wife, Jane, met while he was 
in medical school and she was 
a nursing student at Yale. 
Robert H. Furman, M.D. ’43, FW ’45, 
writes to say: “We’re enjoying 
retirement at La Posada, a contin¬ 
uing care retirement community 
in Green Valley, Ariz." Furman 
attends a medical Journal club 
and weekly grand rounds at the 
University of Arizona School of 
Medicine. He also participates in 
a weekly lecture series called 
"The Forum at La Posada.” 
Roslyn L. MacNish, M.P.H. ’41, of 
Wethersfield, Conn., is retired 
and enjoying photography and 
attending camera clubs and 
councils. During her career 
MacNish was a statistician in 
public health at the Hartford 
Hospital Tumor Clinic and for the 
state of Connecticut’s tuberculo¬ 
sis control program. 
1950s 
Eva Henriksen, M.D. ’54, writes to 
say that "in Los Angeles, I quilt, 
visit with daughter Liz and 
granddaughters Ryann, 8, and 
Addison, 5, and e-mail daughter 
Mary, who with husband Reggis 
has been in South Africa, 
Thailand and Australia as part of 
an around-the-world tour. I do 
anesthesia consultations on 
operating room-related deaths 
for the LA coroner’s office.” 
1960s 
Robert L. Johnson, M.D., HS ’64, 
clinical professor of otolaryngol¬ 
ogy at the University of California, 
San Francisco, for more than 30 
years, writes to say that "almost 
40 years have passed since I was 
an otolaryngology resident at 
Yale. Married for 42 years to 
Barbara, a staff pediatric nurse, 
with three adult children all living 
in the Bay area. My younger 
daughter recently received her 
doctorate in psychology. My wife 
and I returned from Thailand, 
Bhutan and Laos, where I gave 
lectures on sinusitis.” 
1970s 
Ian B. Berger, M.D., M.P.H. ’74, is 
president of Houston-based 
InFOCUS, a nonprofit organiza¬ 
tion promoting eye care for all, 
and director of the InFOCUs 
Center for Primary Eye Care 
Development, whose domestic 
programs in poor and rural areas 
provide eye care for migrant 
farm workers, Native Americans 
and other populations in need. 
InFOCUs has promoted a new 
paradigm, the Vision Station, to 
deliver primary eye care. Berger, 
with colleague Larry Spitzberg, 
PH.D., O.D., has also created the 
Focometer, a hand-held refract¬ 
ing instrument that measures 
visual errors and determines pre¬ 
scriptions. It was designed for 
use in remote or poor areas and 
is used in 40 countries. 
1980s 
Robert S.D. Higgins, M.D. ’85, the 
Mary and John Bent Chair of 
Cardiovascular-Thoracic Surgery 
at Rush-Presbyterian-St. Luke’s 
Medical Center, was honored as 
a leader in public health and 
medicine by the Gift of Hope 
Organ & Tissue Donor Network 
and its African American Task 
Force at a ceremony in Chicago 
Liselotte Pieroth-Vinals and 
Antonio Vinals 
in November. Higgins was hon¬ 
ored for establishing a standard 
of excellence, improving the 
health of communities and sup¬ 
porting efforts to save and 
improve lives through organ and 
tissue donation. 
Marie (Ciacco) Tsivitis, M.P.H. ’86, 
staff associate at the Long Island 
State Veterans Home in Stony 
Brook, N.Y., is teaching a new 
course titled "Issues in Public 
Health” at Stony Brook University 
as an adjunct staff associate in 
infection control.Tsivitis also 
writes that she and her husband 
have two children, Alexandra, 8, 
and Christopher, 4. 
1990s 
Antonio F. Vinals, M.D. ’93, 
writes to say that he and his 
wife, Liselotte Pieroth-Vinals, 
M.D., are enjoying living in 
Manhattan. Vinals is an ophthal¬ 
mologist at the Manhattan 
Eye, Ear and Throat Hospital. He 
and Pieroth met at Yale in 1992. 
She was a visiting international 
medical student and intern at 
Yale and completed her ophthal¬ 
mology training at Columbia 
University and a fellowship in 
oculoplastic surgery at the New 
York Eye and Ear Infirmary, 
where she is now on the staff. 
They are the proud parents of 
Matilde Beatrix, who was born 
at Columbia-Presbyterian 
Hospital on December 12 and 
weighed seven pounds. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
info.med.yale.edu/ymm 
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Robert L. Arnstein, M.D., of 
Hamden, Conn., whose career as 
a psychiatrist at Yale spanned 
almost 40 years, died on October 
27 at the age of 84. For three 
decades, Arnstein was the chief 
psychiatrist at Yale University 
Health Services. Under his guid¬ 
ance, Yale became a national 
model for campus mental health 
programs. In 1971 he became a 
clinical professor of psychiatry 
at the School of Medicine. He 
retired in 1989. 
Robert F. Bradley, M.D. ’43, former 
medical director and president 
of Josiin Diabetes Center in 
Boston, died on October 12. He 
was 83. As president of Josiin 
from 1977 to 1987, he oversaw 
the center’s expansion and 
championed the use of oral 
agents for treating type 2 dia¬ 
betes. A1941 Yale College gradu¬ 
ate, Bradley served in the Navy 
after graduating from the School 
of Medicine and trained at 
the Lahey Clinic, New England 
Deaconess Hospital and Josiin 
Clinic. He served as editor of 
Joslin’s Diabetes Mellitus and as 
an expert witness in the Claus 
von Bulow murder retrial in 1985. 
Mary E. Ellis, M.P.H. ’48, of Decatur, 
Ga., died on September 27 at the 
age of 81. Ellis was a teacher at 
the McLendon Elementary School 
in DeKalb County, Georgia, for 
more than 20 years. She taught 
church school for more than 
50 years and wrote a Christian 
education curriculum for the 
Presbyterian Church. 
Knox H. Finley, M.D. ’30, of San 
Francisco, died on September 15 
at the age of 99. After gradu¬ 
ation from medical school Finley 
completed a fellowship in 
neurology at the Kaiser Wilhelm 
Institute in Germany and was 
subsequently board-certified in 
neurology and psychiatry. He 
practiced medicine for 45 years 
at the California Pacific Medi¬ 
cal Center in San Francisco. 
Julian Frieden, M.D. ’48, of White 
Plains, N.Y., a cardiologist asso¬ 
ciated with Montefiore and 
New Rochelle hospitals, died on 
September 29 of Parkinson’s 
disease. He was 78. Frieden pub¬ 
lished pioneering articles on 
peritoneal dialysis, the measure¬ 
ment of intracardiac pressure, 
the use of lidocaine to stabilize 
heart rhythm and the role of 
salt in hypertension. 
Nancy C. Hildreth, M.P.H. ’78, 
M.PHIL. ’79, PH.D. ’81, of Roch¬ 
ester, N.Y., died on September 
30 after an eight-year battle 
with amyloidosis. She was 54. 
Hildreth was an assistant 
professor of epidemiology at 
the University of Rochester. 
Barry M. Kacinski, M.D. ’80, PH.D. 
’8i, HS ’83, a professor in the 
departments of therapeutic radi¬ 
ology. dermatology, and obstet¬ 
rics and gynecology, died on 
November 20 following a heart 
attack. He was 50. Kacinski led 
groundbreaking research to 
define the effects of growth fac¬ 
tors and oncogenes in the devel¬ 
opment of malignancies. He 
had an international reputation 
for his contributions to the field 
of DNA repair and to the under¬ 
standing of dermatologic and 
gynecologic malignancies. 
Lawrence K. Pickett Sr., M.D. ’44, 
of Ithaca, N.Y., died on November 
15 at the age of 84. Pickett was 
the first pediatric surgeon in the 
Syracuse area, where he prac¬ 
ticed from 1950 to 1964. In 1964 
he came to Yale-New Haven 
Hospital to establish a pediatric 
surgical department. At Yale 
he was named the William H. 
Carmalt Professor of Clinical 
Surgery and Pediatrics. He also 
served as associate dean of clini¬ 
cal affairs and chief of staff of 
the hospital. He retired in 1983. 
Fredrick C. Redlich, M.D., former 
dean of the School of Medicine 
and a founding figure in the 
field of social psychiatry, died on 
January i of congestive heart 
failure. He was 93. 
Redlich, who was born in 
Vienna, came to Yale in 1942 for 
the start of a career that lasted 
more than 30 years. He served 17 
years as chair of the Department 
of Psychiatry and five years as 
dean of the medical school. 
While chair of psychiatry he was 
credited with transforming a 
foundering department into one 
that promoted psychiatry based 
on a mix of basic research, clini¬ 
cal work and behavioral science. 
As one of the earliest practition¬ 
ers of social psychiatry, he stud¬ 
ied links between mental illness 
and social milieu. He was co¬ 
author of nearly 100 scientific 
papers and six books, including 
one he called a “pathography” 
of Hitler’s mental state. 
Robert H. Stevens, M.D. ’36, 
died on November 30 at Yale- 
New Haven Hospital. He was 96. 
During World War II Stevens 
served in the Army, in France 
and Germany, as a neurosurgeon. 
He practiced neurosurgery in 
Utica, N.Y., for 50 years. 
Max Taffel, M.D. ’31, of Barre, Vt., 
died on September 19 at Yale- 
New Haven Hospital. He was 94. 
Taffel, a neurosurgeon, was on 
the Yale-New Haven Hospital 
staff for 46 years. During the 
Iwo Jima and Okinawa cam¬ 
paigns in World War II he was 
the only neurosurgeon on the 
island of Saipan, where he 
earned a Bronze Star Medal. His 
goals were to be “an honest 
surgeon and devoted father, to 
instill the love of learning into 
the hearts and minds of young 
people ... and to do harm to 
no one.” 
Joseph B.Warshaw, M.D..former 
deputy dean for clinical affairs 
and chair of pediatrics at 
the School of Medicine, died on 
December 29 from multiple 
myeloma. Warshaw was 67 and 
"an expert on fetal growth 
and neonatal medical care who 
advanced the understanding of 
the way organs mature in nor¬ 
mal and diabetic pregnancies,” 
according to his obituary in 
The New York Times. For the 
past three years Warshaw had 
served as dean of the Univer¬ 
sity of Vermont College of 
Medicine. Among his accom¬ 
plishments there was the 
launching of an m.d./ph.d. pro¬ 
gram. Warshaw was honored 
last March at the School of 
Medicine at the second "Joseph 
B. Warshaw Symposium on 
Developmental Biology.” 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire,bessinger@yale.edu 
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48 FOlloW-Up Archives 
Running for governor, again OCTOBER 1953 
Alumni Bulletin 
Throughout his eight years as governor of Puerto Rico, Pedro J. 
Rossello, M.D. ’70, M.p.H., concerned himself with two main 
issues—universal health care and statehood for the island. He 
succeeded in one with a reform that brought health insurance 
to all, yet victory narrowly eluded him in the other. In two non¬ 
binding plebiscites, voters expressed a preference for com¬ 
monwealth status. 
In 2000, at the end of his tenure, Rossello chose not 
to seek a third term. Instead he went to Washington to teach 
public health at George Washington University and analyze 
disenfranchisement and universal health care at the Woodrow 
Wilson International Center for Scholars. Early in 2003 Rossello 
announced his return to politics, and in November he won 
the pro-statehood New Progressive Party’s primary with 76 
percent of the vote. This fall he will face two candidates in 
the governor’s race. 
Rossello, who trained and practiced as a pediatric surgeon 
after earning his Yale medical degree, comes to his third race 
with a mixed legacy. In his previous terms he replaced state-run 
hospitals and clinics with an insurance program that increased 
access to health care for the poor [“A New Prescription for Puerto 
Rico,” Winter 1999]. His health care reform had its critics—includ¬ 
ing physicians who found the capitated payments too low. 
Nevertheless, by 2001 more than i.8 million of an estimated 2.1 
million potential clients were enrolled in the ongoing program. 
Despite his vigorous campaigns for statehood—which 
he believes will spur trade and investments on the island— 
Puerto Ricans have voted to maintain commonwealth status. 
And allegations of corruption in his administration have 
dogged him since he left the governor’s office. 
Rossello has not been implicated in any wrongdoing, 
but his former education secretary and the president of the 
island’s Chamber of Commerce were arrested in an investiga¬ 
tion of a kickback scheme. Another executive was convicted of 
extorting payoffs from contractors who wanted access to cabi¬ 
net members. “I know I acted in good faith at all times, not 
only legally, but ethically and morally,” Rossello said in a radio 
interview before the primary. He has pledged to crack down 
on corruption, if elected. He has also vowed to seek another 
referendum on the question of statehood. 
—John Curtis 
“General plans for the construction 
of the new Edward S. Harkness 
Memorial Residence Hall, generous 
gift of the Commonwealth Fund, 
have been completed as the result 
of several meetings of the Building 
Committee with the architects, 
Douglas Orr of New Haven and 
Cuglar, Kimball & Husted of New 
York.... It is hoped that ground can 
be broken early in 1954 and that 
the new quarters for Yale medical 
students can be finished and 
equipped for occupancy in 
September 1955.... 
“One wing, of eleven stories 
and ground floor, will provide 219 
single rooms for male students, as 
well as ten suites for students or 
graduate advisors. The other wing, 
four stories high, will contain 
thirty-five small apartments. The 
latter will be occupied by pairs of 
single women students and by a 
few married medical students and 
their wives. The single rooms will 
Include lavatories and built-in 
closets. Shower rooms will be pro¬ 
vided on each floor. The apart¬ 
ments will consist of a living room, 
bedroom, bath, and kitchenette 
unit. The apartment wing will have 
its own entrance and will also com¬ 
municate with the main lounge. 
Each wing will have its own auto¬ 
matic elevators. Other living quar¬ 
ters will include a large apartment 
for a resident manager and his 
family and a living room-bedroom- 
bath combination for the accom¬ 
modation of visiting lecturers and 
other guests of the school.... 
“Comfort and convenience 
have been emphasized.... The 
completion of the new residence 
hall should increase significantly 
the efficiency and well being of 
the able group of young men and 
women studying at the School 
of Medicine." 
vil|)KINL 
FALL/WINTER I983 
Yale Medicine 
“The John B. Pierce Foundation 
Laboratory celebrated its 50th 
anniversary on November 4th, and 
paid tribute to Dr. A. Pharo Cagge, 
fellow emeritus. Dr. Gagge has 
been a member of the Laboratory’s 
scientific staff since it was founded 
in 1933 to conduct research and 
educational programs ‘for the 
increase of knowledge to the end 
that the general hygiene and com¬ 
fort of human beings and their 
habitations may be advanced.’ 
“Dr. C.E.-A. Winslow was 
appointed the first director of the 
Laboratory while he was chairman 
of the Yale Department of Public 
Health, and he retained both 
offices until his retirement in 1945. 
Under his leadership, and that of 
subsequent directors, the 
Laboratory has gained worldwide 
recognition for its many significant I 
contributions to the field of envi¬ 
ronmental physiology. In recent 
years of energy shortages and 
increasing pollution production, 
their work has assumed added | 
importance as governments seek a j 
balance between energy conserva- I 
tion and a healthful environment, i 
“The close relationship between | 
the Pierce Laboratory and the ; 
Department of Epidemiology and ; 
Public Health has continued....” 
li 
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ON THE COVER AND THESE PACES 
Three-year-old Hailey Lyle (cover) 
was diagnosed with autism at 15 
months. Because her older brother, 
Brendan (this page), had been 
diagnosed with the disorder a year 
earlier, Hailey’s parents were on 
the lookout for symptoms. “At a 
year, we thought we were out of the 
woods with her,” says her mother, 
Pamela Lyle, “but very shortly after 
that she started to lose language and 
spiral down socially." Lyle and her 
husband, Christopher, began to inter¬ 
vene with guidance from the Yale 
Child Study Center. “We went in with 
full force and tried to spend as much 
time as possible with her,” says 
Pamela Lyle. “It’s slow going, but 
she’s definitely improved.” 
OGr4 
CONTENT 
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Mapping the social mind 
The mysteries of autism, an often-intractable disorder of 
aloneness, are starting to give way to discoveries by Yale scientists."" 
Their hope is that early intervention will help autistic children 
develop social ability and a better sense of their place in the world. 
By Peter Farley 
Life on wheels 
Filmmaker and physician Gretchen Berland gave cameras to three 
disabled people and asked them to shoot their everyday lives. 
Rollirig, the documentary that resulted, shows us what the world 
looks like from the seat of a wheelchair. 
By Cathy Shufro 
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2 Letters 
Yale Medicine 
A question of ethics. 
HOW TO REACH US 
Yale Medicine welcomes news and 
commentary. Please send letters 
to the editor (250 words or less) 
and news items to Yale Medicine, 
P.O. Box 7612, New Haven, 
CT 06519-0612, or via electronic 
mail to ymm@yale.edu, and 
include a daytime telephone num¬ 
ber. Submissions may be edited 
for length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
Ethical decisions are 
not always unanimous 
As a former Yale house officer 
trained at Yale nearly 50 years 
ago, I want to congratulate the 
bioethics program described in 
the Spring 2004 edition of Yale 
Medicine [“Two Alternatives, 
Each a Little Wrong"]. 
In the case concerning the 
schizophrenic young man whose 
mother secretly medicated him, 
I agree with the attending physi¬ 
cian. Although society does not 
surreptitiously medicate chronic 
street schizophrenics, in this 
case a dedicated caregiver (his 
mother) was available and, on 
balance, the medication given 
without the patient’s permis¬ 
sion probably contributed to his 
improvement. Unlike the bioethi- 
cist, I would have been willing 
to cooperate with the mother’s 
wishes in this treatment of a 
very major medical disease. 
I agree with the bioethicists 
in the other three cases. 
Many thanks for this inter¬ 
esting discussion. 
Donald P. Feeney, m.d., hs ’s7 
Rockford, III. 
I agree with Dr. Zonana that 
the physician should not have 
colluded with the mother who 
secretly placed medication in 
the psychotic son’s food, even 
though the result was marked 
improvement in the son’s condi¬ 
tion. It is also worth asking 
whether there might have been 
an advance directive in this case, 
in which the son, at a time when 
he was competent, expressed 
a preference for treatment. Is it 
possible that he had spoken in 
the past about the benefits of 
medication? Might he have even 
suggested that his mother hide 
his medicine in his food if he 
again became psychotic? While 
these are unlikely possibilities, 
they highlight the importance 
of considering the wishes an 
incompetent patient may have 
expressed when he was not psy¬ 
chotic. If the son had expressed 
a preference for medication, the 
ethical balance between hon¬ 
esty and patient autonomy on 
the one hand and clinical out¬ 
come on the other would have 
tilted toward treatment. In the 
legal realm, some jurisdictions 
are now recognizing health care 
proxies for psychiatric treatment. 
Burns Woodward, m.d. ’71 
Waban, Mass. 
Max Taffel, a surgeon, 
not a neurosurgeon 
I was sad to read of the death 
of Max Taffel [In memoriam, 
Spring 2004]. 
You reported that Dr. Taffel 
was a neurosurgeon. I believe 
you will find that he was a gen¬ 
eral surgeon. 
Max Taffel was the most 
memorable of the excellent 
teachers I was fortunate enough 
to be exposed to at Yale Medi¬ 
cal School from 1955 to 1959. He 
rarely missed medical grand 
rounds (despite the fact he was 
a surgeon) and he usually 
had something to say that was 
worth listening to and that 
demonstrated the great depth 
and breadth of his knowledge. 
During World War II, he 
might well have been, as you 
reported, “the only neurosur¬ 
geon on ... Saipan,” as a general 
surgeon. In my ji-year career 
as a military general surgeon, 
I did some neurosurgical cases 
myself (emergency head sur¬ 
gery for trauma) when the situa¬ 
tion demanded it. But I think 
you will find that, at least when 
I knew him and scrubbed with 
him (while acting as a substi¬ 
tute surgical intern at Grace- 
New Haven Hospital), Dr. Max 
Taffel was a general surgeon. 
Martin L. Fackler, m.d. ’59 
Cainesville, Fla. 
Dr. Fackler is correct. Max Taffel 
was a general surgeon who had 
received training in thoracic and 
neurological surgery. 
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From the Editor 3 
Seeing with new eyes 
There was a moment, probably sometime in the mid-1980s, 
when my awareness of the politics of disability eclipsed my 
awareness of what it means to be disabled. The latter was 
never that developed, since I grew up without disability and 
had no close friends or relations who were disabled. But 
although my knowledge was second- or third-hand, I wasn’t 
indifferent. Like many others, I had been raised to appreci¬ 
ate the hardships and rights of disabled people, whom we 
knew then as “handicapped.” (The H-word had not yet been 
retired as politically incorrect.) 
At a certain point though, I now realize, I must have 
lost a measure of empathy. This could have been the result 
of my own self-absorption or a reaction to the stridency of a 
particularly militant point of view I encountered somewhere; 
I don’t recall. All I know is that somewhere between my first 
job and third child, a thought nested in my consciousness 
that said, “Sure that’s hard, but life is tough all over.” 
Gretchen Berland’s film Rolling changed all this. 
Rolling, the subject of Cathy Shufro’s article (“Life on 
Wheels,” page 26), is powerful in the simplicity of its basic 
premise: Berland equipped three disabled people in Los 
Angeles with digital video cameras and asked them to record 
the events of their daily lives. The intimate, 70-minute film 
that resulted shows what it is like to depend on a wheelchair, 
and does so in a way that an objective, third-person docu¬ 
mentary likely could not have. For me, the realization that 
life just isn’t as hard for most of us came when one of the 
three protagonists, Vicki Elman, was obliged to roll herself 
off the sidewalk and into city traffic in order to get around a 
carelessly placed newspaper box. The obstacle would have 
been insignificant to another pedestrian, but Elman’s solu¬ 
tion put her life at risk. My new attitude was reinforced later 
in the film when Elman, who has multiple sclerosis, was 
stranded outside her home, alone as the sun went down, 
hours after a van driver, citing company rules, had refused 
to wheel her inside. 
Rolling changed how I feel, but this was not the 
director’s first goal. Berland, an assistant professor of medi¬ 
cine at Yale who began the project as a Robert Wood 
Johnson Clinical Scholar at ucla, says her initial purpose in 
making the film was to explore a rather unconventional 
research tool—the documentary film—and to produce new 
knowledge about disability in the process. “You can use the 
visual medium to explore aspects of a patient’s experience 
that we might not otherwise be able to capture using any 
other kind of data collection tool,” says Berland, who was 
a producer for NOVA and NewsHour before studying medi¬ 
cine. Her colleague Harlan Krumholz, m.d., calls the 
film a much-needed complement to huge analytical studies 
of clinical data that reveal patterns on a large scale but 
contribute little to doctors’ understanding of “the tapestry 
of what makes up [patients’] lives.” 
If you get the chance to see Rolling, jump on it. Two short 
clips may be viewed on our website, yalemedicine.yale.edu, 
and the film is being screened at festivals. In an era when 
politics have become increasingly polarized and we risk cate¬ 
gorizing people as either “us” or “them,” Rolling reminds us 
in a straightforward and honest way of the common ground 
we all share as human beings. “There but for the grace ...” 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
SECOND OPINION BY SIDNEY HARRIS 
"Irs JU3T A IV\\LP HrpERiNSULlSM Dat To 
ISLTT CEIL HTPERPivASiA WiTH A ToucA oF 
IdTPATlC ItJS'-lFFhlltHCY' PEPlTTiON. 
In OTHER vVOCps,^ wATCH Y&UR DIFT. '' 
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4 chronicle news from cedar street 
With President Richard Levin at his side, 
Robert Alpern, left, the 16th dean of 
the medical school, greeted faculty in the 
Historical Library in April. Alpern, who 
served as dean of the University of Texas 
Southwestern Medical School, started 
at Yale on June 1. 
A down-to-earth leader 
who gets things done 
Texas dean Robert Alpern, 
a distinguished nephrologist, 
takes the reins at Yale. 
When Donald W. Seldin, m.d. ’43D, 
HS ’46, was recruiting a chief nephrolo¬ 
gist to the University of Texas (UT) 
Southwestern Medical Center in 1987, 
one of the names on his list was Robert 
J. Alpern, m.d., a junior faculty mem¬ 
ber at the University of California, San 
Francisco (ucsf) and a rising star in 
the field of kidney research. “He had 
just barely finished his own training,” 
recalled Seldin, a Yale alumnus who 
served as Southwestern’s chair of medi¬ 
cine for 38 years and helped build the 
Dallas school into an academic power¬ 
house. “In surveying the country, I 
thought he was one of two people who 
had what I was looking for, despite 
his young age.” 
A dozen years later, Alpern was 
named dean of UT Southwestern’s 
medical school, and in late April of this 
year he was introduced to Yale faculty 
members as the School of Medicine’s 
16th dean. He began work a month 
later, on June i. 
Alperris reputation as an affable 
colleague and a leader who gets 
things done preceded him. “Bob is an 
extraordinary catch for us,” Yale 
President Richard C. Levin told the 
faculty gathering on April 30, “He 
is a person who not only has a record 
of accomplishment [as a dean and 
section chief], but also one who has 
all the human qualities that make 
an outstanding leader. He is a highly 
accomplished scientist, a fabulous 
teacher ... and a person who inspires 
confidence and has the support of vir¬ 
tually everyone with whom he works.” 
A native of Brooklyn, N.Y., who 
grew up on Long Island, Alpern 
attended Northwestern University and 
the University of Chicago’s medical 
school before training in internal medi¬ 
cine at Columbia and nephrology at 
UCSF. At UCSF he was a solidly well- 
rounded academician, excelling as a 
teacher and clinician and launching 
a research career focused on the under¬ 
lying mechanisms of acid-base balance 
in the kidney. He traces his interest in 
medicine to an early love of science and 
a desire to help others and fondly recalls 
the month he spent at Yale as a visiting 
fourth-year medical student in 1975. 
It was in the lab that he met his 
wife and research collaborator, Patricia 
A. Preisig, ph.d. They began working 
together when he was a postdoctoral 
fellow and she was a graduate student 
in the lab of Floyd C. Rector Jr., m.d., 
at ucsf; since then they have focused 
their studies on better understanding 
the role of the kidney’s proximal tubule 
in acid-base regulation. Their work 
has shown how two molecules, the 
Na/H antiporter known as NHE3 and 
the citrate transporter NaDC-i, mediate 
the kidney’s ability to excrete acid and 
defend against a metabolic acidosis. 
Preisig will be moving her lab to 
New Haven as a faculty member in the 
Department of Internal Medicine in 
2005; for the coming academic year, 
she will remain in Dallas, where their 
daughter, Rachelle, will be a high 
school senior. Their son, Kyle, is start¬ 
ing ninth grade. 
Gerhard H. Giebisch, m.d., remem¬ 
bers meeting Alpern in the early 1980s 
5 
when Alpern interviewed at Yale to 
spend time in the Giebisch lab. They 
have remained friends and colleagues 
ever since. According to Giebisch, 
Alpern has become a world leader in 
the field of acid-base regulation in the 
kidney. “His work has really been fun¬ 
damental and pushed the field for¬ 
ward,” said Giebisch, Sterling Professor 
of Gellular and Molecular Physiology, 
citing Alpern’s development of sophisti¬ 
cated fluorescence techniques for meas¬ 
uring acid inside living kidney cells, 
which previously had not been possible. 
Alpern also worked out key details that 
explain how nephrons compensate to 
handle an increased acid load, as might 
occur during kidney failure. 
Search committee members said 
they were impressed by Alpern when he 
visited New Haven in February and 
March. “He listened effectively, he was 
thoughtful and he was down-to-earth,” 
said committee member David L. 
Goleman, m.d., hs ’8o, the interim 
chair of medicine. (According to Seldin, 
Alpern was successful in Dallas because 
he cared a great deal about quality 
and is “thoughtful, composed and bal¬ 
anced.”) In checking Alperris refer¬ 
ences, “one of the striking things about 
him was that there wasn’t a single call 
that wasn’t positive,” another search 
committee member said. “The consen¬ 
sus was that he is absolutely fabulous. 
He comes across as youthful, energetic 
and very, very bright.” And despite his 
easygoing personality, he apparently 
has the ability to make tough decisions. 
“The story we heard more than once 
is that you go into his office to make a 
request, he says no—and you feel 
good about it. That’s a rare talent.” 
Alpern said he is coming to Yale 
with major goals that he began formu¬ 
lating during the interview and nego¬ 
tiation process. “I sensed that at every 
level, from President Levin and Provost 
[Susan] Hockfield all the way down, 
everyone wants to make Yale School 
of Medicine better.” He said he asked 
Levin for significant resources to do 
just that and that “we were in total 
agreement on the vision for the school” 
regarding programs, space and faculty. 
“Without going into details,” he said, 
“the university was generous in its sup¬ 
port.” Levin confirmed this when he 
introduced Alpern in April, noting that 
the economics of medical schools “are 
not what they were 20 years ago.” 
“Medical margins are tight, recover¬ 
ies on grants are not fully compen¬ 
satory, and we recognize that until the 
school develops the kind of philan¬ 
thropic base that it must develop over 
the coming years,” Levin said, “the 
university is going to have to step in 
and provide the resources that will 
stop it from treading water.” 
Alpern said his vision for the school 
is “to have outstanding programs in 
education, research and clinical care. 
These programs should be as good as 
they can be, among the best in the 
world. Yale already has many outstand¬ 
ing programs in these three arenas that 
are likely among the best, but no medi¬ 
cal school is perfect in all aspects. We 
will identify our priorities for program 
improvement and then move forward.” 
As Alpern prepared to move to New 
Haven, UT Southwestern named an 
acting dean to see it through its coming 
search process for a new leader. For 
this post, UT chose a Yale alumnus, 
pharmacologist Alfred G. Gilman, m.d., 
PH.D., a winner of the 1994 Nobel 
Prize in physiology or medicine for the 
discovery of G-proteins. 
Levin praised neurosurgery Ghair 
Dennis D. Spencer, m.d., hs ’77, who 
served as interim dean for the past 
year, for “an absolutely spectacular job” 
shepherding the school and building 
bridges among its diverse constituen¬ 
cies. “He brought this faculty together 
in a way it hadn’t been for some time 
and worked very hard to collaborate, 
not only within the medical school but 
also with the university and hospital, in 
ways that were welcomed by all of us.” 
—Michael Fitzsousa 
For doctors, scientists, 
workshop series is 
an initiative in translation 
Catalin S. Buhimschi, m.d., is just 
starting out on his research career 
studying high-risk pregnancies in the 
obstetrics, gynecology and reproduc¬ 
tive sciences department. Cardiologist 
Albert J. Sinusas, m.d., an associate 
professor in the departments of medi¬ 
cine and diagnostic radiology, investi¬ 
gates diseases that typically occur at 
the other end of life. He looks for 
ways to image and model the beating 
heart, especially after an infarction, 
to improve diagnosis and treatment. 
Under normal circumstances, their 
paths might never cross, but they dis¬ 
covered they had much to talk about 
when they finally met. 
The meeting of the two investiga¬ 
tors was just one of the unlikely, and 
potentially productive, encounters 
among faculty who attended the Dean’s 
Workshop on May 7 in the Anlyan 
Center Auditorium. The meeting was 
the first in a series of events designed 
to bring together basic scientists, 
clinical researchers and clinicians from 
across the School of Medicine to 
explore ways to move basic science 
advances more swiftly to patient care. 
The workshops are part of a larger 
initiative launched last academic year 
by Interim Dean Dennis D. Spencer, 
M.D., HS ’77, who told the overfiow 
audience, “This is an attempt to fur¬ 
ther focus our efforts on why we are 
here: patients and patients’ health.” 
As part of that initiative, Spencer 
also announced a commitment by 
the School of Medicine of up to $i mil¬ 
lion in funding for pilot projects that 
bring basic and clinical scientists from 
different departments together. The 
two-year grants will provide up to 
$150,000 with the aim of generating 
data that will attract additional outside 
funding. Said Spencer, “I visualize a 
research continuum where human 
investigators and basic researchers will 
focus together on a single problem.” 
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Tlie translational research pro¬ 
gram comes partly in response to the 
Roadmap initiative announced by 
the National Institutes of Health (nih) 
last September, nih Director Elias A. 
Zerhouni, m.d., had identified major 
opportunities and gaps in biomedical 
research that no single institute at nih 
could tackle alone, but that the agency 
as a whole could address to make 
the biggest impact. The Roadmap also 
established new funding for research 
across institutes. 
The first Dean’s Workshop focused 
on Yale’s magnetic resonance imaging 
core research facility and some of its 
applications for structural and func¬ 
tional studies. Three faculty members 
from the Magnetic Resonance 
Research Center, James S. Duncan, 
PH.D., R. Todd Constable, ph.d., and 
Douglas L. Rothman, ph.d., spoke 
about their efforts to develop new con¬ 
trast mechanisms and algorithms to 
improve both imaging methods and 
understanding of the results. Much of 
that work results from helping basic 
and clinical investigators carry out 
their research. “We all work in a col¬ 
laborative matrix,” Duncan said. 
Three clinical researchers— 
Sinusas, neuroscientist Marcia K. 
Johnson, ph.d., and diabetes investiga¬ 
tor Gerald I. Shulman, m.d., ph.d., 
gave overviews of their studies using 
imaging technologies. Sinusas said 
findings from his 15-year effort with 
Duncan to model and analyze the 
changing shape and structure of the 
beating heart may help predict heart 
wall damage and patient prognosis fol¬ 
lowing an infarct. 
After the workshop, Buhimschi, an 
instructor in obstetrics and gynecology, 
spoke with Sinusas about his efforts to 
model the changing uterus. “I was 
aware of Yale’s interest in new imaging 
techniques, but I wasn’t aware of Dr. 
Sinusas’ work,” he explained later. “I 
hope to identify ways to pursue our 
idea, maybe even together with him. 
Ultimately, I will apply for a grant.” 
—Marc Wortman 
An author and physician 
helps residents become better 
doctors through writing 
Physicians who listen to their patients’ 
stories—who listen as writers would— 
strengthen their relationships with 
those patients, according to physician 
and author Abraham 'Verghese, m.d., 
M.F.A. And doctors who forge these 
connections to their patients are likely 
to take better emotional care of them¬ 
selves as well, said Verghese, speak¬ 
ing recently at medical grand rounds. 
“To be aware of stories is to be 
empathetic. ... What we’re talking 
about is imagining the patient’s life,” 
said Verghese, director of the Center 
for Medical Humanities and Ethics at 
the University of Texas Health Science 
Center at San Antonio. Verghese wrote 
My Own Country: A Doctor’s Story, a 
memoir of caring for aids patients in 
Tennessee in the early days of the 
epidemic, which Time magazine called 
one of the five best books of 1994. 
Verghese’s talk, “What the Pen 
Teaches the Stethoscope,” was linked 
to a writer’s workshop for residents 
that he’d run last fall. The workshop 
was part of efforts by the Department 
of Internal Medicine to strengthen the 
doctor-patient relationship, said Asghar 
Rastegar, m.d., the department’s asso¬ 
ciate chair for medical education and 
academic affairs. 
“Our goal is to provide a counter¬ 
weight to the increasing use of medical 
technology, which requires less direct 
contact between physician and patient,” 
said Rastegar, who developed the writ¬ 
ing program in partnership with former 
Chair Ralph I. Horwitz, m.d. (Surgeon 
and medical writer Atul Gawande, m.d., 
M.P.H., this year’s Commencement 
speaker, spent time with the residents 
in May.) 
Fourteen medical residents, chosen 
on the basis of writing samples, spent 
two and a half days with Verghese 
critiquing one another’s work. In 
teaching the residents, Verghese used 
techniques he’d learned at the Iowa 
Writers’ Workshop at the University of 
Iowa in 1990-91. The residents com¬ 
piled their stories about patients, both 
fictional and real, in a booklet called 
Capsules. They read from their work 
when Verghese returned in January as 
part of the program financed by a fund 
in memory of Fredrick L. Sachs, m.d. 
Workshop participant Amy M. 
Nuernberg, m.d. ’00, chief resident 
in medicine, said she experienced 
a catharsis while writing about a col¬ 
lege student in her care who had 
died in a matter of weeks. “It made 
EPH RECEIVES GRANT FOR MAPPING LYME DISEASE RISK 
Durland Fish, ph.d., professor of epidemiology, has received a 
$2.9 million, four-year grant from the Centers for Disease Control 
and Prevention to map the risk of Lyme disease infection in the 
eastern United States. Fish and his colleagues will focus on the 
prevalence and genetics of Lyme disease bacteria carried by ticks 
in the largest field study of tick-borne diseases conducted in 
the United States. Satellite imagery and geographic information 
systems will be applied to the project. 
—John Curtis 
7 
me realize how strongly it had 
affected me,” said Nuernberg. “She 
wasn’t just another patient. ... It 
helped me sort out on paper all these 
conflicted emotions.” 
In his talk, Verghese described 
what he’d recommended to the resi¬ 
dents: that they try to delineate in their 
patients’ predicaments elements of 
drama—danger, desire and a crucial 
insight, or epiphany. For patients, a 
simple doctor’s visit can contain all 
these elements, said Verghese: “When 
they come to see you, your patient is 
engaged in a story. ... There is danger 
lurking. There is danger and a great 
desire to walk away with a clean bill of 
health and a blessing to go on.” Good 
news or bad, the diagnosis can be a 
kind of epiphany. 
Verghese acknowledged that it’s 
easy to reduce patients to labels: 
a ROM I becomes a miro who may 
nonetheless need a cabg (that is to 
say: a “rule out myocardial infarction” 
becomes a “myocardial infarction 
ruled out,” possibly needing a “coro¬ 
nary artery bypass graft”). When 
doctors use “the voice of medicine,” 
said Verghese, “they begin to lose sight 
of the person, and people become 
almost disease labels. ... Even though 
it’s the language of medicine you 
record in the chart, let the voice of the 
patient stay alive in your imagination.” 
By writing, and thus bringing to 
the surface the feelings that patients’ 
stories engender, physicians stay 
I in touch with their own humanity. 
! “It’s very difficult to walk through a 
life in medicine and see the carnage 
you and I see and not to experience 
intense emotions,” said Verghese. 
But the “macho culture” of medicine 
encourages doctors to suppress 
their pain. “We’re in a very secret 
and lonely business.” 
Gastroenterologist Michael G. 
Bennick, m.d., concurred with Verghese, 
saying that writing about a painful 
experience provides “an opportunity to 
listen all over again. You needn’t shut 
out that pain; once the blinding light 
passes, it’s often illuminating,” said 
Bennick, an assistant clinical professor 
and the associate chief of medicine, 
who attended the residents’ reading. 
Verghese argued that doctors who 
repress their feelings not only dis¬ 
tance themselves from their patients 
but also “begin to do that to them¬ 
selves.” Verghese noted that doctors 
often guard against pain in dysfunc¬ 
tional ways. “I think of it [medicine] 
as a romantic pursuit, but I have 
seen its seamy underbelly,” said 
Verghese, whose 1998 memoir. The 
Tennis Partner: A Doctor’s Story of 
Friendship and Loss, tells the story of 
a medical resident, a close friend, 
struggling with a powerful addiction 
to drugs. 
Verghese said that reading fiction 
could help doctors reconnect with deep 
feelings. As can writing. 
“I would encourage everybody to 
keep a journal. It keeps you healthy,” 
said Verghese. 
—Cathy Shufro 
NEW INSTITUTE TO EXPLORE CORTEX 
The Kavli Foundation of Oxnard, Calif., has 
endowed the Kavli Institute for Neuro¬ 
science at Yale University to pursue multidis¬ 
ciplinary studies of the cerebral cortex. 
Pasko Rakic, m.d., PH.D.,the Dorys McConnell 
Duberg Professor of Neuroscience and 
professor and chair of neurobiology, will 
direct the new institute. 
“The cerebral cortex is universally recog¬ 
nized as the instrument of human intelli¬ 
gence,” Rakic said. “The goal of the institute 
is to understand how arrangement of the 
nerve cells and their synaptic circuits in the 
cortex embody knowledge of the outside 
world. We will study how molecular changes 
in these circuits imprint learning of some¬ 
thing new and retain what we already 
know. We will also explore how our genome 
constructs the microarchitecture of the 
cerebral cortex, which is able to carry out 
high cognitive functions such as language 
and thought.” 
—John Curtis 
HOSPITAL IMAGING GOES DIGITAL 
Film and paper will become things of the 
past as the Department of Diagnostic 
Radiology begins implementing a digital 
archive of radiological images. The new 
Picture Archiving and Communication 
System is a filmless information system for 
acquiring, sorting, transporting, storing 
and displaying medical images. 
“Imagine how much easier it will be to 
log on and view images and reports rather 
than shuffle through all that X-ray film and 
paper,” said James A. Brink, m.d., interim 
chair of diagnostic radiology. According to 
Steve Bencivengo, director of diagnostic 
imaging at Yale-New Haven Hospital, the 
move to a digital system allows physicians 
to access images and radiology reports 
through a secure hospital network. This new 
system also creates a permanent, non- 
degradable archive. Implementation of the 
new system began last fall and should be 
complete by December of this year. The sys¬ 
tem will archive all diagnostic images. 
—J.C. 
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Rounds MEDICINE AND HEALTH AT YALE 
Searching for a 
second skin 
By introducing a blood supply, 
Yale team overcomes some of the 
shortcomings of artificial skin. 
Before the arrival of artificial skin in 
the 1970S, medical options for severe 
dermatological damage (widespread 
burns, blistering diseases, trauma 
wounds, extensive surgical excisions) 
ranged somewhere between scarce 
and nonexistent. Bandages and oint¬ 
ments were applied, followed by 
hopes and prayers that the patient’s 
skin, the only self-repairing organ 
in the body, would heal itself The 
lifesaving options provided by artifi¬ 
cial skin—human skin equivalents 
composed of everything from engi¬ 
neered porcine skin to skin from 
human cadavers—changed the face 
of dermatology. 
Now, a Yale research team led by 
Jeffrey S. Schechner, m.d. ’91, assist¬ 
ant professor of dermatology, is on 
the verge of changing the face of arti¬ 
ficial skin. 
“[Artificial skins] were originally 
marketed as skin replacements, 
but in reality they functioned as bio¬ 
logical dressings,” said Schechner. 
“They improve wound healing by 
some measurable amounts but they 
are not skin replacements.” 
Schechner’s team, whose findings 
were published in The FASEB Journal, 
suspected that the reason these skin 
equivalents failed was that they did 
not develop perfusion—there were no 
blood vessels to allow blood flow after 
transplantation. The challenge, then, 
was to encourage vascularization in 
this artificial skin; that is, to replicate 
the mechanism of living skin tissue. 
“Without a network of blood 
vessels, there is inadequate delivery 
of oxygen and nutrients in the 
critical posttransplantation period,” 
said Schechner. 
The team’s experimental scaffold 
was acellular dermis (human cadaver 
skin), in which the cells are dead 
but a supportive matrix remains. This 
matrix was seeded with cells taken 
from the veins of umbilical cords 
which were modified to overexpress 
the gene Bcl-2, a modification that 
has previously enhanced blood vessel 
formation. (The Bcl-2 gene produces 
a protein that protects cells from 
enzymes that trigger cell death.) The 
matrix was then transplanted onto 
mice in Schechner’s lab. 
It took more than two years of 
experimentation before Schechner 
had his eureka moment. “Within 
two weeks grafts that contained the 
Bcl-2 endothelial cells consistently 
developed blood vessels. ... and were 
perfused with mouse blood,” he said. 
Further, these grafts held, and 
matured, over an eight-week period. 
Schechner is quick to emphasize 
that theirs is “still an experimental 
model, not a clinical model.” None¬ 
theless, the potential benefit, if it 
does lead to a clinical product, will 
dramatically alter the role of artifi¬ 
cial skin. 
“This has been a huge area of 
research and clinical efforts for many 
in the field,” said Schechner, who is 
also chief of dermatology at the VA 
Connecticut Healthcare System in 
West Haven. “We ail want the best 
way to dress [burn victims and surgi¬ 
cal patients] and decrease the mortal¬ 
ity and morbidity associated with 
these conditions.” 
—Alan Bisbort 
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Increased risk of non- 
Hodgkin’s lymphoma linked 
to hair dye 
warning: The prolonged use of hair 
dye, especially permanent black, brown 
and red, may be hazardous to your 
health. That’s the conclusion reached by 
Yale researchers in a study published on 
January 15 in the American Journal of 
Epidemiology. The scientists found that 
long-term users of hair-coloring prod¬ 
ucts have an increased risk of develop¬ 
ing non-Hodgkiris lymphoma, a cancer 
that attacks the lymphatic system, part 
of the body’s immune system. “We 
found that people who used permanent 
dark hair dye for more than 25 years 
and started before 1980 will have more 
than twice the risk compared to people 
who never used hair-dye products,” said 
Tongzhang Zheng, sc.d., associate 
professor of epidemiology and environ¬ 
mental health. Zheng said the study 
was prompted by an unexplained jump 
in the number of non-Hodgkiris lym¬ 
phoma cases in the last 40 years. In the 
early 1970s, there were about 10 cases 
out of every 100,000 people in the 
United States. By 1990, that number 
had increased to 19 cases. Today it’s 
shll increasing in the United States and 
around the world. 
The health risks of hair dye have 
been explored for years, but Zheng 
says previous studies have been contra¬ 
dictory and inconclusive. He and 
his research team conducted a six-year, 
case-controlled study of 601 Connechcut 
women between the ages of 21 and 
84 diagnosed with varying subtypes of 
non-Hodgkiris lymphoma. The women 
were asked about the type of hair color¬ 
ing they used, the length of rime they 
used the products and their age when 
they stopped. The study included a 
control group of 717 healthy women 
matched by race, age and other factors 
with the case group. 
Researchers found the highest risk 
among users of darker permanent 
dyes, rather than among those who 
used semipermanent or temporary dyes. 
Zheng says that’s because darker dyes 
may contain higher levels of chemicals, 
and permanent dyes use an oxidizing 
process that creates new, potentially 
harmful chemicals. 
The good news is that researchers 
didn’t find any increased risk of non- 
Hodgkiris lymphoma among women 
who started using hair-coloring products 
after 1980. This could be because the 
contents of hair-dye formulas may 
have changed and become safer, or it 
could simply mean that not enough 
rime has passed to evaluate the effects 
on this group. Zheng said further 
studies would have to be conducted to 
determine whether post-1980 hair 
dyes are indeed safer. 
Noting that hair color is directly 
related to image—“how people are per¬ 
ceived and how they perceive them¬ 
selves,” Zheng said that the study results 
need to be duplicated in different popu¬ 
lations. Meantime, users of hair dyes 
should consider the trade-offs and alter¬ 
natives, such as semipermanent dyes. 
-Jennifer Kaylin 
SOME VETS BETTER AFTER 9/11 
After the terror attacks of September 11,2001, 
veterans with pre-existing post-traumatic 
stress disorder (ptsd) showed fewer symp¬ 
toms—including nightmares, reactions to 
loud noises and numbness of feelings—than 
veterans admitted to clinics and hospitals 
in the previous six months and in previous 
years, according to a Yale study. 
“Anecdotal reports from VA clinics sug¬ 
gest that some veterans, far from being 
overwhelmed by the horrific destruction, 
experienced feelings of familiarity, mastery 
and competence as survivors who had 
been exposed to horror in the past, but who 
had experience in coping with the resultant 
painful memories,” said Robert A. Rosenheck, 
M.D., HS ’77, professor of psychiatry and 
epidemiology and public health. His study 
was published last year in Psychiatric Services. 
Although they were far from cured, these 
patients “seem to have benefited from 
the increased sense of community, patriot¬ 
ism and national pride across the country,” 
Rosenheck said. 
—John Curtis 
CUTTING DOWN HELPS SMOKERS QUIT 
Cutting down on the number of cigarettes 
smoked can help older smokers kick the 
habit, according to a Yale study. 
“Most experts will say there is only 
one way to quit smoking and that is to stop 
smoking altogether,” said Tracy A. Falba, 
PH.D., associate research scientist in the 
Department of Epidemiology and Public 
Health and lead author of the study, which 
was published in Add/ct/on, the journal 
of the Society for the Study of Addiction. 
"Cutting down the number of cigarettes 
smoked, however, seems to promote quit¬ 
ting. Cutting down first may be an option 
for people trying to quit.” 
The study used data from a national 
study of Americans between the ages of 
51 and 6i, but the concept could apply to 
smokers of any age, Falba said. 
—J.C 
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Findings from the bench 
The hormonal 
component 
A new study finds a link between 
stress, high levels of estrogen and 
certain mood disorders. 
The ancients blamed women’s sus¬ 
ceptibility to mental illness on low 
body temperature, which made 
them prone to “cold” diseases caused 
by black bile. More recent theories 
blamed the pressures of balancing 
a career and family life. A new study 
suggests that the vulnerability may 
hinge on hormones. 
High levels of estrogen amplify the 
effects of stress on the prefrontal cor¬ 
tex, an area of the brain associated 
with mental disorders such as depres¬ 
sion and post-traumatic stress disor¬ 
der, the Yale study found. This could 
explain why such illnesses occur twice 
as often in women as in men and 
why the discrepancy is most marked 
between puberty and menopause. 
For a study published in the May 
issue of Molecular Psychiatry, neurobi¬ 
ology graduate student Becca Shansky 
and associate professor of neurobiol¬ 
ogy Amy Arnsten, ph.d., exposed rats 
to different levels of stress and then 
tested them on a working memory 
task that depends on the prefrontal 
cortex. Female rats were more sensi¬ 
tive than males to moderate levels of 
stress, but only when the females were 
in the high-estrogen phase of their 
estrus cycle. The same sensitivity was 
seen in females that had their ovaries 
removed and were then implanted 
with time-release estrogen capsules. 
It was not observed in females that 
received a placebo instead of estrogen. 
Now Shansky is trying to sort out 
the mechanism underlying the effect. 
Previous research in Arnsteris lab 
offers a few hints. Stress releases 
excess dopamine and norepinephrine 
in the prefrontal cortex, which activate 
receptors that cause stress-related 
impairment, says Shansky. “It’s also 
known that estrogen regulates the 
expression of these receptors. Now 
we’re trying to see which one or ones 
are involved in mediating this activity.” 
Research by another group at the 
University of Pittsburgh Medical Center 
has added to the picture. Genetic stud¬ 
ies of people with depression turned up 
an alteration in crebi, a gene that 
encodes the regulatory protein creb. 
“We really perked up when we 
heard that, because the very intracellu¬ 
lar pathways that impair the prefrontal 
cortex turn on this gene product,” 
Arnsten said, adding that in young 
women with circulating estrogen, “the 
activity of the intracellular pathway 
might be sufficient to cause significant 
prefrontal cortical dysfunction, lead¬ 
ing to depression.” Shansky has experi¬ 
ments under way to determine whether 
female rats with high estrogen are 
more vulnerable to activation of crebi 
than those vhth low estrogen. 
“It’s very important that our results 
are not interpreted as saying that 
women shouldn’t take stressful jobs or 
expose themselves to stress,” says 
Shansky. “It’s more a matter of looking 
at the mechanisms involved to see if 
we can find new ways of treating 
depression.” It’s also important to note 
that these brain changes occur with 
uncontrollable stress, Arnsten adds. 
A long history of animal and human 
research has shown that a sense of 
control over the stressor protects 
cognitive and physiological responses. 
Though the Yale experiments 
involve lab animals, they may apply 
to people, says Arnsten. The genetic 
studies show changes in the same 
molecular pathway that we are study¬ 
ing in rats. It is very encouraging.” 
—Nancy Ross-Flanigan 
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Yale scientists identify 
an early line of defense against 
West Nile virus 
In the five years since the West Nile 
virus made its first appearance in New 
York, it has spread to virtually all of the 
contiguous 48 states. There has been 
an alarming increase in infections and 
the most serious cases have resulted in 
death from encephalitis. The Centers 
for Disease Control and Prevention 
reported about 9,000 cases of West 
Nile infection last year—more than 
double the number reported in 2002— 
and more than 200 deaths. Among 
those looking for ways to prevent and 
treat West Nile is Erol Fikrig, m.d., 
professor of medicine (rheumatology), 
who has spent the past ii years investi¬ 
gating the biology of arthropod-borne 
illnesses, including Lyme disease. 
Most of those infected with West 
Nile virus experience only mild illness, 
and some have no symptoms at all. 
Only about 30 percent of patients, 
many of them elderly or with compro¬ 
mised immune systems, succumb to 
the most serious form of the illness 
characterized by encephalitis. In a 
paper published last September in The 
Journal of Immunology, Fikrig and his 
colleagues offered a new explanation 
for why most patients are able to suc¬ 
cessfully fight off the virus shortly after 
infection. 
In 2001, Fikrig’s group successfully 
immunized mice against West Nile by 
injecting the mice with genetically 
engineered fragments of the protein 
shell that encapsulates the virus; expo¬ 
sure to the harmless fragments caused 
the mice to develop antibodies against 
the virus. But it took three to four days 
for the vaccinated mice to deploy these 
antibodies, and clinical experience has 
shown that time is of the essence in 
treating West Nile. 
Fikrig thought that in mildly ill 
patients West Nile’s relentless pace 
might have been stalled by some early 
immune response that clears the virus 
and gives these individuals time to 
marshal an antibody defense. He con¬ 
cluded that understanding these very 
early immune reactions is crucial to 
preventing severe illness and death. 
Talking one day with Joseph E. Craft, 
M.D., HS ’77, professor of medicine 
and immunobiology and chief of the 
Section of Rheumatology, Fikrig 
learned of an immune cell with all the 
right characteristics. 
Craft, who specializes in autoim¬ 
mune illnesses such as lupus, has 
extensively studied gamma delta T 
cells, which are believed to serve as a 
bridge between innate immunity, the 
body’s first line of defense, and later 
immune reactions. “We thought that 
gamma delta T cells might play a role 
in this early time window,” Craft said. 
Along with postdoctoral researcher 
Tian Wang, ph.d., Fikrig tested the 
hypothesis. Wang injected West Nile 
into a strain of mice that lack gamma 
delta T cells and found that these 
mutant mice were markedly more 
susceptible to infection than nor¬ 
mal animals, and quicker to develop 
encephalitis and die once infected. 
When Wang injected activated gamma 
delta T cells into the mutants, they 
fought off the disease. 
But Fikrig isn’t yet sure just how 
gamma delta T cells mount an early 
defense against West Nile. With the 
help of Eileen P. Scully, an m.d./ph.d. 
student in Craft’s lab, Fikrig showed 
that the cells multiply dramatically 
and are activated quickly after infec¬ 
tion. Scully also demonstrated a link 
between early and late immune reac¬ 
tions; gamma delta T cells produce 
interferon gamma, a potent molecule 
that attacks viruses and stimulates the 
immune system to produce antibodies. 
Next Fikrig plans to see whether 
gamma delta T cells work in the same 
way in humans. If the results hold 
up, pharmaceutical companies might 
be able to make antiviral drugs that 
fight West Nile by boosting gamma 
delta T cell activity or interferon 
gamma production. 
—Trisha Gura 
A SIGNAL THAT THE END IS NEAR 
A chemotherapeutic agent used against can¬ 
cer for more than 30 years has a secondary 
effect of inducing "death signals” that kill 
neighboring cells, according to Yale scientists. 
The agent, cisplatin, disrupts transcription 
and replication in tumor cells. It helped cyclist 
Lance Armstrong recover from testicular can¬ 
cer and also works against lung, neck, cervi¬ 
cal and ovarian cancers. In a study published 
in the Proceedings of the National Academy 
of Sciences in April, senior author Peter M. 
Glazer, m.d./ph.d. ’87, HS ’91, professor and 
chair of the department of therapeutic radi¬ 
ology, reported that cells affected by cisplatin 
can produce a death signal that also kills 
neighboring cells. The phenomenon occurs 
only when there is a high density of cells that 
touch each other and communicate through 
channels called gap junctions. It also appears 
to require the activation of dna-pk, an 
enzyme involved in dna damage response. 
“If we can understand this mechanism,” 
Glazer said, “it will help us to identify poten¬ 
tial targets for manipulation.” 
—John Curtis 
ENZYME LINKED TO EPILEPSY 
Small amounts of glutamate help the brain 
to function normally, but high concentra¬ 
tions of the neurotransmitter have been 
linked to temporal lobe epilepsy (tle), a com¬ 
mon form of epilepsy that is frequently 
drug-resistant. 
A Yale study published in The Lancet has 
found that people with tle also have low 
levels of glutamine synthetase, an enzyme 
that transforms glutamate into the non¬ 
toxic chemical glutamine. 
“We don’t know why glutamine syn¬ 
thetase is decreased in tle, but this is some¬ 
thing we are exploring in our laboratory 
right now,” said lead author Tore Eid, m.d., 
PH.D., an associate research scientist in the 
laboratory of Nihal C. de Lanerolle, d.phil., 
associate professor of neurosurgery and 
neurobiology. “We also want to see if we 
can stop the seizures and reduce the brain 
damage in tle by boosting the activity 
of glutamine synthetase.” If this turns out 
to be the case, Eid added, then it is possi¬ 
ble that glutamine synthetase could be a 
new target for drug therapy. 
—J.C. 
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Dyslexia’s hidden contours 
Sally Shaywitz scores a hit with a scientific guide to 
diagnosing and treating reading disorders. 
By Cathy Shufro 
At least one child in five has dyslexia, a congenital “wiring 
glitch” in the brain that makes it hard to master what neuro¬ 
scientist and behavioral pediatrician Sally E. Shaywitz, m.d., 
calls “the most elegant and complex of human abilities— 
learning to read.” 
Dyslexia is an inherited problem that cuts across class, 
race and language, says Shaywitz, professor of pediatrics. 
Yet “significantly less than half” of American children with 
dyslexia are even identified. Shaywitz finds this frustrating 
because researchers have developed reliable diagnostic pro¬ 
cedures and evidence-based instruction that, in young stu¬ 
dents, may even rewire the brain. “A huge gap, almost an 
abyss, separates what we know and what happens to people 
with reading problems,” she says. 
Shaywitz has helped close that gap through her own 
research and clinical work and by writing about the science 
of reading and dyslexia. Her goal, she says, is “making 
a complex disorder understandable and treatable.” Five 
years in the writing. Overcoming Dyslexia: A New and 
Complete Science-Based Program for Reading Problems at 
Any Level (Alfred A. Knopf) has brought Shaywitz sus¬ 
tained national attention since its publication in spring 
2003. Soon after. Time ran a cover story on the topic 
that featured Shaywitz prominently. A year later the book, 
a national bestseller that Publishers Weekly called “ground¬ 
breaking,” was in its loth printing; it is also available 
on tape and CD. 
Shaywitz became interested in reading disorders dur¬ 
ing her pediatrics residency at Albert Einstein College of 
Medicine in the late 1960s, when she first heard mothers 
despair because their seemingly bright children were 
foundering at school. Reading ability is falsely taken as 
a “proxy for intelligence,” says Shaywitz, and so children 
with dyslexia often feel stupid or ashamed. Shaywitz has 
heard many dyslexic adults recount “horrible memories 
of being asked to read aloud in class.” 
And yet, paradoxically, Shaywitz finds that among people 
who are smart and creative, the “creme de la creme,” a 
seemingly disproportionate number have dyslexia—medical 
school professors among them. “I can tell you, a significant 
proportion of them have been in my office, with the door 
closed, telling me, ‘I must be the only one,’” says Shaywitz. 
Graeme L. Hammond, m.d., professor of surgery 
(cardiothoracic), who has grappled with dyslexia since 
childhood, says he was gratified to see that the disorder 
was finally getting the attention of scientists and the 
public when he watched Shaywitz discussing dyslexia on 
The NewsHour with Jim Lehrer in 1998. In the epilogue 
of her book, Hammond joins well-known dyslexics, includ¬ 
ing novelist John Irving and financier Charles Schwab, 
in describing the toll it took. Hammond describes how 
dyslexia, like many other handicaps, helps develop differ¬ 
ent, perhaps latent, pathways such as perseverance and 
innovation to accomplish goals. 
In her book, Shaywitz describes dyslexia as a phonologi¬ 
cal weakness. That is, readers with dyslexia have trouble 
translating letters on a page into sounds they represent. 
Although people with dyslexia do learn to read more accu¬ 
rately over time, they do not read rapidly or automatically. 
“What remains for people with dyslexia is how hard they 
have to work, how much effort they have to put in,” 
Shaywitz says. 
The book also corrects several misconceptions. Writing 
letters backwards or transposing them is common among 
novice writers and doesn’t suggest dyslexia. And although 
schools identify three boys with dyslexia for every girl, 
researchers find no significant difference in the prevalence 
of reading disabilities in girls and boys. But boys get more 
attention—they tend to be more rambunctious—while 
many struggling girls go unnoticed and unidentified. The 
book includes checklists of signs of dyslexia and suggests 
which tests are effective for diagnosis. Tests for accuracy 
BOOK NOTES 13 
Sally Shaywitz has, through her 
research and clinical work, 
advanced the study of dyslexia, 
a phonological weakness 
that makes it hard to transiate 
symbols on a page into the 
appropriate sounds. 
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may miss dyslexia, especially in teenagers and adults; test¬ 
ing fluency is essential. 
Shaywitz says educators have remained largely ignorant 
of the huge advances in understanding dyslexia. “The whole 
notion that there’s science or evidence hasn’t been part of 
the culture, so teachers haven’t been provided with the tools.” 
Furthermore, schools often provide only unproven, sporadic 
remediation for a chronic problem. 
The book draws on a decade of laboratory research at Yale 
on differences in brain function between skillful and strug¬ 
gling readers. Shaywitz conducted those studies in partner¬ 
ship with her husband, Bennett A. Shaywitz, m.d., professor 
of pediatrics and neurology. (Both Shaywitzes are also on 
the Child Study Center faculty.) World-renowned leaders in 
the use of imaging to study reading, the Shaywitzes have 
discovered what they call “functional lesions” in the left 
occipitotemporal and parietotemporal regions (behind the 
left ear). These lesions correspond exactly with physical 
lesions in people who have lost the ability to read because 
of a stroke or brain tumor. They discovered this correspon¬ 
dence using functional magnetic resonance imaging, 
studying metabolism in the brain to show which parts of 
the brain readers use as they decode texts, ym 
For My Next Act: Women 
Scripting Life After Fifty 
by Karen Baar, m.p.h. ’81 (Rodale 
Press) Speaking partly from 
her own experience of a midlife 
divorce, Baar describes how 
women are examining their life 
experiences, taking a critical 
look forward and shaping plans 
for their futures. 
Dermatology 
by Jean L. Bolognia, m.d. ’80, hs 
’84, professor of dermatology, 
Joseph L. Jorizzo and Ronald P. 
Rapini (Mosby) This two-volume 
reference set encompasses 
the current knowledge in the 
field. Covering adult and 
pediatric clinical dermatology 
and dermatologic surgery and 
therapy, it provides evidence- 
based support for therapeutic 
recommendations. 
Abetting Madness: The Role 
of Illicit and Prescribed Drugs 
in Promoting Psychotic and 
Manic Disorders 
by Malcolm B. Bowers Jr., m.d., 
HS ’65, professor emeritus of 
psychiatry (Xlibris Corporation) 
The author argues that vulner¬ 
ability to major psychoses is 
related to genetic factors that 
may be set in motion by the 
use of prescribed stimulants and 
antidepressants as well as 
illegal drugs, including cannabis, 
cocaine and lsd. Bowers sug¬ 
gests an approach to the preven¬ 
tion of some psychotic disorders 
based on this hypothesis. 
Hayots Badeevuh: Reminiscences 
of Armenian Life in New York City 
by Levon Z. Boyajian, m.d. '56, 
HS ’60 (Taderon Press) This nar¬ 
rative revolves around the 
Boyajian family and their circle 
of friends in Washington 
Heights, N.Y., in the aftermath of 
the Armenian genocide of 1915. 
Boyajian gives us a view of his 
life as a child and adolescent, 
recounting personal dramas and 
tragedies and anecdotes about 
his community through two 
world wars and the Depression. 
Living Outside Mental Illness: 
Qualitative Studies of Recovery 
in Schizophrenia (Qualitative 
Studies in Psychology Series) 
by Larry Davidson, ph.d., associ¬ 
ate professor of psychiatry (New 
York University Press) Davidson 
offers first-person narratives 
illuminating people’s experi¬ 
ences of schizophrenia and 
recovery.The author shows how 
listening to people diagnosed 
with schizophrenia can affect 
clinical practice and social policy. 
Drugs loi: An Overview for Teens 
by Margaret O. Hyde and John F. 
Setaro, m.d., hs ’86, associate 
professor of medicine (cardiology) 
(Twenty-First Century Books) 
This book provides teenagers 
with an overview of drugs and 
drug abuse, offering straightfor¬ 
ward information about illicit 
drugs.The authors discuss the 
emotional, physical and psycho¬ 
logical ramifications of drug use. 
Bookshelfis a new column in Yale Medicine focusing on Yale 
authors and books of interest to the medical school community. 
Send ideas to Cathy Shufro at cathy.shufro@yale.edu. 
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Investigative Pathways: Patterns 
and Stages in the Careers 
of Experimental Scientists 
by the late Frederic Lawrence 
Holmes, ph.d.. former Avalon 
Professor of Ore History of 
Medicine (Yale University Press) 
Holmes, chair of the Section 
of the History of Medicine 
from 1979 to 2002, examines 
the careers of six pre-eminent 
scientists: Antoine-Laurent 
Lavoisier, Claude Bernard, Hans 
Krebs, Matthew Meselson, 
Franklin Stahl and Seymour 
Benzer. Holmes finds unifying 
themes as he explores the 
motivations for their research, 
how they asked questions 
and solved problems, and the 
breakthroughs they achieved. 
Unexpected Odyssey: From 
Merchant Sailor to Hyperbaric 
Physician 
by Eric P. Kindwall, m.d. '60 (Best 
Publishing Company) Kindwall 
chronicles his varied career 
which has included not only 
studies at Yale and Harvard, 
but also submarine school, serv¬ 
ice in the merchant marines 
and the ciA and a professorship 
in hyperbaric medicine. 
Pediatric Complaints and 
Diagnostic Dilemmas: A Case- 
Based Approach 
by Samir S. Shah, m.d. ’98 
and Stephen Ludwig, m.d. 
(Lippincott Williams & Wilkins) 
Through the exploration of 
119 actual cases, the authors 
show how to recognize key 
diagnostic patterns for more 
accurate evaluation of pedi¬ 
atric illness and injury. 
George Beadle, An Uncommon 
Farmer: The Emergence of 
Genetics in the 20th Century 
by Paul Berg and Maxine F. 
Singer, ph.d. '57 (Cold Spring 
Harbor Laboratory Press) The 
authors provide a biography of 
the Nobel Prize-winning "giant 
of genetics” and president of the 
University of Chicago. Beadle’s 
work from 1940 to i960 marked 
the transition from classical 
genetics to the molecular era. 
Carlos Montezuma, m.d., A 
Yavapai American Hero: The 
Life and Times of an American 
Indian, 1866-1923 
by Leon Speroff, m.d., hs '66 
(Arnica Publishing) This book 
documents the life of one of the 
first Native American physicians. 
A Yavapai Indian, Montezuma 
was taken in the 1870s from his 
family as a boy by Pima Indian 
warriors, who sold him to an 
itinerant photographer. He end¬ 
ed up in Chicago, where he took 
advantage of unexpected educa¬ 
tional and social opportunities, 
ultimately becoming a doctor 
and championing his tribe’s land 
and water rights. 
The descriptions above are based on 
information from the publishers. 
send notices of new books to 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu 
Medical library makes 
the transition from print 
to electronic journals 
These days a physician reading a medical journal is as likely to be peering 
at a monitor as paging through a magazine. Nonetheless, Yale medical 
librarian Daniel Dollar, m.l.s., says libraries are still in the “horseless- 
carriage days” when it comes to making the switch from paper to pixels. 
For instance, librarians still distinguish between an “online 
journal” and a “journal.” “One day we’ll call them all journals,” says 
Dollar, digital resources librarian at the Harvey Cushing/John Hay 
Whitney Medical Library. 
Not that physicians and researchers are still riding horses. One 
service that links citations to full-text articles tracked nearly 190,000 
electronic requests for articles at Yale in 2003. That figure represents 
only “the tip of the iceberg,” Dollar says, because articles can also be 
downloaded from a journal site; through library subscription services, 
such as MDConsult; through the library’s online catalog; or through its 
listing of e-Journals. The library subscribes to 3,300 medical journals 
online and 2,300 in print. Most of those titles overlap, but some jour¬ 
nals are available in only one form or the other. 
Electronic journals add to the library’s costs, for two reasons. 
First, the library generally pays a surcharge of 5 to 15 percent to add 
electronic access to a journal that the library already carries in printed 
form. Second, many readers who once paid for their own copies of 
journals now rely on electronic access and have dropped their sub¬ 
scriptions. In response, publishers are charging libraries more. “There’s 
a reallocation of funds,” says Dollar. “We have titles that have gone 
from a few hundred dollars to several thousand dollars.” 
Online journals have many advantages. Dollar says; they take up 
no shelf space and are accessible remotely. “Folks in the hospital don’t 
have to run over here to get a full text of an article,” says Dollar. And 
online articles sometimes include raw data not offered in print. But 
print articles also have their virtues: they may have better graphics, the 
ads they contain keep subscription costs down, and the reader’s ability 
to page through an entire issue may lead to serendipitous discoveries. 
By far the greatest advantage of print journals is that it’s obvi¬ 
ous how to archive them: simply bind and save them. It’s not nearly as 
clear how to archive electronic journals. Who should be responsible? 
Libraries? Publishers? If an electronic journal ceases publication, what 
happens to its archives? 
To grapple with these questions, Yale has joined a Stanford 
University-based consortium of publishers and libraries called lockss 
(“Lots of Copies Keep Stuff Safe”). 
“We’re in transition,” says Dollar. “It’s exciting, because we get 
to reinvent ourselves. But it’s a time-consuming process, and we may 
stumble along the way.... Essentially we’re taking the library and put¬ 
ting it on a desktop.” 
—Cathy Shufro 
In Circulation is a new column focusing on Yale’s Cushing/Whitney 
Medical Library. 
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Merging data sets 
to fight human disease 
The sequencing of the human 
genome has spawned a wealth 
of knowledge, much of it now 
available online. According to 
Vamsi K. Mootha, M.D., a post¬ 
doctoral fellow at the Broad 
Institute in Cambridge, Mass., 
this is making possible new 
approaches to medical research. 
"The real challenge,” Mootha 
said in a talk sponsored by the 
Department of Genetics in 
March, “will be to integrate 
these data sets with each other 
as well as with what we know 
from the previous literature.” 
As an example, Mootha 
described his participation on an 
international team that sought 
the gene mutation responsible 
for Leigh syndrome, a fatal meta¬ 
bolic disorder that is prevalent in 
a region of French Quebec. The 
team had first determined that 
the culprit gene was one of 30 
on chromosome 2. “The critical 
feature of the disease suggested 
that there might be a mitochon¬ 
drial pathology,” Mootha said. 
Using this clue, the team ana¬ 
lyzed RNA data sets and a map 
of mitochondrial peptides to 
home in on their target. “Using 
relatively freely available data 
we were able to identify the 
candidate gene,” Mootha said. 
—John Curtis 
Biomedical research for 
the world’s neediest 
In 1990 a drug called efiornithine 
came on the market to treat 
African sleeping sickness. But a 
drug marketed to impoverished 
Africans would never turn a 
profit, so in 2000 it was adapted 
for another, less urgent, use— 
removing facial hair. Then, said 
Michele Barry, M.D., HS ’77, an 
international campaign by 
groups such as Medecins Sans 
Frontieres (msf) shamed the 
drug company into restoring the 
drug’s original mission of treat¬ 
ing sleeping sickness. 
Only lo percent of worldwide 
biomedical research spending is 
devoted to diseases that afflict 
90 percent of the world’s peo¬ 
ple, Barry told a March meeting 
of the Justice and the Allocation 
of Health Care group, a seminar 
series organized by the Interdis¬ 
ciplinary Bioethics Project. Barry, 
a professor of medicine and 
public health and director of the 
Office of International Health, 
says MSF has formed an interna¬ 
tional partnership to develop 
medicine for three very neg¬ 
lected diseases that infect mil¬ 
lions of people around the 
world—Chagas disease, African 
sleeping sickness and leishmani¬ 
asis.The partnership, the Drugs 
for Neglected Diseases Initiative, 
hopes to have as many as seven 
drugs available within 12 years. 
Barry, president of the American 
Society of Tropical Medicine and 
Hygiene, has coordinated her 
society’s cooperation toward 
achieving this goal. 
—J.C 
Stumbling across water 
channels, and a Nobel Prize 
In two talks on campus in March 
Peter C. Agre, m.d., noted with 
amusement that when he was 
applying to medical schools, Yale 
turned him down. And, in an 
equally self-effacing vein, when 
he described the work that won 
him a share of the 2003 Nobel 
Prize in chemistry, he attributed 
it to "blind luck.” 
Agre, a professor of medicine 
and biological chemistry at Johns 
Hopkins University School of 
Medicine, described his ground¬ 
breaking research in similar 
terms at the 12th annual Robert 
W. Berliner Memorial Lecture 
and at the 56th annual meeting 
of the Associates of the Cushing/ 
Whitney Medical Library. "We 
weren’t even looking for water 
channels,” he said of his dis¬ 
covery that explained how water 
crosses biological membranes. 
Agre was studying Rh blood 
group antigens and became 
curious about a mysterious pro¬ 
tein that kept turning up in 
his experiments. He detoured 
from his original research and 
identified the first of a family of 
water channel proteins, which 
he dubbed aquaporins. 
“It’s sort of like driving in a 
remote part of Vermont and 
coming upon a city of 200,000 
people that’s not on the map,” 
he said. 
—J.C. 
With acupuncture, an 
integrated view of the body 
Acupuncture entered the Ameri¬ 
can consciousness in 1972, when 
a journalist on President Nixon’s 
trip to China fell ill with appen¬ 
dicitis. Soon after, an account of 
acupuncture's relief of his post¬ 
operative pain and swelling was 
in the news. 
Early in the 20th century, 
however, acupuncture was seen, 
even in China, as a folk remedy. 
In a talk in March sponsored by 
Colloquia, Workshops and Lec¬ 
tures in History of Medicine and 
Science, Bridie J. Andrews, ph.d., 
assistant professor of the his¬ 
tory of science at Harvard, said 
it took a young Chinese doctor 
to make it acceptable. In the 
1920s Cheng Dan’an turned to 
acupuncture to treat his own 
back injury, for which the 
Western medicine he admired 
could only prescribe opiates. 
Intrigued by the success of the 
treatment, he applied his knowl¬ 
edge of anatomy to acupunc¬ 
ture and in 1932 published a 
book showing new acupuncture 
points, in 1993 magnetic reso¬ 
nance imaging suggested that 
certain biochemical pathways 
are affected by acupuncture. 
“Biomedical research into 
acupuncture,” Andrews said,“is 
producing a much more inte¬ 
grated view of body function, 
which is something that bio¬ 
medicine has been striving for 
for some time.” 
—J.C. 
Homage to the crown prints 
By Cathy Shufro At 50, one of the world’s best collections of medical imagery 
draws on humor and history. 
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A woman diagnosed 
with hysteria is the 
centerpiece of a 
popular lithograph, 
a copy of which 
once adorned Sig¬ 
mund Freud’s 
consultation room in Vienna. The 1887 
print shows the hypnotized woman 
before a roomful of men. Two assistants 
reach out to break her fall; beside her, 
French neurologist Jean-Martin Charcot 
lectures about hysteria. 
Une Legon du Docteur Charcot d la 
Salpitriere is part of the collection 
of prints on medical topics that Yale 
psychiatrist Clements C. Fry, m.d., 
began assembling in the early 1930s. 
When Fry, the former director of stu¬ 
dent mental health at Yale, died in 
1955, he left his 2,000 prints to the 
university. Now nearing its 50th 
anniversary, it is one of the world’s 
largest and most prominent collec¬ 
tions of medical prints. 
Fry selected prints as records of 
medicine’s history and public image; 
for their rarity; and—as often as not— 
because he found them funny: a 1937 
New Yorker cartoon by Whitney Darrow 
Jr. shows a woman dressed as Napoleon, 
complete with sword, campaign hat and 
oversized epaulets. ITer hand tucked 
into her jacket, she faces a balding psy¬ 
chiatrist across the desk, who tells 
her: “It's a pity I didn’t get to your case 
earlier, Mrs. Perkins.” 
An 1859 lithograph by Honore 
Daumier combines satire with histori¬ 
cal evidence that lay people tried their 
hands at the novel therapy of hypno- 
hsm. A man dangles a huge diamond 
ring above the face of a mesmerized 
matron. “The new entertainment at par¬ 
ties,” the caption reads, “or, how to 
amuse and make a fool of yourself in 
public without a quarrel.” 
By day Fry, who joined the faculty 
in 1926 and pioneered mental health 
for students, ran the Division of Mental 
Hygiene at the Department of Univer¬ 
sity Health. He devoted his leisure time 
to collecting, says Susan E. Wheeler, 
M.A., curator of the Clements C. Fry 
Collection of Medical Prints and Draw¬ 
ings, which is housed in the Cushing/ 
Whitney Medical Library. “This was 
his avocation, his relaxation. To be 
a collector was very typical in that era 
in this environment,” says Wheeler, 
whose book. Five Hundred Years of 
Medicine in Art (Ashgate), catalogs 
the collection. 
Fry considered his bachelor apart¬ 
ment at Trumbull College a sort of 
medical museum, but his intent was 
less scholarship than pleasure. “What 
I try to do is to get the things I can 
have fun with,” he wrote to a print 
seller in the 1930s. 
LEFT Sigmund Freud once hung a copy of 
this popular lithograph, Une Lecon du Docteur 
Charcot a ta Salpetriere, in his consultation 
room in Vienna. Part of a collection of prints 
assembled by Yale psychiatrist Clements C. 
Fry, M.D., it shows a hypnotized woman during 
a lecture on hysteria. 
OPPOSITE TOP Peter Arno’s charcoal and 
watercolor cartoon depicting a psychiatrist 
and his patient appeared in The New Yorker 
in 1936. 
OPPOSITE BOTTOM Anatomical Theatre at 
Leiden was sold as a souvenir at the University 
of Leiden in the Netherlands. The well-dressed 
men and women touring the dissection hall 
in this i6io engraving by W. Swanenburg show 
that the upper classes of 17th-century Europe 
were interested in anatomy. 
Several recurring themes appear in 
the satirical prints that interested Fry, 
says Wheeler. “One is the ineffective¬ 
ness of the doctor. ... Another is the cost 
of medicine. What you also see in the 
satirical prints is people making fun 
of pain—laughing at the pain of illness 
and the pain of therapy.” 
Although Fry collected works by 
Rembrandt and Hogarth, artistic 
merit alone wouldn’t justify a place 
in his collection. He wanted prints 
that depicted the history of medicine. 
For example. Anatomical Theatre at 
Leiden, shows more than a dozen 
well-dressed men and women wan¬ 
dering through the dissection 
hall. The rare 1610 engraving by 
W. Swanenburg demonstrates that 
educated people of the early 17th 
century were fascinated by anatomy. 
Fry’s spirit lives on in the library’s 
continuing effort to keep the collec¬ 
tion current. 
“The collection is a living collection,” 
says Wheeler. 
Cathy Shufro is a contributing editor of 
Yale Medicine. 
A boxed set of 10 note cards representing 
five satirical prints from the Fry collection 
is for sale for $10 at the medical library 
circulation desk. The cards can be ordered 
by mail for $12 per box by telephoning 
the library at 203-785-5352. 
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Mapping the social mind 
19 
The mysteries of autism, an often-intractable disorder of 
aloneness, are starting to give way to discoveries by Yale scientists. 
Their hope is that early intervention will help autistic children 
develop social ability and a better sense of their place in the world. 
By Peter Farley 
Photographs by Daphne Geismar 
Brendan Lyle, who turns 5 in 
August, has made progress since 
his diagnosis of autism at age 2. 
“When he was first diagnosed, 
he was pretty indifferent to 
people. He was very much in his 
own world, and very quiet,” 
according to his mother, Pamela 
Lyle. “Through constantly work¬ 
ing with him, I think we’ve 
exposed him to the social world 
and he really, really does well 
with it now.” At left, Brendan 
romps with his father, Christopher, 
on a trampoline at home in 
Orange, Conn. 
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20 Mapping the social mind 
Humans share such solid 
bonds with family, friends 
and community that we can 
scarcely imagine what it 
might be like to be a tiger, or 
a spider or any of die myriad 
of Earth’s creatures that lead 
solitary lives. Many mam¬ 
mals leave their kin forever 
after weaning and, aside 
from sporadic encounters with mates, live out their entire 
lives in solitude. In what seems to us an utterly alien life cycle, 
the hatchlings of some species are left to dieir own devices 
at birth: emerging from the safety of the egg, they confront 
the wide world all alone. 
Relationships are so fundamental to our nature that, 
since the dawn of child psychology, researchers have won¬ 
dered at the immensely powerful innate attachment of infants 
and parents, the very first social link forged in human life. 
Arnold L. Gesell, m.d., ph.d., the prolific scientist and scholar 
who founded the Yale Child Study Center, used the relatively 
new medium of cinematography to analyze infant behavior 
beginning in the 1920s; he noted that even a newborn baby 
will turn its head toward the sound of its mother’s voice and, 
when lifted from the crib, will naturally mold its tiny body to 
conform to hers. 
As Fred R. Volkmar, m.d., the Irving B. Harris Profes¬ 
sor of Child Psychiatry, Psychology and Pediatrics in the Child 
Study Center, says, “Cesell saw that, for the child, the parent’s 
face and voice are the most important things in tlie world.” 
However, in a now-classic 1943 article, the Johns 
Hopkins psychiatrist Leo Kanner, m.d., described a group of 
children who were puzzling exceptions to this rule. These 
children, whom Kanner dubbed “autistic,” had marked diffi¬ 
culties with language; engaged in repetitive, bizarre behavior; 
and—most poignantly—were inexplicably inclined toward 
aloneness. Kanner’s autistic patients were largely indifferent 
to their parents and, as they grew, to people in general. 
Instead, they seemed inexorably drawn to objects. 
“Every one of the children, upon entering the office, 
immediately went after blocks, toys or other objects, without 
paying the least attention to the persons present,” Kanner 
wrote. “It would be wrong to say that they were not aware of 
the presence of persons. But the people, so long as they left 
the child alone, figured in about the same manner as did the 
desk, the bookshelf or the filing cabinet.” 
Sixty years on, autism remains among the most 
mysterious and intractable of psychological disorders. Most 
psychological treatments depend on communication, 
and the insistent inwardness at the core of the condition has 
stymied generations of researchers and therapists. 
But a newfound hopefulness is in evidence at the 
Child Study Center. Volkmar, an expert on the diagnosis and 
classification of autism, is also something of a scientific 
impresario; over the past several years he has assembled an 
autism research team as diverse and productive as any in 
the world. The group’s efforts received recognition from the 
National Institutes of Health in 2002, in the form of a $5 
million grant as part of the nih’s Studies to Advance Autism 
Research and Treatment (staart) initiative. Buoyed by a 
surge in federal funding and public awareness and inspired by 
new findings on the effectiveness of early intervention and 
the changeability of the human brain, these Yale researchers 
are using cutting-edge technologies—functional neuroimag¬ 
ing studies, eye-tracking devices and specially designed com¬ 
puter games—to shed new light on the riddle of autism. 
“Refrigerator mothers” no more 
The Yale Child Study Center is set back some distance from 
South Frontage Road at the northern fringe of the medical 
school campus, hard by the noise and bustle of Route 34. Only 
a small sign and an unassuming brick facade are visible from 
the road, so Volkmar urges visitors to watch for “the Mayan 
temple,” his fanciful name for the colossal parking garage just 
across the street. 
But the center is a landmark of the first order in the 
study of child development. Since its founding in 1911 by 
Cesell, the father of the field in America, the center’s mission 
has been to bring child psychiatrists, pediatricians and psy¬ 
chologists together under one roof—an all-embracing 
approach to child development in which research is tightly 
intertwined with protecting children’s health and welfare. 
The melding of research and treatment infuses day-to- 
day life at the center with a distinctive vigor. It is a place where 
children—patients, research subjects or both—chat excitedly 
in waiting rooms piled with toys and backpacks, while scien¬ 
tists, physicians, parents and staff hustle through a multistory 
warren of offices, labs and clinics. 
21 
OPPOSITE AND BELOW 
Hailey Lyle seems to relate best 
to others when engaged in 
rough-and-tumble play, such as 
this session with her father, 
Christopher Lyle, in the family’s 
backyard. 
One particularly circuitous corridor in the center leads 
to Volkmar’s office, a spacious, book-lined room with a wall 
of windows that looks out onto a sunlit courtyard. An affable 
man who favors hiking boots and a slightly loosened tie, 
Volkmar led the group that redefined autism in the latest edi¬ 
tion of the American Psychiatric Association’s Diagnostic and 
Statistical Manual, or DSM, the bible of psychiatric diagnosis. 
For decades, Volkmar says, autistic children and adults 
were routinely misdiagnosed as mentally retarded or schizo¬ 
phrenic. During the 1950s and 1960s, when psychoanalysis 
was ascendant, the pain and desperation felt by parents 
of autistic children were compounded by certain prominent 
child psychiatrists, most notably Bruno Bettelheim of the 
University of Chicago’s Orthogenic School, who declared 
that the condition was caused by inadequate parenting, and 
in particular by cold, aloof “refrigerator mothers.” 
By 1980, when autism was first formally recognized 
in the DSM, it had become generally accepted that the condi¬ 
tion is caused by some breakdown in normal neurological 
development, but parents’ emotions can still be whipsawed 
between hope and despair by what Volkmar calls “the flavor 
of the week”—a regular stream of media coverage of pur¬ 
ported cures or breakthroughs. In 1998, for example, it was 
widely reported that some autistic children experienced 
dramatic recoveries after receiving injections of synthetic 
secretin, a gut hormone. However, recent clinical trials of the 
therapy have been inconclusive at best. 
With Volkmar’s guidance, the latest edition of the DSM 
reflects the current view that autism disorders comprise a 
spectrum of conditions that fall along a continuum of sever¬ 
ity. At one end of the scale is full-blown autism, with major 
language difficulties; repetitive, sometimes self-destructive 
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22 Mapping the social mind 
behavior; virtually complete social isolation; and profound 
intellectual disability. At the other end is Asperger’s syn¬ 
drome, a condition in which patients are verbally fluent and 
sometimes highly intelligent, but in many cases are so 
socially disabled that, in Volkmar’s words, “they couldn’t 
walk into a McDonald’s and get a cheeseburger and change.” 
Patients whose symptoms fall somewhere in between 
these two extremes make up the less-well-defined diagnostic 
realm of pdd-nos or “pervasive developmental disorders, 
not otherwise specified,” 
The autism spectrum disorders are four times more 
common in boys than girls. Although many more children 
are diagnosed with these disorders today than 20 years ago, 
Volkmar believes the rising number of cases reflects better 
diagnosis and a higher level of awareness of autism among 
physicians and the general public rather than a true increase 
in incidence of the disorder. 
Many autistic children and adults possess uncanny 
abilities, but usually in one narrow—and often quite arcane— 
realm. Some are musical or artistic prodigies; others can 
recite from memory the complete train schedules from 
countries they have never set foot in, or describe what the 
weather was like in a given place for any day in recorded 
history. But Volkmar says that few patients have the wide 
range of extraordinary skills so memorably put to use by 
Dustin Hoffman in his otherwise accurate portrayal of the 
autistic Raymond Babbit in the 1988 movie Rain Man. 
Finding each patient’s place on the autism spectrum 
is challenging because the symptoms and developmental 
course of patients in all three categories vary tremendously. 
“If you were in a room with 100 autistic patients, first 
you’d be struck by how different they are from one another, 
but then you would quickly realize how similar they are,” 
Volkmar says. And what’s similar in patients across the 
spectrum is an overpowering disability in social interactions. 
Do you see what I see? 
The social disabilities at the heart of the autism spectrum 
are brought vividly to life in a videotape made at the Child 
Study Center’s developmental disabilities clinic by Ami J. 
Klin, PH.D., Harris Associate Professor of Child Psychology 
and Psychiatry. In one clip, an autistic toddler intently plays 
with a toy while Klin moves into her field of vision until his 
face is only inches from her eyes. Because of what Klin calls 
the “gravitational pull” of objects on the autistic child’s mind, 
the girl behaves as if she were completely blind to him. 
But her vision is perfect: we soon see her crawling excitedly 
toward a tiny orange candy on the floor that she had spied 
from across the room. 
Given the primacy of social interactions in human 
life, scientists have proposed that we have evolved special 
brain mechanisms for perceiving faces. In experiments, 
normal subjects perceive faces more quickly than objects, 
apparently because faces are seen as wholes, whereas objects 
are first seen as a collection of component parts. However, 
it has been known since the late 1970s that autistic subjects 
see objects just as quickly as faces. For them, it seems, 
faces have no special status—they hold no more interest 
than chairs, spoons or airplanes. 
Until recently, it was difficult to develop these findings 
further. In collaboration with Warren R. Jones, a graduate 
student and research associate in the Child Study Center, Klin 
has probed more deeply into this phenomenon using a tech¬ 
nology known as eye tracking, which allows experimenters 
to precisely monitor where a person is looking at any given 
time (See sidebar, p. 25). When Klin and Jones showed emo¬ 
tionally charged excerpts from Mike Nichols’ 1966 film Who’s 
Afraid of Virginia Woolf?, for example, normal subjects tended 
to focus on the actors’ eyes. However, autistic viewers fixed 
their gaze on mouths or, in many cases, on incidental objects 
in the periphery of the scene; while Richard Burton and 
Elizabeth Taylor kissed passionately in a Virginia Woolf clip, 
one autistic viewer pored over a light switch on a distant wall. 
For other eye-tracking experiments, Klin and Jones 
have adapted the motion-capture technique used to 
create computer-generated characters in motion pictures 
(such as the Gollum character in the Lord of the Rings 
movies) to generate minimalist “point-light” animations 
of actors playing patty-cake or engaged in some other 
activity that appeals to children. As still images, point-light 
displays look like star maps, a random collection of white 
dots on a dark background. But when they move, nor¬ 
mal subjects instantly and irresistibly recognize a human 
figure. Klin and Jones placed a correctly oriented point- 
light animation side by side with an upside-down anima¬ 
tion on a split computer screen, and eye tracking revealed 
that normal children prefer to watch the correct version. 
However, autistic children show no preference whatsoever. 
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Brendan Lyle didn’t speak at all 
until he went to school. He first 
communicated through American 
Sign Language and has developed 
a vocabulary of about lOO words. 
Now he also has well over 100 
spoken words at his command, but 
has difficulty enunciating them. 
“About 25 percent are easily 
understood by the general public; 
I understand them all,” says his 
mother, Pamela Lyle. “This is a child 
I never thought would speak, and 
now he’s doing pretty well.” Mother 
and son kiss through the mesh 
surrounding the trampoline. 
indicating that they do not recognize the human being rep¬ 
resented by the dots. 
Our social instincts are so deeply rooted that they 
can be triggered even in the absence of faces or suggestions 
of human figures. In a separate line of work from his eye¬ 
tracking studies, Klin has been using a short film devised by 
the psychologists Fritz Heider and Marianne Simmel during 
the 1940s that features a few simple geometric shapes— 
a big triangle, a circle, a smaller triangle—moving about the 
screen. Heider and Simmel discovered that, when asked to 
describe this film, people almost invariably impose a social 
interpretation on it; instead of speaking in terms of inani¬ 
mate shapes passively changing positions, viewers invent 
stories in which, for example, a chase might be taking place 
between a bullying big triangle and a terrified little triangle. 
But according to Klin, autistic subjects do not personify the 
shapes in the film, and rely instead on purely physical 
metaphors in their descriptions. 
A brain space for faces? 
Given the dramatic differences in autistic patients’ behavior 
compared to that of other individuals, one would expect 
that there would be conspicuous differences between autistic 
and nonautistic brains. But according to neuroimaging 
expert Robert T. Schultz, ph.d., associate professor in the 
Child Study Center, finding such markers has been surpris¬ 
ingly difficult, and only a few studies in the neurobiology 
of autism have stood the test of time. 
Neuroscientists have known since 1997 that pictures 
of faces, but not pictures of simple objects, activate a 
small patch of the cortex by the right ear that has come to 
be known as the fusiform face area, or ffa. But when 
Schultz and his colleagues showed pictures of faces to autis¬ 
tic patients in a 2000 study using functional magnetic 
resonance imaging (fMRi), they found little activation in 
the ffa; instead the study revealed a high level of activity 
in nearby brain regions involved in recognizing objects. 
Schultz’s results have since been confirmed by at least 
six other research teams—a rare instance of consensus in 
an area where solid findings have been elusive—and they 
provide the tantalizing beginnings of a neural explanation 
for the object-centered worldview first described six decades 
ago by Kanner and so clearly revealed in Klin and Jones’ eye¬ 
tracking studies. But Schultz isn’t certain whether the ffa 
deficit he found actually causes social disability by itself or 
reflects some wider disturbance in brain circuitry. 
In an intriguing new collaboration, Schultz and Klin 
are using Heider and Simmel’s film of geometric forms in 
fMRi experiments to sketch out a map of the entire “social 
brain,” Schultz’s term for an interconnected network of 
brain regions—including the amygdala, the medial frontal 
cortex, the superior temporal sulcus and the ffa—that seem 
to be crucial for normal human social interaction. In a 
recent study with normal subjects, Schultz and Klin found 
that perceived social interactions between the geometric 
forms strongly activate all the components of the brain’s 
social network, including the ffa—a quite surprising result 
since the film contains no images of faces. Based on these 
results, Schultz and Klin believe that “face area” may be a 
misnomer for the ffa: this brain area may not just be sensi¬ 
tive to faces, but it may be a more general-purpose area 
for perception of and knowledge about people and social 
interactions, however abstract. Schultz believes it may 
occupy a central place in the circuitry of the social brain. 
Schultz’s former Yale colleague Isabel Gauthier, 
PH.D., now at Vanderbilt University, has also argued for a 
broader view of the ffa. Gauthier has shown that, in peo¬ 
ple who have special expertise, such as car enthusiasts 
or bird-watchers, the ffa can be activated by pictures of the 
objects of their affection, whether they be T-birds or war¬ 
blers. Moreover, along with Michael J. Tarr, ph.d., of Brown 
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24 Mapping the social mind 
University, Gauthier has shown that this “expertise effect” 
can be produced in normal adults by intensively training 
them to recognize subtle differences between previously 
unfamiliar objects. Gauthier and Tarr used “Greebles,” doll- 
like objects that look almost identical to the casual observer. 
As one would expect, when the experiment began, pictures 
of Greebles did not activate the ffa, but once Gauthier and 
Tarr’s subjects were “Greeble experts” who could quickly and 
reliably tell one Greeble from another, the ffa was signifi¬ 
cantly activated whenever they saw a picture of a Greeble. 
In the clinic, a social-skills primer 
Gauthier and Tarr’s Greeble work elegantly demonstrates 
that the ffa is a changeable structure, which may have 
direct implications for the treatment of autism. Schultz 
believes that by adulthood the components of the social brain 
in autistic patients may be severely weakened by a lifetime 
of social deprivation, but inspired by Gauthier’s work, he 
is working with colleagues at a STAARX-funded clinic housed 
in the Temple Medical Genter in New Haven to find out 
whether very early intervention and social training can head 
off some of this cumulative neurological fallout. 
“We are betting on brain plasticity,” says Katarzyna 
Ghawarska, ph.d., an associate research scientist who heads 
up an ambitious screening program at the clinic. Ghawarska 
is refining eye-tracking techniques to diagnose autism dur¬ 
ing infancy in the hope that the brains of very young autistic 
children might still be malleable enough to absorb what 
she calls “pivotal” social skills. “We treat each and every child 
as a child with endless potential,” she says. 
As newly diagnosed children enter treatment at the 
STAART clinic. Associate Research Scientist Gheryl Klaiman, 
PH.D., will eventually teach them to use Let’s Face It!, a 
computer game created in collaboration with James W. 
Tanaka, ph.d., of the University of Victoria in Ganada, 
that has been specially designed to hone autistic kids’ face- 
recognition skills. Because it is difficult to perform fMRi 
studies with very young children, especially autistic children, 
Klaiman and Schultz plan to assess whether Let’s Face It! 
is inducing brain changes by measuring event-related poten¬ 
tials, electrical signals that are detectable on the scalp with 
equipment similar to that used in the more familiar eeg 
technique. At the same time, Klin and Jones plan to use eye 
tracking to see whether tools such as Let’s Face It! can 
change young autistic children’s performance on their face- 
perception and point-light display tasks. 
The team hopes that developing “social expertise” 
through early intervention might gently steer autistic 
children away from isolation and coax them toward the rich 
social world that is their human birthright. With an opti¬ 
mism tempered by decades of grappling with this most 
stubborn of disorders, Volkmar says frankly, “We don’t know 
if it will work, but we’re going to give it our best shot.” 
Keeping science grounded 
Science proceeds deliberately, and it will be some time 
before the members of the group know whether they can 
make a real impact on autism by transforming the social 
brain. In the meantime, autistic children and their families 
remain locked in a difficult daily struggle. Lawrence D. 
Scahill, PH.D., an associate professor in the Ghild Study 
Genter and the School of Nursing and a pioneer in pediatric 
psychopharmacology, has focused his energies on rigor¬ 
ously testing existing drug treatments for autism. Scahill and 
his colleagues recently published a landmark clinical study 
of risperidone, an antipsychotic drug, which provided the 
first conclusive evidence that the drug can successfully con¬ 
trol violent tantrums in autistic children. 
Scahill says that the $5 million staart grant is “a real 
shot in the arm” that buys much-needed certainty in his 
field, which has long been plagued by studies too small and 
too poorly designed to draw firm conclusions. “’The govern¬ 
ment is now funding autism research at a level where we 
can get sample sizes that are respectable,” Scahill says. 
“That’s a real first. Now we can not only answer the primary 
scientific questions, but we may finally be able to provide 
real guidance to clinicians on how to treat these kids.” 
Klin would agree. The greatest strength of Yale’s autism 
group, he says, isn’t in tools or techniques, or even in the tal¬ 
ents of the group’s individual members. What is most impor¬ 
tant, he says, is the unusual fusion of clinical work and research 
at the Ghild Study Genter, which keeps the team’s science 
firmly grounded in the real lives of patients and their families. 
“Our very best hypotheses come from our observa¬ 
tions of individual children,” Klin says. “We try to match sci¬ 
ence with disability, one child at a time.” ym 
Peter Farley is a freelance science writer based in Boston. Daphne Geismar 
is a graphic designer and photographer based in New Haven. 
Liz Tayior, “Men of Stars" 
and humanoid robots: 
new tools to study autism 
' Tlie eyes may or may not be the' 
; (jateway to the soul, but they are 
providing Yale researchers Ami J. . 
Kiln, PH.0., Warren R. Jones and - . - 
Pred R. Volkmar, M.0,, with an 
unprecedented glimpse into the 
workings of the autistic mind, 
; thanks to lightweight eye-tracking 
. devices and motion-capture sys¬ 
tems like those used by Hollywood 
directors to create computer- 
generated characters. ■. 
Autistic children and adults are 
often less threatened by techno¬ 
logical devices than they are by : 
people, and many are infatuated ■' = 
: v with television programs and 
;K films. In their eye-tracking work, ■■ 
ij;; Klin and Jones have-benefited 
ji!; from both tendencies In naturalis 
tic studies that mirror real-world 
;-:V. behavior better than typical,-- • ■ 
■ highly controlled psychological ■ ^ 
‘■"acperiments. ' 
■ Eye tracking allows scietJtlsts 
to show a film or stiil image and 
■ see precisely where In the frame 
■ the subject is looking. The newest ■' 
’■■■ head-mounted trackers .are rela-' 
■ tively inexpensive, and subjects— 
::j- even Infants—-can move their" ■ ■
heads freely during experiments.'' 
-.1 Experimenters secure a light- ■ 
Si: weight rig, which looks a bit like 
a futuristic baseball cap, to a 
subject’s bead with a comfortable 
leather headband. Two metal 
tubes, each equipped with an 
infrared lamp and a high-speed 
, infrared camera, swoop down 
from the headband to a spot Just 
. under the eyes. 
The infrared lamps invisibly 
illuminate the eyes for the cam¬ 
eras, which make recordings at the 
rate of 6o frames per second and 
stream the information into a 
computer. Sophisticated image- 
■, analysis software instantly finds 
the centers of the pupils in each 
of these thousands of images. ,' 
All this happens so quickly that a ■ ■ 
. cursor corresponding to a subject’s 
direction of gaze can be superim¬ 
posed on the experimental image 
as the subject is looking at it. 
This technique has revealed 
that the gaze of autistic subjects 
; has a distinctive signature. Normal'. ■
■ subjects who watched the classic 
:; Elizabeth Taylor film Who's Afraid ■ 
of Virginia Woolf? focused mostly ; ■ 
■ on the actors' eyes, and made 
. appropriate shifts in gaze when ■: 
■ ■: characters made pointing ges¬ 
tures. Autistic subjects, however,' 
often focused on irrelevant objects 
iiway from the center of the' ■ ■ ■ 
frame, and their eye movements 
■'.. were tentative and unpredictable 
'■ in response to the actors’ gestures. ■ 
.. . To create the GoHum character 
for the Lord of the Rings trilogy, 
director Peter Jackson relied 
V on motion-capture technology, in '■ 
which an actor's body is fitted ; 
'\Vith .lights and the resulting' 
' points of light are used to recon-^; ; 
. struct the actor’s movements and 
embody them in a new, computer-" . 
■generated“skin.” _.'".■ 
Klin and Jones also use motion.., 
capture to create point-light dis- ■ 
plays of actors’movements. The 
raw point-light displays look like 
constellations when seen as still 
■ images but they are recognizable ■ 
as moving human forms, even to 
very young children, the instant 
they begin to move. “When my 
son saw a still version, he said 
‘Starsi’” Klin recalls.“But when he 
saw it move, he said, ‘Ah! It’s a 
man of stars!”’This exquisite sen¬ 
sitivity to “biological movement” 
is so critical for survival that it can 
: be demonstrated even in nonhu¬ 
man primates. ; ■ . 
Using eye trackers to monitor 
children’s shifts in gaze while 
they watched moving point-light 
displays that were either correctly 
oriented or upside-down, Klin 
and Jones discovered that normal 
: children have a decided preference 
for right-side-up displays. Autistic 
children seem to detect no differ¬ 
ence between the two, which Klin 
and Jones interpret as a deficit 
In perceiving biological movement 
'■ in autism.' 
Klin and Volkmar have just 
received a grant from the Doris 
Duke Charitable Foundation for 
; a remarkable new collaboration 
: with Brian Scassellati, ph.d., 
:';'■ assistant professor of computer 
science. Scassellati builds robots 
with human-like facial expressions ■ 
to study children’s soda! develop¬ 
ment, and he and Klin plan to 
examine whether the robots V . 
might be a less threatening way 
? for autistic patients to develop 
social skills. 
: Klin says that in order for this 
newest work to be successful, chil¬ 
dren would have to perceive the 
robots in social terms, but he says 
he has few worries on that front 
after watching his three-year-old 
daughter's reaction to a prototype 
that seemed to ignore her: “It took 
her only a few seconds to start 
fighting with this robot, because it 
; was snoring!” 
Filmmaker and physician Gretchen Beriand gave cameras to three disabled people and asked 
them to shoot their everyday lives. Rolling, the documentary that resulted, shows us what thi 
world looks like from the seat of a wheelchair. By cathy shufro 
Ernie Wallengren, one of the subjects and creators of the film Rolling, con¬ 
tinued to coach his son's basketbali team after the neurodegenerative 
disease als took away his ability to walk. He recorded his day-to-day experi 
ence for the film using a video camera mounted on his wheelchair. 
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28 Life on wheels 
Filmmaker Cretchen Berland, an 
assistant professor of medicine 
at Yale and former producer for 
NOVA, thought that telling the 
story from her subjects’ point of 
view would give viewers a deeper 
understanding of what it means 
to be disabled. “When you give 
the camera to someone else, it 
shifts the power. It’s much more 
a process of discovery for both 
subject and researcher.” 
ricki Elman sits in her 
wheelchair, stranded on the sidewalk in front of her California 
house. Her wheelchair motor has stalled, and the van driver has 
refused to roll her into her house, saying it’s against the rules. 
She can’t phone for help, because her cell phone is getting no 
signal. Elman, who has multiple sclerosis, uses the lightweight 
camera mounted on her wheelchair to film herself. She is sob¬ 
bing, struggling to regain her calm. “I guess I will spend the 
night here,” murmurs the 51-year-old woman. As the sky dark¬ 
ens, her face melts into a silhouette. 
Ernie Wallengren can’t walk anymore, and he knows 
things will get much worse as his disease progresses. He has 
ALS, a fatal neurodegenerative disease. “I am bored beyond 
belief. The boredom—boy, is that the mainstay of life with als,” 
says the 48-year-old television writer and producer, whose 
credits include The Waltons, Falcon Crest and Touched by an 
Angel. He stares silently into the camera for a few seconds. He 
sighs. “This is going to suck.” A rhythmic thumping comes from 
another room; one of his five children is practicing drums. 
Sixteen months later, when Wallengren can no longer 
speak, he films himself wearing a headset that translates sub¬ 
tle head movements into Morse code. A computer translates 
the code into an artificial voice. It speaks for Wallengren in a 
monotone. “It’s a tedious process that limits how often I can 
yell at my children.” 
At the age of 16, Galen Buckwalter was ranked third in 
the half mile in the state of Pennsylvania and ran “for the 
sheer fun of it.” Then, he says, “a smooth swan dive on a nice 
summer day ended when I hit a rock and was left paralyzed 
from the neck down. I’ve used a wheelchair for 30 years 
now.” As he films some friends shooting baskets, he says, “I’d 
take them all to the cleaner back in the day. That’s one thing 
I can do, is talk about the glory days. Who’s going to argue 
with me?” 
These scenes come from Rolling, an award-winning docu¬ 
mentary about life in a wheelchair produced by Gretchen K. 
Berland, m.d., an assistant professor of medicine, who came 
to Yale three years ago after a career in public television and 
a subsequent career shift into medicine. Beginning in the 
summer of 2001, Berland asked Los Angeles-area residents 
Elman, Wallengren and Buclcwalter to record the view from 
a wheelchair. She gave each of them a small video camera, 
lots of tape and free reign. 
“I had no idea what those three people would film,” 
Berland recalls. She expected they’d mostly record daily achvi- 
hes in a wheelchair: getting dressed, opening doors, transfer¬ 
ring from wheelchair to driver’s seat—what Buckwalter 
jokingly calls “Gimp loi.” And at first, that’s what they hlmed. 
“Then, over hme, something happened,” says Berland. 
“They began to film more than the processes of care. They 
began to use the cameras to document the events that were 
impacting their lives.” Over the course of two years, the three 
recorded 212 hours of tape. From that raw material, Berland 
and her co-director, Rhode Island him editor Michael Majoros, 
crafted a 72-minute documentary. The result is a him, says 
Berland, that “makes the invisible visible.” 
Last fall. Rolling was named best documentary at the 
Independent Film Project conference for works in progress, 
held in New York Gity. Oscar-winning Los Angeles hlm- 
maker Ghuck Workman, one of hve jurors for the documen¬ 
tary competition, said the panel chose Rolling as the best 
work among 63 juried entries. 
“I’ve never seen anything like that before, where the 
hlmmaker didn’t try to manipulate the material,” says Work¬ 
man. “It’s very easy for a [documentary] hlmmaker to manipu¬ 
late and push an agenda. She was allowing the reality to speak 
to us. She was allowing the disabled people to speak to us.” 
Rolling was one of 14 new American hlms chosen by 
the Independent Film Project for screening at the European 
Film Market, which was held in conjunction with the Berlin 
Film Festival in February. A week later, at the invitation of 
the New York Film Society, Berland and Majoros showed and 
discussed the him at Lincoln Center in New York. Execurives 
from Sony Pictures Classics have asked Berland for a copy 
to review, and she hopes that the him will be broadcast on 
television. (When a major commercial network discussed the 
possibility of airing the show if she would make the three 
subjects’ lives appear less arduous, however, she declined.) 
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30 Life on wheels 
“Broadcast, for me, is just the first way to get the film 
out,” says Berland. She also wants the film seen by legisla¬ 
tors, medical students, practicing physicians and people who 
make health care policy, so they can visualize the lives of the 
1.6 million Americans who use wheelchairs. “I think that dis¬ 
ability rights is where civil rights was 40 years ago,” she says. 
Patient as filmmaker 
Borland’s work did not grow out of advocacy. Granted, in dis¬ 
seminating her film, Berland uses her documentary in a con¬ 
ventional way: to educate audiences about a set of problems. 
However, her work originated not as investigative journalism 
but rather as a means of doing research. 
“You can use the visual medium to explore aspects of a 
patient’s experience that we might not otherwise be able to 
capture using any other kind of data collection tool,” Berland 
explains. “When you give the camera to someone else, it 
really shifts the power. It’s much more really, truly, a process 
of discovery for both subject and researcher. ... I didn’t control 
the camera. They controlled what they chose to show us.” 
What emerged are the stories of three people “trying 
to live with as much dignity as possible. Three people—not 
three people in wheelchairs—who were very different peo¬ 
ple.” (Wallengren died in May 2003 at age 50.) 
The film shows the three enjoying themselves: Buck- 
waiter singing “Charlie” with his rock band; Wallengren 
careering down the sidewalk in his motorized wheelchair in 
a race against his son; Wallengren trying not to laugh while 
drinking orange soda, as a boy from the all-star basketball 
team he coaches teases: “Do not make a guy with a neuro¬ 
logical disorder laugh”; Elman, triumphant and elated, after 
she falls from bed while transferring into her wheelchair and 
then strategizes with two neighbors about how to lift her 
safely off her bedroom floor. “We did it!” exults Elman. “We 
didn’t even call the paramedics!” 
Rolling also shows the three subjects enduring the 
humiliations imposed by insensitive doctors and thoughtless 
architects and by the irrationality and inadequacy of the 
health care system. Elman reveals these indignities most 
starkly in her self-portrait. On the night she is stranded out¬ 
side her house, a neighbor does eventually rescue her. But 
when her electric wheelchair first breaks down, her internist 
tells her that she is “shit out of luck.” Elman cannot afford 
a spare chair, and the doctor tells her that if no “babysitter” 
is found to assist her while the chair is out for repair, she 
must go to a nursing home for “a couple of days, at least.” In 
fact, she spends a month in the nursing home, a month that 
begins with her struggle simply to enter the building. No 
one hears her pounding on the front door, and she uses all 
her strength to heave the door open. Later that day, she films 
an aide refusing to take her to the bathroom; the aide tells 
Elman to use a bedpan or a diaper instead. After that, Elman 
tells us, the nursing home took away the camera. 
The day she finally goes home, Elman falls and must 
return to the nursing home. After a month in bed with no 
physical therapy, she is debilitated. Berland reports that the 
bill for the two nursing home stays totaled $11,700. The cost 
would have gone far toward the $22,400 needed for a new 
chair. “How does one quantify the indignity she experi¬ 
enced?” asks Berland. 
Scenes from Rolling resonated for New Haven resi¬ 
dent Bjorn Ljungstrom, a wheelchair user for 10 years who 
saw the film last fall when Berland screened it at Yale’s 
Program for Humanities in Medicine. “The humiliation adds 
up more and more so you get crushed down. It gets to you,” 
says Ljungstrom, a retired engineer who moved here from 
Sweden six years ago to marry an American. “You can have a 
very good life in a wheelchair,” he says, but “you have to get 
the right equipment, the right assistance. All of this is more 
difficult and more expensive in America, compared to 
Sweden, where I have never paid one cent for equipment.” 
He bridles at the comment by one audience member 
that Berland’s depiction of disabled people is uplifting 
because it reveals the triumph of the human spirit over 
adversity. “Should we be impressed by slaves who survive?” 
asks Ljungstrom. 
“This really has to be shown to as many people as 
possible,” says Alex Diaz de Villalvilla, a first-year medical 
student who also attended the screening. “I was amazed 
at how little assistance 'Vicki [Elman] has and how poorly the 
health care system responds to people like her. She’s not a 
one and only.” He says the film should be shown, in particu¬ 
lar, to health care policy-makers, so that they will see “exactly 
what they’re responsible for.” 
Working for nova 
Despite a background in television, Berland never expected 
to use filmmaking in medical research. She thought she’d 
31 
left the medium behind when she enrolled in medical school 
in 1992 after five years of making documentaries for public 
television. Since age five, she’d planned to be a doctor like 
her father, whom she describes as “the kind of physician you 
want to take care of you.” He still practices in Portland, 
Ore., where she grew up, the older of two daughters. (Her 
sister works for the World Bank, specializing in the role 
water quality plays in international conflict.) Borland thought 
she’d like medicine because it combines science, advocacy 
and making people’s lives better. 
Then, as a biology major at Pomona College in 
California, she’d become fascinated by the challenge of mak¬ 
ing science accessible to a nonexpert audience. She worked 
for NOVA, the science series at wgbh in Boston, and later 
for the MacNeil/Lehrer NewsHour in New York. At NOVA, she 
and her colleagues would spend a year on a show lasting 
a single hour. “One year to one hour,” she says. That hour 
could draw an audience of millions. 
Borland worked on seven shows, including one about 
the race to develop the superconductor that won her team an 
Emmy in 1988, and a documentary on chaos theory. 
After several years in television, Borland tried to imag¬ 
ine how she would feel at 40, looking back on her career. 
She recognized that she would regret not studying medicine. 
At age 28, she enrolled at the Oregon Health Sciences 
University. She felt sure she’d left her life in television behind. 
“I didn’t want to be a TV doctor.” 
As it turned out, Borland did not forsake film for long. 
Her first reunion with the camera occurred during a psychia¬ 
try rotation. While visiting teenagers in the city’s juvenile 
justice center, she asked the incarcerated teens where they 
pictured themselves in five years. “Dead,” they replied. The 
stories they told her, of violence, exploitation and depriva¬ 
tion, “were never in the chart.” She thought: “Here they are 
I' in a multimillion-dollar sophisticated jail, and we have no 
: idea about who these kids are. We know nothing about their 
lives.” She got a grant to give cameras to five teenagers out- 
I side the jail, and they made a film that was broadcast on 
public access TV. 
When she moved to St. Louis in 1996 for a residency 
' in medicine at Washington University, she used film again. 
She lent cameras to a dozen fellow residents who filmed a 
i “video diary” of what happened on call. Covering overnight 
i for another doctor, she says “is the experience where resi¬ 
dents really learn to be doctors. There’s no manual that tells 
you what to do, and it can be very stressful.” The 1998 half 
hour film, Cross-Cover, has been distributed to 150 residency 
programs nationwide as a springboard for discussion. 
Getting the idea for the wheelchair film was 
“serendipitous.” It came to Borland in 1999, when she was 
a fellow at ucla’s Robert Wood Johnson Clinical Scholars 
Program, which trains young physicians to do health serv¬ 
ices research aimed at improving health care. Borland was 
attending a medical conference—and casting about for an 
idea for her research project—when she noticed a participant 
who used an electric scooter. Everything took longer for the 
woman: getting through doors, rolling up to the microphone 
to ask a question. “I thought, ‘I wonder what her life is like.’” 
Borland could simply have interviewed the woman, 
and others in wheelchairs, but the questions would have 
reflected what Borland wanted to know. “That assumes we 
can define the boundaries of what is important,” says 
Borland. “The camera lends itself to discovering something 
new. In medicine we interrupt people every seven seconds. 
The camera gives the patient power.” 
While giving cameras to teenagers and to residents 
had been sidelines to her main occupation of training to be a 
doctor, the stakes were higher when Borland began work on 
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32 Life on wheels [ 
At the heart of disability, 
a “positive perception 
of self” 
Calen Buckwalter, ph.o., agreed to 
film life from his wheelchair to 
show that a disabled person is nei¬ 
ther a hero nor a victim, just an 
ordinary person doing his best to 
shape a satisfying life. At the 
least, Buckwalter thought, the film 
would “normalize” him and the 
other wheelchair users in the docu¬ 
mentary. It would help viewers 
feel more at ease around people in 
wheelchairs. 
Rolling managed to do much 
more than that, says Buckwalter. 
“We went further," says the 
California research psychologist, 
who lost the use of his legs in a 
1973 diving accident. “We pre¬ 
sented an analysis of what is at 
the essence of disability.” That 
essential element, common to all 
people with disabilities, he says, “is 
the need to integrate dependence 
into our daily lifestyle, in a way 
that’s egosyntonic—consistent 
with a positive perception of self.” 
The award-winning film, pro¬ 
duced by Yale internist Gretchen K. 
Berland, m.d., shows three lives 
lived at odds with a culture that 
teaches that “we have to be lone 
guns.” “My reality is I’m dependent 
on a wheelchair,” says Buckwalter 
in a telephone interview last win¬ 
ter. “That doesn’t change every¬ 
thing, but it changes quite a bit.... 
For me to exist—to borrow a 
phrase—I need a village.” 
Buckwalter used the camera 
Berland gave him to record both 
pleasant and distressing moments: 
he banters with friends around 
a campfire, and he teases his wife, 
Deborah, for choosing schmaltzy 
music when they share a glass of 
wine. He shows himself reconnoi- 
tering the parking lot outside their 
Pasadena loft to avoid dog feces 
as he rolls out to his car. 
In the scene that he found most 
difficult to film, he muses about 
the increasing pain in his shoul¬ 
ders, arthritic from years of lifting 
himself in and out of his chair. 
At age 47, Buckwalter faces the 
prospect of switching to an expen¬ 
sive motorized wheelchair. The 
change will be a blow to his self- 
image. “Even after I got hurt, I still 
considered myself a very physical 
man,” he says. “I viewed my injury 
as very static. It wasn’t going 
to change as I aged.” But, he now 
acknowledges, “being disabled, 
you age in dog years.” 
Buckwalter joined Berland’s 
documentary project when she 
was a Robert Wood Johnson 
clinical scholar at ucla, looking 
for wheelchair users to collabo¬ 
rate on her film. The two met 
through a fellow in Berland’s 
group who was getting help on 
his project from Buckwalter, 
who works at the Southern Cali¬ 
fornia Kaiser Permanente Medi¬ 
cal Croup developing tests for 
age-related cognitive changes. 
Buckwalter almost died last 
summer when medication he 
took to prevent blood clots caused 
a catastrophic gastrointestinal 
bleed. As he struggled to survive, 
Buckwalter recalls, “I was just 
trying to get in touch with what 
was good about me.... I think it 
was one of those times where if 
I didn’t really want to live, I could 
have gone. And I really did want 
to live.” 
As he regains his strength, he 
reports that he is “feeling almost 
ecstatic at being alive and being 
engaged.... Life is very bright right 
now, and Rolling is part of that 
brightness for me. I literally feel 
blessed to be part of this. Because 
when 1 watch Rolling, I feel like I’m 
part of something much bigger 
than me: I think it succeeds at por¬ 
traying disability as a situation 
that does not at all impede having 
a richly rewarding life.” 
Galen Buckwalter, who was paralyzed in a diving accident 30 years ago, 
says that Rolling demystifies and normalizes the experience of wheelchair 
users: "I think it succeeds at portraying disability as a situation that does 
not at all impede having a richly rewarding life.” 
Rolling. This was part of her research as a fellow in the clini- | 
cal scholars program, where expectations are high. Although 
Berland also worked on a quantitative study of the accuracy 
and sophistication of medical information on the Internet, I 
taking on a film project marked her as nontraditional. 
“I wasn’t sure what I was looking for. That’s where peo- 1  
pie get nervous, because it’s risky. You don’t have a hypothesis ■ 
you’re going to test or an outcome that you’re going to meas- i 
ure.” She wasn’t even sure how she would use the tapes she :j 
got from Elman, Wallengren and Buclcwalter, whom she found :|! 
through colleagues. At first, she thought she might use film 
sequences to illustrate a paper about the lives of people who j 
use wheelchairs. But in the end, she realized that the footage j > 
was so powerful that it had the capacity to become a film. j 
Finding that powerful footage was “a process of dis- ; f 
covery,” says co-director Majoros, a film editor and documen- t 
tary filmmaker on the faculty of the Rhode Island School t 
of Design. Joining the project after shooting had begun, j a 
Majoros quickly saw that editing Rolling would differ from » 
editing a documentary he’d filmed himself When you shoot k 
your own footage, he says, “it’s pretty obvious what the good ai 
stuff is and the bad stuff is.” Because Rolling was filmed by ai 
“neophytes,” he and Berland had to search, without precon- 
ceptions, for “the pieces that tell a story.” Among hours and te 
33 
hours of seemingly dull footage, Majoros recalls, “all of a 
sudden there’d be a 45-second gem.” 
He noticed some differences between his choices and 
Berland’s. In deciding what to include, he says, “I will tend 
to opt on the side of a good story. She will come at it much 
more from an academic background—to make sure we 
aren’t misrepresenting something.” 
Berland had already worked with Majoros, on Cross- 
Cover, having met him through a colleague. She found 
a collaborator of a different sort—and made a Yale con¬ 
nection—through her work as a clinical scholar at ucla. 
Attending meetings of clinical scholars from around the 
nation, she got to know Harlan M. Krumholz, m.d., a 
professor of medicine, who heads Yale’s clinical scholars pro¬ 
gram, a sister program to ucla’s. Over time, Krumholz 
developed into an across-the-continent mentor for Berland. 
Anyone doing scholarly work needs support, but when 
the work is unconventional, she says, “it really helps to have 
someone in your corner. Harlan as well as others here 
[at Yale] have provided that support.” 
Krumholz helped to recruit Berland to the Yale faculty, 
and since November 2001 she has served as a core faculty 
member of the clinical scholars program. She spends about 
a third of her time as an internist, treating patients through 
the School of Medicine’s primary care program and teaching 
medical students and residents. 
“Gretchen has an enormous amount of creativity and 
vision around issues very relevant to the way in which our 
health care system works,” says Krumholz. “Her work helps 
us see what may be right in front of us but may not be visi¬ 
ble to us.” 
A complement to large studies 
Two factors that obscure the physician’s view of the patient’s 
experience are pressures on doctors to be efficient and 
the advent of megascale studies. “Gretcheris work is all the 
more important because we’re in an era when house calls 
are no longer made,” says Krumholz. During standard 15- 
minute office visits, “physicians have lost the opportunity 
to explore what patients’ lives are really like,” he says. Also, 
advances in information technology allow researchers to 
amass and analyze huge quantities of data and to observe 
patterns. But, says Krumholz, “enormous data sets are very 
reductionist. Standardized collection of data doesn’t allow 
for nuance and for understanding the tapestry of what 
makes up people’s lives. ... Whether it’s research, or art or 
some combination, Gretchen’s work is a great complement 
to the studies in which we’re dealing with large numbers 
of people.” 
Berland has begun another research project using 
cameras and has ideas for two others. She is working with 
Krumholz to study what happens when a hospitalized 
patient has a cardiac arrest. The camera will serve as a data 
collection tool for a study of how hospital staff handles 
“codes.” Berland also wants to learn about health care from 
the perspective of ordinary people by giving them cameras. 
She is thinking of doing that research in the defunct manu¬ 
facturing hub of Waterbury, Conn. She wants to use film to 
study how patients re-enter the outside world after spending 
time in the hospital. 
Krumholz said Berland’s work must face the test 
imposed on all qualitative research: is it generalizable? He 
answers yes. “The truths that you see when you watch her 
film ring so true, resonate so well, that you just know these 
aren’t isolated experiences of these individuals. These 
themes transcend these individuals and must speak to a 
broader experience. 
“The challenge she faces is whether an academic 
medical center can adapt to understand how to credit this 
work, because it is so far outside the mainstream. ... The 
academic system is used to counting papers published.” 
Berland’s view of herself as a researcher came 
through clearly to filmmaker Workman. Unprompted by any 
discussion of what constitutes research, he called Rolling “a 
scientific study ... a scientific presentation of what happens” 
to Elman, Wallengren and Buckwalter. 
Workman admires what he called the “purity” of the 
film. “You don’t have Charlton Heston or Gene Hackman 
narrating it. It’s so much more interesting for an audience to 
make their own decisions about this.” And he said that audi¬ 
ences have seen so much nonfiction that “they have a very 
good detector of what isn’t real and what isn’t truthful.” 
Viewers can tell that Berland has not distorted the material 
to construct an audience-pleasing film. 
“I hope the movie goes far,” says Workman. “I hope 
she makes more movies.” 
Cathy Shufro is a contributing editor of Yale Medicine. 
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Graduate school dean 
moves to Yale College 
Psychology professor Peter 
Salovey replaces Richard 
Brodhead as dean of the 
undergraduate school. 
A little over a year after he was 
appointed dean of the graduate 
school, PETER SALOVEY, PH.D. 
’86, has taken on a new post as 
dean of Yale College. He replaces 
Richard H. Brodhead, ph.d., who 
left Yale to become president of 
Duke University. 
Salovey, the Chris Argyris 
Professor of Psychology, is deputy 
director of the Center for Inter¬ 
disciplinary Research on aids 
based at the School of Public 
Health, where he is also a profes¬ 
sor. His work on message fram¬ 
ing has explored the effectiveness 
of health promotion campaigns 
designed to reduce risky behaviors 
that can lead to infection with 
hiv/aids and other sexually trans¬ 
mitted diseases. He has conducted 
similar work on health communi¬ 
cations targeting cancer preven¬ 
tion behaviors. 
In more than 200 publications 
he has reported on human emo¬ 
tion and health psychology. His 
research has explored the psycho¬ 
logical consequences of the arousal 
of emotion, especially the ways in 
which mood and emotion influ¬ 
ence autobiographical memory 
and social interaction. With John 
D. Mayer, PH.D., Salovey developed 
the theory of emotional intelli¬ 
gence, showing that people have 
a wide range of measurable emo¬ 
tional skills that profoundly affect 
their thinking and action. 
Salovey has served on the 
National Science Foundation 
Social Psychology Advisory Panel 
and the National Institute of 
Mental Health (nimh) Behavioral 
Science Working Croup, and is 
presently a member of the nimh 
National Advisory Mental Health 
Council. He was a recipient of the 
National Science Foundation’s 
Presidential Young Investigator 
Award and of the 2001 National 
Cancer Institute’s CiS Partner in 
Research Award. 
Salovey has been chair of the 
psychology department and direc¬ 
tor of undergraduate studies and 
graduate studies. He has won the 
William Clyde DeVane Medal for 
Distinguished Scholarship and 
Teaching at Yale College and the 
Les Hixon ’63 Prize for Teaching 
in the Social Sciences. 
Jon Butler, ph.d., chair of the 
Department of History, profes¬ 
sor of religious studies and the 
William Robertson Coe Professor 
of American Studies and History, 
will replace Salovey as dean of 
the Graduate School of Arts and 
Sciences. 
Former Cancer Center 
director honored 
with professorship 
Vincent T. DeVita Jr., M.D., has 
been named the Amy and Joseph 
Perella Professor of Medicine in 
recognition of his contributions 
to cancer research and treatment. 
The chair was endowed in 
December with a gift of $2.5 mil¬ 
lion to strengthen the Yale Cancer 
Center’s ability to develop transla¬ 
tional research and new treat¬ 
ments. Joseph R. Perella,a mem¬ 
ber of the cancer center’s advisory 
board, is chair of The Institutional 
Securities Group at Morgan 
Stanley. His wife, Amy Perella, is a 
survivor of Hodgkin’s disease. 
Following DeVita’s tenure the 
chair will be renamed the Vincent 
T. DeVita Professor of Medicine 
and will support a physician at 
the cancer center with a strong 
clinical research background in 
the treatment of cancer. 
DeVita, a former director of 
the National Cancer Institute, 
was director of the Yale Cancer 
Center from 1993 until last July. 
He now chairs the Yale Cancer 
Center Advisory Board and is a 
professor of medicine and epi¬ 
demiology and public health. 
He serves on the editorial boards 
of numerous scientific journals 
and is the author or co-author of 
more than 450 scientific articles. 
Faculty members 
selected as fellows 
of AAAS 
Three members of the Yale Univer¬ 
sity faculty with medical school 
affiliations were named fellows of 
the American Academy of Arts 
and Sciences (aaas) in May. 
Donald M. Engelman, PH.D. ’67, 
the Eugene Higgins Professor of 
Molecular Biophysics and Bio¬ 
chemistry, uses X-ray diffraction, 
neutron scattering, electron 
microscopy, optical spectroscopy 
and biochemical methods to 
determine how the primary 
sequences of membrane pro¬ 
teins determine their three- 
dimensional structures and 
how they function. 
Paul A. Fleury, PH.D., dean of 
the Faculty of Engineering, is 
the Frederick William Beinecke 
Professor of Engineering and 
Applied Physics. At Yale he has 
been a catalyst in the emergence 
of engineering as a cohesive link 
between the physical and bio¬ 
medical sciences. 
Susan Hockfield, PH.D., provost 
of Yale University, is the William 
Edward Gilbert Professor of 
Neurobiology and former dean of 
the Graduate School of Arts and 
Sciences. She studies the develop¬ 
ment of the mammalian brain 
and the progression of the deadly 
glioma type of brain tumor. She 
has written more than 90 scien¬ 
tific publications and is the pri¬ 
mary author of Molecular Probes 
of the Nervous System: Selected 
Methods for Antibodies and 
Nucleic Acid Probes. 
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Sharon Inouye Susan Hardy Curtis Patton Margaret Bia Sidney Blatt James Comer 
Sharon K. Inouye, M.D., aa.P.h. ’8g, 
professor of medicine (geriatrics), 
associate clinical professor of 
nursing and co-director of the 
Yale Program on Aging, received 
the Ewald W. Busse Research 
Award in Biomedical Sciences at 
the Gerontological Society of 
America’s 56th meeting in San 
Diego, Calif. Inouye was recog¬ 
nized for her contributions to 
advancing the scientific under¬ 
standing of delirium and 
functional decline. At the same 
meeting, Susan E. Hardy, M.D., 
postdoctoral fellow in geriatric 
medicine and a ph.d. candidate 
in investigative medicine, was 
awarded the Person-in-Training 
Award. Hardy was honored for 
her paper “Predictors of Recov¬ 
ery of Independent adl Func¬ 
tion Among Mewly Disabled 
Community-Dwelling Older 
Persons.” 
Two members of the medi¬ 
cal school faculty have been 
named to a re-established 
Minority Advisory Council 
(mac). The MAC will advise 
President Richard C. Levin on 
the appropriateness of policies 
related to minority groups. 
The medical school faculty 
members are Liia D. Cariaga-Lo, 
ED.D., assistant dean of diversity 
at the graduate school and 
assistant clinical professor at 
the Child Study Center, and 
Curtis L Patton, PH.D., professor 
of epidemiology (microbiology) 
and director of International 
Medical Studies. 
Three Yale faculty members 
were honored in April by the 
National Kidney Foundation 
(nkf) of Connecticut with the 
Pioneers in Transplantation 
Awards; Margaret J. Bia, m.d., 
professor of medicine (nephrol¬ 
ogy), Marc I. Lorber, M.D., profes¬ 
sor of surgery (transplantation), 
and Bernard Lytton, m.b.b.S., 
the Donald Guthrie Professor 
Emeritus of Surgery. 
Sidney J. Biatt, ph.d., professor 
of psychiatry and psychology 
and chief of psychology in the 
Department of Psychiatry, is 
the recipient of the 2004 award 
for Distinguished Scientific 
Contributions from the Divi¬ 
sion of Clinical Psychology 
of the American Psychological 
Association. 
James P. Comer, M.D., M.P.H., HS 
’66, the Maurice Falk Professor 
of Child Psychiatry in the Child 
Study Center, was honored 
with the seventh annua! John P. 
McGovern Behavioral Sciences 
Award by the Smithsonian 
Institution.The award, pre¬ 
sented in January by Sen. Hillary 
Rodham Clinton (N.Y.), recog¬ 
nizes individuals in the behav¬ 
ioral sciences, literature and 
other professions who have 
made outstanding contributions 
to furthering the understand¬ 
ing of the family in America. 
Joseph E. Craft, M.D., HS ’77, pro¬ 
fessor of medicine and immuno¬ 
biology, has been named director 
of the Investigative Medicine 
Program at Yale. Craft replaces 
Keith A. Joiner, m.d., m.p.h. ’03, 
who left in February to become 
dean of the University of Arizona 
College of Medicine. The Investi¬ 
gative Medicine Program pro¬ 
vides rigorous research training 
for physicians in laboratory 
science or patient-oriented 
research leading to the award¬ 
ing of a PH.D. degree. 
Elena L. Crigorenko, ph.d. ’96, 
associate professor of psychol¬ 
ogy and associate professor of 
child studies in the Child Study 
Center, has won the 2004 
American Psychological Associa¬ 
tion (apa) Award for Distin¬ 
guished Scientific Early Career 
Contribution to Psychology 
(Developmental).This award is 
given once every three years to 
an outstanding young scientific 
investigator less than 10 years 
post-PH.D. 
Michael Kashgarian, M.D. ’58, HS 
’63, professor of pathology and 
molecular, cellular and develop¬ 
mental biology, received the 
Jacob Churg Award of the Renal 
Pathology Society in March at 
the meeting of the United 
States and Canadian Academy 
of Pathology in Vancouver, 
British Columbia.The Jacob 
Churg Award is presented annu¬ 
ally to an individual who has 
made major contributions to the 
field of nephropathology. 
Marvin Moser, M.D., clinical pro¬ 
fessor of medicine and editor in 
chief of the Journal of Clinical 
Hypertension, has received the 
International Society of Hyper¬ 
tension Award for Outstand¬ 
ing Contributions to Clinical 
Research and Treatment in the 
Management of Hypertension. 
Susan S. Spencer, PH.D., professor 
of neurology, has received 
the Clinical Investigator Award 
from the American Epilepsy 
Society/Milken Family Founda¬ 
tion, to recognize her contribu¬ 
tions to epilepsy research. She 
received the award in December 
2003 at the annual meeting of 
the American Epilepsy Society 
in Boston. 
V. Robin Weersing, PH.D., assist¬ 
ant professor in the Child 
Study Center, was one of six 
researchers named a William T. 
Grant Scholar in April by the 
William T. Grant Foundation. A 
$300,000 five-year grant will 
support her research on devel¬ 
oping and disseminating effec¬ 
tive interventions for depression 
and anxiety in youth. 
Barry L. Zaret, M.D., the Robert 
Berliner Professor of Medicine, 
chief of the Section of Cardio¬ 
vascular Medicine and professor 
of diagnostic radiology, received 
a 2004 Ellis Island Medal of 
Honor in May for his outstand¬ 
ing contributions to American 
medicine.The medal was cre¬ 
ated in 1986 “to honor the 
many ancestral groups who 
through struggle, sacrifice and 
success helped build this great 
nation.” Presidents, senators, 
congressional leaders and Nobel 
Prize winners are among those 
to receive the medals. Zaret’s 
family is from Belorussia, an 
area also known as White Russia 
that was once part of the 
Russian Empire. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yak Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger{g)yale.edu 
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36 students 
Nduka Amankulor and Brian 
Nahed looked over the 
Match list with Interim Dean 
Dennis Spencer. 
Subspecialties? 
That’s our specialty 
The 2004 Match shows that 
Yale students, like their peers, want 
a niche to call their own. 
By llene Wong 
“Have any of you guys been having 
Match nightmares.^” one of my class¬ 
mates asked in March, a week or so 
before the 2004 residency placements 
were announced for 25,000 U.S. medi¬ 
cal students (including 107 here in New 
Haven). Many of us had indeed slept 
fitfully while waiting to leam where we 
would be spending the next phase of our 
training, and for good reason. Yale medi¬ 
cal students flocked this year toward 
the most competitive subspecialties, and 
with precious few slots in these pro¬ 
grams, the process was more than a little 
nerve-wracking. “It can be a real game 
of chance,” Nancy R. Angoff, m.p.h. ’81, 
M.D. ’90, HS ’93, the associate dean for 
student affairs, had warned us. “There 
are no guarantees.” 
The late 1990s saw a shift away 
from subspecialty training in favor of 
generalist careers. More than half the 
students in the Yale classes of 2000 
and 2002, for example, chose resi¬ 
dencies in internal medicine, family 
practice and pediatrics, and nationally 
the figure was higher. This year, 
fewer than 40 percent of Yale students 
entered these tracks, favoring instead 
such highly sought-after fields as der¬ 
matology and radiology, which also 
carry higher salaries. One reason 
seems to be debt, which will average 
$109,457 for graduating students this 
year, according to the Association of 
American Medical Colleges. Another is 
the desire for a controllable lifestyle 
with less call and shorter hours. 
Families have changed, and most 
physicians will not have a stay-at-home 
spouse to support a round-the-clock 
practice. But beyond this, Yale medical 
students may be predisposed to sub¬ 
specialize because that is where their 
curiosity leads them. My classmates 
are likely to want to become experts in 
a field and to call something their own. 
For nearly every medical student. 
Match Day is the undeniable climax of 
four years, a day in which anxiety yields 
to profound certainty with the rip of an 
envelope. I approached the third Thurs¬ 
day in March on a more even keel than 
most. Like 16 of my classmates who 
applied for the early-match specialties 
(otolaryngology, neurology, neurosur¬ 
gery, ophthalmology and urology), I had 
received an early-morning call in January 
informing me of my match. One 
moment I was being roused from sleep 
by a ringing phone; the next I knew for 
certain where I would be and what I 
would be doing for the next six years. 
Many of my friends were on rotations or 
in class that morning, so my celebration 
was protracted and intimate. I shared the 
news with my family and distant friends 
by phone in the quiet of my room. 
March 18, however, was an entirely 
different matter. After spending the 
morning discussing professionalism 
with John S. Hughes, m.d., hs ’76, 
and other faculty members, we filed 
into the Marigolds dining area at 11:40 
(our itinerary for the day had helpfully 
noted that from 11:30 to noon, we 
would experience a time when the 
“tension mounts”). Family members, 
significant others and classmates tak¬ 
ing a fifth year joined the jittery crowd. 
At noon the doors to Harkness ball¬ 
room opened and my classmates 
rushed in to open their envelopes. 
There was a lot of joy and just a little 
bit of disappointment as people met 
their match. At around 12:10 the full 
match list was released and students 
huddled in groups to marvel at the col¬ 
lective picture, which was on the whole 
incredibly rosy: an unprecedented 12 
students matched in dermatology: a 
dozen future pediatricians almost uni¬ 
formly matched at their first choice; six 
students apiece placed in the competi¬ 
tive fields of orthopaedics, ophthalmol¬ 
ogy, urology and radiology. 
At times it seemed like there were 
too many people to congratulate. Eliza 
Auerbach, who will be going to 
Columbia for pediatrics (her first 
choice), summed up the sentiments of 
many of my classmates, noting that 
she was “happy, but overwhelmed.” 
Vernee N. Belcher was ecstatic 
about staying at Yale for internal medi¬ 
cine/primary care. But even before 
tearing open that fateful envelope, she 
reflected that we all had much to be 
grateful for by having been at Yale 
Med: “No matter where we match, it’s 
clear we will all be great doctors.” 
llene Wong is beginning her residency in urol¬ 
ogy this summer at Stanford. 
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2004 residency placements for 
Yale medical students 
The Office of Student Affairs has pro¬ 
vided the following list, which outlines 
the results of the National Resident 
Matching Program for Yale’s medical 
graduates. Some names appear twice 
because the graduate is entering a one- 
year program before beginning a specialty 
residency. The transitional designation 
is a one-year program with three-month 
rotations in different specialties. 
California 
California Pacific Medical Center, 
San Francisco 
Paul Kim, radiation oncology 
Contra Costa Regional Medical 
Center, Martinez 
Pramita Kuruvilla, family practice 
Harbor-UCLA Medical Center,Torrance 
Chirag Shah, emergency medicine 
Santa Clara Valley Medical Center, 
San Jose 
Paul Kim, transitional 
St. Mary Medical Center, Long Beach 
Ragui Sedeek, medicine-preliminary 
Stanford University Programs 
Bao Duong, emergency medicine 
Katharine Fast, internal medicine 
Saif Ghole, general surgery 
Cambria Hembree, internal medicine 
llene Wong, surgery-preliminary, 
urology 
University of California, San Francisco 
Michael Eisenberg, surgery¬ 
preliminary, urology 
Mona Kotecha, anesthesiology 
Liana Kretschmar, pediatrics 
Roberto Lugo, orthopaedic surgery 
James McCabe, internal medicine 
Harsimran Singh, internal medicine 
Connecticut 
FJospital of Saint Raphael, 
New Haven 
Paul El-Fishawy, medicine-preliminary 
Cinthia Guzman, transitional 
Nabil Salib, general surgery 
John Soderberg, medicine-preliminary 
Elizabeth Arleo, Rupali Gandhi, 
Reena Rupani and Cinthia Guzman 
shared a moment of joy over their 
successful matches. 
Yale-New Haven Hospital 
Nduka Amankuior, surgery¬ 
preliminary, neurosurgery 
Vernee Belcher, internal 
medicine/primary 
Michael Bloch, psychiatry-adult/child 
Victoria Bruegel Sanchez, 
orthopaedic surgery 
Severine Chavel, medicine¬ 
preliminary, dermatology 
Keith Choate, medicine¬ 
preliminary, dermatology 
Oscar Colegio, medicine¬ 
preliminary, dermatology 
Craig Dushey, orthopaedic surgery 
Rina Garcia, internal medicine/ 
primary 
Grahame Gould, surgery-preliminary, 
neurosurgery 
Michael Greenspan, internal medicine 
Cinthia Guzman, ophthalmology 
Karl Haglund, medicine- 
primary-preliminary 
Joseph Harburger, internal medicine 
Byron Kennedy, general surgery 
Elaine Kung, medicine- 
primary-preliminary 
Elin Lisska, internal medicine 
Kavita Mariwalla, dermatology 
Paola Uranga, general surgery 
Erica Wang, obstetrics and gynecology 
District of Coiumbia 
Georgetown University Hospital 
Heather Shelsta, transitional 
Walter Reed Army Medical Center 
Clifton Mo, internal medicine 
Washington Hospital Center 
Mona Kotecha, medicine-preliminary 
iilinois 
University of Chicago Hospitals 
Jennifer Blair, emergency medicine 
Melissa Kirkwood, general surgery 
Elaine Kung, dermatology 
Maryland 
Johns Hopkins Hospital, Baltimore 
Renee Boynton-Jarrett, pediatrics 
William Burns, general surgery 
John Koethe, internal medicine 
National Naval Medical Center, 
Bethesda 
Suneil Ramchandani, internal medicine 
Massachusetts 
Beth Israel Deaconess Medical 
Center, Boston 
Wei Chan Hwang, internal medicine 
Benjamin Negin, internal medicine 
Jared Weiss, internal medicine 
Brigham and Women’s Hospital, 
Boston 
Mark Berman, internal 
medicine/primary 
Ugonna Duru, obstetrics and 
gynecology 
Darlene Cabeau, radiation oncology 
Karl Haglund, radiation oncology 
Timothy Henrich, internal medicine 
Christopher Herndon, 
obstetrics and gynecology 
Stephanie Holler, diagnostic radiology 
Alfred Lee, internal medicine 
Jacqueline William, pathology 
Carney Hospital, Boston 
Ryan Jean-Baptiste, medicine¬ 
preliminary 
Children’s Hospital of Boston 
Virginia Cohen, pediatrics 
Rupali Gandhi, pediatrics 
Dena Springer, pediatrics 
Rachel Willner, pediatrics 
Massachusetts Eye and Ear Infirmary, 
Boston 
Ben Kim, ophthalmology 
Massachusetts General Hospital, 
Boston 
Allyson Bloom, internal medicine 
Amir Fathi, internal medicine 
Kavita Mariwalla, medicine-preliminary 
AshrafThabet, diagnostic radiology 
Parsia Vagefi, general surgery 
Erik Weiss, surgery-preliminary, urology 
Mount Auburn Hospital, Cambridge 
Darlene Gabeau, medicine-preliminary 
Ben Kim, medicine-preliminary 
Michigan 
University of Michigan Hospitals, 
Ann Arbor 
Sarah Kohnstamm, internal medicine 
New Hampshire 
Dartmouth-Hitchcock Medical 
Center, Lebanon 
Jennifer Fines, pediatrics 
Adam Pearson, orthopaedic surgery 
Hilary Ryder, internal medicine 
New Jersey 
UMDNJ-New Jersey Hospital, Newark 
Robyn Siperstein, dermatology 
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38 students 
Erica Wang and her husband, 
Stephen Shiao, read over the 
letter announcing her match in 
ob/gyn at Yale-New Haven 
Hospital. Shiao is in his fifth year 
of the M.D./PH.D. program. 
Bahar Firoz and Jesse James 
studied the list of matches to see 
where classmates were headed. 
New Mexico 
University of New Mexico Health 
Sciences Center, Albuquerque 
Lawrence Goldstein, emergency 
medicine 
New York 
Albert Einstein College/Jacobi 
Medical Center, Bronx 
Jessica Newman, dermatology 
Albert Einstein College/Montefiore 
Medical Center, Bronx 
Brent Little, diagnostic radiology 
Jane Schneider, medicine-preliminary 
Beth Israel Medical Center 
Jessica Newman, medicine-preliminary 
Lenox Hill Hospital 
Elizabeth Arleo, medicine-preliminary 
Memorial Sloan-Kettering Cancer 
Center 
Richard Awdeh, transitional 
Stephanie Holler, transitional 
Mount Sinai Hospital 
Bahar Firoz, medicine-preliminary 
Tamiesha Frempong, medicine¬ 
preliminary 
Brent Little, medicine-preliminary 
New York Eye and Ear Infirmary 
Ragui Sedeek, ophthalmology 
New York Medical College at 
St. Vincent’s Hospital 
Ashraf Thabet, medicine-preliminary 
New York Methodist Hospital, 
Brooklyn 
Ryan Jean-Baptiste, diagnostic 
radiology 
New York-Presbyterian Hospital- 
Columbia 
Eliza Auerbach, pediatrics 
Paola Ayora, pediatrics 
Cordelia Carter, orthopaedic surgery 
Caroline Jjingo, internal medicine 
Daniel Prince, orthopaedic surgery 
New York-Presbyterian Hospital- 
Cornell 
Elizabeth Arleo, diagnostic radiology 
New York University School of 
Medicine 
Bahar Firoz, dermatology 
Rachel Levy, internal medicine/primary 
Reena Rupani, medicine-preliminary 
SUNY Health Science Center, 
Brooklyn 
Jane Schneider, dermatology 
University of Rochester/Strong 
Memorial Hospital 
Emily Lambert, medicine-preliminary- 
neurology, dermatology 
North Carolina 
Duke University, Durham 
Richard Awdeh,.ophthalmology 
John Soderberg, dermatology 
University of North Carolina 
Hospital, Chapel Hill 
Shannelle Campbell, general surgery 
Ohio 
Cleveland Clinic Foundation 
Edward Cho, surgery-preliminary, 
otolaryngology 
Pennsylvania 
Albert Einstein Medical Center, 
Philadelphia 
Robyn Siperstein, transitional 
Allegheny General Hospital, 
Pittsburgh 
Eduardo Marchan, surgery- 
preliminary, neurosurgery 
Children’s Hospital of Philadelphia 
Spencer Epps, pediatrics 
Laura Mobisson, pediatrics 
Hospital of the University of 
Pennsylvania, Philadelphia 
Charles Baillie, internal medicine 
Kathryn Davis, medicine-preliminary, 
neurology 
Myriam Fernandes, obstetrics and 
gynecology 
Sean Lucan, family practice 
Alejandro Necochea, internal medicine 
Alejandro Reti, pathology 
Scheie Eye Institute/University of 
Pennsylvania, Philadelphia 
Tamiesha Frempong, ophthalmology 
Thomas Jefferson University, 
Philadelphia 
Ada-Nkem Nwaneri, family practice 
Wills Eye Hospital, Philadelphia 
Heather Shelsta, ophthalmology 
Rhode Island 
Rhode Island Hospital/Brown 
University, Providence , 
Reena Rupani, dermatology j 
Texas 
University of Texas Southwestern 
Medical School, Dallas | 
Jenny Yiee, surgery-preliminary, urology 
Washington j 
University of Washington Affiliated 
Hospitals, Seattle I 
Rajasekhara Ayyagari, surgery¬ 
preliminary, urology 
Zachary Coldberger, internal medicine 
Eric Gustafson, pediatrics 
Grace Kalish, diagnostic radiology 
Marco Salazar, surgery-preliminary, 
Virginia Mason Medical Center, 
Seattle 
Grace Kalish, transitional 
39 
In a darkened Harkness, 
video reigns king of the 
second-year show 
An ad from the Office of Admissions in 
the program for this year’s second-year 
show congratulated the Class of 2006, 
then playfully added, “We were the first 
to spot your extraordinary talent.” While 
watching this buoyant and risque mid¬ 
winter revue any given year, one has to 
wonder if singing, dancing and writing 
ability might not factor into the admis¬ 
sions process to some small degree. For 
an amateur show, it’s pretty good enter¬ 
tainment—especially for insiders who 
get the jokes and barbs. 
This year, videography topped the 
list of talents behind a sophomoric (by 
definition) production titled Not Another 
znd-Year Show. The title may have been 
a reference to the near-total absence 
of plot. Digital camcorders and do-it- 
yourself editing software have fueled an 
increasing number of video sketches 
as part of the show each February, and 
the trend was strong enough this time 
to keep the stage clear of performers for 
good chunks of the evening. 
Among the highlights on screen was 
; an opening video sequence taken from 
The Sopranos, with a cigar-smoking Craig 
Platt navigating an suv through the 
gritty highways approaching downtown 
BELOW LEFT No recent show has missed 
a mention of former Dean David Kessler, who 
left Yale last year. In this year’s performance, 
Richard Silverman, Dennis Spencer and Robert 
Gifford sang an ode to the departed dean,"We 
Lost Our Dean to San Francisco.” center Stacy 
Uybico, who choreographed a Tahitian dance 
New Haven. Snippets of video enabled 
the show’s creators to parody the movie 
Top Gun, with Associate Dean Nancy R. 
Angoff, M.p.H. ’81, M.D. ’90, HS ’93 
(in the role of the sexy flight instructor) 
playing opposite Doug Lyssy’s head¬ 
strong Maverick, who rode a red Ducati 
motorcycle onto the stage. Another 
movie parody cast Davendar Khera and 
Timmy Sullivan as arch rivals in a 
sendup of the Ben Stiller/Owen Wilson 
comedy Zoolander called “Zoolabber.” 
A series of video interviews with 
faculty members including Michael J. 
Caplan, Susan J. Baserga, Herbert S. 
Chase and Lawrence J. Rizzolo allowed 
student Simon Best to embarrass his 
victims with trick questions on advanced 
topics in science (“If the ridge line of a 
house is pointing due south, and on a 
sunny day a rooster lays an egg precisely 
on the center of that ridge, which way 
will the egg roll?”). A Saturday Night 
Live-inspired segment gave the school’s 
registrar the chance to bowl over unruly 
students in the persona of “Terry Tolson, 
Student Affairs Office Linebacker.” And 
one of the most original clips was pro¬ 
duced by Todd Ebbert, whose 2-year-old 
daughter. Alia, excelled as a young med 
student in the making in a sketch titled 
“Kaplan for Kids.” (She correctly pointed 
to her frontal cortex, xiphoid process 
and patella.) 
number, is joined onstage by classmate Craig 
Platt. RIGHT Kendra Klang and Ahou Meydani 
danced through the show’s opening number, 
“La Vie Yale Med." Set in Marigolds, the scene 
highlights various aspects of life at the medi¬ 
cal school. Here, chorus girls show how Yale’s 
environment allows them to break taboos. 
The live-action portion of the show 
included a clever piece called “Heart 
Sounds,” patterned after gallops and 
murmurs: a Tahitian dance number 
choreographed by Stacy Uybico and 
Joel Hernandez; amazing break danc¬ 
ing by Eddie Teng; and a tender and 
comedic pas de deux by Craig Platt 
and Deepak Rao. Continuing a tradi¬ 
tion of exploring the limits of taste, a 
number titled “Club Moist” probed New 
Haven’s club scene and the full range 
of sexually transmitted diseases one 
might encounter among the clientele. 
In the end, lacking a plot didn’t seem 
to hamper the ability of Not Another 
2nd-Year Show to charm and entertain. 
Eor the past five or six years, most of 
the story lines had revolved around 
former Dean David A. Kessler, m.d., 
who left Yale last June for a similar post 
in California. This show, too, managed 
a nod to Kessler in its final number, 
“We Lost Our Dean to San Francisco,” 
which was sung by Angoff, Interim 
Dean Dennis D. Spencer, m.d., hs 
’77, Admissions Director Richard A. 
Silverman and former Deputy Dean 
Robert H. Gifford, m.d., hs ’67. 
The proceeds of the show, more 
than $3,000, were donated to 
the Community Health Care Van in 
New Haven. 
—Michael Fitzsousa 
TERRY DACR. 
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40 Alumni FACES 
As a young psychiatrist, Aaron Beck realized 
that traditional psychoanalysis wasn’t making his 
patients better. He developed an alternative 
therapy that revolutionized psychiatric thought. 
Challenging Freud, 
starting a revolution 
A residency requirement became 
a passion for one doctor and changed 
the field of psychiatry. 
As a neurology resident at the Cushing 
VA Hospital in Framingham, Mass., 
Aaron T. Beck, m.d. ’46, was required 
to do a rotation in psychiatry. But what 
began as an academic obligation soon 
became a career-altering opportunity, 
as Beck saw the value of using psycho¬ 
logical tools to help some patients. 
“I got stuck in psychiatry and never 
got out of it,” Beck says today, five 
decades later. “In neurology there 
wasn’t much you could do in terms of 
treatment in those days. What fasci¬ 
nated me about psychiatry was that 
people with neuroses could actually be 
treated and made better.” 
Beck went on to become one of the 
most influential figures in American 
psychiatry. As a young doctor in the 
1960s, he challenged the theories of 
Sigmund Freud and triggered a revo¬ 
lution in psychology, founding a 
treatment method known as cognitive 
therapy. He recently received the 2004 
University of Louisville Grawemeyer 
Award for Psychology, which includes 
a $200,000 prize, for his ground¬ 
breaking contribution to the field 
of psychology. 
“He is the latest of the great system 
creators in psychotherapy,” says Bruce 
J. Rounsaville, m.d., fw ’78, professor 
of psychiatry at the School of Medicine. 
“In the same tradition as Sigmund 
Freud and Carl Rogers, he made a major 
difference in the way people approach 
psychotherapy.” 
Early in his career Beck adhered to 
the teachings of Freud, specifically the 
value of psychoanalysis. But when he 
began noticing that his patients weren’t 
getting any better, he developed an 
alternative treatment that focused on 
the patient’s immediate feelings and 
perceptions rather than unearthing 
repressed fears and conflicts, as is cen¬ 
tral to Freudian psychoanalysis. “Since 
patients are aware of their conscious 
thoughts, it’s not as difficult [as tradi¬ 
tional psychotherapy, which requires 
the exhumation of buried memories] to 
correct misperceptions,” he says dur¬ 
ing a phone interview from his office 
in Philadelphia. 
Cognitive therapy is based on a spe¬ 
cific understanding of how the human 
mind works. Beck says. “People with 
certain types of neurotic disorders dis¬ 
tort the way they view themselves. They 
see through a negative lens, so all expe¬ 
riences are twisted around to something 
negative. Cognitive therapy offers strat¬ 
egies to identify that negative distorted 
thinking and to help the patient cor¬ 
rect it.” Unlike adherents of Freudian 
psychotherapy. Beck doesn’t believe one 
has to trace the origin of an emotional 
problem in order to treat it. “It’s not 
necessary to go back to early trauma,” 
he says. “What’s important is address¬ 
ing the problem that has arrived.” 
Cognitive therapy has been used to 
treat a range of patients, from 
depressed housewives to schizophren¬ 
ics. Most recently, Beck has applied 
his theories to analyzing the minds of 
terrorists. In his 1999 book. Prisoners 
of Hate: The Cognitive Basis of Anger, 
Hostility, and Violence (HarperCollins), 
Beck concludes that the terrorist mind¬ 
set is “just as distorted as those of neu- 
rotic patients.” He describes how ter¬ 
rorists make sweeping generalizations 
about their enemies. This, in turn, 
makes it easier to demonize them, so 
that the use of terror becomes equated, 
in the terrorist’s mind, with survival. 
Beck’s theories have been used by the 
National Center for Conciliation in 
Northern Ireland to help defuse ten¬ 
sions there. 
Experts in the field of psychology at 
Yale agree that one of Beck’s most sig¬ 
nificant contributions is that he identi¬ 
fied treatment components that could 
be tested empirically, and then he con¬ 
ducted the tests. 
“Everyone has a therapy they think 
works,” says Alan E. Kazdin, ph.d., the 
John M. Musser Professor of 
Psychology and director of the Child 
Study Center. “But Dr. Beck took it to 
the next step. He developed a thera¬ 
peutic model, a therapeutic technique 
and then he did the research.” 
Beck, who developed treatment 
techniques for depression, wanted to 
test the commonly held belief that 
there is a correlation between depres¬ 
sion and suicide. Through controlled 
studies, which have been replicated, he 
was able to show that it’s not depres¬ 
sion per se, but rather feelings of hope¬ 
lessness (which may or may not be 
associated with depression) that are 
predictive of suicide. 
“Dr. Beck was not only able to 
I show the efficacy of cognitive behav¬ 
ioral therapy for depression, but along 
the way, he developed tools like the 
j Beck Depression Inventory that have 
i become staples of clinical research,” 
i says John H. Krystal, m.d. ’84, the 
Robert L. McNeil Jr. Professor of 
Clinical Pharmacology and deputy 
chair for research for the Department 
of Psychiatry. He added that Beck’s 
I work, while primarily directed toward 
psychotherapy research, has stimulated 
research on the common neurological 
mechanisms underlying psychotherapy 
. and pharmacotherapy. “Many psychia- 
i’ trists like myself found the emergence 
of cognitive behavioral therapy to be a 
factor that stimulated interest in the 
mechanisms underlying the interac¬ 
tions of pharmacologic and psychoso¬ 
cial treatments. Studying these 
complex interactions has become a 
major research focus.” 
Kazdin says the treatment methods 
used for some aggressive and violent 
children at the Child Conduct Clinic, a 
specialty clinic affiliated with the Child 
Study Center, are “within the general 
rubric” of the techniques pioneered by 
Beck. “His techniques have been used 
primarily for adults diagnosed with 
depression and later, anxiety,” Kazdin 
says, “but there are variants of it that can 
be effective when used for children.” 
“He’s grounded in the research tra¬ 
dition,” says Rounsaville. “He’s com¬ 
mitted to seeing it through, to making 
sure his therapies meet the standards 
for efficacy.” Rounsaville, who is the 
director of the substance abuse treat¬ 
ment unit at Yale’s psychiatry depart¬ 
ment, said a new manual prepared by 
the unit draws on cognitive behavioral 
therapy techniques to help cocaine 
addicts. “This derives directly from Dr. 
Beck’s work,” he says. 
Beck, 83, University Professor 
Emeritus of Psychiatry at the Univer¬ 
sity of Pennsylvania School of Medi¬ 
cine and a member of the Institute of 
Medicine and the National Academy 
of Sciences, was awarded the Rhoda 
and Bernard Sarnat International Prize 
in Mental Health last year. He still has 
an active research unit at Penn, study¬ 
ing the effectiveness of treating schizo¬ 
phrenic patients with a combination of 
medication and cognitive therapy. He 
has written or co-written 17 books on 
cognitive therapy, depression and other 
emotional disorders. 
Beck said Yale’s philosophy of 
encouraging students to be curious 
and critical taught him to play with 
ideas and not just memorize facts. “It 
was the best possible system for my 
own personal development,” he says. 
“I learned to have an open mind and 
treasure learning for its own sake.” 
—Jennifer Kaylin 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
Yale Medicine, P.O. Box 7612, New Haven, 
CT 06519-0612. 
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42 Alumni FACES 
Public health alumna 
watches over a growing cohort 
of female veterans 
Irene Trowell-Harris’ brothers and sisters 
must have thought she was joking when 
she pointed to a plane flying over their 
family’s farm in rural South Carolina 
and declared: “One day I'm going to fly 
and work on an airplane.” 
“We all laughed,” recalls Trowell- 
Harris, R.N., M.P.H. ’73, ED.D. It did 
seem unlikely on that day in 1954 that 
their 14-year-old sister would ever set 
foot on an airplane. The children lived 
in a farmhouse that initially lacked run¬ 
ning water in Aiken, S.C., and attended 
an all-black school. True, if anyone 
from the family was going to make it, it 
might be Irene, the third of ii children. 
“I always had a lot of responsibility. I 
was the one who always stayed focused, 
made sure everybody did their school- 
work and housework and farm work,” 
recalls Trowell-Harris. 
Trowell-Harris did find a way to fly, 
as an Air National Guard nurse. And 
she rose steadily in the Air National 
Guard to reach the rank of major 
general—the first African-American 
woman to achieve that rank in the 
National Guard. A month after retiring 
from the Guard in September 2001, she 
accepted an appointment by President 
Bush as director of the Department of 
Veterans Affairs Center for Women 
Veterans. Her office monitors the wel¬ 
fare of the 1.7 million women who have 
served in the Armed Forces. 
To get this far, Trowell-Harris com¬ 
bined realism with idealism. She made 
decisions that would give her maximum 
support in overcoming the barriers of 
poverty and racism. She chose nursing 
because she knew she would always 
have a job, and she sought a career in 
the military because its rules to some 
extent protected her against discrimina¬ 
tion (although it was not until 1974 that 
Congress required the Armed Services 
to drop its 2 percent cap on women in 
the military). 
“I wanted to be successful. ... So I 
decided I would use my skills to work 
within the system. But all along, my 
goal was to help change the system later 
on, not just for myself, but for others.” 
As director of the Center for Women 
Veterans, Trowell-Harris works to 
ensure that female veterans know about 
the benefits available to them, including 
inpatient and outpatient health care, 
counseling, insurance and home and 
business loans. She also works with 
veterans affairs committees in Congress 
to introduce legislation that benefits 
female veterans. For instance, Trowell- 
Harris helped back a new law that pro¬ 
vides money and services for disabled 
children of women exposed to the 
herbicide Agent Orange in Vietnam. 
Trowell-Harris notes that services 
to female veterans will become increas¬ 
ingly important as the proportion of 
women in the military increases. 
Women now constitute 6.5 percent of 
the nation’s 26 million living veterans, 
and the percentage will increase for two 
reasons: first, because the number of 
women in active service has risen, to 17 
percent; and second, because male 
veterans, mostly from World War II, are 
dying at a rate of 1,400 per day. 
Trowell-Harris was born just two 
generations away from slavery: her 
grandfather, Jim Trowell, was enslaved 
until he was in his early 20s. After the 
Civil War, a white family took him 
From a farmhouse in South Carolina, Irene 
Trowell-Harris went on to become a nurse and 
major general in the Air National Guard. 
under its wing, bequeathing him 50 
acres in South Carolina that Trowell- 
Harris’ parents gradually enlarged into 
a 200-acre farm. Trowell-Harris was 
bom in the farmhouse in 1939 and 
grew up helping her parents raise cot¬ 
ton, com, peas and watermelon and 
tend cattle, pigs and chickens. The fam¬ 
ily would pile into a mule-drawn wagon 
to go to town and to attend the Mount 
Hill Baptist Church on Sundays. 
When Trowell-Harris finished high 
school, she considered her options. 
In 1955, “Afncan-American females had 
three choices: secretary, teacher or 
nurse.” Nursing would not only provide 
steady work, but it would allow her to 
earn money as an aide while she was a 
student, helping finance college for her 
brothers and sisters. (Among them 
would be another nurse, a pilot, three 
small-business owners and a physician.) 
Trowell-Harris earned her nursing 
diploma on a Friday in the spring of 
1959, and by Monday she was working 
two jobs. A hurricane had destroyed the 
family farm, and she was helping her 
family financially. “I felt fmstrated, but I 
knew if I didn’t help, we would lose the 
whole farm.” It took two years for the 
family to get back on its feet, and then 
Trowell-Harris went north. She got fur¬ 
ther training as a psychiatric nurse at 
New York Hospital-Comell Medical 
Center in White Plains, and then relo- 
Gualberto Ruano is trying to understand how 
genes influence the way patients respond to diet, 
nutrition, exercise and environmental exposures. 
Gated to New York City where she would 
work for 20 years. There she heard 
from a fellow nurse about the Air 
National Guard. 
She signed up in 1963, and a year 
later she flew for the first time. On week¬ 
ends, during vacations and during stints 
of active duty, she worked as a flight 
nurse on jets evacuating patients from 
battlefields, and she saw the world. 
While serving in the Air National 
Guard, she spent two years at Yale 
studying for her master’s in public 
health. The School of Public Health rec¬ 
ognized her in June 2001 by naming 
her to its Alumni Public Service Honor 
Roll. She also earned her doctorate in 
education from Columbia University. 
Now, in her spare time, Trowell- 
Harris attends the nationally known 
Mount Olive Baptist church in Arlington, 
Va., plays racquetball and rides on the 
bike trails near her suburban Virginia 
home. She was married for a decade, 
divorcing in 1983, and has no children, 
but she has helped 14 of her 32 nieces 
and nephews pay for college. At the 
family reunions she organizes every 
three years, she tells them to stay in 
touch, to keep their lives in balance and 
to keep learning. She advises them 
“to turn obstacles into steppingstones” 
and that persistence pays off. One of 
her stories illustrates this: early in her 
career in the Guard, a chief nurse 
warned her that she’d never make it 
past major, “no matter how good I 
was. I just thanked her and said ‘OK.’” 
She went four ranks beyond major, to 
major general. 
“Why do you think I have worked so 
hard within the system?" she asks. “To 
get it changed.” 
—Cathy Shujro 
‘‘Population doctor” applying 
tools of genomics in 
quest for prevention strategies 
Seven years after his graduation, 
Gualberto Ruano, ph.d. ’92, m.d. ’97, 
isn’t content to treat one patient at a 
time. Instead he is continuing a long¬ 
term effort to personalize medicine 
through a population approach. “I 
really think of myself as treating the 
world,” he said. 
From 1992 to 1996, Ruano was 
chief scientific officer and then CEO at 
BIOS Laboratories, a New Haven-based 
company that manufactured and sold 
genetics research products. Then, in 
1997, he founded Genaissance Pharma¬ 
ceuticals, a personalized medicine 
company that uses genomic data to 
guide drug-discovery strategies. Led by 
Ruano as ceo, Genaissance went pub¬ 
lic in 2000, and the company is still 
operating at Science Park in New 
Haven, but Ruano decided the time 
was right for a shift in focus—away 
from treatment and toward prevention. 
Last autumn Ruano launched Geno- 
mas, a company that will market 
diagnostic systems using genetic and 
physiological markers to assess nonphar- 
macological strategies for improving 
patient health. Ruano predicts that pre¬ 
vention of obesity will be the first signifi¬ 
cant application of this technology. 
“It’s time to look at prevention with 
the same level of seriousness as we 
think of drugs,” he said. “Everyone 
knows that prevention is good, but the 
results have been very mixed at best. ... 
Now the obesity epidemic will force 
us in the medical profession to apply 
cutting-edge science to develop strate¬ 
gies to optimize prevention.” 
The goal of Genomas is to apply 
genomic technologies to understand¬ 
ing the way genes influence patients’ 
responses to diet, nutrition, exercise 
and environmental exposures. The 
first step is to conduct research that 
will be as exacting and scientifically 
based as the controlled clinical trials 
that are required when new drugs are 
developed. “We have to find out what 
the genetic markers are and evaluate 
them,” Ruano said. At this point 
Genomas has a handful of employees 
and is self-funded, but it has licensed 
research findings in exercise genetics, 
and in June it became a bricks-and- 
mortar entity. Ruano and Hartford 
Hospital announced a collaboration 
to explore the role of genetics in the 
ways people lose weight and respond 
to exercise. As part of their collabo¬ 
ration Genomas moved into office and 
laboratory space at the hospital. 
Ruano’s aim is nothing short of cre¬ 
ating an operating system for health 
care of the future. “The more we can 
customize care based on dna, the 
more we can use our understanding of 
genomics to improve life and create 
new industries.” But he’s not stopping 
there. The next step, he said, is mental 
health. “Psychology is also influenced 
by the variability in people’s genes, but 
stay tuned. That’s for the next story.” 
—Jennifer Kaylin 
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Steven Scheinman Nicholas Spinelli and Viola Spinelli Sanford Cockerell David Morton John Kelly Jr. 
Alumnus named dean 
at suNY Upstate 
STEVEN J. SCHEINMAN, M.D. ’77, 
HS ’80, FW ’84, professor of medi¬ 
cine and pharmacology and chief 
of nephrology at the State Univer¬ 
sity of New York Upstate Medical 
University, has been named execu¬ 
tive vice president and dean of 
the College of Medicine. 
Scheinman’s research on 
the genetics of kidney disease, 
with a focus on kidney stones, 
has been funded by the National 
Institutes of Health since 1985. 
He has been listed in Best Doctors 
in America and Who’s Who in 
America. Scheinman, who joined 
the faculty at the upstate medical 
school in 1984, is the school’s 21st 
dean since its founding in 1834 
as Geneva Medical College. 
Brother and sister 
honored by Bridgeport 
Hospital 
Two Yale alumni were among six 
individuals honored for their sup¬ 
port of Bridgeport Hospital at a 
recent celebration of its 125th 
anniversary. Throughout his career 
NICHOLAS P.R. SPINELLI, M.D. 
’44, has improved the lives of 
thousands as a physician in pri¬ 
vate practice, on staff and later as 
director of medical education at 
Bridgeport Hospital, and as direc¬ 
tor of the School of Medicine’s 
alumni affairs office. His sister, 
VIOLA J. SPINELLI, M.P.H.’65, 
began as a research assistant 
at Yale, went on to manage her 
brother’s medical practice and 
became an associate administra¬ 
tor, senior vice president and 
chief operating officer of Bridge¬ 
port Hospital. 
1930s 
Albert W. Diddle, M.D. ’36, pro¬ 
fessor and chair emeritus of 
obstetrics and gynecology at the 
University of Tennessee Memorial 
Research Center and Hospital, 
is a life fellow of the American 
Gynecological and Obstetrical 
Society. He is also a member of 
the Central Association of 
Obstetricians and Gynecologists, 
the Continental Gynecological 
Society and Sigma Xi,The 
Scientific Research Society. 
1940s 
Sanford F. Cockerell, M.D. ’45, of 
Independence, Mo., retired in 
2000 from his pediatric practice 
after 50 years. His son, Charles, 
and daughter, Michele, took over 
the practice, which has eight 
other physicians, two nurse 
practitioners and offices in two 
cities. Cockerell says that his 
activities include racquetball, 
gardening and duck hunting. For 
the past 15 years he has served 
as president of the Independ¬ 
ence Hunting Club, which main¬ 
tains a waterfowl marsh 35 
miles from his home. 
David E. Morton, M.D. ’48, HS ’55, 
who retired from the practice 
of internal medicine in 1993, relin¬ 
quished the post of managing 
partner of the Lake Medical 
Building in Pueblo, Colo., in Janu¬ 
ary. Morton’s first two grand 
children, Hina Kojima and Akemi 
Ozoa, were born in 2003. He still 
travels frequently to Denver to 
visit his daughter, and to Boston, 
Seattle, Japan and Europe. 
1960s 
John J. Kelly Jr., M.D. ’69, HS ’71, 
professor and chair of neurology 
at the George Washington 
University Medical Center in 
Washington, D.C., was named to 
the Brown University Football 
Team of the Decade for the 
1960s. Kelly played varsity foot¬ 
ball at Brown from 1962 through 
1964 as a fullback and line¬ 
backer. He also played varsity 
baseball. He and other team¬ 
mates were honored In Provi¬ 
dence in November, when they 
were introduced during half 
time of the Brown-Penn game 
and at a dinner and reception 
that evening. 
1970s 
H. Steven Moffic, M.D. ’71, pro¬ 
fessor of psychiatry and behav¬ 
ioral medicine at the Medical 
College of Wisconsin, is principal 
investigator for a grant from 
the U.S. Department of Health 
and Human Services for the pro¬ 
vision of marriage enrichment 
services to Milwaukee’s refugee 
community. 
Rebecca A.Taub, M.D. ’78, for¬ 
merly executive Director of 
biology at Bristol-Myers Squibb, 
was named vice president of 
research, metabolic diseases, at 
Hoffmann-La Roche in Nutley, 
N.J., in March. Metabolic dis¬ 
eases, such as diabetes and 
obesity, are a major research 
focus of the company. 
Ross M. Tonkens, M.D. ’74, has 
been appointed global scientific 
head of cardiovascular therapeu¬ 
tics for Quintiles Transnational 
Corp., the world’s largest con¬ 
tract research organization, in 
Research Triangle Park, N.C. 
Tonkens was a cardiologist in 
Beverly Hills before moving to 
Las Vegas, where he founded 
his own clinical research site 
H. Steven Moffic Rebecca Taub 
and started a venture capital 
fund. While in Nevada he also 
served as medical director for 
Intracorp, a Cigna Healthcare 
case management subsidiary, 
and managed several successful 
statewide political campaigns. 
Virginia A. Zakian, PH.d. ’75, the 
Harry C. Wiess Professor in the 
Life Sciences and professor of 
molecular biology at Princeton 
University, has been named to 
the National Advisory General 
Medical Sciences Council. Council 
members, who serve four-year 
terms, perform the second level 
of peer review for research and 
research training grant applica¬ 
tions assigned to the National 
Institute of General Medical 
Sciences. Zakian studies the struc¬ 
ture and replication of eukary¬ 
otic chromosomes, using yeast 
as a model organism. 
1980s 
Michael D. Burg, M.D. ’87, assist¬ 
ant clinical professor of medicine 
at the University of California, 
San Francisco, Fresno’s Medical 
Education Program, is on sab¬ 
batical and serving as the Emer¬ 
gency Medicine Residency 
Program director at the Onze 
Lieve Vrouwe Gasthuis in 
Amsterdam, Netherlands. This 
hospital was the first in that 
country to start an emergency 
medicine residency. 
David Fassler, M.D. ’82, clinical 
associate professor of psychiatry 
at the University of Vermont 
College of Medicine, testified 
before the Psychopharmacologic 
Drugs Advisory Committee of 
the Food and Drug Administra¬ 
tion in February on behalf of the 
American Psychiatric Association 
(apa). Fassler, a trustee of the 
45 
Ross Tonkens Virginia Zakian Mary Ann Cray Eric Nestler Samir Suresh Shah 
APA and vice chair of the Assem¬ 
bly of the American Academy 
of Child and Adolescent Psychia¬ 
try (aacap), addressed the diag¬ 
nosis and treatment of childhood 
and adolescent depression and 
the safety and efficacy of anti¬ 
depressant medication. At the 
request of the American Bar 
Association, he also testified 
before legislatures in Nevada, 
New Hampshire and Wyoming 
on bills to eliminate juvenile 
executions. Fassler helped draft 
and pass the apa and aacap 
position statements on the juve¬ 
nile death penalty, based on sci¬ 
entific evidence concerning 
adolescent brain development. 
David M. Gaba, M.D. ’8o, director 
of the Patient Safety Center 
of Inquiry at the VA Palo Alto 
(Calif.) Health Care System 
and professor of anesthesiology 
at Stanford University, has 
been awarded the 2003 David 
M. Worthen Award for Academic 
Excellence. This award, the 
highest given by the Department 
of Veterans Affairs, recognizes 
outstanding achievements of 
national significance in health 
professions education. 
Mary Ann (Fagan) Gray, PH.D., 
FW ’87, owner of Gray Strategic 
Advisors, which advises public 
and private biotechnology com¬ 
panies, has joined the board 
of Dyax Corporation, a company 
that focuses on antibodies, 
small proteins and peptides as 
therapeutic products for unmet 
medical needs, particularly 
in the areas of inflammation 
and oncology. 
Eric J. Nestler, PH.D. ’82, M.D. ’83, 
the Lou and Ellen McCinley 
Distinguished Chair in Psychiat¬ 
ric Research at the University 
of Texas Southwestern Medical 
Center at Dallas, has been 
named one of 10 recipients of 
the Bristol-Myers Squibb 
Freedom To Discover Grant. 
Nestler will use the unrestricted 
grant to identify molecular 
and cellular changes that drugs 
of abuse produce in the brain, 
and to characterize the genetic 
and environmental factors that 
determine individual differ¬ 
ences in the ability of the drugs 
to produce these changes. 
Edwin Trevathan, M.D., M.P.H., 
HS ’84, professor of neurology 
and pediatrics and director 
of the Pediatric Epilepsy Center 
at Washington University in 
St. Louis, has completed, along 
with his colleagues, studies 
of clinical data used to diag¬ 
nose epilepsy and of outcomes 
of epilepsy surgery among 
children. Trevathan and his co¬ 
investigators are conducting 
population-based surveillance 
and epidemiological studies 
of autism, mental retardation 
and epilepsy among children 
in St. Louis. 
1990s 
Brian G. Cole, M.D., M.P.H. ’95, 
and Yale College alumnus Lucas 
W. Campos, m.d., have launched 
Ivy League Pharmaceutical 
Consultants and Associates in 
Tyrone, Pa.Their mission is to 
produce and interpret sound 
evidence for new pharmaceuti¬ 
cal applications. Cole also has 
practices in Hawaii and New 
York, and occasionally serves as 
a cruise ship doctor in North 
Africa, the Baltics, the Mediter¬ 
ranean, the Caribbean and, most 
recently, the Hawaiian Islands. 
“God has blessed me and I’m 
very grateful!” 
Jeffrey M. Dembner, M.D. ’96, 
has completed his neurological 
surgery training at Stanford 
University Medical Center and 
is now in private practice in 
Newport Beach, Calif Dembner 
is also affiliated with Hoag 
Memorial Hospital Presbyterian. 
Jiyon Lee, M.D. ’96, is in private 
practice at Rye Radiology 
Associates in Rye Brook, N.Y., 
after training at Columbia 
Presbyterian. She and her hus¬ 
band have two children, 
Serena, 3, and Aaron, 15 months 
in March. Lee ran the Philadel¬ 
phia marathon last fall where 
she saw former classmate Eric A. 
Gomes, M.D. ’96, an internist 
in Princeton, N.J. She offers to 
talk with any medical students 
or radiology residents who 
are interested in seeing what a 
private practice environment 
is like in Westchester. 
Jonathan M. Rothberg, M.S., 
M.P.H. ’87, PH.D. ’91, president 
and chief executive officer of 
CuraGen Corporation in Bran¬ 
ford, Conn., was elected in 
February to The National 
Academy of Engineering (nae). 
Rothberg’s membership honors 
his contribution to the applica¬ 
tion of engineering principles to 
the mining of genomic informa¬ 
tion for the discovery and devel¬ 
opment of new drugs. 
Samir Suresh Shah, M.D. '98, is 
completing fellowships in pedi¬ 
atric infectious diseases and 
general pediatrics at the Child¬ 
ren’s Hospital of Philadelphia, 
while working toward his mas¬ 
ter of science degree in clinical 
epidemiology at the University 
of Pennsylvania School of 
Medicine’s Center for Clinical 
Epidemiology and Biostatistics. 
2000S 
Alicia L. Arbaje, m.d. ’00, M.P.H., a 
Robert Wood Johnson Clinical 
Scholar at Johns Hopkins 
Medical Institutions, is focusing 
her research on problems 
related to fragmentation in the 
health care delivery system, in 
particular the difficulties that 
chronically ill patients face. 
Michele Lynn Frascatore, M.M.S. 
’02, and Alan Francis Colwell 
were married on July 12,2003, in 
Waterbury, Conn. Frascatore is a 
physician assistant at Middlesex 
Cardiology in nearby Middle- 
town. Colwell is pursuing a mas¬ 
ter’s degree in environmental 
science at the University of New 
Haven and works for GeoDesign 
in Middlebury as an environ¬ 
mental consultant. 
Rocco Angelo lannucci, M.D. ’02, 
and Alisa Mary Marko were 
married on July 26,2003, in up¬ 
state New York, lannucci is a 
resident in psychiatry at Massa¬ 
chusetts General Hospital/ 
McLean Hospital in Boston. 
Neda N. Pakdaman, M.D. ’00, 
has completed her residency in 
internal medicine at Stanford 
and is now an internist practic¬ 
ing in a multispecialty group. 
Pakdaman was married in 
May 2003. 
SEND alumni news TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
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46 in Memoriam 
Martha Brochin, M.D. ’88, HS ’91, 
died at age 45 on January 22 in 
New Haven. Brochin was a clini¬ 
cal instructor in pediatrics at 
Yale from 1991 until her death. 
She also had a private pediatric 
practice in Hamden, Conn., for 
the past 12 years. 
Jordi Casals-Ariet, M.D., a Yale 
epidemiologist who almost died 
of Lassa fever while seeking 
the virus that causes it, died in 
Manhattan on February 10. 
He was 92. 
Casals-Ariet established a 
taxonomy of more than io,ooo 
viruses. He came to Yale in 1964 
when the Rockefeller Founda¬ 
tion moved its insect-borne 
infections program here. In 1969 
he fell ill after working with 
Lassa virus, a hemorrhagic fever 
virus named for the Nigerian vil¬ 
lage where it was first detected. 
Although Casals-Ariet was saved 
by antibodies taken from a 
nurse who had survived Lassa 
fever in Africa, he stopped his 
research later that year after a 
lab technician on his team died. 
After his retirement from 
Yale in 1981 he worked at the 
Mount Sinai School of Medicine 
in Manhattan. His last paper 
was published in 1998. 
Allan J. Ersley, M.D., who while 
at Yale in the 1950s identified a 
hormone used in a synthetic 
form to treat anemic disorders, 
died on November 12 in Haver- 
ford, Pa. He was 84. 
Ersley was on the faculty of 
Thomas Jefferson University in 
Philadelphia for 43 years. His 
best-known finding occurred in 
1953 when he was working at 
Yale. He found that the rate of 
red blood cell formation in nor¬ 
mal animals increased after 
they were injected with blood 
plasma from rabbits that had 
been made anemic. He deter¬ 
mined that the anemic condi¬ 
tion led to an increase in levels 
of erythropoietin, a hormone 
that helps to generate new 
red blood cells. Years later the 
hormone was isolated from 
blood and genetically engi¬ 
neered to treat chronic anemia 
in chemotherapy patients and 
in people with kidney failure. 
It was also abused by athletes 
who took it to enhance their 
performance. 
Helen A. Forbes, wife of the late 
Thomas R. Forbes, m.d., died on 
October 28 in Hamden, Conn. 
She was 97. 
Forbes came to Yale in 1945 
with her husband, who served 
as the Ebenezer K. Hunt Pro¬ 
fessor of Anatomy and as an 
associate dean of the School of 
Medicine. She was best remem¬ 
bered for organizing weekday 
teas, a tradition that had faculty 
and students mingling over tea 
and snacks prepared by faculty 
wives. She also worked with 
first-year medical students to 
plan the annual variety show, 
Aesculapian Frolic. 
Cornelius P. Frey, M.D., HS ’44, a 
general surgeon and plastic and 
reconstructive surgeon, died on 
January 22. He was 90. 
During his career Frey was 
associated with George 
Washington University Hospital 
and was a member of the 
American Society for Surgery of 
the Hand. From 1949 to 1953 
he was the team doctor for the 
Washington Redskins. 
Richard H. Greenspan, M.D., pro¬ 
fessor emeritus at Yale School of 
Medicine, died on February 28 
after a long illness. He was 78. 
Greenspan graduated magna 
cum laude from Syracuse Univer¬ 
sity College of Medicine in 1948. 
After training at Michael Reese 
Hospital and the University of 
Minnesota and a fellowship 
at the University of Minnesota 
Hospitals, he served as a captain 
in the U.S. Air Force. In i960, 
he came to Yale as an assistant 
professor of radiology. Four 
years later he became professor 
of radiology and chief of chest 
radiology at the University 
of California, San Francisco. 
Returning to Yale in 1973, as pro¬ 
fessor and chair of diagnostic 
radiology, Greenspan served as 
associate dean for clinical affairs 
from 1986 to 1991 and was 
granted emeritus status in 1994. 
He retired from active practice 
in 1999. 
Greenspan was a founding 
member and president of the 
Fleischner Society and president 
of the Association of University 
Radiologists. He was an accom¬ 
plished violinist and a member 
of the board of directors of the 
Neighborhood Music School in 
New Haven. 
Frank D. Law, M.D. ’49, HS ’55, 
died on January 23 in Lewistown, 
Pa. He was 79. 
Law served in the V-12 
Navy, a college training program 
that began in 1943 to meet 
the need for commissioned offi¬ 
cers in World War II. He was a 
member of the First Unitarian 
Church, the American College 
of Surgeons, the Philadelphia 
Academy of Surgery and 
the Philadelphia Committee 
on Trauma. 
Anthony B. Minnefor, M.D., HS 
’65, an authority on infectious 
diseases, died on December 5 
at his home in Morris Plains, N.J. 
He was 66. 
After a fellowship in infec¬ 
tious disease at Johns Hopkins, 
Minnefor Joined the Air Force 
and reached the rank of captain. 
He worked as a pediatrician in 
upstate New York and from 1980 
to 1992 he was director of infec¬ 
tious diseases at St. Joseph’s 
Hospital and Medical Center 
in Paterson, N.J. He lectured 
throughout the United States 
and Europe on infectious 
disease. 
Robert H. Owens, M.D. ’46, died 
on January 15 at the Mayo Clinic 
in Scottsdale, Ariz. He was 81. A 
urologist, Owens practiced medi¬ 
cine for more than 40 years and 
worked with patients at the 
Veterans Administration hospi¬ 
tal in Kansas City, Mo., until 
shortly before his death. 
Elroy R. Peterson, M.D., HS ’46, 
died on October 7 at his home 
in Ames, Iowa. He was 85. 
Peterson served as a physi¬ 
cian in the U.S. Navy during 
World War II, first on a landing 
craft during the Normandy 
invasion and later on an aircraft 
carrier in the Pacific. After the 
war he came to Yale for a resi¬ 
dency in internal medicine, in 
1952 he joined McFarland Clinic, 
a physician-owned multispe- 
ciaity clinic in central Iowa. He 
was a diplomate of the Ameri¬ 
can Board of Internal Medicine 
and a member of the American 
College of Physicians and Alpha 
Omega Alpha. 
James Radcliffe Jr., m.d. ’38, died 
at his home in Fairhaven, Mass., 
on January 27. He was 93. 
Radcliffe served in the Navy 
during World War II and was 
among the first physicians to 
arrive in Luzon in the Philippines 
after Allied forces retook the 
islands. After his honorable dis¬ 
charge as a lieutenant in 1946, 
he became the first board- 
certified specialist in internal 
medicine in New Bedford, Mass. 
He founded the New Bedford 
Diabetes Association and served 
on the personnel board of the 
Fairhaven Visiting Nurse 
Association. He was chief of 
staff at St. Luke’s Hospital in 
New Bedford from 1968 to 1972. 
Richard H. Rapkin, M.D., HS '63, 
vice chair of pediatrics at 
the University of Medicine 
and Dentistry of New Jersey 
(UMDNJ), died of brain cancer 
on November 19. He was 68. 
■ As a captain in the Army 
Medical Corps, Rapkin treated 
children of soldiers at Fort 
I Leonard Wood in Missouri. He 
I taught pediatrics at Rutgers 
I Medical School, which subse- 
! quently merged with New 
I Jersey College of Medicine and 
I. Dentistry to form umdnj. He 
i; was a practicing pediatrician in 
f Somerville and pediatrician at I the Somerset School in Warren 
I for more than 30 years. 
Franklin H. Schaefer, M.D., HS ’49, 
i died on February 2 in Elyria, Ohio, 
|i after a brief illness. He was 83. 
I After serving in the U.S. Army 
Medical Corps during World 
War II, Schaefer trained in pedi¬ 
atric diseases at Yale. In 1955 
he became the first pediatrician 
serving Elyria, where he prac¬ 
ticed medicine until his retire¬ 
ment in 1985. He was a member 
of the Lorain County Medical 
Society and Elyria American 
Legion Post 12. 
Cecil G. Sheps, M.D., M.P.H. ’47, 
professor of social medicine and 
epidemiology and vice chancel¬ 
lor for health affairs at the 
University of North Carolina, 
died at his home in Chapel Hill 
of pneumonia on February 8. 
He was 90. 
Sheps was a founding mem¬ 
ber of the Institute of Medicine 
of the National Academy of 
Sciences and a member of the 
New York Academy of Medicine. 
He was former director of Beth 
Israel hospitals in New York and 
Boston and a professor at 
Harvard Medical School. He also 
taught at the Mount Sinai 
School of Medicine. Sheps served 
with the Royal Canadian Medical 
Corps during World War 11. 
Robert E. Shope, M.D., an author¬ 
ity on infectious diseases and 
professor emeritus in the 
Department of Epidemiology 
and Public Health, died on 
January 19 in Galveston,Texas, 
of complications from a lung 
transplant. He was 74. 
At the time of his death 
Shope was working at the Uni¬ 
versity of Texas Medical Branch 
in Galveston. He went to Texas 
in 1995 after a 30-year career at 
Yale. One of the leading virolo¬ 
gists of his generation, he led or 
participated in investigations 
of Rift Valley fever, Lassa fever, 
Venezuelan hemorrhagic fever, 
yellow fever and other diseases. 
He served as president of the 
American Society for Tropical 
Medicine and Hygiene and 
received the Bailey K. Ashford 
Award, the Richard M. Taylor 
Award, the Walter Reed Medal 
and numerous other prestigious 
awards and citations. 
Shope came to Yale in 1965 
as an assistant professor of pub¬ 
lic health. He was director of 
the Yale Arbovirus Research 
Unit, director of medical educa¬ 
tion and head of the Division of 
Infectious Disease Epidemiology. 
His travels took him to almost 
every part of the world where 
mosquitoes or rodents harbor 
viruses. 
Lawrence C. Sylvia, M.D., HS ’65, 
former medical director of the 
Central Jersey Blood Center, died 
on November 15 at his home in 
Ocean, N.J. He was 70. 
During his career Sylvia held 
faculty appointments at Tufts, 
Yale, Harvard and Hahnemann 
universities. He was director of 
laboratories at Monmouth 
Medical Center in Long Branch, 
N. J. He was also a fellow of the 
College of American Pathologists 
and a member of the National 
Board of Medical Examiners. 
Arthur A.Terrill, AA.D. '48, died 
at age 79 on January 13 at the 
Army Residence Community 
in San Antonio,Texas. A colonel 
in the Marine Corps, Terrill was 
on active duty until 1982. He 
was a diplomate of the Ameri¬ 
can Board of Surgery and a 
fellow of the American College 
of Surgeons. 
William P. Walsh, M.D. ’46, who 
maintained a private medical 
practice in New Bedford, Mass., 
died on December 25 at his 
home. He was 81. 
Walsh served in the Navy 
during World War II. He was a 
member of the American 
Medical Association, the 
Massachusetts Medical Society 
and the New Bedford High 
School Football Fathers Club and 
a former board member of the 
New Bedford Boys & Girls Club. 
Myron E. Wegman, M.D. ’32, HS 
’36, M.P.H., professor and 
dean emeritus of the University 
of Michigan School of Public 
Health, died on April 14 in 
Ann Arbor, Mich., of congestive 
heart failure. He was 95. 
For more than 40 years, 
starting in 1949, Wegman con¬ 
ducted an annual summary 
of vital statistics. The report, 
published every December in 
Pediatrics, the journal of the 
American Academy of Pediatrics, 
is a compendium of govern¬ 
ment records on births, fertility 
rates, infant mortality and other 
data. Wegman was an early pro¬ 
ponent of broad training pro¬ 
grams to modernize maternal 
and child health care.To combat 
infant mortality he taught 
rural doctors about advances in 
pediatrics. Before arriving at 
Michigan, he spent eight years 
with the Pan American Health 
Organization, a regional office 
of the World Health Organiza¬ 
tion. He served as president 
of the American Public Health 
Association, the Association 
of Schools of Public Health and 
the Pan American Health and 
Education Foundation. 
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Early in 2002, Karen M. Schmidt, m.p.h. ’00, described for read¬ 
ers of Yale Medicine her hiv prevention work in Kenya—and 
how it helped her avoid a traffic ticket (See “Moving Beyond 
Fear,” Winter 2002). Later that year she returned to the United 
States to begin working as a consultant. Her subsequent 
assignments took her to the Philippines and Ethiopia. She also 
worked on adolescent reproductive health manuals for pro¬ 
grams in Botswana,Tanzania, Ghana and Uganda. 
In December, a year after her departure from Nairobi, 
she returned to East Africa to work for the Center for Global 
Health and Economic Development, a joint project of the Earth 
Institute at Columbia University and Columbia’s Mailman 
School of Public Health. She plans to spend about a year as a 
technical advisor to the Ministry of Health in Kigali, the capital 
of Rwanda, the site of massacres a decade ago that killed 
between 800,000 and 1 million people. The country is calm, 
Schmidt says, but people refer to “the events of 1994” and 
signs of the genocide remain. "The Parliament building and a 
few others still have bullet holes.” 
Known as the pays des mille collines (land of a thousand 
hills) in French, one of three languages spoken there along 
with English and Kinyarwanda, Rwanda is a tiny, densely popu¬ 
lated countryjust south of the equator. 
“My job is to get people talking and to encourage the 
government to keep moving towards better health care 
financing mechanisms,” says Schmidt. “I work for a project 
called MacroHealth, which is helping countries implement the 
findings of the World Health Organization’s Commission on 
Macroeconomics and Health, and I will be working a bit on the 
Access Project, which helps countries that are applying for 
or have received money from the Global Fund To Fight aids. 
Tuberculosis and Malaria.” 
As often as not, she spends her days overcoming what 
elsewhere might seem like minor obstacles. “Massive amounts 
of money are flowing into health,” she says,“but it’s all ear¬ 
marked for projects, so if the ministry runs out of paper or fuel 
or can’t pay its phone bill, you have to cope.” 
—John Curtis 
The Yale-New Haven 
Medical Center 
“The Yale School of Medicine and 
the Grace-New Haven Community 
Hospital will expand their affili¬ 
ated activities under a new program 
to be known as the ‘Yale-New 
Haven Medical Center.’ Both the 
School and Hospital will retain 
their independent corporate struc¬ 
tures but will embark on a joint 
development program for care of 
patients and for medical research 
and teaching, thus providing 
southern New England with a 
major medical center similar in 
concept to the Columbia- 
Presbyterian Medical Center in 
New York City. 
“The joint announcement of 
the medical center plans was 
made in February by President A. 
Whitney Griswold of Yale and 
President George S. Stevenson of 
the Hospital. They explained that 
the immediate objective of the 
Yale-New Haven Medical Center 
Plan would be the development of 
a program of public relations, fund 
raising promotion, and program 
development. ‘Experience of other 
great medical centers,’they said, 
‘shows that hospital and medical 
school functions and activities 
cannot be separated when pre¬ 
senting programs to the public. 
Strengthening and support of one 
of the partners materially assists 
the other.’ 
“Hiram Sibley has been 
appointed Director of Program 
Development for the new medical 
center. Mr. Sibley is an authority 
on hospital finance and has served 
as Executive Director of the 
Connecticut Hospital Association 
since 1948.” 
\ale Mcdidne 
SUMMER 1979 
Yale Medicine 
Peter Parker; Physician— 
Missionary—Diplomat 
“It has been said that Peter Parker 
opened China at the point of a 
lancet. When he arrived in that far 
country in November of 1834 at the 
age of thirty, after a voyage of 140 
days, it was at a time in history 
when the Chinese were giving scant 
welcome to Western ‘barbarians.’ 
Their culture was viewed with con¬ 
tempt, their commercial ambitions 
with suspicion. But in Peter Parker’s 
lancet they discovered healing and 
relief from many conditions hither¬ 
to considered hopeless, and as 
thousands passed through the hos¬ 
pital he founded in Canton in 1835, 
it might be said that Parker did in 
truth open China in a way never 
achieved by the blasting guns of 
British men-of-war. 
“Parker has been the subject of 
two biographies (G.B. Stevens and 
W.F. Markwick, 1896, and E.V. 
Guiick, 1973) and a number of 
shorter studies—most recently by 
C.G. Roland and J.O. Key (1978) and 
Peter Pitt {1971) and earlier, several 
by members of the Yale faculty: 
Samuel C. Harvey, Charles J. 
Bartlett, Eugene M. Blake, Harvey 
Cushing, the Rev. Kenneth S. 
Latourette, Levin W. Waters, and 
others interested in him as ‘initia¬ 
tor of modern medicine in China,’ 
‘the founder of modern medical 
missions,’ ‘Yale’s first ophthalmolo¬ 
gist,’ and Commissioner to the 
Chinese Empire, for in addition to 
distinguished service as physician 
and missionary, he represented the 
United States officially in his later 
years in fostering friendship and 
understanding between the two 
nations. This article will focus on 
Parker the diplomat.” 
-o 
c 
n 
“O OJ 
Specialties 
Anesthesiology 
Child Study Center 
Dermatology 
Diagnostic Radiology 
Genetics 
Internal Medicine 
Laboratory Medicine 
Neurology 
Neurosurgery 
Obstetrics and 
Gynecology 
Ophthalmology 
Orthopaedics and 
Rehabilitation 
re i 
S Q- 
(Z (0 
<U 
- 5 « -s 
^ o a! 
E 01 CQ 
I 8 c 2 
I s = S 
h: .E “ 
Pathology 
Pediatrics 
Psychiatry 
Surgery 
peutic Radiology 
Yaie Cancer Center 
Innovation. 
Yale Medical Group physicians are responsible for 
the development of many treatment breakthroughs 
that improve the lives of patients. 
Excellence. 
Year after year, Yale Medical Group physicians 
are recognized as leaders in their fields — 
regionally and nationally. 
Compassion. 
Yale Medical Group physicians are dedicated 
to a respectful, caring, individual approach 
to patient care. 
For more information about our physicians or programs please visit: 
www.yalemedicalgroup.org or to find a Yale physician, call: 
1-877 YALEMDS (925-3637). 
Primary Care 
Yale Internal Medicine 
Associates 
The Yale Medical Group, consisting of the full-time faculty of the Yale University School of Medicine, 
is one of the largest academic group practices in the United States, with over 100 specialty and 
subspecialty areas. 
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